Multi-centre study of neuroanatomical abnormalities in individuals at Ultra High Risk of Psychosis by Tognin, Stefania
This electronic thesis or dissertation has been 











The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
 
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT                                                                         
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to: 
 Share: to copy, distribute and transmit the work  
 
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any 
way that suggests that they endorse you or your use of the work).  
 Non Commercial: You may not use this work for commercial purposes. 
 No Derivative Works - You may not alter, transform, or build upon this work. 
 
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 













Download date: 06. Nov. 2017
	   1	  
	  
	  
Multi-­‐centre	  study	  of	  neuroanatomical	  abnormalities	  in	  




Institute	  of	  Psychiatry,	  Psychology	  and	  Neuroscience	  
King’s	  College	  London	  
	  
	  
Submitted	  for	  the	  degree	  of	  Doctor	  of	  Philosophy	  






	   2	  
Abstract	  Individuals	  experiencing	  prodromal	  symptoms	  of	  psychosis	  have	  a	  very	  high	  risk	  of	  developing	   the	   disorder	   ranging	   from	   18%-­‐36%	   within	   three	   years	   of	   the	   first	  clinical	   presentation.	   Currently,	   it	   is	   not	   possible	   to	   predict	  which	   individuals	  will	  subsequently	   become	   psychotic	   only	   on	   the	   basis	   of	   their	   presenting	   clinical	  features.	   This	   potentially	   prevents	   the	   selective	   delivery	   of	   specialised	   clinical	  interventions	   to	   those	   individuals	   more	   likely	   to	   develop	   psychosis,	   which	   is	  desirable,	  both	  from	  an	  ethical	  point	  of	  view	  and	  for	  a	  more	  targeted	  use	  of	  available	  treatments.	   Neuroimaging	   may	   aid	   prediction	   as	   recent	   neuroimaging	   studies	  suggest	   that	   there	   are	   neuroanatomical	   differences	   in	   people	   at	   ultra	   high	   risk	  (UHR)	   for	  psychosis	   relative	   to	  healthy	   control	   subjects.	   Furthermore,	  within	  UHR	  cohorts,	   those	   who	   later	   develop	   a	   psychotic	   disorder	   (UHR-­‐T,	   transition)	   often	  show	   more	   marked	   structural	   alteration	   than	   those	   that	   do	   not	   (UHR-­‐NT,	   non-­‐transition).	  However	  the	  findings	  have	  been	  inconsistent	  and	  this	  may	  partly	  reflect	  the	   use	   of	   small	   samples	   and	   different	   analytic	  methods.	   The	   aim	   of	   this	   doctoral	  project	   was	   to	   assess	   brain	   structure	   in	   individuals	   at	   UHR	   of	   psychosis	   using	   a	  larger	   sample	   than	   in	   previous	   studies.	   This	  was	   achieved	  by	   combining	  Magnetic	  Resonance	  Imaging	  (MRI)	  data	  from	  four	  different	  scanning	  sites	  and	  using	  a	  range	  of	   different	   analytic	   methods	   including	   voxel-­‐based	   morphometry,	   voxel-­‐based	  cortical	   thickness	   analysis	   and	   multivariate	   machine	   learning.	   The	   use	   of	   these	  methods	  allowed	  a	  comprehensive	  investigation	  of	  neuroanatomical	  differences	  in	  a	  large	   cohort	   and,	   between	   UHR-­‐T	   and	   UHR-­‐NT	   cases	   in	   terms	   of	   i)	   regional	   gray	  matter	  volume;	  ii)	  cortical	  thickness;	  and	  iii)	  subtle	  and	  distributed	  patterns	  of	  gray	  matter	   alterations.	   Findings	   suggest	   that	   there	   are	   neuroanatomical	  abnormalities	   that	  precede	  the	  emergence	  of	  psychosis	  within	  a	  distributed	  fronto-­‐temporal	   network.	   In	   addition,	   UHR	   and	   healthy	   controls	   are	  distinguishable	   at	   the	   individual	   level	   based	   on	   information	   on	   the	   gray	  matter	   volume,	   whereas	   UHR-­‐T	   and	   UHR-­‐NT	   are	   distinguishable	   at	   the	  individual	   level	   using	   cortical	   thickness	   information.	   Nevertheless,	   the	  accuracies	  reported	  remain	  relatively	  low	  to	  be	  applied	  in	  real-­‐world	  clinical	  settings.	   Results	   from	   this	   project	   contribute	   to	   expanding	   the	   available	  knowledge	  on	  the	  UHR	  population.	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1.	  Introduction	  
1.1.	  Ultra	  High	  Risk	  for	  psychosis	  Psychotic	   disorders	   like	   schizophrenia	   have	   an	   estimated	   annual	  incidence	  of	   between	  9.2	   and	  15.2	  per	  100,000,	   although	   the	   incidence	  rate	   might	   vary	   depending	   on	   geographic	   location	   and	   socio	  demographic	  background	   (Kirkbride,	   Fearon	  et	   al.	   2006,	  McGrath,	   Saha	  et	  al.	  2008,	  van	  der	  Werf,	  Hanssen	  et	  al.	  2014).	  Schizophrenia	  is	  a	  severe	  disabling	   psychotic	   disorder	   that	   affects	   approximately	   1%	   of	   the	  worldwide	  population	  and	  carries	  devastating	  effects	  on	   the	   individual,	  their	  carers	  and	  on	  wider	  society	  (van	  Os	  and	  Kapur	  2009).	  This	  illness	  is	  characterised	  primarily	   by	   positive	   symptoms	   (including	   hallucinations	  and	  delusions),	  negative	  symptoms	  and	  alterations	  of	  volition	  (including	  social	   withdrawal	   and	   lack	   of	   motivation),	   cognitive	   decline	   (including	  difficulties	  in	  memory,	  attention	  and	  executive	  functioning)	  and	  affective	  dysregulation	   (van	   Os	   and	   Kapur	   2009).	   Despite	   several	   advances	   in	  biological	  psychiatry	  over	  the	  past	  half	  a	  century,	  the	  pathophysiology	  of	  schizophrenia	  is	  not	  fully	  understood.	  The	  neurodevelopmental	  model	  of	  psychosis	   postulates	   that	   the	   illness	   is	   the	   end	   state	   of	   abnormal	  neurodevelopmental	  processes	  that	  started	  years	  before	  the	  illness	  onset	  (Murray	  and	  Lewis	  1987,	  Weinberger	  1987,	  Rapoport,	  Giedd	  et	  al.	  2012).	  In	  line	  with	  this	  model,	  there	  is	  increasing	  interest	  in	  the	  initial	  phases	  of	  psychotic	   illness	   and	  particularly	   the	   phase	   that	   precedes	   the	   first	   full-­‐blown	  psychotic	  episode.	  A	  better	  understanding	  of	  early	  and	  prodromal	  phases	  may	   help	   identify	   factors	   associated	   with	   vulnerability	   and	   the	  development	  of	  psychosis.	  	  
	  The	  first	  psychotic	  episode	  typically	  arises	  around	   late	  adolescence	  and	  early	   adulthood	   (Hafner,	   Maurer	   et	   al.	   1993,	   Kirkbride,	   Fearon	   et	   al.	  2006).	   The	   period	   that	   precedes	   the	   first	   psychotic	   episode	   is	  retrospectively	   called	   the	   “prodromal	   phase”.	   During	   this	   phase,	  which	  can	  last	  days,	  months	  or	  even	  years,	  the	  individual	  usually	  experiences	  a	  progressive	  decline	  in	  social	  and	  occupational	  functioning	  together	  with	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the	   emergence	   of	   attenuated	   psychotic	   symptoms	   (Yung,	   Phillips	   et	   al.	  2004).	  The	  symptoms	  experienced	  by	  these	  individuals	  are	  qualitatively	  similar	   to	   those	   experienced	   by	   patients	   with	   psychosis	   although	   they	  are	  less	  severe	  and	  less	  frequent.	  Individuals	  in	  this	  stage	  are	  said	  to	  have	  an	  “at	  risk	  mental	  state”	  (ARMS)	  and	  therefore	  to	  be	  at	  “ultra	  high	  risk”	  (UHR)	  of	  developing	  psychosis	  (Yung,	  Phillips	  et	  al.	  1998,	  Yung,	  Phillips	  et	  al.	  2004).	  Not	  all	  individuals	  presenting	  with	  these	  characteristics	  will	  develop	   a	   psychotic	   disorder.	   Results	   from	   a	   recent	   meta-­‐analysis	  suggest	   that	   only	   about	   18%-­‐36%	   of	   UHR	   populations	   will	   develop	   a	  psychotic	   disorder	   within	   three	   years	   of	   the	   first	   clinical	   presentation,	  while	  the	  remainder	  will	  not	  (Fusar-­‐Poli,	  Bonoldi	  et	  al.	  2012).	  	  	  In	   the	   past	   two	   decades	   increased	   research	   efforts	   have	   been	   directed	  towards	  the	  study	  of	  the	  prodromal	  phase	  that	  precedes	  the	  first	  episode	  of	   full-­‐blown	   psychotic	   illness.	   This	   phase	   is	   of	   particular	   interest	   as	   it	  offers	  a	  unique	  window	  to	  explore	   the	  mechanisms	  underlining	  disease	  onset	   in	   the	   absences	   of	   confounding	   factors	   such	   as	   antipsychotic	  medication	  and	  illness	  chronicity.	  In	  particular,	  investigations	  during	  the	  prodromal	   phase	   can	   identify	   potential	   biomarkers	   and	   factors	  associated	  with	  illness	  progression.	  These	  data	  could	  one	  day	  be	  used	  to	  identify	   those	   individuals	   who	   will	   develop	   a	   psychotic	   disorder	   and	  those	  who	  will	  not	  when	   they	   first	  present	   to	   the	  clinical	   services.	  This	  would	  allow	  a	  more	  efficient	  use	  of	  the	  clinical	  resources	  available	  within	  early	   intervention	   services	   for	   psychosis.	   Moreover,	   there	   is	   now	  compelling	   evidence	   that	   antipsychotic	   medication,	   in	   addition	   to	   the	  well-­‐known	   side	   effects,	   may	   also	   have	   a	   long-­‐term	   impact	   on	   brain	  structure	   (Ho,	  Andreasen	  et	  al.	  2011)	  and	   function	   (Fusar-­‐Poli,	  Broome	  et	  al.	  2007).	  This	  provides	  an	  additional	  ethical	  need	  for	  trying	  to	  identify	  individuals	   that	   will	   and	   will	   not	   develop	   the	   disorder	   at	   the	   earliest	  possible	   stage.	   Identifying	   biological	   markers	   that	   can	   predict	   the	  transition	   to	   psychosis	   is	   also	   important	   in	   light	   of	   the	   recent	  development	   of	   the	   staging	  model	   (McGorry,	   Purcell	   et	   al.	   2007,	   Agius,	  Goh	  et	  al.	  2010).	  Specifically,	  the	  identification	  of	  such	  biomarkers	  would	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allow	   a	   more	   accurate	   definition	   of	   the	   different	   stages	   of	   risk	   and	  therefore	  would	  allow	  for	  more	  targeted,	  earlier,	  safer	  and	  more	  effective	  intervention	   (McGorry,	   Purcell	   et	   al.	   2007).	   Stage-­‐specific	   interventions	  might	  prevent	  or	  delay	   the	  progression	   to	  a	   later	   stage	  or	   facilitate	   the	  regression	  to	  an	  earlier	  stage.	  	  	  Two	   approaches	   have	   been	   adopted	   to	   define	   individuals	   at	   increased	  risk	   for	   psychosis:	   genetically,	   due	   to	   a	   positive	   family	   history	   of	  psychosis	  (e.g.	  Edinburgh	  High	  Risk	  Study	  (Hodges,	  Byrne	  et	  al.	  1999))	  or	  clinically	  due	   to	   the	  presence	  of	  psychotic-­‐like	   symptoms	   (e.g.	  Personal	  Assessment	   and	   Crisis	   Evaluation	   -­‐	   PACE	   -­‐	   clinic	   in	   Melbourne,	   (Yung,	  Yuen	  et	  al.	  2005)).	  Both	  approaches	  have	  been	  successfully	  used	   in	   the	  past	  two	  decades,	  however,	  the	  genetic	  high-­‐risk	  approach	  appears	  only	  to	  identify	  a	  relatively	  small	  (10-­‐20%)	  proportion	  of	  individuals	  that	  will	  go	  on	   to	  develop	  psychosis	   and	   it	   is	   associated	  with	   a	  potentially	   large	  time	   gap	   between	   the	   subject	   entry	   to	   the	   study	   and	   the	   transition	   to	  psychosis	   (Johnstone,	   Ebmeier	   et	   al.	   2005).	   The	   clinical	   high-­‐risk	  approach	   focuses	   on	   the	   presence	   of	   attenuated	   positive	   symptoms	   of	  psychosis	   and	   does	   not	   require	   the	   presence	   of	   genetic	   vulnerability	  although	  this	  is	  included	  among	  the	  screening	  criteria	  (Yung,	  Yuen	  et	  al.	  2005).	  The	  advantage	  of	  this	  approach	  is	  the	  relatively	  higher	  number	  of	  expected	  transitions	   to	  psychosis.	  The	   first	  studies	   that	  employed	  these	  criteria	  reported	  transition	  rates	  of	  40%	  at	  6	  months	  (Yung,	  Phillips	  et	  al.	  1998);	  40.8%	  (Yung,	  Phillips	  et	  al.	  2003)	  and	  34.6%	  (Yung,	  Phillips	  et	  al.	  2004)	   at	   one-­‐year	   follow-­‐up.	   However,	   transitions	   rates	   seem	   to	   have	  decreased	   since	   these	   initial	   studies.	   A	   recent	   meta-­‐analysis	   estimated	  that	   the	  average	  rate	   for	   transition	  was	  18%	  after	  6	  months,	  22%	  after	  one	  year	  and	  up	   to	  36%	  after	  3	  years	   (Fusar-­‐Poli,	  Bonoldi	   et	   al.	   2012).	  Several	  reasons	  have	  been	  suggested	  to	  explain	  the	  decrease	  in	  transition	  rate.	  With	   the	   increased	  awareness	  around	   the	  high	  risk	  syndrome	  and	  availability	  of	  early	  intervention	  services	  it	  is	  plausible	  that	  the	  decrease	  in	   transition	   rates	   might	   be	   due	   to:	   i)	   a	   reduction	   in	   the	   duration	   of	  untreated	   symptoms	   in	   patients	   prior	   to	   receiving	   help	   and	   therefore	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improved	  long-­‐term	  outcome,	  ii)	  an	  improvement	  in	  the	  effectiveness	  of	  treatments	   provided,	   or	   iii)	   more	   “not	   truly”	   at-­‐risk	   individuals	   being	  included	   increasing	   the	  number	  of	   false	  positives	   (Yung,	  McGorry	   et	   al.	  2007).	  	  Two	  main	  sets	  of	  criteria	  have	  been	  used	  to	  define	  the	  clinically	  high-­‐risk	  individuals:	  the	  “at	  risk	  mental	  state”	  (ARMS)	  or	  “ultra	  high	  risk”	  (UHR)	  and	  the	  “basic	  symptoms”	  (BS)	  criteria.	  The	  UHR	  criteria	  mainly	  focus	  on	  attenuated	  positive	  symptoms	  and	  presumably	  identify	  individuals	  in	  the	  “late”	   prodromal	   phase.	   The	   basic	   symptoms	   criteria	   mainly	   focus	   on	  phenomenological	   disturbances	   that	   are	   usually	   present	   at	   very	   early	  stages	   prior	   to	   the	   onset	   of	   psychosis	   and	   presumably	   identify	  individuals	  in	  an	  “early”	  prodromal	  phase	  (Schultze-­‐Lutter,	  Klosterkotter	  et	   al.	   2014).	   The	   UHR	   inclusion	   criteria	   represent	   a	   combination	   of	  genetic/trait	  and	  state	  risk	  factors	  and	  they	  require	  the	  presence	  of	  one	  or	   more	   of	   the	   following:	   attenuated	   psychotic	   symptoms	   (APS),	   brief	  limited	   intermittent	   psychotic	   symptoms	   (BLIPS)	   lasting	   up	   to	   seven	  days	   and	   resolving	   spontaneously,	   without	   the	   use	   of	   antipsychotic	  medication,	   or	   trait	   vulnerability	   (family	   history	   or	   schizotypal	  personality)	  plus	  a	  marked	  decline	  (i.e.	  30%)	  in	  psychosocial	  functioning	  over	   the	   past	   12	   months	   (Genetic	   Risk	   and	   Deterioration	   Syndrome:	  GRD),	   (Yung,	  Yuen	  et	  al.	  2005).	   In	  particular,	  UHR	   individuals	  can	  meet	  the	  GRD	  criteria	  either	  because	  of	  a	  positive	  family	  history	  for	  psychosis	  or/and	   because	   they	   meet	   criteria	   for	   having	   schizotypal	   personality	  disorder	   (Yung,	   Yuen	   et	   al.	   2005).	   A	   number	   of	   studies	   investigating	  vulnerability	   to	   psychosis	   have	   indeed	   focused	   on	   patients	   with	  schizotypal	  personality	  disorder	  (SPD)	  but	  also	  healthy	  individuals	  with	  high	   levels	   of	   psychometric	   schizotypy	   (Raine,	   Reynolds	   et	   al.	   1994,	  Raine,	  Lencz	  et	  al.	  2002,	  Modinos,	  Mechelli	  et	  al.	  2010,	  Ettinger,	  Mohr	  et	  al.	  2015).	  Individuals	  with	  SPD	  or	  high	  level	  of	  psychometric	  schizotypy	  are	   thought	   to	   share	   genetic,	   phenomenological	   and	   cognitive	   features	  with	   patients	   with	   schizophrenia,	   although	   the	   observed	   deficits	   are	  milder	   than	   those	   in	   patients	   (Raine,	   Reynolds	   et	   al.	   1994,	   Siever,	  
	   14	  
Koenigsberg	   et	   al.	   2002,	   Ettinger,	  Mohr	   et	   al.	   2015).	  Although	   the	  UHR	  and	  schizotypy	  constructs	  partially	  overlap,	  individuals	  with	  SPD	  or	  high	  level	  of	  psychometric	  schizotypy	  seem	  to	  be	  associated	  with	  a	  relatively	  lower	   transition	   rate	   (i.e.	   around	  5%,(Chapman,	  Chapman	  et	   al.	   1994))	  compared	   to	   UHR	   individuals	   (Fusar-­‐Poli,	   Bonoldi	   et	   al.	   2012).	   In	  addition	   when	   screening	   individuals	   with	   psychometric	   schizotypy	   or	  SPD	  there	  is	  no	  age	  restriction	  as	  there	  is	  with	  clinically	  UHR	  individuals	  (i.e.	  around	  35	  years	  old,	  (Yung,	  Phillips	  et	  al.	  1998)).	  Individuals	  have	  to	  meet	  at	   least	  one	  of	   the	  UHR	  criteria	  during	  the	  12	  months	  prior	  to	  the	  screening	  assessment.	  On	  the	  other	  hand,	  basic	  symptoms	  are	  subjective	  disturbances	   of	   thought	   processing,	   language	   and	   attention	   that	   are	  distinct	   from	   classical	   positive	   psychotic	   symptoms,	   in	   that	   they	   are	  independent	   of	   abnormal	   thought	   content	   (Schultze-­‐Lutter	   2009).	   The	  different	   instruments	   for	   the	   screening	   of	  UHR	   individuals	   used	   by	   the	  four	  centres	  involved	  in	  this	  study	  will	  be	  discussed	  in	  details	  in	  Chapter	  2	  (Table	  2.1	  and	  section	  2.2.).	  	  
	  There	   are	   several	   challenges	   that	   complicate	   the	   identification	   of	  individuals	   at	   ultra	   high	   risk	   for	   psychosis.	   In	   particular,	   prodromal	  symptoms	   overlap	   considerably	  with	   other	   psychiatric	   conditions	   such	  as	   bipolar	   disorder	   (Ellison-­‐Wright	   and	   Bullmore	   2010),	   personality	  disorders	  (Nitzburg,	  Malhotra	  et	  al.	  2014,	  Tschoeke,	  Steinert	  et	  al.	  2014),	  but	   also	   with	   psychotic-­‐like	   experiences	   that	   might	   occur	   in	   the	   non-­‐psychiatric	  population	  (van	  Os,	  Hanssen	  et	  al.	  2000,	  van	  Os,	  Linscott	  et	  al.	  2009).	   The	   prevalence	   of	   psychotic-­‐like	   symptoms	   in	   the	   general	  population	   is	  estimated	   to	  be	  around	  5%	  (van	  Os,	  Linscott	  et	  al.	  2009).	  This	   means	   that	   the	   majority	   of	   people	   reporting	   psychotic-­‐like	  experiences	   do	   not	   go	   on	   to	   develop	   symptoms	   that	   require	   clinical	  interventions	   (van	   Os	   et	   al.,	   2009).	   For	   some	   individuals,	   however,	  psychotic-­‐like	   experiences	   may	   gradually	   increase	   in	   severity	   and	  frequency	   and	   become	   associated	   with	   distress,	   particularly	   in	   the	  context	   of	   mood	   and	   anxiety	   disturbances	   (Fusar-­‐Poli,	   Nelson	   et	   al.	  2014).	  To	  date,	   it	   is	   not	  possible	   to	   identify	   individuals	  who	  will	   go	  on	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and	  develop	  frank	  psychosis	  based	  only	  on	  clinical	  observations.	  A	  recent	  study	  provides	  further	  evidence	  supporting	  the	  observation	  that	  clinical	  impression	   is	   insufficient	   for	   predicting	   psychosis	   outcome	   (Nelson	  2010).	   Therefore,	   it	   is	   critical	   to	   develop	   alternative	   tools	   that	   may	  inform	   clinical	   assessment,	   particularly	   the	   identification	   of	   ultra	   high	  risk	   individuals	   that	   are	   most	   likely	   to	   develop	   psychosis,	   remain	  functionally	  impaired	  and/or	  show	  symptoms	  progression	  overtime.	  The	  importance	   is	   twofold;	   first,	   it	   would	   allow	   a	   more	   efficient	   use	   of	  psychological	   and	   pharmacological	   treatments	   in	   the	   UHR	   population;	  second,	   it	  would	  shed	  light	  on	  the	  neurobiological	  changes	  that	  precede	  frank	  psychosis.	  	  
1.2.	  Structural	  brain	  abnormalities	  in	  UHR	  for	  psychosis	  As	  mentioned	  above,	   to	  date	   it	   is	  not	  possible	  to	  distinguish	   individuals	  who	   will	   subsequently	   develop	   psychosis	   only	   based	   on	   their	   clinical	  presentation.	  Neuroimaging	  offers	  a	  promising	  translational	  tool	  for	  the	  characterization	   of	   brain	   abnormalities	   in	   individuals	   at	   UHR	   for	  psychosis	   and	   of	   the	   potential	   biomarkers	   that	   might	   allow	   the	  identification	   of	   individuals	   who	   will	   go	   on	   to	   develop	   psychosis.	  Consistent	  with	  this	  notion,	  a	  growing	  number	  of	  studies	  using	  structural	  Magnetic	   Resonance	   Imaging	   (MRI)	   have	   identified	   neuroanatomical	  differences	   between	   individuals	   at	   UHR	   and	   healthy	   controls,	   and	  between	  UHR	  who	   subsequently	   did	   and	   did	   not	   develop	   psychosis.	   In	  the	  following	  sections	  an	  overview	  of	  the	  neuroimaging	  studies	  in	  UHR	  is	  provided.	  	  
1.2.1.	  Gray	  matter	  abnormalities	  in	  UHR	  for	  psychosis	  compared	  to	  
healthy	  controls	  	  Structural	  MRI	  has	  revealed	  a	  number	  of	  neuroanatomical	  differences	  at	  first	  clinical	  presentation	  between	  UHR	  individuals	  and	  healthy	  controls.	  In	  whole-­‐brain	  voxel-­‐based	  morphometry	   (VBM)	  studies,	  UHR	  subjects,	  regardless	   of	   clinical	   outcome,	   showed	   reduced	   gray	  matter	   volume	   in	  the	   frontal	   lobe	   and	   lateral	   (Meisenzahl,	   Koutsouleris	   et	   al.	   2008)	   and	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medial	   temporal	   regions	   (Borgwardt,	   Riecher-­‐Rossler	   et	   al.	   2007,	  Meisenzahl,	   Koutsouleris	   et	   al.	   2008).	   Studies	   that	   used	   a	   region	   of	  interest	   (ROI)	   approach	   reported	   both	   gray	   matter	   volume	   increases	  (Buehlmann,	  Berger	  et	  al.	  2010)	  and	  reductions	  (Phillips,	  Velakoulis	  et	  al.	  2002)	   in	   the	  hippocampus,	   reductions	   in	   the	  planum	  polare/temporale,	  insula	   and	   superior	   temporal	   gyrus	   (Takahashi	   et	   al.	   2009,	   2010),	  increases	  in	  the	  pituitary	  volume	  (Garner,	  Pariante	  et	  al.	  2005,	  Buschlen,	  Berger	  et	  al.	  2011),	  and	  reductions	  in	  the	  anterior	  cingulate	  cortex	  (ACC)	  (Rothlisberger,	  Riecher-­‐Rossler	  et	  al.	  2012)	  in	  the	  UHR	  group	  compared	  to	   healthy	   controls.	   However,	   other	   ROI	   studies	   did	   not	   find	   any	  significant	  differences	  between	  healthy	  controls	  and	  UHR	  subjects	  in	  the	  medial	   temporal	   lobe	   (Wood,	   Yucel	   et	   al.	   2005,	   Velakoulis,	  Wood	   et	   al.	  2006).	  	  
	  Neuroanatomical	  alterations	   in	  psychosis	  may	  be	  expressed	  not	  only	   in	  terms	  of	  alterations	  in	  gray	  matter	  volume	  or	  density	  but	  also	  as	  changes	  in	   regional	   cortical	   thickness	   (Narr,	  Bilder	   et	   al.	   2005,	  Narr,	   Toga	   et	   al.	  2005,	   Fornito,	   Yucel	   et	   al.	   2008,	   Venkatasubramanian,	   Jayakumar	   et	   al.	  2008,	   Schultz,	   Koch	   et	   al.	   2010)	   and	   the	   degree	   of	   cortical	   thickness	  asymmetry	  (Haller,	  Borgwardt	  et	  al.	  2009).	  In	  line	  with	  this	  notion,	  UHR	  individuals	   have	   reduced	   cortical	   thickness	   in	   the	   prefrontal,	   ACC,	  inferior	   parietal,	   superior	   temporal	   and	   parahippocampal	   cortices	  relative	  to	  healthy	  controls	  (Jung,	  Kim	  et	  al.	  2011).	  A	  more	  recent	  study	  also	   reports	   increased	   cortical	   thinning	   over	   time	   in	   the	   left	   middle	  temporal	   gyrus	   in	   UHR	   individuals	   compared	   to	   healthy	   controls	  (Ziermans,	  Schothorst	  et	  al.	  2012).	  
1.2.2.	  White	  matter	  abnormalities	  in	  UHR	  for	  psychosis	  compared	  to	  
healthy	  controls	  A	   few	  studies	  have	   investigated	  white	  matter	  abnormalities	   in	   the	  UHR	  population	   using	   either	   VBM	   or	   diffusion	   tensor	   magnetic	   resonance	  imaging	   (DTI).	   A	   VBM	   study	   reported	   that	   UHR	   patients	   showed	  significantly	   lower	  white	  matter	   volume	   in	   the	   right	   superior	   temporal	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lobe	  compared	  to	  healthy	  controls	  (Witthaus,	  Brune	  et	  al.	  2008).	  Another	  study	   investigating	   brain	   volumes	   (i.e.	   total	   brain,	   gray	   matter,	   white	  matter,	  cerebellum	  and	  ventricles)	  and	  brain	  density	  reported	  that	  UHR	  individuals	  showed	  a	  smaller	  increase	  in	  total	  white	  matter	  volume	  over	  time	   compared	   to	  healthy	   controls.	   Post	   hoc	   analyses	   indicated	   a	  more	  pronounced	   decrease	   over	   time	   in	   total	   white	   matter	   volume	   in	   UHR	  individuals	  who	  developed	  psychosis	   relative	   to	   controls,	   and	  a	  greater	  decrease	  in	  total	  brain	  volume	  than	  individuals	  who	  were	  not	  psychotic.	  In	  addition,	   the	  same	  authors	  reported	  no	  gray	  or	  white	  matter	  density	  differences	   between	   groups	   at	   baseline,	   follow-­‐up	   or	   over	   time	  (Ziermans,	  Schothorst	  et	  al.	  2012).	  	  With	   respect	   to	  DTI,	   a	  number	  of	   studies	  have	  compared	   individuals	  at	  UHR	   against	   healthy	   controls	   (Peters,	   de	   Haan	   et	   al.	   2008,	   Karlsgodt,	  Niendam	  et	  al.	  2009,	  Peters,	  Schmitz	  et	  al.	  2009,	  Bloemen,	  de	  Koning	  et	  al.	  2010,	  Peters,	  Dingemans	  et	  al.	  2010,	  Carletti,	  Woolley	  et	  al.	  2012,	  von	  Hohenberg,	  Pasternak	  et	  al.	  2014).	  Two	  studies	  reported	  a	  reduction	  of	  fractional	   anisotropy	   (FA),	   an	   index	   of	   white	   matter	   integrity,	   in	   the	  white	  matter	  of	  the	  frontal	  lobe	  (Peters,	  Schmitz	  et	  al.	  2009,	  Bloemen,	  de	  Koning	   et	   al.	   2010),	   while	   another	   found	   a	   reduction	   in	   the	   superior	  longitudinal	   fasciculus	   (SLF)	   (Karlsgodt,	   Niendam	   et	   al.	   2009).	   A	  longitudinal	  DTI	  study	  (Carletti,	  Woolley	  et	  al.	  2012)	  reported	  relatively	  widespread	   reductions	   in	   FA	   the	   splenium	   and	   body	   of	   the	   corpus	  callosum,	   the	   inferior	   and	   SLF,	   the	   inferior	   fronto-­‐occipital	   fasciculus.	  Further	   reductions	   were	   also	   observed	   in	   the	   external	   capsule,	   the	  internal	  capsule	  and	  the	  posterior	  corona	  radiate	  (Carletti,	  Woolley	  et	  al.	  2012).	  Another	  recent	  study	  observed	  increased	  mean	  diffusivity	  (MD),	  a	  measure	   of	   white	   matter	   integrity,	   in	   several	   clusters	   in	   the	   right	  hemisphere	   including	   the	   superior	   longitudinal	   fasciculus,	   posterior	  corona	   radiata,	   and	   corpus	   callosum	   (von	   Hohenberg,	   Pasternak	   et	   al.	  2014).	   The	   authors	   also	   observed	   an	   increased	   radial	   diffusivity	   (RD),	  another	  measure	  of	  white	  matter	  integrity,	  in	  the	  posterior	  parietal	  lobe	  (von	   Hohenberg,	   Pasternak	   et	   al.	   2014).	   Two	   studies	   reported	   no	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significant	  differences	  in	  white	  matter	  between	  UHR	  and	  healthy	  controls	  (Peters,	   de	   Haan	   et	   al.	   2008,	   Peters,	   Dingemans	   et	   al.	   2010).	   The	  observed	   DTI	   results	   seem	   rather	   heterogeneous,	   possibly	   due	   to	  different	   methods	   used,	   such	   as	   tractography	   (Peters,	   de	   Haan	   et	   al.	  2008,	   Peters,	   Dingemans	   et	   al.	   2010),	   voxel-­‐wise	   whole-­‐brain	   spatial	  statistics	   (Peters,	   Schmitz	   et	   al.	   2009,	   Bloemen,	   de	   Koning	   et	   al.	   2010,	  Carletti,	  Woolley	  et	  al.	  2012)	  or	  tract-­‐based	  spatial	  statistics	  (Karlsgodt,	  Niendam	   et	   al.	   2009,	   von	   Hohenberg,	   Pasternak	   et	   al.	   2014);	   and	  differences	  in	  sample	  size.	  	  
1.2.3.	  Gray	  matter	  differences	  in	  UHR-­‐T	  compared	  to	  UHR-­‐NT	  Structural	  MRI	  has	  revealed	  a	  number	  of	  neuroanatomical	  differences	  at	  first	   clinical	   presentation	   between	   individuals	   who	   subsequently	  made	  transition	   to	   psychosis	   (UHR-­‐T)	   and	   those	   who	   did	   not	   (UHR-­‐NT).	   In	  whole-­‐brain	   VBM	   studies,	   UHR-­‐T	   relative	   to	   UHR-­‐NT	   subjects	   showed	  reduced	   gray	  matter	   volume	  of	   the	  medial	   and	   lateral	   temporal	   cortex,	  anterior	   cingulate	   cortex	   (ACC),	   insular,	   inferior	   and	   superior	   frontal	  cortices	   (Borgwardt,	   McGuire	   et	   al.	   2008),	   and	   reduced	   gray	   matter	  density	  of	  the	  left	  temporal	  lobe	  and	  right	  cerebellum	  (Job,	  Whalley	  et	  al.	  2005).	  While	  the	  above	  studies	  used	  a	  cross-­‐sectional	  design,	  a	  number	  of	   investigations	  have	  employed	  a	  within-­‐subject	   longitudinal	  design	   to	  examine	   the	  neuroanatomical	   changes	   that	   occur	   in	   individuals	   at	  UHR	  around	   the	   time	   of	   illness	   onset.	   These	   studies	   report	   progressive	  reductions	  in	  the	  gray	  matter	  volume	  of	  the	  orbitofrontal	  and	  cerebellar	  cortices	  (Pantelis,	  Velakoulis	  et	  al.	  2003,	  Borgwardt,	  McGuire	  et	  al.	  2008),	  fusiform	   and	   parahippocampal	   cortices	   and	   cingulate	   gyrus	   (Pantelis,	  Velakoulis	   et	   al.	   2003);	   superior	   frontal,	   inferior	   temporal,	   superior	  parietal	  cortices	  and	  precuneus	  (Borgwardt,	  McGuire	  et	  al.	  2008)	  in	  UHR-­‐T	  compared	  to	  UHR-­‐NT.	  
	  In	   addition,	   VBM	   studies	   employing	   an	   ROI	   approach	   indicated	   that	  individuals	   who	   subsequently	   made	   transition	   to	   psychosis	   showed	  reduced	  volume	  in	  the	  bilateral	  insula	  (Takahashi,	  Wood	  et	  al.	  2009)	  and	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the	   left	  ACC	   (Rothlisberger,	   Riecher-­‐Rossler	   et	   al.	   2012),	   and	   increased	  volume	   of	   the	   pituitary	   gland	   (Garner,	   Pariante	   et	   al.	   2005,	   Buschlen,	  Berger	   et	   al.	   2011)	   and	   the	   hippocampus	   (Buehlmann,	   Berger	   et	   al.	  2010).	  A	  recent	  VBM	  investigation	  has	  also	  shown	  that,	  in	  individuals	  at	  UHR	   for	  psychosis,	   lower	   scores	   on	   a	   semantic	   fluency	   task,	  which	   is	   a	  measure	   of	   executive	   functioning,	   are	   associated	   with	   reduced	   gray	  matter	   density	   in	   a	   distributed	   network	   including	   the	   right	  superior/middle	   temporal	   gyrus,	   the	   right	   insula	   and	   the	   left	   ACC,	  suggesting	  that	  the	  combination	  of	  these	  two	  types	  of	  data	  could	  inform	  outcome	   prediction	   in	   this	   population	   (Meijer,	   Schmitz	   et	   al.	   2011).	   In	  addition,	   using	   an	   ROI	   approach,	   within-­‐subject	   studies	   have	   found	  greater	   progressive	   reductions	   in	   the	   gray	  matter	   volume	   of	   the	   insula	  (Takahashi,	  Wood	   et	   al.	   2009),	   planum	   polare,	   planum	   temporale,	   and	  caudal	  region	  (Takahashi,	  Wood	  et	  al.	  2009)	  in	  UHR-­‐T	  compared	  to	  UHR-­‐NT.	  Other	  studies	  found	  a	  decrease	  in	  hippocampal	  volume	  over	  time	  and	  no	  differences	   in	  pituitary	  volume	  both	  at	   the	   follow-­‐up	   time	  point	  and	  over	   time	   in	   individuals	   at	   UHR	   independently	   of	   clinical	   outcome	  (Walter,	  Studerus	  et	  al.	  2012,	  Walter,	  Studerus	  et	  al.	  2014).	  Using	  Cortical	  Pattern	   Matching,	   an	   advanced	   brain	   warping	   technique	   that	   allows	  extracting	  information	  on	  cortical	  gray	  matter	  density	  and	  thickness,	  Sun	  and	  colleagues	  (2009)	  have	  also	  revealed	  brain	  surface	  contraction	  in	  the	  prefrontal	   cortex	   in	   UHR-­‐T	   compared	   to	   UHR-­‐NT	   (Sun,	   Phillips	   et	   al.	  2009).	  With	   regard	   to	   cortical	   thickness,	   UHR-­‐T	   compared	   to	   UHR-­‐NT	  individuals	  presented	  with	  cortical	  thinning	  of	  the	  ACC	  (Fornito,	  Yung	  et	  al.	   2008).	   However,	   a	   few	   ROI	   studies	   did	   not	   find	   any	   significant	  differences	   in	   cortical	   thickness	   between	   individuals	  who	   subsequently	  did	  and	  did	  not	  make	  conversion	  to	  psychosis	  (Yucel,	  Wood	  et	  al.	  2003,	  Velakoulis,	  Wood	  et	   al.	   2006,	  Takahashi,	  Wood	  et	   al.	   2009,	  Buehlmann,	  Berger	   et	   al.	   2010,	   Hannan,	   Wood	   et	   al.	   2010,	   Wood,	   Kennedy	   et	   al.	  2010).	   Finally,	   a	   longitudinal	   study	   investigating	   cortical	   thickness	  reported	   progressive	   thinning	   of	   the	   anterior	   cingulate,	   precuneus	   and	  temporo-­‐parieto-­‐occipital	   cortex	   in	   UHR-­‐T	   compared	   to	   UHR-­‐NT	   and	  healthy	  controls	  (Ziermans,	  Schothorst	  et	  al.	  2012).	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1.2.4.	  White	  matter	  differences	  in	  UHR-­‐T	  compared	  to	  UHR-­‐NT	  	  A	  small	  fraction	  of	  studies	  of	  the	  UHR	  population	  have	  investigated	  white	  matter	  abnormalities	  associated	  with	  transition	  to	  psychosis	  using	  either	  VBM	   or	   DTI.	   Only	   two	   studies	   have	   investigated	   white	   matter	  abnormalities	   in	   UHR	   subjects	   as	   a	   function	   of	   clinical	   outcome	   using	  VBM	  (Walterfang,	  McGuire	  et	  al.	  2008,	  Ziermans,	  Schothorst	  et	  al.	  2012).	  In	  the	  first	  study,	  UHR-­‐T	  subjects	  showed	  increased	  white	  matter	  volume	  in	   the	   left	   frontal	   lobe	   and	   a	   progressive	   decrease	   in	   the	   left	   fronto–occipital	   fasciculus	   (Walterfang,	   McGuire	   et	   al.	   2008).	   In	   the	   second	  study,	  UHR-­‐T	   subjects	   showed	  a	  decrease	   in	   total	  white	  matter	  volume	  relative	   to	   healthy	   controls	   but	   not	   relative	   to	   UHR-­‐NT,	   in	   addition	   to	  which	   the	   comparison	   between	   UHR-­‐NT	   and	   controls	   was	   also	   not	  significant	   (Ziermans,	   Schothorst	   et	   al.	   2012).	   Using	   DTI,	   three	   studies	  have	  subdivided	  the	  UHR	  group	  according	  to	  clinical	  outcome	  (Karlsgodt,	  Niendam	  et	  al.	  2009,	  Bloemen,	  de	  Koning	  et	  al.	  2010,	  Carletti,	  Woolley	  et	  al.	   2012).	   One	   of	   these	   studies	   revealed	   that	   UHR-­‐T	   had	   lower	   FA	   at	  baseline	   compared	   to	   healthy	   controls	   in	   the	   medial	   frontal	   region	  (Bloemen,	  de	  Koning	  et	  al.	  2010).	  In	  addition,	  UHR-­‐T	  had	  lower	  FA	  in	  the	  white	   matter	   lateral	   to	   the	   right	   putamen	   and	   in	   the	   left	   superior	  temporal	  gyrus	  but	  higher	  FA	  in	  the	  left	  posterior	  temporal	  white	  matter,	  compared	  to	  UHR-­‐NT	  (Bloemen,	  de	  Koning	  et	  al.	  2010).	  Finally,	  in	  UHR-­‐T,	  the	   FA	   in	   the	   left	  middle	   temporal	   lobe	  was	  negatively	   associated	  with	  the	  severity	  of	  positive	  symptoms	  (Bloemen,	  de	  Koning	  et	  al.	  2010).	  The	  remaining	   two	   studies	   reported	   no	   cross-­‐sectional	   differences	   in	  white	  matter	  integrity	  between	  UHR-­‐T	  and	  UHR-­‐NT	  (Karlsgodt,	  Niendam	  et	  al.	  2009,	   Carletti,	   Woolley	   et	   al.	   2012).	   	   However,	   Carletti	   and	   colleagues	  (2012)	   reported	   a	   progressive	   FA	   reduction	   in	   the	   left	   frontal	   white	  matter	  in	  UHR-­‐T,	  which	  was	  not	  evident	  in	  UHR-­‐NT	  (Carletti,	  Woolley	  et	  al.	  2012).	  	  
1.3.	  Pattern	  classification	  and	  UHR	  for	  psychosis	  Taken	   collectively,	   the	   above	   studies	   provide	   evidence	   for	   regional	  neuroanatomical	  alterations	  in	  individuals	  at	  ultra	  high	  risk	  for	  psychosis	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relative	  to	  healthy	  controls,	  most	  evidently	  in	  a	  distributed	  network	  that	  includes	  lateral	  and	  medial	  temporal	  structures,	  prefrontal	  and	  cingulate	  regions,	  insula,	  cerebellum,	  frontal	  and	  temporal	  white	  matter.	  It	  should	  be	   noted	   that	   the	   above	   results	   were	   based	   on	   univariate	   statistical	  analyses	  that	  are	  sensitive	  to	  effects	  that	  are	  robust	  and	  clearly	  localised;	  however,	   it	   is	   possible	   that	   neuroanatomical	   changes	   in	   psychiatric	  disorders	   (including	   psychosis)	   may	   be	   subtle	   and	   distributed	  throughout	   the	   brain.	   In	   addition,	   the	   above	   results	   were	   based	   on	  average	   group-­‐differences,	   and	   therefore	   do	   not	   allow	   for	   the	  characterization	   at	   the	   level	   of	   the	   individual.	   In	   day-­‐to-­‐day	   clinical	  practice,	   however,	   the	   clinician	   is	   required	   to	   make	   individual	  assessments	  and	  treatment	  decisions	  about	  individual	  patients.	  In	  recent	  years,	   an	   increasing	   number	   of	   studies	   have	   therefore	   adopted	  alternative	   analytical	   approaches	   based	   on	   multivariate	   machine	  learning	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012,	  Pettersson-­‐Yeo,	  Benetti	  et	  al.	  2013).	   Multivariate	   machine	   learning	   methods	   allow	   one	   to	   make	  predictions	  that	  are	  specific	  to	  a	  given	  individual,	  rather	  than	  providing	  an	  average	  estimate	  for	  a	  group.	  This	  greatly	  increases	  the	  translational	  potential	   of	   the	   results	   in	   a	   real	   word	   clinical	   setting.	   For	   example,	  Support	  Vector	  Machine	  (SMV)	  allows	  for	  the	  simultaneous	  comparison	  of	  all	  brain	  voxels	  with	  the	  advantage	  of	  being	  able	  to	  take	  into	  account	  the	   inter-­‐relationship	   between	   voxels,	   detect	   subtle	   and	   distributed	  differences	   across	   the	   brain	   and	  make	   inference	   at	   the	   individual-­‐level	  (Lao,	   Shen	   et	   al.	   2004,	  Noble	   2006,	  Norman,	   Polyn	   et	   al.	   2006).	  Recent	  studies	  using	  multivariate	  methods	  report	  high	  levels	  of	  accuracy	  in	  the	  prediction	  of	  group	  membership,	  effectively	  distinguishing	  between	  UHR	  and	   healthy	   controls,	   between	   UHR-­‐T	   and	   UHR-­‐NT	   subjects	  (Koutsouleris,	   Meisenzahl	   et	   al.	   2009,	   Koutsouleris,	   Borgwardt	   et	   al.	  2012)	   and	   between	   UHR-­‐T	   and	   first	   episode	   psychosis	   (Borgwardt,	  Koutsouleris	   et	   al.	   2013).	   For	   instance,	   Koutsouleris	   and	   colleagues	  (2009)	   using	   volumetric	   analysis	   of	   structural	   MRI	   have	   successfully	  distinguished	   UHR-­‐T	   group	   from	   HC	   group	   with	   an	   accuracy	   of	   94%,	  UHR-­‐NT	  from	  HC	  with	  an	  accuracy	  of	  86%	  and	  UHR-­‐T	  from	  UHR-­‐NT	  with	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an	  accuracy	  of	  82%	  (Koutsouleris,	  Meisenzahl	  et	  al.	  2009).	  Similar	  results	  from	   an	   independent	   data	   set	   study	   showed	   classification	   accuracy	  respectively	   of	   92.3%	   for	   healthy	   controls	   and	   UHR-­‐T,	   of	   66.9%,	   for	  healthy	   controls	   and	   UHR-­‐NT	   and	   of	   84.2%,	   for	   UHR-­‐T	   and	   UHR-­‐NT	  (Koutsouleris,	  Borgwardt	  et	  al.	  2012).	  The	  same	  authors	  combined	  MRI	  data	   from	   two	   early	   intervention	   services	   and	   transition	   outcome	  was	  correctly	   predicted	   in	   80%	   of	   the	   test	   cases	   (Koutsouleris,	   Riecher-­‐Rossler	   et	   al.	   2014).	   Finally,	   in	   a	   recent	   study,	   UHR-­‐T	   individuals	   have	  been	   successfully	   distinguished	   from	   those	   who	   experienced	   a	   first	  episode	  of	  psychosis	  with	  an	  accuracy	  of	  80%	  (Borgwardt,	  Koutsouleris	  et	  al.	  2013).	  	  	  The	   majority	   of	   the	   studies	   employing	   multivariate	   machine	   learning	  methods	   in	   the	   UHR	   population	   have	   focused	   on	   prediction	   of	   group	  membership	   (e.g.	   UHR/HC)	   or	   clinical	   outcome	   in	   terms	   of	  transition/non-­‐transition	   to	   psychosis.	   However	   follow-­‐up	   studies	   of	  individuals	  at	  UHR	  have	  shown	  heterogeneity	  both	  in	  terms	  of	  symptoms	  progression	   and	   level	   of	   functioning	   independently	   of	   clinical	   outcome	  (i.e.	  transition/non-­‐transition).	  For	  example,	  a	  recent	  study	  reported	  that	  after	   three	   years	   form	   the	   first	   presentation	   about	   75%	   of	   UHR	  individuals	  that	  do	  not	  develop	  a	  psychotic	  disorder	  also	  show	  symptom	  remission	  and	  no	  longer	  meet	  UHR	  criteria.	  Conversley,	  25%	  of	  cases	  still	  present	   with	   sub-­‐threshold	   symptoms	   (Velthorst,	   Nieman	   et	   al.	   2011).	  However,	   another	   study	   reported	   that	   some	   of	   those	   who	   present	  complete	   or	   partial	   symptomatic	   remission	   remain	   at	   a	   lower	   level	   of	  functioning	  when	  compared	  to	  a	  non-­‐psychiatric	  population	  (Addington,	  Cornblatt	   et	   al.	  2011).	  A	   further	   study	   reported	   that	  only	  30%	  of	   those	  who	   do	   not	   develop	   psychosis	   meet	   full	   symptomatic	   and	   functional	  remission	  (Schlosser,	   Jacobson	  et	  al.	  2012).	  Recent	  studies	  have	  applied	  other	  multivariate	  machine	  learning	  techniques	  such	  as	  Relevance	  Vector	  Regression	   (RVR)	   to	   make	   quantitative	   predictions	   of	   a	   variable	   of	  interest	  (i.e.	  patient’s	  score	  on	  a	  clinical	  scale).	  This	  technique	  has	  been	  applied	   in	   several	   neuroimaging	   studies	  of	   healthy	   individuals	   (Franke,	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Ziegler	   et	   al.	   2010,	   Mwangi,	   Hasan	   et	   al.	   2013),	   of	   patients	   with	  psychiatric	   (Mwangi,	   Matthews	   et	   al.	   2012,	   Gong,	   Li	   et	   al.	   2014)	   and	  neurological	   disorders	   (Stonnington,	   Chu	   et	   al.	   2010).	   However,	   this	  technique	  has	  never	  been	  employed	  to	  make	  quantitative	  predictions	  in	  the	  UHR	  population.	  	  	  In	   conclusion,	   to	   date	  multivariate	  machine	   learning	  methods	  provided	  promising	   results	   based	   on	   a	   relatively	   small	   group	   of	   subjects;	   to	  evaluate	   their	   translational	   applicability	   in	   real	   world	   clinical	   settings,	  however,	   more	   evidence	   must	   be	   collected	   in	   a	   larger	   and	   more	  representative	   group	   of	   subjects.	   In	   addition,	   although	   these	   methods	  have	   been	   successfully	   employed	   to	   make	   predictions	   about	   group	  membership	   and	   clinical	   outcome	   in	   people	   at	  UHR	   for	   psychosis,	   they	  have	   yet	   to	   be	   employed	   to	  make	   quantitative	   prediction	   of	   symptoms	  progression	  in	  this	  population.	  	  
1.4.	  Multi-­‐centre	  approach	  for	  the	  study	  of	  UHR	  individuals	  	  Individual	   structural	   imaging	   studies	   often	   report	   contrasting	   findings.	  This	   inconsistency	  might	  be	  partially	  explained	  by	  the	  characteristics	  of	  the	  specific	  samples	  investigated.	  For	  example	  different	  research	  centres	  might	   use	   different	   inclusion	   criteria	   and	   therefore	   have	   relatively	  different	   clinical	   samples.	   Although	   the	   transition	   rate	   associated	   with	  the	  different	  screening	  criteria	   is	  very	  similar	  (Fusar-­‐Poli,	  Bonoldi	  et	  al.	  2012),	   it	   cannot	   be	   excluded	   that	   the	   use	   of	   different	   semi-­‐structured	  interviews	   can	   result	   in	   the	   recruitment	   of	   individuals	   with	   relatively	  distinctive	   clinical	   profiles.	   The	   individuals	   recruited	   using	   different	  diagnostic	  tools	  might	  also	  be	  in	  a	  different	  stage	  of	  risk.	  According	  to	  the	  “early”	  versus	  “late”	  prodrome	  model	  proposed	  by	  the	  German	  Research	  Network	  on	  Schizophrenia	  (GRNS),	  individuals	  meeting	  GRD	  criteria	  and	  subjects	  experiencing	  “basic	  symptoms”	  are	  thought	  to	  be	  at	  a	  lower	  risk	  stage;	  while	  individuals	  meeting	  APS	  and	  BLIPS	  criteria	  are	  thought	  to	  be	  at	   a	   higher	   risk	   stage.	   Consistent	   with	   this	   model,	   in	   a	   recent	   study,	  Nelson	   and	   colleagues	   (Nelson,	   Yuen	   et	   al.	   2011)	   have	   investigated	   the	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different	   degree	   of	   risk	   associated	   to	   the	   UHR	   criteria.	   Based	   on	   this	  study	   UHR	   inclusion	   criteria	   predict	   transition	   over	   six	   months	   in	   the	  order	  of	  GRD	  group	  alone,	  APS	  group	  and	  BLIPS	  group.	  These	  differences	  in	   transition	   risk	   associated	   with	   distinct	   UHR	   criteria	   might	   reflect	  different	   underlying	   neurobiological	   features.	   In	   addition,	   the	   samples	  might	   differ	   in	   age,	   gender,	   genetic	   vulnerability,	   co-­‐morbidities,	  substance	  use	  and	  medication	  use.	  Another	  possible	  source	  of	  variability	  across	   different	   studies	   relates	   to	   the	   relatively	   small	   sample	   size	  (Button,	  Ioannidis	  et	  al.	  2013)	  as	  it	  is	  very	  difficult	  for	  a	  single	  centre	  to	  recruit	   a	   relatively	   large	   number	   of	   UHR	   individuals.	   Sample	   size	   is	   a	  particular	  problem	  for	  the	  comparison	  between	  UHR	  subjects	  who	  later	  develop	   psychosis	   and	   those	   who	   do	   not,	   which	   entails	   a	   further	  subdivision	  of	  the	  UHR	  sample	  according	  to	  clinical	  outcome.	  Lastly,	  past	  studies	   have	   used	   a	   wide	   range	   of	   analytical	   techniques	   to	   investigate	  structural	   abnormalities	   and	   this	   further	   complicates	   results	  comparisons.	  	  	  A	  way	  to	  overcome	  these	  complications,	  to	  improve	  statistical	  power	  and	  the	  generalizability	  of	  the	  results	  is	  to	  use	  a	  multi-­‐centre	  approach,	  with	  the	   pooling	   of	   data	   to	   produce	   a	   relatively	   large	   total	   sample.	   This	  approach,	   which	   has	   been	   successfully	   employed	   in	   neuroimaging	  studies	   of	   other	   CNS	  disorders	   in	  which	   subject	   recruitment	   is	   difficult	  (Nestor,	  Rupsingh	  et	  al.	  2008,	  Stonnington,	  Tan	  et	  al.	  2008),	  was	  used	  in	  the	  present	  doctoral	  work.	  	  
1.5.	  Outline	  and	  objectives	  of	  the	  studies	  
1) Are	   there	   neuroanatomical	   brain	   differences	   between	   UHR	   and	  
healthy	  controls?	  	  My	   first	   objective	   was	   to	   use	   voxel-­‐based	   morphometry	   (VBM)	   and	  voxel-­‐based	   cortical	   thickness	   (VBCT)	   measurements	   to	   test	   whether	  there	  are	  volumetric	  and	  cortical	  alterations	  in	  UHR	  cohorts	  that	  can	  help	  to	  distinguish	  them	  form	  healthy	  controls.	  I	  aimed	  to	  investigate	  whether	  these	   analytical	   techniques	   are	   also	   able	   to	   provide	   complementary	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information	   depending	   on	   the	   underlying	   pathophysiological	  mechanisms.	   This	   part	   of	  my	   doctoral	  work	   is	   described	   in	   Chapters	   3	  and	  4.	  	  
2) Are	  there	  neuroanatomical	  brain	  differences	  between	  UHR-­‐T	  and	  
UHR-­‐NT?	  My	   second	   objective	   was	   to	   use	   VBM	   and	   VBCT	  measurements	   to	   test	  whether	   there	   are	   volumetric	   and	   cortical	   alterations	   that	   can	   help	   to	  distinguish	  between	  UHR-­‐T	  and	  UHR-­‐NT.	  I	  aimed	  to	  investigate	  whether	  these	   analytical	   techniques	   are	   also	   able	   to	   provide	   complementary	  information	   depending	   on	   the	   underlying	   pathophysiological	  mechanisms.	   This	   part	   of	  my	   doctoral	  work	   is	   described	   in	   Chapters	   3	  and	  4.	  
	  
3) Can	  brain	  structure	  information	  be	  used	  to	  aid	  the	  identification	  of	  
UHR	  individuals?	  	  My	   third	   objective	   was	   to	   use	   a	   multivariate	   pattern	   classification	  technique,	   Support	  Vector	  Machine	   (SVM),	   to	   distinguish	   between	  UHR	  and	  HC,	  using	  structural	  imaging	  data	  (i.e.	  volume	  and	  cortical	  thickness).	  This	  part	  of	  my	  doctoral	  work	  is	  described	  in	  Chapter	  5.	  	  
	  
4) Can	  brain	  structure	  information	  be	  used	  to	  aid	  the	  identification	  of	  
those	  individuals	  who	  will	  make	  transition	  to	  psychosis	  (UHR-­‐T)?	  	  My	   fourth	   objective	   was	   to	   use	   a	   multivariate	   pattern	   classification	  technique,	   SVM,	   to	   distinguish	   between	   UHR-­‐T	   and	   UHR-­‐NT,	   using	  structural	   imaging	  data	  (i.e.	  volume	  and	  cortical	  thickness).	  This	  part	  of	  my	  doctoral	  work	  is	  described	  in	  Chapter	  5.	  	  
	  
5) Can	   brain	   structure	   information	   be	   used	   to	   predict	   symptom	  
progression	  in	  UHR	  individuals?	  	  	  My	   fifth	   objective	   was	   to	   use	   a	   multivariate	   pattern	   classification	  technique,	   Relevance	   Vector	   Regression	   (RVR),	   to	   make	   quantitative	  prediction	  of	  symptom	  progression	  in	  UHR,	  using	  structural	  imaging	  data	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(i.e.	   volume	   and	   cortical	   thickness).	   This	   analysis	   was	   performed	   in	   a	  single	  centre	  where	  more	  detailed	   follow-­‐up	   information	  was	  available.	  This	  part	  of	  my	  doctoral	  work	  is	  described	  in	  Chapter	  6.	  	  
2.	  Methods	  
2.1.	  Study	  sample	  In	   the	   past	   two	   decades	   increased	   efforts	   have	   been	   directed	   to	   the	  identification	  of	  the	  individuals	  experiencing	  possible	  prodromal	  signs	  of	  psychosis	   in	   order	   to	   isolate	   factors	   that	   are	   associated	   with	   the	  development	   of	   this	   illness.	   Several	   approaches	   have	   been	   used	   to	  identify	  people	  at	  increased	  risk	  of	  psychosis.	  One	  approach	  has	  applied	  the	   genetic	   risk	   criteria	   identifying	   individuals	   that	   have	   a	   first-­‐degree	  relative	   with	   a	   psychotic	   disorder	   (Hodges,	   Byrne	   et	   al.	   1999).	   This	  approach	  however	   is	  associated	  with	  relatively	   low	  predictability,	   since	  10-­‐20%	   of	   individuals	   who	   meet	   these	   criteria	   go	   on	   to	   develop	  psychosis	   (Johnstone,	   Ebmeier	   et	   al.	   2005).	   Another	   approach	   has	  focused	   on	   young	   individuals	   who	   are	   experiencing	   the	   emergence	   of	  “basic	   symptoms”.	  Basic	   symptoms	  are	  described	  as	   subjective	   changes	  in	   cognitive,	   emotional,	   motor	   and	   autonomic	   function,	   as	   well	   as	   in	  bodily	   sensations,	   external	   perceptions,	   and	   tolerance	   to	   normal	   stress	  (Schultze-­‐Lutter,	   Klosterkotter	   et	   al.	   2014).	   Approximately	   70%	   of	  individuals	   experiencing	   basic	   symptoms	   will	   develop	   a	   psychotic	  disorder	  in	  the	  following	  10	  years	  (Klosterkotter,	  Hellmich	  et	  al.	  2001).	  A	  further	  approach	  has	  employed	  a	  strategy	  that	  combines	  state	  and	  trait	  risk	   factors.	  This	  “close-­‐in”	  strategy	   focuses	  on	   individuals	   in	   the	  age	  of	  maximum	   incidence	   of	   the	   disorder	   and	   includes	   the	   screening	   of	  psychotic-­‐like	  symptoms	  and	  positive	  family	  history	  (Yung,	  Phillips	  et	  al.	  1998).	  	  	  Three	   semi-­‐structured	   interviews	   have	   been	   developed	   for	   the	  assessment	   of	   young	   individuals	   at	   high	   risk	   of	   psychosis:	   the	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Comprehensive	   Assessment	   of	   At-­‐Risk	   Mental	   States	   (CAARMS),	   the	  Structured	   Interview	   for	   Prodromal	   Syndromes	   (SIPS)	   and	   the	  companion	   Scale	   of	   Prodromal	   Symptoms	   (SOPS),	   and	   the	   Basel	  Screening	  Instruments	  for	  Psychosis	  (BSIP).	  The	  CAARMS	  was	  developed	  by	   Yung	   and	   colleagues	   (Yung,	   Yuen	   et	   al.	   2005)	   at	   the	   Personal	  Assessment	   and	   Crisis	   Evaluation	   (PACE)	   clinic	   in	   Melbourne	   and	   has	  been	   used	   in	   Australia,	   Asia	   and	   Europe.	   The	   SIPS/SOPS	   have	   been	  developed	   by	  McGlashan	   and	   colleagues	   and	   have	   been	  mostly	   used	   in	  North	   American	   studies	   (McGlashan,	   Zipursky	   et	   al.	   2003,	   Miller,	  Zipursky	  et	   al.	   2003).	  The	  BSIP	  has	  been	  developed	  by	  Riecher-­‐Rossler	  and	  colleagues	  in	  the	  FEPSY	  clinic	  in	  Basel	  (Riecher-­‐Rossler,	  Aston	  et	  al.	  2008).	  Interestingly,	  the	  “attenuated	  psychotic	  symptoms”	  as	  defined	  by	  the	  CAARMS	  (see	  Table	  2.1.)	  are	  partly	  overlapping	  with	  the	  Chapman’s	  scales	  (Chapman,	  Edell	  et	  al.	  1980,	  Eckblad	  and	  Chapman	  1983)	  and	  the	  Rust	   Inventory	   of	   Schizotypal	   Cognition	   (RISC),	   (Rust	   1988),	   that	  measure	   schizotypal	   personality	   variation.	   This	   suggests	   the	   possible	  presence	   in	   the	   UHR	   clinical	   sample	   of	   people	   also	   presenting	   with	  schizotypal	   personality	   traits.	   In	   addition,	   two	   instruments	   have	   been	  developed	  for	  the	  assessment	  of	  basic	  symptoms:	  the	  Bonn	  Scale	  for	  the	  assessment	   of	   Basic	   Symptoms	   (BSABS),	   (Gross	   1987),	   and	   the	  Schizophrenia	   Proneness	   Instrument,	   Adult	   Version	   (SPI-­‐A),	   (Schultze-­‐Lutter	   2007),	   both	   used	   in	   Europe.	   These	   instruments	   assess	   self-­‐perceived	   cognitive	   and	   perceptual	   changes.	   Details	   relative	   to	   the	  different	  instruments	  are	  reported	  in	  Table	  2.1.	  	  	  
Table	  2.1.	  Assessment	  Instruments	  for	  clinical	  high	  risk	  samples	  





Subthreshold	  attenuated	  positive	  symptoms:	  e.g.	  ideas	  of	  reference,	  ‘magical’	  thinking,	  perceptual	  disturbance,	  
Subthreshold	  attenuated	  positive	  symptoms:	  e.g.	  unusual	  ideas,	  paranoia/suspiciousness,	  grandiosity,	  perceptual	  disturbance,	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paranoid	  ideation,	  odd	  thinking	  and	  speech;	  held	  with	  either	  subthreshold	  frequency	  or	  subthreshold	  intensity;	  present	  for	  more	  than	  1	  week	  within	  the	  past	  year	  and	  for	  less	  than	  5	  years	  







Transient	  psychotic	  symptoms:	  symptoms	  in	  the	  realm	  of	  delusions,	  hallucinations,	  disorganization;	  duration	  of	  the	  episode	  <	  1	  week;	  spontaneous	  remission;	  symptoms	  occurred	  within	  1	  year	  but	  for	  not	  longer	  than	  5	  years	  







First-­‐degree	  relative	  with	  a	  psychotic	  disorder	  or	  schizotypal	  personality	  disorder,	  or	  an	  individual	  with	  schizotypal	  personality	  disorder	  and	  significant	  decrease	  in	  mental	  state	  or	  functioning*	  maintained	  for	  at	  least	  1	  month	  and	  for	  less	  than	  
First-­‐degree	  relative	  with	  a	  psychotic	  disorder	  OR	  an	  individual	  with	  schizotypal	  personality	  disorder	  AND	  a	  significant	  decrease	  in	  functioning*	  in	  the	  past	  month	  compared	  to	  one	  year	  ago	  
First-­‐degree	  family	  member	  with	  schizophrenia	  or	  ante/prenatalcomplications	  and	  significant	  decrease	  in	  functioning*	  for	  less	  than	  1	  month	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5	  years	  
Basic	  
Symptoms	  (BS)	   	   	  
Subtle	  subjective	  disturbances	  of	  cognition	  and	  perception:	  at	  least	  1	  of	  10	  Basic	  symptoms	  with	  a	  score	  of	  at	  least	  3	  within	  the	  last	  3	  months	  and	  first	  occurrence	  within	  1	  year	  or	  cognitive	  disturbances	  :	  at	  least	  2	  of	  9	  basic	  symptoms	  with	  a	  score	  at	  least	  3	  within	  the	  last	  3	  months	  
	  
Table	   2.1.	   adapted	   from	   a	   published	   paper	   (Valli,	   Tognin	   et	   al.	   2012).	  *Defined	  as	  a	  30%	  drop	  in	  Global	  Assessment	  of	  Functioning	  Scale	  score	  within	  the	   last	   year.	   Abbreviations:	   APS,	   Attenuated	   Psychotic	   Symptoms;	   BS,	   Basic	  Symptoms;	   BIP/BLIP,	   Brief	   (limited)	   Intermittent	   Psychotic	   episode;	   BSABS,	  Bonn	   Scale	   for	   the	   assessment	   of	   Basic	   Symptoms;	   CAARMS,	   Comprehensive	  Assessment	   of	   the	   At	   Risk	  Mental	   State;	   GRD,	   Genetic	   Risk	   and	   Deterioration	  syndrome;	  SIPS/SOPS,	  Structured	  Interview	  for	  Prodromal	  Syndromes	  (Scale	  of	  Prodromal	   Symptoms);	   SPI-­‐A,	   Schizophrenia	   proneness	   instrument	   Adult	  version.	  
2.2.	  Recruitment	  	  UHR	   participants	  were	   recruited	   from	   four	   specialised	   clinical	   services	  for	  young	  people	  at	  risk	   for	  psychosis	   in	  London,	  Basel,	  Melbourne	  and	  Munich.	  Recruitment	  details	   and	   criteria	  used	  by	   the	   single	   centres	   are	  reported	  below.	   Sociodemographic	   characteristics	   of	   the	   study	   samples	  by	  site	  are	  reported	  in	  Appendix	  3	  (Table	  A3.1.	  and	  A3.2.).	  	  
	  
London:	   All	   participants	   at	   UHR	   of	   developing	   psychosis	   from	   the	  London	  site	  were	  recruited	   through	   the	  Outreach	  and	  Support	   in	  South	  London	   (OASIS)	   service	   (Fusar-­‐Poli,	   Byrne	   et	   al.	   2013).	   OASIS	   is	   a	  community	  mental	  health	  service	  that	  provides	  support	  and	  treatment	  to	  young	   people	   aged	   between	   14	   and	   35	   who	   are	   considered	   to	   be	   at	  increased	  risk	  of	  developing	  psychosis.	  OASIS	  is	  part	  of	  the	  South	  London	  and	  Maudsley	  NHS	  Foundation	  Trust	  (SLAM;	  www.slam.nhs.uk),	  it	  covers	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the	  boroughs	  of	  Lambeth	  and	  Southwark	  and	  has	   recently	  expanded	   to	  the	  borough	  of	  Lewisham.	  The	  service	  started	  operating	  in	  2001	  and	  its	  aims	  are	  to	  provide	  support	  and	  treatment	  to	  UHR	  individuals	  in	  order	  to	  prevent	   or	   delay	   the	   transition	   to	   psychosis.	   OASIS	   offers	   a	   follow-­‐up	  period	   of	   two	   years	   during	   which	   clients	   are	   offered	   psychological	  interventions,	   pharmacological	   treatment	   if	   required,	   medical	   reviews,	  practical	   support	   with	   the	   aim	   of	   reducing	   symptoms,	   social	   and	  occupational	  impairment,	  and	  improving	  outcome	  if	  any	  clients	  go	  on	  to	  develop	   psychosis.	   UHR	   individuals	   were	   defined	   using	   PACE	   criteria	  (Yung	   et	   al.	   1998)	   and	   assessed	   using	   the	   CAARMS	   (Yung,	   Yuen	   et	   al.	  2005).	   UHR	   individuals	   meet	   PACE	   criteria	   if	   they	   display	   one	   of	   the	  following:	   1)	   Attenuated	   Psychotic	   Symptoms	   (APSs)	   that	   include	  disorder	  of	  thought	  content	  or	  form,	  disorder	  of	  perceptions	  that	  do	  not	  reach	  the	  threshold	  for	  a	  DSM-­‐IV	  diagnosis	  of	  psychotic	  disorder;	  2)	  Brief	  Limited	  Intermittent	  Psychotic	  Symptoms	  (i.e.	  symptoms	  are	  of	  psychotic	  intensity	   and	   frequency	   but	   they	   do	   not	   last	   for	  more	   than	   7	   days	   and	  resolve	   spontaneously);	   3)	   positive	   family	   history	   or	   schizotypal	  personality	   disorder	   plus	   a	   marked	   decline	   (i.e.	   30%)	   in	   psychosocial	  functioning	   over	   the	   past	   12	   months	   (Genetic	   Risk	   and	   Deterioration	  Syndrome:	   GRD)	   as	   assessed	   by	   the	   Global	   Assessment	   of	   functioning	  (GAF),	  (Endicott,	  Spitzer	  et	  al.	  1976).	  	  	  
Basel:	   All	   individuals	   at	   risk	   for	   psychosis	   in	   Basel	   were	   recruited	  through	  the	  FEPSY	  (Frueherkennung	  von	  Psychosen	  =	  early	  detection	  of	  psychosis)	   clinic	   (Riecher-­‐Rossler,	   Gschwandtner	   et	   al.	   2007).	   UHR	  individuals	  were	   assessed	   using	   the	   BSIP	   (Riecher-­‐Rossler,	   Aston	   et	   al.	  2008),	   the	   Brief	   Psychiatric	   Rating	   Scale	   (BPRS)	   (Rhoades	   and	   Overall	  1988),	  and	   the	  Scale	   for	   the	  Assessment	  of	  Negative	  Symptoms	  (SANS),	  (Andreasen	  1989).	  The	  BSIP	  was	  used	  to	  evaluate	  prodromal	  symptoms	  (defined	   according	   to	   DSM-­‐III-­‐R)	   occurring	   in	   the	   last	   5	   years;	  nonspecific	   prodromal	   signs	   (Hafner,	   Riecher	   et	   al.	   1991)	   in	   the	   last	   2	  years;	  previous	  or	  current	  psychotic	  symptoms,	  psychosocial	  functioning	  over	   the	   last	   5	   years,	   substance	   dependency;	   and	   psychotic	   disorders	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among	   first	   and	   second	   degree	   relatives.	   The	   UHR	   group	   was	   defined	  using	   criteria	   corresponding	   to	   the	   PACE	   criteria	   (Yung,	   Phillips	   et	   al.	  1998).	  	  
Melbourne:	   All	   individuals	   at	   risk	   for	   psychosis	   in	   Melbourne	   were	  recruited	  through	  the	  PACE	  clinic	  which	  manages	  young	  people	  at	  risk	  of	  developing	   a	   psychotic	   illness	   (Yung,	   Phillips	   et	   al.	   1998).	   The	   UHR	  individuals	  were	  screened	  according	  to	  the	  PACE	  criteria	  (Yung,	  Phillips	  et	   al.	   1998,	   Yung,	   Yuen	   et	   al.	   2005)	   and	  were	   assessed	   using	   the	  BPRS	  (Rhoades	  and	  Overall	  1988),	  and	  the	  SANS,	  (Andreasen	  1989).	  	  
	  
Munich:	  All	  individuals	  at	  risk	  for	  psychosis	  in	  Munich	  were	  recruited	  at	  the	  Early	  Detection	   and	   Intervention	  Centre	   for	  Mental	   Crises,	   Ludwig-­‐	  Maximilians-­‐University	   (Meisenzahl,	  Koutsouleris	  et	   al.	  2008).	  Potential	  UHR	   individuals	   were	   examined	   according	   to	   a	   standardized	   inclusion	  criteria	   checklist	   with	   operationalized	   definitions	   of	   different	   types	   of	  prodromal	   symptoms:	   basic	   symptoms	   taken	   from	   the	   BSABS	   (Gross	  1987),	   attenuated	   psychotic	   (APSs)	   and	   brief	   limited	   intermittent	  psychotic	   symptoms	   (BLIPSs)	   as	   defined	   by	   the	   PACE	   criteria	   (Yung,	  Phillips	  et	  al.	  1998).	  	  	  Although	   the	   single	   centres	   have	   used	   different	   screening	   instruments,	  the	   criteria	   adopted	   to	   identify	   and	   assess	   UHR	   individuals	   were	  comparable	   across	   sites	   and	   corresponded	   to	   the	   PACE	   criteria	   (Yung,	  Yuen	  et	  al.	  2005).	  	  Healthy	   controls	   ages	   18	   to	   35	   (ages	   16	   to	   35	   in	   Melbourne),	   were	  recruited	   over	   the	   same	   period	   by	   the	   single	   centres	   from	   the	   same	  socio-­‐demographic	   area	   through	   local	   advertisement.	   Healthy	  participants	   had	   no	   history	   of	   psychiatric	   disorder	   and	   had	   no	   first-­‐degree	  relatives	  with	  a	  diagnosis	  of	  a	  psychotic	  illness.	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2.2.1.	  Transition	  rates	  across	  sites	  Potential	  differences	  in	  the	  proportion	  of	  individuals	  who	  transitioned	  to	  psychosis	  across	   the	  different	   sites	  were	  examined	  using	  a	  Chi-­‐squared	  test.	   The	   fraction	   of	   participants	   who	   transitioned	   to	   psychosis	   varied	  from	  40%	  to	  9.5%	  (Table	  A3.1,	  and	  A3.2.	  Appendix	  3).	  A	  chi-­‐squared	  test	  across	  four	  centres	  (after	  removing	  the	  London	  -­‐	   Institute	  of	  Psychiatry	  site	  that	  comprised	  of	  only	  2	  UHR-­‐T	  individuals	  and	  was	  excluded	  from	  most	  of	  the	  analyses)	  was	  not	  significant	  (χ²(3)=7,	  p=0.072	  based	  on	  the	  data	   reported	   in	   Chapter	   3;	   χ²(3)=4.259,	   p=0.235	   based	   on	   the	   data	  reported	   in	   Chapters	   4	   &	   5).	   Therefore,	   although	   nominally	   different	  transition	   rates	   were	   observed	   in	   the	   different	   centres,	   there	   was	   no	  statistically	   significant	   effect	   of	   site	   on	   the	   percentage	   of	   those	   who	  transitioned	   to	   psychosis.	   The	   percentages	   of	   UHR	   individuals	   by	   site	  who	  have	  transitioned	  to	  psychosis	  are	  reported	  in	  Table	  3.1.	  in	  Chapter	  3	  and	  in	  Table	  4.1	  in	  Chapter	  4.	  
2.2.2.	  Inclusion	  and	  exclusion	  criteria	  Participants	  in	  the	  two	  groups	  met	  the	  following	  criteria:	  	  
• Age	  18	  to	  35	  years	  old	  (Melbourne:	  16	  to	  35	  years	  old)	  
• No	  history	  of	  a	  neurological	  disorder	  or	  severe	  head	  injury	  	  
• No	   past	   or	   present	   diagnosis	   of	   schizophrenia	   spectrum	   or	   bipolar	  disorder,	  as	  well	  as	  borderline	  personality	  disorder,	  delirium,	  dementia,	  amnestic	   or	   other	   cognitive	   disorders,	   mental	   retardation,	   and	  psychiatric	  disorder	  due	  to	  a	  somatic	  factor,	  following	  DSM-­‐IV	  criteria	  
• Estimated	  premorbid	  IQ	  greater	  than	  70	  
• No	   evidence	   of	   alcohol	   or	   drug	   use	   meeting	   DSM-­‐IV	   criteria	   for	  dependence	  disorder	  
• No	  contraindication	  to	  exposure	  to	  a	  magnetic	   field	  such	  as	  presence	  of	  metal	  implants	  pacemakers,	  and	  pregnancy	  	  Participants	   in	   the	   healthy	   control	   group	   met	   the	   following	   additional	  criteria:	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• No	  history	  of	  psychiatric	  disorder	  	  
• No	   history	   of	   a	   first-­‐degree	   relative	   with	   a	   diagnosis	   of	   a	   psychotic	  disorder.	  	  
2.2.3.	  Ethics	  Ethical	   approval	   for	   the	   study	   was	   obtained	   separately	   at	   the	   single	  centres.	  	  
2.2.4.	  Informed	  consent	  Informed	  written	   consent	  was	  obtained	   from	  all	   the	  participants	   at	   the	  single	  centres.	  	  
2.2.5.	  Data	  protection	  All	  data	  of	  the	  study	  were	  stored	  in	  compliance	  with	  the	  Data	  Protection	  Act	   1998.	   Participants	  were	   referred	   to	   by	   study	  number	   only.	   Contact	  details	  were	  stored	  on	  a	  password-­‐protected	  server.	  	  
2.2.6.	  Confidentiality	  Confidentiality	   was	   discussed	   with	   all	   the	   participants	   at	   the	   single	  centres.	   It	   was	   stated	   that	   they	   would	   not	   be	   identifiable	   in	   any	  publications	  arising	  from	  the	  study	  and	  that	  there	  would	  not	  be	  any	  way	  of	  linking	  their	  identity	  to	  the	  study.	  All	  subjects	  agreed	  that	  their	  general	  practitioner	   would	   be	   contacted	   should	   any	   medically	   relevant	  information	  require	  further	  investigation.	  	  	  	  
2.3.	  Structural	  Magnetic	  Resonance	  Imaging	  	  Structural	   MRI	   relies	   on	   the	   concept	   of	   nuclear	   magnetic	   resonance	  (NMR).	   	   Protons	   contained	   in	   atomic	   nuclei	   have	   a	   positive	   electrical	  charge	  and	  revolve	  around	  an	  axis.	  This	  quantum	  quality	  spin	  produces	  a	  magnetic	   field	   with	   a	   north-­‐south	   polarity	   along	   the	   spin	   axis	   (the	  magnetic	  vector).	  In	  the	  absence	  of	  an	  external	  magnetic	  field,	  individual	  spins	   are	   randomly	   oriented	   and	   bulk	   material	   has	   no	   magnetisation.	  However,	  when	   an	   external	  magnetic	   field	   B0	   is	   applied,	   the	   individual	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magnetic	  spins	  align	  with	  it	  or	  rather	  process	  around	  the	  magnetic	  field	  direction.	  	  	  A	   spinning	   proton	   can	   have	   different	   energies	   depending	   on	   its	  orientation	   relative	   to	   the	   applied	   magnetic	   field	   B0.	   MRI	   techniques	  measure	   the	   effects	   of	   changing	   the	   spin	   of	   particular	   atomic	  nuclei.	   In	  living	   organisms	   the	   most	   abundant	   source	   of	   protons	   derives	   form	  hydrogen	   atoms	   contained	   in	   water.	   For	   the	   simple	   spin	   system	   of	  hydrogen,	  the	  spinning	  nucleus	  can	  have	  two	  orientations	  relative	  to	  the	  applied	  magnetic	   field	   B0.	   The	   parallel	   orientation	   is	   associated	  with	   a	  low	  energy	  state,	  while	  the	  anti-­‐parallel	  orientation	  is	  associated	  with	  a	  high-­‐energy	  state.	  The	  sum	  over	  all	  the	  nuclei	   in	  an	  object	  gives	  the	  net	  magnetisation	   of	   the	   object.	   Its	   description	   is	   based	   on	   a	   coordinate	  system	  with	  the	  z	  axis	  being	  in	  the	  direction	  of	  the	  applied	  magnetic	  field	  B0.	  	  In	  the	  resulting	  magnetisation	  state	  more	  spins	  are	  in	  the	  low	  rather	  than	   in	   the	   high-­‐energy	   state.	   Summing	   the	   contributions	   of	   singular	  magnetic	  vectors	  will	   therefore	  give	  a	  net	  magnetic	  vector	  M0	  along	  the	  direction	   of	   the	   applied	   magnetic	   filed.	   In	   addition,	   the	   rotating	  magnetisation	  of	  each	  nucleus	  has	  a	  small	  component	  projecting	  onto	  the	  
zy	  plane,	  transverse	  to	  the	  filed	  direction.	  However,	  in	  resting	  conditions,	  opposing	  magnetic	  components	  of	   the	   transverse	  magnetisation	  sum	  to	  zero.	  	  	  With	   the	   application	   of	   an	   oscillating	   radiofrequency	   electromagnetic	  field	  B1,	  perpendicular	  to	  the	  main	  magnetic	  field	  B0,	  spins	  can	  be	  excited	  from	   the	   low	   to	   the	   high-­‐energy	   state.	   The	   most	   efficient	   transfer	   of	  energy	  occurs	  when	  the	  oscillating	  frequency	  of	  the	  B1	  and	  the	  frequency	  of	  the	  protonic	  spin	  are	  the	  same.	  	  This	  phenomenon	  is	  called	  resonance	  and	  will	  result	  in	  a	  decrease	  of	  the	  longitudinal	  field	  M0.	  A	  second	  effect	  of	   the	   radiofrequency	   (RF)	   pulse	   B1	   is	   that	   protons	   are	   brought	   into	  coherence.	  Individual	  magnetic	  vectors	  in	  the	  transverse	  plane	  no	  longer	  cancel	   to	  zero,	  pointing	   instead	   in	   the	  same	  direction	  and	  resulting	   in	  a	  new	   magnetic	   vector	   M1	   on	   the	   transverse	   plane.	   The	   transverse	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component	  of	  the	  magnetic	  vector	  determines	  the	  detectable	  NMR	  signal	  because	  it	  induces	  an	  electric	  current	  detected	  by	  a	  coil	  on	  the	  xy	  plane.	  The	  amplitude	  of	  the	  current	  depends	  on	  the	  proton	  density,	  with	  higher	  density	   determining	   greater	   magnetisation	   vector	   returning	   to	   its	  original	   position	   along	   the	   z	   axis	   (i.e.	   relaxation).	   The	   molecular	  environment	  is	  reflected	  in	  the	  time	  variation	  of	  signal	  amplitude	  as	  the	  nuclei	  return	  to	  equilibrium.	  This	  process	  is	  gradual	  and	  happens	  in	  two	  ways:	   a)	   energy	   can	   be	   given	   to	   neighbouring	   molecules	   in	   the	  surrounding	  environment	  (spin-­‐lattice	  relaxation),	  and	  b)	  energy	  can	  be	  transferred	  to	  nearby	  nuclei	  (spin-­‐spin	  relaxation).	  	  	  
T1	   relaxation:	   Spin-­‐lattice	  or	  T1	   relaxation	  describes	   the	   re-­‐growth	  of	  the	   magnetisation	   vector	   along	   the	   z	   axis,	   an	   exponential	   process	  described	  by	  the	  T1	  time	  constant.	  Excited	  protons	  will	  dissipate	  energy	  to	  molecules	  of	  the	  surrounding	  structures	  (lattice)	  as	  heat	  and	  the	  exact	  composition	  of	  the	  environment	  will	  affect	  T1.	  	  
T2	   relaxation:	   Spin-­‐spin	   or	   T2	   relaxation	   describes	   the	   disappearing	  coherence	  of	  the	  transversal	  magnetic	  vector	  M1	  on	  the	  xy	  plane,	  which	  occurs	   at	   a	   different	   rate	   to	   the	   recovery	   of	  magnetisation	   along	   the	   z	  axix.	   The	   term	   spin-­‐spin	   refers	   to	   the	   fact	   that	   interactions	   between	  protons	   determine	   the	   rate	   of	   T2	   relaxation.	   No	   energy	   is	   lost,	   but	   an	  exchange	   of	   energy	   between	   protons	   causes	   their	   rotation	   to	   become	  desynchronised,	  resulting	  in	  a	  gradual	  decrease	  of	  M1.	  	  
2.3.1.	  Image	  formation	  	  Using	   a	   homogenous	   field	   B0	   would	   not	   produce	   a	   tomographic	   image	  because	   all	   protons	   would	   experience	   the	   same	   magnetic	   field	   and	  therefore	   the	   frequencies	   of	   their	   emitted	   signal	   would	   be	   identical.	   A	  non-­‐uniform	  magnetic	  field	  B1	  is	  thus	  applied	  in	  order	  for	  the	  resonance	  frequencies	  of	  spins	   to	  vary	  within	   the	  sample.	  This	  gradient	  will	  cause	  protons	   to	   emit	   different	   frequency	   signals	   according	   to	   their	   spatial	  position.	   For	   each	   frequency	   component	   of	   the	   measured	   signal,	   the	  known	  value	  of	   the	  applied	  strength	  and	  direction	  of	   the	  magnetic	   field	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can	  be	  used	  to	  calculate	  the	  position	  from	  which	  the	  signal	  originated.	  A	  non-­‐uniform	  magnetic	  field	  is	  combined	  with	  a	  spin	  echo,	  a	  pulse	  used	  to	  dampen	  the	   loss	  of	   transversal	  magnetisation	  that	   is	  determined	  by	  the	  inhomogeneity	   of	   the	   magnetic	   field	   itself.	   If	   the	   signal	   were	   acquired	  measuring	   frequencies	   only,	   its	   spectrum	   would	   be	   a	   one-­‐dimensional	  projection	   of	   spin	   density	   in	   the	   selected	   slice.	   To	   produce	   a	   two-­‐dimensional	  image,	  encoding	  on	  a	  second	  axis	  is	  required.	  Locations	  are	  encoded	  by	  frequency	  on	  the	  first	  axis,	  and	  by	  phase	  on	  the	  second	  axis.	  Location	   dependent	   phase	   is	   achieved	   using	   further	   gradient	   on	   the	  second	  axis.	  The	  duration	  of	  the	  applied	  gradient	  dictated	  the	  degree	  to	  which	   local	   transversal	   magnetisations	   are	   dephased.	   A	   series	   of	  increasing	  pulse	   lengths	  will	   enable	  a	   reconstruction	  of	   the	   frequencies	  giving	   rise	   to	   dephasing	   of	   transversal	   magnetisation.	   Step-­‐wise	  increases	   in	   both	   gradients	   divide	   the	   sample	   into	   volume-­‐elements	   or	  voxels.	   Spins	   in	   one	   voxel	   experience	   the	   same	   frequency	   and	   phase	  encoding	   and	   the	   signal	   from	   a	   given	   voxel	   is	   the	   sum	  of	   all	   individual	  spin	  contributions.	  The	  resolution	  of	  the	  image	  depends	  on	  the	  size	  of	  the	  voxels,	  which	  is	  determined	  by	  the	  step	  size	  of	  the	  gradients.	  	  
2.3.2.	  Image	  acquisition	  parameters	  
London	   The	   MR	   images	   were	   acquired	   on	   a	   1.5	   T	   GE	   NV/I	   Signa	   LX	  Horyzon	   system	   (General	   Electric,	   Milwaukee,	   WI,	   USA)	   at	   Mapother	  House,	   Maudsley	   Hospital.	   T1-­‐weighted	   Inversion	   Recovery	   Spoiled	  Gradient	  structural	  images	  were	  acquired	  with	  the	  following	  acquisition	  parameters:	   time-­‐to-­‐echo,	   5.2	   milliseconds;	   time-­‐to-­‐repetition,	   15.9	  milliseconds;	  flip	  angle,	  20°;	  field	  of	  view,	  220	  x	  200	  mm;	  slice	  thickness,	  1.5	  mm;	  number	  of	  slices,	  128;	  matrix	  size,	  256	  x	  256	  x	  124.	  Another	  set	  of	   MR	   images	   were	   acquired	   on	   a	   3	   T	   GE	   Excite	   II	   at	   the	   Centre	   for	  Neuroimaging	   Sciences	   (CNS)	   using	   a	   fast	   Spoiled	   Gradient	   Recalled	  (FSPGR)	   with	   the	   following	   acquisition	   parameters:	   time-­‐to-­‐echo,	   2.82	  milliseconds;	  time-­‐to-­‐repetition,	  6.96	  milliseconds;	  flip	  angle,	  20°;	  field	  of	  view,	   280	   x	   280	   mm;	   slice	   thickness,	   1.1	   mm;	   number	   of	   slices,	   196;	  matrix	  size,	  256	  x	  256.	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Basel	   Subjects	   were	   scanned	   using	   a	   Siemens	   (Erlangen,	   Germany)	  Magnetom	  Vision	  1.5	  T	  scanner	  at	  the	  University	  Hospital	  Basel.	  A	  three-­‐dimensional	   volumetric	   spoiled	   gradient	   recalled	   echo	   sequence	  generated	  176	  contiguous,	  1	  mm	  thick	  sagittal	  slices.	  Imaging	  parameters	  were:	   time-­‐to-­‐echo,	   4	  milliseconds;	   time-­‐to-­‐repetition,	   9.7	  milliseconds;	  flip	  angle,	  12;	  matrix	  size,	  200	  x	  256;	  field	  of	  view,	  25.6	  x	  25.6	  cm	  matrix;	  and	  voxel	  size,	  1.28	  x	  1	  x	  1	  mm.	  	  
Melbourne	  The	  MR	  images	  were	  obtained	  on	  a	  GE	  Signa	  1.5	  T	  scanner	  at	  the	  Royal	  Melbourne	  Hospital	  (RMH)	  and	  at	  the	  Royal	  Children	  Hospital.	  A	   three-­‐dimensional	   volumetric	   spoiled	   gradient	   recalled	   echo	   in	   the	  steady	   state	   sequence	   generated	  124	   contiguous,	   1.5	  mm	   thick	   coronal	  slices.	  Imaging	  parameters	  were:	  time-­‐to-­‐echo,	  3.3	  milliseconds;	  time-­‐to-­‐repetition,	  14.3	  milliseconds;	  flip	  angle,	  30°;	  matrix	  size,	  256	  x	  256;	  field	  of	  view,	  24	  x	  24	  cm	  matrix;	  voxel	  dimensions,	  0.937	  x	  0.937	  x	  1.5	  mm.	  	  	  
Munich	   The	  MR	   images	   were	   obtained	   on	   a	   1.5	   T	   system	   (Magnetom	  Vision;	  Siemens,	  Erlangen,	  Germany).	  Imaging	  was	  performed	  with	  a	  T1-­‐weighted	   three-­‐dimensional	   magnetization	   pre-­‐pared	   rapid-­‐acquisition	  gradient	  echo	  sequence	  with	  the	  following	  acquisition	  parameters:	  time-­‐to-­‐repetition,	   11.6	   milliseconds;	   time-­‐to-­‐echo,	   4.9	   milliseconds;	   field	   of	  view,	  230	  mm;	  512	  x	  512	  matrix;	  126	  contiguous	  axial	  sections	  of	  1.5	  mm	  thickness;	  and	  voxel	  size,	  0.45	  x	  0.45	  x	  1.5	  mm.	  
	  The	  datasets	  collected	  in	  the	  four	  centres	  were	  combined	  to	  form	  a	  large	  multi-­‐centre	  sample.	  	  
Chapter	   3	   sample.	   The	   study	   described	   in	   this	   chapter	   included	   five	  datasets:	  the	  two	  datasets	  from	  London,	  the	  one	  from	  Basel,	  the	  one	  from	  Melbourne,	  and	  the	  one	  from	  Munich.	  	  
Chapter	   4	   and	   5	   samples.	   The	   studies	   described	   in	   these	   chapters	  included	  four	  datasets:	  one	  from	  London	  (i.e.	  1.5	  T),	  the	  one	  from	  Basel,	  the	  one	  from	  Melbourne,	  and	  the	  one	  from	  Munich.	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Chapter	  6	   sample.	  The	  study	  described	  in	  this	  chapter	  included	  only	  a	  subsample	  of	  the	  London	  dataset	  (i.e.	  1.5	  T).	  	  
2.4.	  Structural	  image	  analyses	  Several	  different	  packages	  are	  available	  for	  the	  analysis	  of	  imaging	  data.	  Statistical	   Parametric	   Mapping	   (SPM,	   http://www.fil.ion.ucl.ac.uk/spm)	  is	   one	   of	   the	   most	   used.	   Version	   SPM8	   implemented	   in	   MATLAB	   7.1	  (MathWorks,	   Natick,	   MA,	   USA)	   was	   employed	   in	   this	   doctoral	   work.	  Image	   analysis	   of	   structural	   images	   was	   performed	   using	   voxel	   based	  morphometry	   (VBM)	   and	   voxel	   based	   cortical	   thickness	   (VBCT).	   Both	  involved	   voxel-­‐wise	   statistical	   analysis	   of	   pre-­‐processed	   structural	  images,	   implemented	   with	   SPM8	   running	   under	   MATLAB	   7.1.	   VBM	  identifies	   regional	  differences	   in	   cerebral	   tissue	  by	   comparing	  different	  brains	  on	  a	  voxel-­‐by-­‐voxel	  base	  (Ashburner	  and	  Friston	  2000).	  In	  order	  to	   compare	   different	   brains,	   all	   the	   structural	   images	   are	   spatially	  normalised	  to	  the	  same	  stereotactic	  space,	  segmented	  in	  gray	  and	  white	  matter	  and	  smoothed	  by	  convolution	  with	  a	  Gaussian	  kernel	  (Ashburner	  and	   Friston	   2000).	   	   An	   additional	   ‘modulation’	   step	   can	   be	   applied	   to	  preserve	  the	  total	  volume	  as	  opposed	  to	  concentration	  (Mechelli,	  Price	  et	  al.	  2005).	  An	  alternative	  approach	  that	  can	  be	  employed	  to	  assess	  brain	  differences	   between	   groups	   is	   to	   estimate	   the	   cortical	   thickness.	   This	  procedure	   involves	   the	   identification	   of	   the	   inner	   and	   outer	   cortical	  surfaces.	   Two	   approaches	   have	   been	   employed	   to	   estimate	   cortical	  thickness:	   surface	  based	   and	   voxel-­‐based.	   In	   surface-­‐based	   approaches,	  image	   information	   and	   surface	   geometry	   are	   used	   to	   construct	   a	  representation	   of	   the	   gray	   and	   white	   matter	   surfaces.	   The	   cortical	  thickness	   is	   therefore	   estimated	   by	   computing	   the	   distance	   between	  corresponding	  points	  in	  the	  two	  surfaces	  (Fischl	  and	  Dale	  2000).	  In	  voxel	  based	  approaches,	  such	  as	  VBCT,	  the	  gray	  and	  white	  matter	  boundaries	  are	  defined	  only	  on	  the	  basis	  of	  voxel	  information	  and	  therefore	  cortical	  thickness	   is	   estimated	   based	   on	   the	   trajectory	   between	   the	   two	  boundaries	  within	  each	  voxel	  (Hutton,	  De	  Vita	  et	  al.	  2008).	  	  	  
	   39	  
The	  VBM	  analysis	  of	  gray	  matter	  volume	  returns	  a	  mixed	  measure	   that	  depends	  on	  cortical	  thickness	  as	  well	  as	  cortical	  folding	  and	  gyrification	  (i.e.	  cortical	  surface	  area),	  whereas	  the	  VBCT	  analysis	  measures	  the	  one-­‐dimensional	  scalar	  thickness	  of	  the	  cortex	  at	  each	  voxel	  location	  (Hutton,	  De	   Vita	   et	   al.	   2008).	   Therefore	   VBM	   and	   VBCT	   can	   be	   considered	   as	  complementary	   methods	   that	   can	   characterise	   different	   morphological	  aspects	  of	  the	  brain.	  Preprocessing	  details	  relative	  to	  VBM	  and	  VBCT	  are	  reported	  below,	  in	  section	  2.4.1.1	  and	  2.4.1.2.	  	  
2.4.1.	  Image	  preprocessing	  	  VBM	  and	  VBCT	  share	  the	  same	  initial	  preprocessing	  steps	  and	  voxel-­‐wise	  statistical	  approaches.	  Structural	  images	  were	  firstly	  pre-­‐processed	  with	  a	  unified	   segmentation	  procedure.	  The	  unified	   segmentation	  procedure	  (Ashburner	   and	   Friston	   2005)	   implemented	   in	   SPM8	  (http://www.fil.ion.ucl.ac.uk/spm)	  was	   used	   to	   segment	   all	   the	   images	  into	  gray	  matter	  (GM),	  white	  matter	  (WM)	  and	  cerebrospinal	  fluid	  (CSF)	  partitions.	   Images	  were	  then	  pre-­‐processed	  and	  analysed	  using	  the	  two	  alternative	   approaches	   (i.e.	   VBM	   and	   VBCT)	   that	   allowed	   extracting	  information	  on	  gray	  matter	  volume	  and	  cortical	  thickness	  respectively.	  	  
2.4.1.1.	  Preprocessing	  of	  gray	  matter	  volume	  for	  VBM	  analyses	  A	  fast	  diffeomorphic	  image	  registration	  algorithm	  (DARTEL)	  was	  used	  to	  warp	  the	  gray	  matter	  partitions	  into	  a	  new	  study-­‐specific	  reference	  space	  with	   an	   isotropic	   spatial	   resolution	   of	   1.5mm3	  (Ashburner	   and	   Friston	  1997,	  Ashburner	  2007,	  Ashburner	  and	  Friston	  2009).	  The	  warped	  gray	  partitions	   were	   then	   affine	   transformed	   into	   the	   MNI	   space.	   An	  additional	   ‘modulation’	   step	   (Mechelli,	   Price	   et	   al.	   2005)	   was	   used	   to	  scale	  the	  gray	  matter	  probability	  values	  by	  the	  Jacobian	  determinants	  of	  the	  deformations	  to	  ensure	  that	  the	  total	  amount	  of	  gray	  matter	  in	  each	  voxel	  was	  conserved	  after	  the	  registration.	  As	  a	  final	  step	  the	  gray	  matter	  probability	  values	  were	  smoothed	  using	  a	  8mm	  FWHM	  Gaussian	  kernel.	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2.4.1.2.	  Preprocessing	  of	  cortical	  thickness	  for	  VBCT	  analyses	  	  A	  voxel-­‐based	  Laplacian	  method	  (Jones,	  Buchbinder	  et	  al.	  2000,	  Hutton,	  De	  Vita	  et	  al.	  2008)	  was	  used	   to	  create	  a	  voxel-­‐based	  cortical	   thickness	  (VBCT)	   map	   for	   each	   subject	   using	   the	   GM,	   WM	   and	   CSF	   partitions	  created	   in	   the	   segmentation	   step.	   The	   resulting	   VBCT	   maps	   contained	  cortical	  thickness	  (CT)	  values	  within	  voxels	  identified	  as	  gray	  matter	  and	  zeros	  outside	  the	  cortex	  and	  were	  saved	  in	  the	  native	  space	  of	  the	  input	  images	   (0.5mm3	   resolution).	  Each	  VBCT	  map	  was	  warped	   into	   the	  new	  DARTEL	  reference	  space	  by	  applying	  the	  corresponding	  subject	  specific	  deformation	   field	   and	   resampled	   to	   an	   isotropic	   voxel	   size	   of	   1.5mm3.	  The	  warped	  images	  were	  then	  scaled	  by	  the	  Jacobian	  determinant	  of	  the	  deformation	   and	   smoothed	   with	   a	   6mm	   FWHM	   Gaussian	   kernel.	   The	  same	  warps,	   modulation	   and	   smoothing	   were	   also	   applied	   to	   a	   binary	  mask	   created	   from	   each	   original	   VBCT	  map.	   Subsequently	   the	  warped,	  scaled	   and	   smoothed	   VBCT	   maps	   were	   divided	   by	   the	   corresponding	  warped,	  scaled,	  and	  smoothed	  mask.	  The	  effect	  of	  this	  procedure	  was	  to	  project	   the	   Gaussian	   smoothing	   kernel	   applied	   to	   the	   warped	   images,	  into	  the	  native	  space	  of	  the	  subject	  while	  preserving	  the	  CT	  value	  over	  a	  region	  the	  size	  of	  the	  smoothing	  kernel.	  	  
2.4.1.3.	  Statistical	  analyses	  The	   voxel-­‐wise	   statistical	   analysis	   on	   gray	  matter	   volumes	   and	   cortical	  thickness	   was	   performed	   using	   the	   General	   Linear	   Model,	   a	   flexible	  framework	   that	  allows	  a	  number	  of	  different	  statistical	   tests,	  under	   the	  assumption	  that	  the	  data	  are	  described	  by	  effects	  of	   interest,	  confounds	  of	  no	  interest	  and	  residual	  component	  of	  error.	  After	  fitting	  the	  model	  to	  the	   data,	   parameters	   are	   estimated	   for	   each	   effect	   entered	   into	   the	  model.	  Standard	  parametric	  statistics	  (t-­‐test	  and	  F-­‐test)	  are	  then	  applied	  to	  the	  estimated	  parameters	  in	  order	  to	  test	  hypothesis	  about	  differences	  between	  effects	  of	  interest	  and	  the	  results	  are	  then	  reported	  as	  Statistical	  Parametric	   Maps	   (SPMs).	   At	   this	   stage	   many	   voxel-­‐wise	   tests	   are	  computed	  and	  a	  correction	  for	  multiple	  comparisons	  is	  necessary.	  During	  the	   preprocessing,	   the	   images	   have	   been	   smoothed	   and	   gray	  matter	   in	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neighbouring	  voxels	  is	  highly	  correlated,	  therefore	  a	  standard	  Bonferroni	  correction	   would	   not	   be	   appropriated.	   A	   correction	   for	   multiple	  comparisons	  based	  on	  Gaussian	  Random	  Fields	   (GRF)	   theory	   is	  applied	  to	   minimize	   the	   risk	   of	   false	   positives	   in	   a	   random	   data	   set	   (Worsley,	  Marrett	  et	  al.	  1996).	  	  
2.4.2.	  Multivariate	  analysis	  of	  structural	  data	  Standard	  mass-­‐univariate	  analyses	  allow	  the	  identification	  of	  anatomical	  differences	   that	   are	   statistically	   significant	   at	   the	   group	   level;	   these	  however	   are	   of	   limited	   use	   in	   clinical	   practice	   where	   a	   clinician	   must	  make	   inferences	   at	   the	   individual	   level.	   A	   further	   characteristic	   of	   the	  mass-­‐univariate	   approach	   is	   that	   it	   treats	   each	   voxel	   individually	   and	  therefore	   is	   ideally	   suited	   to	   identifying	   strong,	   localised	   differences;	  however	  it	  is	  not	  very	  sensitive	  to	  signals	  from	  different	  regions	  that	  are	  spatially	  correlated.	  A	  third	  consideration	  is	  that	  structural	  MRI	  data	  are	  multivariate	   in	  nature	  because	  each	  brain	  volume	  contains	   information	  relative	   to	   thousands	   or	   voxels.	   Univariate	   approaches	   that	   involve	  multiple	   testing	   and	   the	   subsequent	   corrections	   for	   multiple	  comparisons	  may	  therefore	  be	  too	  conservative	  and	  not	  sensitive	  enough	  to	   detect	   network-­‐level	   alterations.	   Multivariate	   machine	   learning	  analyses	  have	  therefore	  been	  applied	  to	  neuroimaging	  data	  to	  investigate	  spatially	  distributed	  alterations	   in	  the	  brain	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012).	  	  	  Machine	   learning	   is	   a	   branch	   of	   artificial	   intelligence	   that	   allows	   the	  automatic	   extraction	   of	   information	   from	   data	   by	   the	   use	   of	  computational	   and	   statistical	   algorithms.	   Within	   the	   field	   of	   machine	  learning,	   statistical	   pattern	   recognition	   focuses	   on	   the	   recognition	   of	  patterns	  and	  regularities	  in	  data	  to	  classify	  data	  into	  different	  categories	  (Bishop	   2006).	   In	   the	  machine	   learning	   application	  with	   neuroimaging	  data,	  brain	  images	  are	  treated	  as	  spatial	  patterns	  and	  statistical	  learning	  methods	   are	   used	   to	   identify	   which	   statistical	   properties	   allow	   the	  discrimination	   between	   categories	   or	   conditions	   (e.g.	   patients	   vs	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controls).	   	  The	  pattern	   identification	  process	   consists	   in	   two	  phases.	   In	  the	   training	   phase,	   the	   algorithm	   identifies	   the	   features	   that	   best	  distinguish	   the	   two	   populations	   or	   conditions.	   In	   the	   testing	   phase,	   a	  previously	  unseen	  subject	   is	   then	  attributed	  to	  one	  of	   the	  groups	  based	  on	   the	   algorithm	  previously	  developed.	  Within	   this	   general	   framework,	  there	   are	   a	   number	   of	   specific	   machine	   learning	   methods	   that	   can	   be	  applied	  to	  neuroimaging	  data.	  In	  the	  present	  thesis,	  I	  used	  two	  of	  them:	  Support	  Vector	  Machine	  (SVM)	  and	  Relevance	  Vector	  Regression	  (RVR).	  
	  Support	  Vector	  Machine	  (SVM)	  is	  a	  multivariate	  method	  that	  allows	  the	  binary	   classification	   or	   categorization	   of	   individual	   data	   into	   class	   or	  categories.	  In	  neuroimaging,	  the	  three	  dimensional	  data	  (i.e.	  MR	  images)	  are	  transformed	  into	  an	  input	  vector	  (Haynes	  and	  Rees	  2006).	  Input	  data	  are	  classified	  into	  two	  groups	  based	  on	  class	  labels.	  The	  algorithm	  is	  then	  trained	  in	  order	  to	  find	  a	  hyperplane	  that	  best	  separates	  the	  input	  space.	  A	   hyperplane	   is	   an	   n-­‐dimentional	   generalisation	   of	   a	   plane.	   This	   in	   an	  affine	   subspace	  of	  n-­‐1	  dimension	   that	   splits	   an	  n-­‐dimensional	   space.	   In	  situations	  of	  high	  dimensionality,	  where	  dimensions	  (e.g.	  voxels)	  exceed	  the	   number	   of	   data	   points	   (e.g.	   volumes	   or	   scans),	   several	   different	  hyperplanes	   that	   correctly	   separate	   the	   data	   are	   possible.	   The	   SVM	  algorithm	   (Vapnik	   1999)	   finds	   the	   hyperplane	   with	   the	   maximal	  separation	   between	   classes.	   Each	   hyperplane	   is	   parameterised	   by	   a	  weight	  vector	  w.	  The	  projection	  of	  each	  data	  point	  onto	  the	  weight	  vector	  is	  used	  to	  find	  the	  maximum	  margin,	  where	  the	  margin	  is	  the	  distance	  of	  the	   closest	   training	  data	  point	   to	   the	  hyperplane.	  The	  points	  nearest	   to	  the	  margin	  are	  the	  most	  important	  for	  the	  classification	  because	  they	  are	  the	  ones	  that	  define	  the	  hyperplane	  and	  they	  are	  called	  ‘support’	  vectors.	  	  The	   vector	  w	   is	   called	   the	   classifier’s	   weight	   vector	   and	   it	   carries	   the	  information	   about	   which	   variables	   or	   voxels	   are	   relevant	   for	  discriminating	  between	  groups.	  The	  weight	  vector	  can	  be	  plotted	  to	  form	  a	   discriminating	   map	   that	   shows	   the	   relative	   importance	   or	   weight	   of	  each	   voxel	   in	   the	   brain	   for	   the	   classification.	   Predictive	   power	   can	   be	  assessed	  over	  a	  series	  of	  characteristics	  such	  as	  accuracy,	  sensitivity	  (e.g.	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the	   proportion	   of	   patients	   identified	   as	   having	   a	   condition),	   specificity	  (e.g.	   the	   proportion	   of	   controls	   identified	   as	   not	   having	   a	   condition),	  positive	   and	   negative	   predictive	   values.	   Statistical	   significance	   of	   the	  accuracy	   can	   be	   determined	   by	   permutation	   testing;	   this	   involves	  repeating	   the	   classification	   procedure	   with	   a	   different	   random	  permutation	   of	   the	   training	   group	   labels,	   and	   dividing	   the	   number	   of	  permutations	   achieving	   higher	   sensitivity	   and	   specificity	   than	   the	   true	  labels	  by	  the	  total	  number	  of	  permutations.	  	  SVM	   permits	   the	   classification	   of	   individual	   observations	   into	   distinct	  groups	   or	   class	   (e.g.	   UHR-­‐T	   vs	   UHR-­‐NT)	   but	   cannot	   be	   used	   to	   predict	  continuous	   variables	   (e.g.	   change	   in	   a	   patient’s	   score).	   Thus	   an	  alternative	   machine	   learning	   method	   known	   as	   Relevance	   Vector	  Regression	   (RVR)	   will	   also	   be	   used	   to	   allow	   the	   characterization	   of	  clinical	  response	  in	  terms	  of	  a	  continuous	  variable	  (Tipping	  2001).	  This	  will	  allow	  the	  estimation	  of	  the	  value	  of	  neuroimaging	  data	  for	  predicting	  quantitative	  changes	  in	  clinical	  measures	  without	  the	  need	  for	  an	  a	  priori	  cut-­‐off	  to	  distinguish	  between	  those	  who	  did	  and	  did	  not	  make	  transition.	  
	  	  Relevance	  Vector	  Regression	  (RVR)	  is	  a	  multivariate	  regression	  method	  set	   in	   fully	   probabilistic	   Bayesian	   framework.	   Under	   this	   framework,	   a	  zero-­‐mean	   Gaussian	   prior	   is	   introduced	   over	   the	   model	   weights,	  governed	   by	   a	   set	   of	   hyperparameters,	   one	   for	   each	   weight.	   The	  most	  probable	   values	   for	   these	   hyperparametres	   are	   estimated	   from	   the	  training	  data,	  with	  sparseness	  achieved	  due	  to	  the	  posterior	  distribution	  of	   many	   of	   the	   weights	   peaking	   sharply	   around	   zero.	   These	   training	  vectors	   associated	  with	   non-­‐zero	  weights	   are	   referred	   to	   as	   ‘relevance’	  vectors.	   The	   optimised	   posterior	   distribution	   over	   the	   weights	   can	   be	  used	  to	  predict	  the	  target	  value	  (e.g.	  a	  patient’s	  score	  on	  a	  clinical	  scale)	  for	  a	  previously	  unseen	  input	  vector	  (e.g.	  VCBT	  maps)	  by	  computing	  the	  predictive	  distribution	  (see	  Tipping,	  2001	  for	  a	  detailed	  description).	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In	   the	   present	   doctoral	   work	   the	   toolbox	   Pattern	   Recognition	   for	  Neuroimaging	  Toolbox	  (PRoNTo;	  http://www.mlnl.cs.ucl.ac.uk/pronto/)	  was	   used	   to	   perform	   the	   multivariate	   analyses	   of	   the	   structural	   data	  (Schrouff,	  Rosa	  et	  al.	  2013).	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3.	   Neuroanatomical	   abnormalities	   that	   predate	   the	   onset	   of	  
psychosis:	  a	  multi-­‐centre	  voxel-­‐based	  morphometry	  study	  
	  
(Adapted	  from	  published	  paper,	  Appendix	  1,	  A1.1.)	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3.1.	  	  Introduction	  Psychotic	   disorders	   are	   usually	   preceded	   by	   a	   prodromal	   phase	   in	  which	   there	   is	  a	  gradual	  deterioration	  of	  global	  and	  social	   functioning	  and	  the	  emergence	  of	  attenuated	  psychotic	  symptoms	  (Hafner,	  Maurer	  et	  al.	  1993,	  Yung,	  Yuen	  et	  al.	  2005).	  However,	  not	  all	  people	  with	  these	  features	   go	   on	   to	   develop	   a	   full-­‐blown	   psychotic	   disorder;	   18-­‐36%	  develop	  psychosis,	  usually	  within	  36	  months,	  but	  the	  remainder	  do	  not	  (Fusar-­‐Poli,	  Bonoldi	   et	   al.	   2012).	   Subjects	  presenting	  with	   this	   clinical	  syndrome	   are	   thus	   said	   to	   be	   at	   “ultra	   high	   risk”	   (UHR)	   of	   psychosis	  (Yung,	   Phillips	   et	   al.	   1998).	   Recent	   trials	   suggest	   that	   clinical	  intervention	   in	   the	   UHR	   population	   may	   reduce	   the	   risk	   of	   later	  transition	  to	  psychosis	  (Amminger,	  Edwards	  et	  al.	  2002,	  McGorry,	  Yung	  et	  al.	  2003,	  Killackey	  and	  Yung	  2007).	  	  However,	  it	  is	  difficult	  on	  purely	  clinical	   grounds	   to	   distinguish	   individuals	   who	   will	   later	   become	  psychotic	  from	  those	  who	  will	  not	  (McGorry,	  Yung	  et	  al.	  2003,	  Riecher-­‐Rossler,	   Gschwandtner	   et	   al.	   2007,	   Riecher-­‐Rossler,	   Pflueger	   et	   al.	  2009).	  This	  prevents	   the	   selective	  delivery	  of	  potentially	  preventative	  interventions	  to	  the	  subgroup	  that	  are	  most	  likely	  to	  become	  psychotic,	  which	  is	  desirable	  both	  from	  an	  ethical	  standpoint,	  and	  in	  terms	  of	  the	  efficient	  use	  of	  health	  care	  resources.	  	  	  Recent	  studies	  using	  magnetic	  resonance	  imaging	  (MRI)	  have	  examined	  whether	   there	  are	  neuroanatomical	  differences	  between	  UHR	  subjects	  who	   subsequently	   develop	   psychosis	   and	   those	   who	   do	   not	   (Phillips,	  Velakoulis	   et	   al.	   2002,	   Job,	   Whalley	   et	   al.	   2003,	   Pantelis,	   Yucel	   et	   al.	  2003,	  Garner,	  Pariante	  et	  al.	  2005,	  Job,	  Whalley	  et	  al.	  2005,	  Velakoulis,	  Wood	  et	  al.	  2006,	  Borgwardt,	  McGuire	  et	  al.	  2007,	  Borgwardt,	  Riecher-­‐Rossler	  et	  al.	  2007,	  Borgwardt,	  McGuire	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Koutsouleris,	  Schmitt	  et	  al.	  2009,	  Witthaus,	  Kaufmann	  et	  al.	  2009,	  Buehlmann,	   Berger	   et	   al.	   2010).	   A	   number	   of	   differences	   in	   regional	  grey	   matter	   volume	   have	   been	   reported,	   but	   the	   findings	   have	   been	  inconsistent;	  this	  may	  partly	  reflect	  the	  use	  of	  small	  samples.	  However	  UHR	  subjects	  are	  difficult	  to	  recruit	  and	  specialised	  clinical	  services	  are	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usually	  required.	  Thus	  it	  is	  difficult	  for	  any	  single	  centre	  to	  scan	  a	  large	  sample.	   Sample	   size	   is	   a	   particular	   problem	   for	   the	   key	   comparison	  between	  UHR	  subjects	  who	   later	  develop	  psychosis	  and	   those	  who	  do	  not,	  which	  entails	  a	  further	  subdivision	  of	  the	  UHR	  sample	  according	  to	  clinical	  outcome.	  A	  potential	  solution	  is	  to	  conduct	  multi-­‐centre	  studies,	  with	  the	  pooling	  of	  data	  to	  produce	  a	  relatively	  large	  total	  sample.	  This	  approach	   has	   been	   successfully	   employed	   in	   neuroimaging	   studies	   of	  other	   CNS	   disorders	   in	  which	   subject	   recruitment	   is	   difficult	   (Nestor,	  Rupsingh	  et	  al.	  2008,	  Stonnington,	  Tan	  et	  al.	  2008).	  	  In	   the	   present	   study,	   magnetic	   resonance	   whole-­‐brain	   images	   were	  acquired	   from	   five	  MRI	   scanners	   in	  London	   (two	  sites),	  Basel,	  Munich	  and	   Melbourne.	   The	   objective	   was	   to	   identify	   the	   most	   robust	  neuroanatomical	  abnormalities	  in	  subjects	  at	  UHR,	  and	  to	  compare	  UHR	  subjects	   who	   subsequently	   made	   a	   transition	   to	   psychosis	   with	   UHR	  subjects	  who	  did	  not.	  At	  each	  site,	  subjects	  were	  scanned	  at	  first	  clinical	  presentation,	  and	  followed	  clinically	  for	  an	  average	  of	  two	  years,	  so	  that	  they	   could	   then	   be	   subcategorized	   according	   to	   clinical	   outcome.	   The	  MRI	   data	   from	  each	   site	  were	   combined	   to	   form	   a	   large	  UHR	   sample,	  which	  was	  subdivided	  into	  subjects	  who	  had	  developed	  psychosis	  and	  subjects	   who	   had	   not.	   MRI	   data	   from	   a	   number	   of	   matched	   healthy	  controls	  were	  also	  acquired	  at	  each	  site.	  	  	  The	   first	   prediction,	   based	   on	   data	   from	   previous	   studies	   (Phillips,	  Velakoulis	   et	   al.	   2002,	   Job,	   Whalley	   et	   al.	   2003,	   Pantelis,	   Yucel	   et	   al.	  2003,	  Garner,	  Pariante	  et	  al.	  2005,	  Job,	  Whalley	  et	  al.	  2005,	  Velakoulis,	  Wood	  et	  al.	  2006,	  Borgwardt,	  McGuire	  et	  al.	  2007,	  Borgwardt,	  Riecher-­‐Rossler	  et	  al.	  2007,	  Borgwardt,	  McGuire	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Koutsouleris,	  Schmitt	  et	  al.	  2009,	  Witthaus,	  Kaufmann	  et	  al.	  2009,	  Buehlmann,	   Berger	   et	   al.	   2010),	   was	   that	   the	   UHR	   group	   as	   a	   whole	  would	   show	   regional	   volumetric	   differences	   relative	   to	   controls	   that	  were	  qualitatively	  similar	  to	  those	  seen	  In	  patients	  with	  schizophrenia.	  The	   main	   hypothesis	   was	   that	   UHR	   subjects	   who	   later	   developed	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psychosis	   would	   show	   differences	   in	   grey	   matter	   volume	   relative	   to	  those	   who	   did	   not	   in	   the	   inferior	   frontal,	   parahippocampal,	   and	  superior	  temporal	  cortex,	  areas	  most	  frequently	  implicated	  in	  previous	  studies.	   Critically,	   these	   predictions	   were	   based	   on	   the	   results	   of	  previous	  single	  centre	  studies	  on	  people	  at	  risk	  for	  psychosis	  or	  with	  a	  first	  episode	  of	  psychosis	  (Job,	  Whalley	  et	  al.	  2003,	  Pantelis,	  Velakoulis	  et	  al.	  2003,	  Farrow,	  Whitford	  et	  al.	  2005,	  Garner,	  Pariante	  et	  al.	  2005,	  Borgwardt,	  McGuire	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Sun,	  Phillips	  et	  al.	  2009,	  Takahashi,	  Wood	  et	  al.	  2009,	  Takahashi,	  Wood	  et	  al.	  2009).	  	  
3.2.	  Methods	  
3.2.1.	  Sample	  All	   the	  UHR	   subjects	  were	   recruited	   from	   specialised	   clinical	   services	  for	   people	   at	   high	   risk	   of	   psychosis	   in	   London,	   Basel,	  Melbourne	   and	  Munich.	   In	   total	   there	   were	   data	   from	   182	   patients	   at	   UHR.	   Most	  (168/182,	   93%)	   of	   the	  UHR	   group	   had	   never	   taken	   antipsychotics	   or	  mood	   stabilizers;	   14	   (7%)	   had	   been	   exposed	   to	   antipsychotics,	   the	  mean	   exposure	   time	   was	   13	   months	   (SD=19.3).	   At	   each	   site,	   healthy	  controls	   from	   the	   same	   geographical	   area	   as	   the	   UHR	   subjects	   were	  recruited	   through	   local	   advertisement.	   The	   total	   control	   sample	  comprised	   167	   subjects,	   and	  was	   comparable	   to	   the	   total	   UHR	   group	  with	  respect	  to	  gender,	  age,	  and	  ethnicity	  (details	  are	  reported	  in	  Table	  
3.2.).	   Recruitment	  details	   are	   reported	   in	  Chapter	  2,	   sections	  2.2.	   and	  2.2.2.	  	  In	   the	   30.6	   months	   (mean	   follow	   up	   period;	   SD=10.4)	   subsequent	   to	  scanning,	  48	  (26.4%)	  of	  the	  UHR	  sample	  developed	  psychosis	  (UHR-­‐T),	  and	  134	  did	  not	  (UHR-­‐NT).	  Each	  site	  yielded	  a	  dataset	  that	  included	  an	  UHR-­‐T	  group,	  an	  UHR-­‐NT	  group	  and	  a	  control	  group,	  with	  the	  exception	  of	  one	  of	   the	  London	  datasets,	   from	  which	  the	  UHR-­‐T	  group	  too	  small	  (n=2)	   to	   be	   included	   in	   the	   combined	   UHR-­‐T	   versus	   UHR-­‐NT	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comparison	  (Table	  3.1.).	  Clinical	  measures	  for	  each	  site	  are	  reported	  in	  Appendix	  2.	  	  	  
Table	  3.1.	  Number	  of	  subjects	  for	  site	  
Site	   UHR-­‐NT	   UHR-­‐T	   Healthy	  Controls	  London	  (Institute	  of	  Psychiatry)	   19	  (90.5%)	   2	  (9.5%)	   27	  London	  (Maudsley	  Hospital)	   42	  (84%)	   8	  (16%)	   37	  Basel	   23	  (65.7%)	   12	  (34.3%)	   22	  Munich	   24	  (60%)	   16	  (40%)	   42	  Melbourne	   26	  (72.2%)	   10	  (27%)	   39	  Total	   134	  (73.6%)	   48	  (26.4%)	   167	  
3.2.2.	  Image	  acquisition	  	  	  At	   all	   five	   sites,	   volumetric	   MR	   images	   were	   acquired	   using	   a	   T1-­‐	  weighted	  protocol.	  At	  four	  sites	  the	  scanner	  field	  strength	  was	  1.5T,	  at	  one	  it	  was	  3T.	  Three	  sites	  used	  General	  Electric	  scanners,	  and	  two	  used	  Siemens	  scanners.	  The	  details	  of	  the	  image	  acquisition	  sequence	  varied	  between	  scanners,	  as	  reported	  in	  Chapter	  2,	  section	  2.3.2.	  	  	  
3.2.3.	  Data	  analysis	  
3.2.3.1.	  Sociodemographic	  data	  and	  clinical	  parameters	  	  Differences	   in	  demographics	  and	  clinical	  profile	  between	  groups	  were	  examined	  using	  one-­‐way	  analysis	  of	  variance	   (ANOVA)	   for	  parametric	  data,	  and	  a	  chi	  square	  test	  for	  non-­‐parametric	  data,	  with	  the	  Statistical	  Package	   for	   the	  Social	   Sciences	  17.0	   (SPSS	  17.0	   for	  Windows),	   (Table	  
3.2.).	  	  Sociodemographic	  characteristics	  of	  the	  study	  samples	  by	  site	  are	  reported	  in	  Appendix	  3	  (Table	  A3.1.).	  
3.2.3.2.	  Preprocessing	  Group-­‐related	  differences	  in	  gray	  matter	  volume	  were	  examined	  using	  Voxel-­‐based	   Morphometry	   (VBM),	   as	   implemented	   in	   SPM8	   software	  (http://www.fil.ion.ucl.ac.uk/spm)	   running	   under	   Matlab	   7.1	   (Math	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Works,	  Natick,	  MA,	  USA).	  First,	  T1-­‐weighted	  1	  volumetric	  images	  were	  pre-­‐processed	   using	   the	   Diffeomorphic	   Anatomical	   Registration	   using	  Exponentiated	   Lie	   algebra	   (DARTEL)(Ashburner	   2007)	   SPM8	   toolbox.	  This	  approach	  involves	  the	  creation	  of	  a	  study-­‐specific	  template	  and	  the	  segmentation	   of	   each	   individual	   image	   using	   such	   template,	   with	   the	  aim	  of	  maximizing	  accuracy	  and	  sensitivity	  (Yassa	  and	  Stark	  2009).	  The	  following	  steps	  were	  followed	  for	  VBM	  preprocessing:	  (1)	  checking	  for	  scanner	  artifacts	  and	  gross	  anatomical	   abnormalities	   for	  each	   subject;	  (2)	   setting	   the	   image	  origin	   to	   the	  anterior	   commissure;	   (3)	  using	   the	  DARTEL	  toolbox	  to	  produce	  a	  high-­‐dimensional	  normalization	  protocol	  (Ashburner	   2007);	   (4)	   checking	   for	   homogeneity	   across	   the	   sample;	  and	  (5)	  using	  standard	  smoothing	  (i.e.,	  8	  mm).	  A	  “modulation	  step”	  was	  also	  included	  in	  the	  normalization	  in	  order	  to	  preserve	  the	  information	  about	   the	   absolute	   gray	   matter	   values	   (Ashburner	   and	   Friston	   2000,	  Mechelli,	   Price	   et	   al.	   2005).	   After	   this	   preprocessing,	   smoothed,	  modulated,	   normalised	   data	   were	   obtained	   and	   were	   subsequently	  used	  for	  the	  statistical	  analysis.	  	  
3.2.3.3.	  Statistical	  analyses	  Two	  statistical	  analyses	  were	  performed	  using	  SPM8	  software.	  First,	  an	  analysis	  of	  variance	  (ANOVA)	  was	  used	  to	  compare	  grey	  matter	  images	  from	   UHR	   subjects	   (UHR-­‐T	   and	   UHR-­‐NT	   combined)	   and	   healthy	  controls.	   In	   this	   analysis,	   scanner	   site	   was	   modelled	   as	   a	   factor,	  resulting	   in	   a	   total	   of	   10	   experimental	   groups.	   Second,	   an	   analysis	   of	  variance	  (ANOVA)	  was	  performed	  to	  compare	  grey	  matter	  images	  from	  UHR	  subjects	  who	   later	  became	  psychotic	  (UHR-­‐T),	  UHR	  subjects	  who	  did	   not	   become	   psychotic	   (UHR-­‐NT),	   and	   healthy	   controls.	   In	   this	  analysis,	  scanner	  site	  was	  again	  modelled	  as	  a	  factor,	  resulting	  in	  a	  total	  of	   14	   experimental	   groups	   (one	   UHR-­‐NT	   group	   was	   too	   small	   for	  analysis;	  see	  above).	  Including	  scanner	  site	  as	  a	  factor	  in	  the	  statistical	  analysis	  allowed	  to	  (i)	  model	  scanner-­‐related	  variance	  in	  the	  data	  which	  had	   the	   impact	   of	   reducing	   error	   variance	   and	   increasing	   statistical	  sensitivity	   and	   (ii)	   examine	   the	   impact	   of	   scanner	   site	   by	   testing	   for	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scanner	  effects	  and	  scanner	  x	  group	  interactions.	  To	  assess	  how	  much	  of	  the	  inter-­‐individual	  variance	  in	  regions	  which	  differed	  between	  UHR-­‐T	   and	   UHR-­‐NT	   was	   explained	   by	   diagnostic	   group	   and	   scanner	   site	  respectively,	   the	  ηp2	  measure	  of	   effect	   size	  was	  performed	   in	  SPSS.	   In	  both	   analyses,	   age,	   gender,	   ethnicity	   and	   use	   of	   medication	   were	  modelled	  as	  covariates	  of	  no	  interest	  to	  reduce	  the	  potential	   impact	  of	  these	  variables	  on	   the	   findings.	   In	  order	   to	   identify	   regionally	   specific	  changes	   that	   were	   not	   confounded	   by	   global	   differences,	   the	  proportional	  scaling	  option	  was	  used.	  Statistical	  inferences	  were	  made	  at	  p	  <	  0.05	  after	  family-­‐wise	  error	  (FWE),	  with	  an	  extent	  threshold	  of	  5	  voxels.	  	  
3.2.3.4.	  ROI	  analyses	  	  In	  addition	  to	  the	  whole-­‐brain	  analysis,	  regions	  of	  interest	  (ROIs)	  were	  used	  to	  examine	  between	  group	  differences	  in	  areas	  where	  volumetric	  abnormalities	   have	   previously	   been	   identified	   in	   studies	   of	   people	   at	  high	   risk	   for	   psychosis,	   or	   patients	   with	   first	   episode	   psychosis	   (Job,	  Whalley	   et	   al.	   2003,	   Farrow,	  Whitford	   et	   al.	   2005,	   Job,	  Whalley	   et	   al.	  2005).	   	   	  These	  comprised	  the	  left	  parahippocampal	  gyrus	   (-­‐23,	  6,	  -­‐20),	  	  (Farrow,	  Whitford	  et	  al.	  2005),	   right	   inferior	   frontal	  gyrus	   (45,	  37,	  0),	  (Job,	  Whalley	  et	  al.	  2003),	  and	  the	  left	  superior	  temporal	  gyrus	  	  (-­‐49,	  -­‐31,	   2),	   (Job,	  Whalley	   et	   al.	   2005).	   The	   coordinates	   from	   the	   previous	  studies	   that	  had	   reported	   the	  most	   significant	   effects	   in	   these	   regions	  were	   included	   in	   a	  mask;	   importantly,	   none	   of	   these	   previous	   studies	  had	   included	   data	   from	   subjects	   who	   participated	   in	   the	   present	  investigation.	   Using	   the	   simpleROIbuilder	   toolbox	  (http://www.fil.ion.ucl.ac.uk/spm/ext/),	   I	   created	   a	   mask	   which	  included	   the	   three	   chosen	   regions	   of	   interest.	   This	  mask	   consisted	   of	  three	  spheres	  with	  a	  radius	  of	  8	  mm	  corresponding	  to	  the	  three	  regions	  of	   interest	   and	   comprising	   a	   total	   of	   758.71	   voxels.	  Within	   the	  mask,	  statistical	   inferences	  were	  made	   at	  p	   <	   0.05	   after	   FWE	   correction	   for	  multiple	  comparisons.	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3.3.	  Results	  
3.3.1.	  Sociodemographic	  data	  and	  clinical	  parameters	  	  	  	  There	  were	  no	  significant	  differences	  between	  the	  UHR-­‐T,	  UHR-­‐NT	  and	  healthy	   control	   groups	   in	   age,	   gender,	   total	   grey	   matter	   volume	   and	  ethnicity	   (Table	   3.2.).	   Clinical	   characteristics	   per	   site	   are	   reported	   in	  Appendix	  2.	  	  	  	  
Table	  3.2.	  Sociodemographic	  data	  and	  global	  brain	  volumes	  of	  study	  samples	  	  
Characteristics	   	  Healthy	  Controls	  (n=	  167)	  	  
UHR-­‐T	  (n=	  48)	   UHR-­‐NT	  (n=	  134)	   Significance	  
Age	  (mean,	  SD)	   23.5	  ±	  4.2	   22.73	  ±	  4.5	   23.3	  ±	  5.3	   F(2,	  346)	  =	  0.552	  
p	  =	  0.58	  
Gender	  (Female/Male)	   63/104	   14/34	   51/83	   χ22	  	  =	  2.541	  p	  =	  0.28	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  140/167	  11/167	  10/167	  6/167	  
	  42/48	  1/48	  0/48	  5/48	  
	  106/134	  7/134	  6/134	  15/134	  
	  	  	  	  	  	  	  	  	  	  	  	  	  
χ26	  	  =	  11.122	  
p	  =	  0.09	  
Handedness	  Right	  Left	  Ambidextrous	  
	  147	  14	  6	  
	  44	  3	  1	  
	  126	  6	  2	   χ24	  	  =	  3.355	  p	  =	  0.50	  
GMV	  (mean,	  SD)	   	  0.948	  ±	  0.11	  	   0.945	  ±	  0.08	   0.937	  ±	  0.10	   F(2,	  346)	  =	  0.450	  p	  =	  0.64	  	  
3.3.2.	  Differences	  between	  the	  UHR	  and	  control	  groups	  The	  UHR	  group	  had	  less	  grey	  matter	  volume	  than	  controls	  (at	  p	  <	  0.05	  after	  FWE	  correction)	  in	  three	  areas	  of	  frontal	  cortex:	  the	  medial	  orbital	  gyrus	  and	  the	  gyrus	  rectus	  bilaterally,	  and	  the	  right	  anterior	  cingulate	  gyrus	   (Figure	   3.1.,	   Table	   3.3.).	   In	   these	   regions	   there	   was	   no	  significant	   effect	   of	   medication	   even	   at	   trend	   level	   (p	   <	   0.05	  uncorrected).	  There	  were	  no	  areas	  where	  UHR	  subjects	  had	  more	  grey	  matter	  volume	  than	  controls.	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Figure	  3.1.	  
	  
Figure	  3.1.	  Differences	  between	  the	  ultra	  UHR	  and	  HC	  groups.	  The	  images	  show	  the	  medial	  orbital	  region,	  where	  the	  total	  UHR	  sample	  showed	  reduced	  gray	  matter	  volume	  relative	  to	  HC	  (p	  <	  0.05	  FWE	  corrected).	  	  
	  
Table	  3.3.	  MNI	  coordinates	  
HC>UHR	  









Medial	  orbital	  gyrus	   Right	   7	   40.5	   -­‐16.5	   130	   5.44	   0.001	  Left	   -­‐18	   52.5	   -­‐16.5	   30	   4.94	   0.005	  Cingulate	  gyrus	   Right	   12	   58.5	   9	   50	   5.35	   0.001	  Gyrus	  rectus	   Right	   3	   25.5	   -­‐25.5	   73	   4.94	   0.01	  Left	   -­‐4	   25.5	   -­‐22.5	   4.80	   0.02	  
	  
Table	   3.3.	  MNI	   coordinates	   and	   z	   scores	   for	   regions	   showing	   differences	   in	  gray	   matter	   volume	   between	   UHR	   and	   HC	   groups.	   Abbreviations:	   Hem,	  hemisphere;	  UHR,	  ultra	  high	  risk,	  HC,	  healthy	  controls.	  	  	  
3.3.3.	   Differences	   between	   UHR	   subjects	   who	   did	   and	   did	   not	  
develop	  psychosis	  Region-­‐of-­‐interest	  analysis	  revealed	  reduced	  grey	  matter	  volume	  in	  the	  UHR-­‐T	   relative	   to	   the	   UHR-­‐NT	   group	   in	   the	   anterior	   part	   of	   the	   left	  parahippocampal	   gyrus	   (bordering	   the	   uncus),	   (p	   <	   0.05	   after	   FWE	  correction,	  Figure	  3.2.),	  where	  the	  difference	  between	  UHR-­‐T	  and	  UHR-­‐NT	  accounted	  for	  14%	  of	  the	  total	  variance.	  In	  this	  region,	  there	  was	  no	  significant	   effect	   of	   medication	   even	   at	   trend	   level	   (p	   <	   0.05	  uncorrected).	  Plotting	  of	  gray	  matter	  values	  revealed	  that	  this	  reduction	  was	  evident	  in	  each	  of	  the	  four	  sites	  examined	  for	  this	  contrast	  (Figure	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3.2.).	  There	  were	  no	  significant	  differences	  in	  the	  other	  ROIs	  (i.e.	  in	  the	  right	  inferior	  frontal	  gyrus,	  and	  the	  left	  superior	  temporal	  gyrus).	  	  In	  order	   to	  examine	   the	  predictive	  value	  of	  gray	  matter	  volume	   in	   the	  left	   parahippocampal	   gyrus,	   I	   extracted	   gray	   matter	   values	   from	   the	  peak	  voxel	  and	  performed	  a	  series	  of	  cross-­‐validation	  analyses	  using	  a	  predictive	   linear	   model	   in	   SPSS	   software.	   This	   involved	   developing	   a	  predictive	   model	   based	   on	   a	   data	   set	   from	   a	   single	   scanner	   site	   and	  testing	  it	  in	  each	  of	  the	  other	  data	  sets;	  the	  average	  predictive	  accuracy	  was	   62%	   (sensitivity	   =	   61%;	   specificity	   =	   65%).	   I	   also	   performed	   a	  three-­‐fold	   cross-­‐validation	   analysis	   irrespective	   of	   scanner	   site	  which	  involved	  developing	  a	  predictive	  model	  based	  on	  two	  thirds	  of	  the	  total	  sample	  and	  testing	  it	  in	  the	  remaining	  one	  third;	  this	  yielded	  an	  average	  accuracy	  of	  67%	  (sensitivity	  =	  68%;	  specificity	  =	  66%).	  	  	  
Figure	  3.2.	  
	  
Figure	   3.2.	   Differences	   between	   UHR-­‐T	   and	   UHR-­‐NT.	   The	   UHR-­‐T	  individuals	  had	   less	   gray	  matter	  volume	   than	  did	   the	  UHR-­‐NT	   individuals	   in	  the	   left	   parahippocampal	   gyrus,	   bordering	   the	   uncus	   (MNI	   [Montreal	  Neurological	   Institute]	  coordinates	  x,	  y,	  and	  z:	  −21,	  6,	  and	  −27,	  respectively).	  For	  visualization	  purposes,	  effects	  are	  displayed	  at	  p	  <	  0.05	  uncorrected.	  The	  plot	  shows	  mean	  gray	  matter	  volumes	  for	  the	  two	  UHR	  subgroups	  at	  each	  site	  (x-­‐axis:	  1	  indicates	  London,	  United	  Kingdom;	  2,	  Basel,	  Switzerland;	  3,	  Munich,	  Germany;	   and	   4,	   Melbourne,	   Australia);	   values	   on	   the	   y-­‐axis	   refer	   to	   cubic	  millimeters	  per	  voxel.	  Error	  bars	  represent	  SD.	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3.4.	  Discussion	  MRI	   was	   used	   to	   study	   a	   large	   sample	   of	   UHR	   subjects	   created	   by	  pooling	  data	  from	  five	  sites.	  The	  UHR	  subjects	  were	  followed	  clinically	  subsequent	   to	   scanning	   and	   subcategorised	   according	   to	   which	  individuals	  developed	  psychosis	  and	  which	  did	  not.	  	  	  On	  the	  basis	  of	  previous	  MRI	  studies	  of	  smaller	  UHR	  samples	  collected	  at	  single	  sites,	  (Phillips,	  Velakoulis	  et	  al.	  2002,	  Job,	  Whalley	  et	  al.	  2003,	  Pantelis,	  Yucel	  et	  al.	  2003,	  Garner,	  Pariante	  et	  al.	  2005,	  Job,	  Whalley	  et	  al.	  2005,	  Velakoulis,	  Wood	  et	  al.	  2006,	  Borgwardt,	  McGuire	  et	  al.	  2007,	  Borgwardt,	  Riecher-­‐Rossler	  et	  al.	  2007,	  Borgwardt,	  McGuire	  et	  al.	  2008,	  Fornito,	   Yung	   et	   al.	   2008,	   Koutsouleris,	   Schmitt	   et	   al.	   2009,	  Witthaus,	  Kaufmann	  et	  al.	  2009,	  Buehlmann,	  Berger	  et	  al.	  2010)	  I	  first	  tested	  the	  hypothesis	   that	   the	   UHR	   group	   as	   a	   whole	   would	   show	   volumetric	  abnormalities	   relative	   to	   controls	   that	   were	   qualitatively	   similar	   to	  those	   seen	   in	   patients	   with	   schizophrenia.	   Consistent	   with	   this	  prediction,	   the	   UHR	   group	   expressed	   significant	   reductions	   in	   grey	  matter	  volume	  in	  the	  prefrontal	  and	  anterior	  cingulate	  cortex	  (p	  <	  0.05	  after	  FWE	  correction),	  areas	   that	  have	  been	  consistently	   implicated	   in	  volumetric	   neuroimaging	   studies	   of	   schizophrenia	   (Steen,	   Mull	   et	   al.	  2006).	   Interestingly,	   reductions	   in	   similar	   regions	   of	   the	   prefrontal	  cortex	   have	   been	   associated	   with	   high	   scores	   in	   psychometric	  schizotypy	   in	   healthy	   individuals,	   further	   providing	   support	   for	   a	  phenomenological	   and	   phonotypical	   continuum	   with	   schizophrenia	  spectrum	   disorders	   (Ettinger,	  Williams	   et	   al.	   2012).	   In	   contrast,	   I	   did	  not	   identify	   areas	   where	   there	   was	   more	   grey	   matter	   volume	   in	   the	  UHR	  sample	  than	  in	  controls.	  	  	  The	  main	   prediction	   was	   that	   the	   UHR	   subjects	   who	   later	   developed	  psychosis	  would	  show	  differences	  in	  regional	  grey	  matter	  volume	  in	  the	  inferior	   frontal,	   parahippocampal,	   and	   superior	   temporal	   cortex	  compared	  to	  those	  who	  did	  not	  become	  psychotic.	  This	  hypothesis	  was	  in	   part	   confirmed:	   the	   subgroup	   that	   subsequently	   became	   psychotic	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showed	   relatively	   reduced	   grey	  matter	   volume	   in	   the	   anterior	  part	   of	  the	  left	  parahippocampal	  gyrus,	  bordering	  the	  hippocampal	  uncus	  (p	  <	  0.05	  after	  FWE	  correction).	   In	   this	  area,	   there	  was	   less	  grey	  matter	   in	  UHR-­‐T	  than	  controls	  (p	  <	  0.05	  corrected),	  but	  no	  significant	  difference	  between	   the	   UHR-­‐NT	   and	   control	   groups.	   A	   series	   of	   cross-­‐validation	  analyses	  also	   revealed	   that	  gray	  matter	  volume	   in	   this	   region	  allowed	  discrimination	  between	  UHR-­‐T	  and	  UHR-­‐NT	  with	  an	  accuracy	  of	  up	  to	  67%.	   In	  contrast	   to	  some	  previous	  single	  centre	  studies,	   (Job,	  Whalley	  et	   al.	   2003,	   Job,	   Whalley	   et	   al.	   2005)	   no	   significant	   differences	   were	  found	  in	  either	  the	  inferior	  frontal	  or	  superior	  temporal	  gyri.	  	  	  Reductions	  in	  parahippocampal	  volume	  have	  been	  reported	  in	  high	  risk	  subjects	   relative	   to	   controls	   (Job,	   Whalley	   et	   al.	   2003),	   as	   have	  alterations	   in	   parahippocampal	   function	   (Allen,	   Stephan	   et	   al.	   2010).	  Over	  time	  reductions	  in	  parahippocampal	  volume	  have	  been	  described	  in	  high	  risk	  subjects	  with	  transient	  or	  isolated	  psychotic	  symptoms	  (Job,	  Whalley	  et	  al.	  2005)	  and	  longitudinal	  reductions	  have	  been	  described	  in	  high	   risk	   subjects	  who	  developed	  psychosis	   (Buehlmann,	  Berger	  et	   al.	  2010).	   Moreover	   cross-­‐sectional	   comparisons	   indicate	   that	   patients	  with	   first	   episode	   psychosis	   have	   thinner	   parahippocampal	   cortical	  thickness	   than	   both	   controls	   and	   UHR	   subjects.	   Past	   studies	   suggest	  that	   the	   parahippocampal	   region	   is	   one	   of	   the	   most	   robust	   sites	   of	  volume	  reduction	  in	  chronic	  schizophrenia	  (Shenton,	  Kikinis	  et	  al.	  1992,	  Shenton,	  Dickey	  et	  al.	  2001,	  Seidman,	  Pantelis	  et	  al.	  2003,	  Steen,	  Mull	  et	  al.	   2006).	   Contemporary	   animal	   models	   of	   psychosis	   propose	   that	  altered	   parahippocampal	   activity	   drives	   subcortical	   dopamine	  dysfunction	   (Grace	   2012).	   These	   observations	   are	   consistent	  with	   the	  notion	   that	   the	   parahippocampal	   cortex	   is	   critically	   implicated	   in	  psychotic	  disorders.	  	  At	  the	  time	  of	  scanning,	  the	  UHR-­‐T	  and	  UHR-­‐NT	  groups	  were	  clinically	  indistinguishable;	   the	   volumetric	   differences	   that	   were	   observed	  between	   them	   could	   be	   interpreted	   as	   neurobiological	  markers	   of	   an	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especially	   increased	  vulnerability	  to	  psychosis,	  or	  early	  manifestations	  of	   a	   neuropathological	   process	   underlying	   the	   transition	   to	   psychosis.	  Because	  the	  data	   in	  the	  present	  work	  were	  collected	  at	  a	  single	  cross-­‐sectional	   time-­‐point,	   it	   cannot	   be	   determined	   at	   what	   stage	   these	  differences	  first	  emerged.	  This	  issue	  could	  be	  addressed	  by	  longitudinal	  neuroimaging	   studies	   of	   subjects	   at	   different	   time-­‐points	   within	   the	  prodromal	  phase	  of	  psychosis.	  	  	  A	  limitation	  of	  the	  present	  work	  is	  that	  that	  the	  data	  were	  collected	  on	  different	   scanners	   and	   using	   different	   acquisition	   sequences	   (Meda,	  Giuliani	   et	   al.	   2008,	   Segall,	   Turner	   et	   al.	   2009,	   Stonnington,	   Chu	   et	   al.	  2010).	   Nevertheless	   the	   present	   results	   are	   unlikely	   to	   represent	   an	  artefact	  due	  to	  the	  use	  for	  different	  scanners	  for	  several	  reasons.	  Firstly,	  I	   sought	   to	   control	   for	   these	   effects	   by	   only	   using	  MRI	   data	   collected	  with	   T1-­‐weighted	   sequences	   and	   by	   modelling	   scanner	   site	   as	   an	  independent	   factor	   in	   the	   statistical	   analysis.	   Secondly,	   a	   comparable	  proportion	  of	  controls,	  non-­‐converters	  and	  converters	  were	  scanned	  at	  each	   scanning	   site,	   with	   the	   exception	   of	   one	   of	   the	   London	   datasets	  which	   was	   therefore	   excluded	   from	   the	   UHR-­‐T	   versus	   UHR-­‐NT	  comparison.	  Thirdly,	  plotting	  of	  gray	  matter	  values	  suggested	   that	   the	  differences	  between	  UHR-­‐T	  and	  UHR-­‐NT	  groups	  were	  evident	  not	  only	  across	  different	  centres	  but	  also	  within	  each	  site	  and	  therefore	  cannot	  be	  explained	  by	  inter-­‐scanner	  differences	  (Figure	  3.2).	  Fourthly,	  when	  the	  impact	  of	  scanner	  site	  was	  examined,	  no	  evidence	  of	  either	  scanner	  effects	   or	   scanner	   x	   group	   interactions	   was	   found	   in	   regions	   which	  differed	  between	  groups,	  even	  when	   lowering	   the	  statistical	   threshold	  to	   p	   <	   0.05	   (uncorrected).	   Finally,	   the	   present	   approach	   to	   the	  integration	  of	  multi-­‐scanner	  data	  within	  the	  same	  statistical	  model	  has	  been	   employed	   successfully	   in	   previous	   studies	   which	   also	   combined	  different	   scanners	   and	   acquisition	   sequences	   (Meda,	   Giuliani	   et	   al.	  2008,	  Stonnington,	  Tan	  et	  al.	  2008,	  Segall,	  Turner	  et	  al.	  2009,	  Suckling,	  Barnes	   et	   al.	   2010);	   these	   studies	   typically	   found	   that	   scanner	  differences	   were	   substantially	   less	   than	   group	   differences.	   Consistent	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with	  this,	  in	  the	  present	  work	  scanner-­‐related	  variance	  (11%)	  was	  less	  than	  group-­‐related	  variance	  (14%)	   in	  the	   left	  parahippocampal	  region	  which	  differed	  between	  UHR-­‐T	  and	  UHR-­‐NT	  groups.	  The	  impact	  of	  the	  use	   of	   different	   scanners	   and	   acquisition	   sequences	   could	   be	   further	  controlled	   for	   by	   scanning	   the	   same	   individuals	   at	   each	   site,	   but	   this	  was	  not	  feasible	  in	  the	  present	  investigation.	  	  	  The	   data	   from	   the	   present	   study	   suggest	   that	   in	   future	   it	   may	   be	  possible	  to	  use	  MRI	  to	  facilitate	  the	  prediction	  of	  psychosis	  in	  those	  at	  high	  risk	  (Job,	  Whalley	  et	  al.	  2006).	  This	  would	  be	  particularly	  useful	  in	  the	  clinical	  management	  of	  subjects	  at	  UHR,	  as	   it	   is	  difficult	   to	  predict	  which	  individuals	  will	  go	  on	  to	  develop	  psychosis	  on	  the	  basis	  of	  their	  clinical	  features	  (Yung,	  Phillips	  et	  al.	  2004).	  As	  a	  result,	  it	  is	  not	  possible	  to	   focus	   the	   delivery	   of	   clinical	   resources,	   such	   as	   putatively	  preventative	  treatments	  (McGorry	  and	  Killackey	  2002),	  to	  the	  subgroup	  of	  UHR	  subjects	  who	  will	  later	  become	  psychotic.	  Clinical	  application	  of	  neuroimaging	   in	   this	   context	   requires	   the	   identification	   of	   predictive	  markers	   at	   an	   individual	   level,	   whereas	   the	   present	   data	   represent	  group	   differences.	   Image	   analysis	   methods	   that	   classify	   individual	  subjects	   according	   to	   patterns	   of	   data	   associated	   with	   diagnostic	  categories	   may	   provide	   a	   means	   of	   addressing	   this	   issue	   (Mourao-­‐Miranda,	  Bokde	  et	  al.	  2005).	  	  
3.4.1.	  Conclusions	  In	   conclusion,	   the	   UHR	   is	   associated	  with	   alterations	   in	   regional	   grey	  matter	   volume,	   and	   within	   this	   population,	   reductions	   in	   the	  parahippocampal	  region	  may	  be	  specifically	  linked	  to	  the	  later	  onset	  of	  psychosis.	  These	  findings	  suggest	  that	  neuroimaging	  data	  may	  facilitate	  the	  prediction	  of	  illness	  in	  subjects	  at	  high	  risk	  of	  psychosis,	  and	  inform	  the	  development	  of	  new	  interventions	  designed	  to	  delay	  or	  prevent	  its	  onset.	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4.	  Reduced	  parahippocampal	  cortical	  thickness	  in	  subjects	  at	  
ultra	   high	   risk	   for	   psychosis:	   a	   multi-­‐centre	   voxel-­‐based	  
cortical	  thickness	  study	  
	  
(Adapted	  from	  published	  paper,	  Appendix	  1,	  A1.2.)	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4.1.	  Introduction	  As	  discussed	  in	  Chapter	  1	  and	  Chapter	  3,	  the	  vast	  majority	  of	  structural	  neuroimaging	  studies	   in	  UHR	   individuals	  have	   focused	  on	  gray	  matter	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volume,	   however,	   neuroanatomical	   alterations	   in	   psychosis	   may	   be	  expressed	  not	   only	   in	   terms	  of	   gray	  matter	   volume	  but	   also	   as	   subtle	  changes	  in	  cortical	  thickness.	  While	  the	  analysis	  of	  gray	  matter	  volume	  returns	   a	   mixed	   measure	   that	   depends	   on	   local	   cortical	   thickness	   as	  well	   as	   cortical	   folding	   and	   gyrification	   (i.e.	   cortical	   surface	   area),	   the	  analysis	   of	   cortical	   thickness	   is	   considered	   to	   specifically	   target	   the	  presence	   of	   cortical	   atrophy	   (Hutton,	   De	   Vita	   et	   al.	   2008,	   Hutton,	  Draganski	   et	   al.	   2009).	   Therefore	   the	   two	   approaches	   provide	  complementary	   information	   and	   one	   can	   be	   more	   sensitive	   than	   the	  other	   depending	   on	   the	   process	   underlying	   neuroanatomical	   changes.	  Cortical	   thickness	   in	   the	   human	   brain	   can	   be	   examined	   using	   the	  automated	  data	  analysis	  of	  T1-­‐weighted	   images	  (Hutton,	  De	  Vita	  et	  al.	  2008).	   Application	   of	   this	   approach	   in	   patients	  with	   first	   episode	   and	  established	   schizophrenia	   suggests	   that	   there	   is	   a	   cortical	   thinning	   in	  the	   anterior	   cingulate	   (Narr,	   Bilder	   et	   al.	   2005,	   Fornito,	   Yucel	   et	   al.	  2008,	   Schultz,	   Koch	   et	   al.	   2010),	   prefrontal	   (Narr,	   Bilder	   et	   al.	   2005,	  Venkatasubramanian,	  Jayakumar	  et	  al.	  2008,	  Schultz,	  Koch	  et	  al.	  2010),	  temporal	   (Narr,	   Bilder	   et	   al.	   2005,	   Fornito,	   Yucel	   et	   al.	   2008),	   and	  occipital	   (Narr,	   Toga	   et	   al.	   2005)	   cortices.	   In	   UHR	   subjects,	   reduced	  cortical	   thickness	   has	   been	   reported	   in	   the	   prefrontal,	   anterior	  cingulate,	   inferior	   parietal,	   superior	   temporal	   and	   parahippocampal	  cortices	  compared	  to	  healthy	  controls	  (Jung,	  Kim	  et	  al.	  2011).	  One	  study	  has	   reported	   that	   in	   UHR	   individuals	   who	   subsequently	   developed	  psychosis	   the	   anterior	   cingulate	   cortex	  was	   thinner	   than	   in	   UHR	   that	  did	  not	  become	  ill	  (Fornito,	  Yung	  et	  al.	  2008).	  A	  longitudinal	  study	  has	  reported	   a	   progressive	   thinning	   in	   the	   anterior	   cingulate,	   precuneus	  and	  temporo-­‐parietal-­‐occipital	  cortex	  compared	  to	  UHR-­‐NT	  and	  healthy	  controls	  (Ziermans,	  Schothorst	  et	  al.	  2012).	  Another	  study	  did	  not	  find	  differences	   in	   cortical	   thickness	   between	   individuals	   at	   UHR,	   patients	  with	   a	   first	   psychotic	   episode	   and	   healthy	   controls,	   but	   the	   groups	  differed	  in	  cortical	  thickness	  asymmetry	  (Haller,	  Borgwardt	  et	  al.	  2009).	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As	   with	   volumetric	   studies,	   the	   findings	   from	   studies	   of	   cortical	  thickness	   in	   UHR	   subjects	   may	   have	   been	   inconclusive	   due	   to	   the	  relatively	  small	  sample	  sizes	  examined	  to	  date.	  A	  multi-­‐centre	  approach	  was	   therefore	   adopted	   in	   the	   present	   work.	   The	   main	   aim	   was	   to	  combine	  MRI	  data	  from	  multiple	  centres	  and	  measure	  cortical	  thickness	  in	  large	  samples	  of	  UHR	  subjects	  and	  healthy	  controls.	  The	  second	  aim	  was	   to	   compare	   cortical	   thickness	   in	   UHR	   subjects	  who	   subsequently	  did	   or	   did	   not	   developed	   psychosis.	  Whole-­‐brain	  magnetic	   resonance	  images	   were	   acquired	   from	   individuals	   at	   UHR	   for	   psychosis	   and	  healthy	  controls	  at	   four	  psychiatric	   research	  centres	   in	  London,	  Basel,	  Munich	   and	   Melbourne.	   At	   each	   site,	   subjects	   were	   scanned	   at	   first	  clinical	   presentation,	   and	   followed	   up	   clinically	   or	   in	   the	   context	   of	  research	   projects	   for	   at	   least	   two	   years,	   so	   that	   they	   could	   be	  subcategorized	   according	   to	   psychosis	   outcome.	   The	   MRI	   data	   from	  each	   site	   were	   combined	   to	   form	   a	   large	   UHR	   sample,	   which	   was	  subdivided	   into	   subjects	   who	   later	   had	   developed	   psychosis	   and	  subjects	  who	  had	  not.	  The	  thickness	  of	  the	  cerebral	  cortex	  was	  assessed	  using	  a	  voxel-­‐based	  cortical	  thickness	  (VBCT)	  approach	  that	  generates	  maps	  from	  MRI	  data	  in	  which	  each	  voxel	  in	  the	  gray	  matter	  is	  assigned	  a	  thickness	   value	   and	   regionally	   specific	   differences	   are	   compared	   on	   a	  voxel-­‐by-­‐voxel	  basis	  (Hutton,	  De	  Vita	  et	  al.	  2008,	  Hutton,	  Draganski	  et	  al.	  2009).	  This	  method	  differs	  from	  others	  reported	  in	  the	  literature	  as	  it	   does	   not	   require	   the	   construction	   of	   a	   three-­‐dimensional	  model	   for	  extracting	   cortical	   thickness	   values.	   For	   instance,	   surface-­‐based	  techniques	  involve	  the	  generation	  of	  surface	  models	  that	  are	  driven	  by	  image	   information	   and	   surface	   geometry	   to	   fit	   the	   gray	   and	   white	  matter	  surfaces	  of	  the	   image	  (Fischl	  and	  Dale	  2000,	  Hutton,	  De	  Vita	  et	  al.	   2008).	   Cortical	   thickness	   is	   subsequently	   defined	   at	   surface	   points	  and	   is	  computed	  based	  on	  the	  measure	  of	   the	  distance	  between	  them.	  Another	   approach	   involves	   extracting	   only	   the	   surface	   between	   the	  gray	  and	   the	  white	  matter	   and	   then	  mapping	   towards	   the	   surface	   the	  thickness	   values	   that	   are	   derived	   by	   calculating	   the	   distance	   between	  voxels	  in	  the	  cortex	  and	  the	  surface	  (Lerch	  and	  Evans	  2005,	  Hutton,	  De	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Vita	  et	  al.	  2008).	  	  In	  contrast,	  using	  the	  VBCT	  technique,	  gray	  and	  white	  matter	  boundaries	  are	  defined	  on	  the	  basis	  of	  whole	  voxel	  information	  (Jones,	  Buchbinder	  et	  al.	  2000,	  Hutton,	  De	  Vita	  et	  al.	  2008)	  and	  cortical	  thickness	  is	  calculated	  at	  every	  volumetric	  point	  within	  the	  cortex	  and	  based	   on	   the	   length	   of	   the	   trajectory	   from	   one	   boundary	   to	   another	  (Hutton,	  De	  Vita	  et	  al.	  2008).	  	  	  	  The	  first	  prediction,	  based	  on	  data	  from	  previous	  studies	  (Narr,	  Bilder	  et	  al.	  2005,	  Fornito,	  Yucel	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Schultz,	  Koch	  et	  al.	  2010,	  Jung,	  Kim	  et	  al.	  2011,	  Ziermans,	  Schothorst	  et	  al.	  2012)	  was	  that	  the	  UHR	  group	  as	  a	  whole	  would	  show	  differences	  in	  cortical	  thickness	   relative	   to	   controls	   in	   areas	   that	   have	   previously	   been	  identified	   in	  studies	  of	  cortical	   thickness	   in	  UHR	  subjects	  and	  patients	  with	   first	   episode	   psychosis:	   the	   frontal,	   anterior	   cingulate,	  parahippocampal,	   temporal,	   parietal	   cortices	   and	   the	   precuneus.	   The	  second	   prediction	   was	   that	   within	   the	   UHR	   sample	   subjects	   who	  developed	   psychosis	   subsequent	   to	   scanning	   would	   show	   more	  pronounced	   cortical	   thickness	   abnormalities	   in	   these	   regions	   (Narr,	  Bilder	  et	  al.	  2005,	  Fornito,	  Yucel	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Schultz,	  Koch	  et	  al.	  2010,	  Jung,	  Kim	  et	  al.	  2011,	  Ziermans,	  Schothorst	  et	  al.	  2012)	  than	  those	  who	  did	  not.	  	  
4.2.	  Methods	  	  
4.2.1.	  Sample	  All	   the	  UHR	   subjects	  were	   recruited	   from	   specialised	   clinical	   services	  for	   this	   group	   in	   London	   (i.e.	   1.5T	   scanner),	   Basel,	   Melbourne	   and	  Munich.	   Data	   were	   combined	   from	   these	   four	   sites.	   This	   sample	  partially	  overlaps	  with	  the	  multi-­‐centre	  sample	  described	  in	  Chapter	  3	  (Mechelli,	   Riecher-­‐Rossler	   et	   al.	   2011),	   and	   includes	   subjects	   that	  participated	  in	  previous	  single	  centre	  studies	  of	  grey	  matter	  volume	  in	  this	   population.	   In	   total	   there	  were	  MRI	   data	   from	  167	  UHR	   subjects.	  MRI	  data	  acquired	  from	  healthy	  volunteers	  from	  the	  same	  geographical	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area	  as	  the	  UHR	  subjects	  at	  each	  site	  were	  combined	  to	  form	  a	  control	  dataset.	   The	   total	   control	   sample	   comprised	   150	   subjects,	   and	   was	  comparable	   to	   the	   total	   UHR	   sample	  with	   respect	   to	   gender,	   age,	   and	  ethnicity	   (details	   are	   reported	   in	   Table	   4.1	   and	   4.2.).	   Recruitment	  details	  are	  reported	  in	  Chapter	  2,	  sections	  2.2.	  and	  2.2.2.	  	  
Table	  4.1.	  Number	  of	  subjects	  for	  site	  
Site	   UHR-­‐NT	   UHR-­‐T	   Healthy	  Controls	  London	  Maudsley	  Hospital	   44	  (78.6%)	   12	  (21.4%)	   47	  Basel	   23	  (65.7%)	   12	  (34.3%)	   22	  Munich	   24	  (60%)	   16	  (40%)	   42	  Melbourne	   26	  (72.2%)	   10	  (27.8%)	   39	  Total	   117	  (70%)	   50	  (30%)	   150	  	  In	   the	   following	   30.6	   months	   (SD=10.4),	   50	   (30%)	   of	   the	   UHR	  individuals	   developed	   psychosis	   (UHR-­‐T)	   and	   117	   did	   not	   (UHR-­‐NT).	  Transition	   to	   psychosis	   during	   the	   follow-­‐up	   period	   was	   established	  according	  to	  the	  Diagnostic	  and	  Statistical	  Manual	  of	  Mental	  Disorders,	  Fourth	  Edition	  (DSM-­‐IV)	  criteria	  based	  on	  clinical	  consensus	  between	  at	  least	   two	  experienced	  psychiatrists.	  Most	  of	   the	  UHR	  group	  (147/167,	  84%)	  had	  never	  taken	  antipsychotics	  at	  time	  of	  scanning;	  20	  (12%)	  had	  been	   exposed	   to	   antipsychotics;	   the	   mean	   antipsychotic	   medication	  exposure	   time	   was	   7.5	   weeks	   (SD=11.1).	   UHR	   participants	   that	   were	  receiving	  medication	  were	  scanned	  at	  the	  London	  or	  Basel	  sites.	  Clinical	  characteristics	  of	  the	  UHR	  subjects	  are	  reported	  in	  Appendix	  2.	  	  
4.2.2.	  Image	  acquisition	  At	   all	   four	   sites,	   volumetric	   MR	   images	   were	   acquired	   using	   scanner	  field	   strengths	   of	   1.5T	   and	   a	   T1-­‐weighted	   protocol.	   Two	   sites	   used	  General	   Electric	   scanners	   (i.e.	   London	   and	  Melbourne),	   and	   two	   used	  Siemens	   scanners	   (i.e.	   Basel	   and	   Munich).	   The	   details	   of	   the	   image	  acquisition	  sequence	  are	  reported	  in	  Chapter	  2,	  section	  2.3.2.	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4.2.3.	  Data	  analysis	  
4.2.3.1.	  Sociodemographic	  data	  Sociodemographic	   differences	   between	   groups	   were	   examined	   using	  one-­‐way	   analysis	   of	   variance	   (ANOVA)	   for	   parametric	   data,	   and	   a	   chi	  square	   test	   for	  non-­‐parametric	   data,	   as	   implemented	   in	   the	   Statistical	  Package	   for	   the	  Social	   Sciences	  19.0	   (SPSS	  19.0	   for	  Windows),	   (Table	  
4.2.).	  Sociodemographic	  characteristics	  of	  the	  study	  samples	  by	  site	  are	  reported	  in	  Appendix	  3	  (Table	  A3.2.).	  
4.2.3.2.	  Preprocessing	  Preprocessing	   for	   the	   analysis	   of	   cortical	   thickness	   was	   carried	   out	  using	   the	   procedure	   described	   by	   Hutton	   and	   colleagues	   (Hutton,	   De	  Vita	  et	  al.	  2008,	  Hutton,	  Draganski	  et	  al.	  2009).	   In	  brief,	  all	   the	   images	  were	   visually	   checked	   and	   resampled	   to	   a	   voxel	   size	   of	   1	   mm3	  using	  trilinear	   interpolation.	   Using	   the	   unified	   segmentation	   procedure	  implemented	   in	   SPM8	   (http://www.fil.ion.ucl.ac.uk/spm),	   the	   images	  were	   segmented	   into	   gray	   matter	   (GM),	   white	   matter	   (WM),	   and	  cerebrospinal	   fluid	   (CSF)	   (Ashburner	   2007).	   For	   each	   subject,	   this	  resulted	   in	   a	   set	   of	   3	   images	   in	   the	   same	   space	   as	   the	   original	   T1-­‐weighted	  image,	  in	  which	  each	  voxel	  was	  assigned	  a	  probability	  of	  being	  GM,	  WM,	  and	  CSF,	  respectively.	  A	  voxel-­‐based	  cortical	  thickness	  (VBCT)	  map	  was	  created	  for	  each	  subject	  using	  the	  GM,	  WM,	  and	  CSF	  segments	  created	  in	  the	  previous	  step	  (Hutton,	  De	  Vita	  et	  al.	  2008).	  This	  method	  is	   implemented	   as	   a	   toolbox	   for	   SPM	   (Hutton,	   De	   Vita	   et	   al.	   2008,	  Hutton,	   Draganski	   et	   al.	   2009).	   In	   brief,	   it	   uses	   the	   input	   tissue	  probability	   maps	   and	   a	   transformed	   labeled	   brain	   atlas	  (http://www.fil.ion.ucl.ac.uk/spm/ext/#IBASPM).	   Starting	   from	   the	  initial	  estimate	  of	  the	  GM/WM	  boundary,	  layers	  of	  1	  voxel	  in	  thickness	  are	   successively	   added	   to	   surround	   the	   WM	   allowing	   voxels	   to	   be	  identified	  where	  the	  GM	  from	  different	  sides	  of	  a	  sulcus	  was	  in	  contact.	  Once	  all	  GM	  voxels	  have	  been	  processed	  in	  this	  way,	  Laplace’s	  equation	  is	   solved	   for	   all	   voxels	   between	   the	   final	   GM/WM	   and	   GM/CSF	  boundaries	   resulting	   in	   a	   scalar	   field	   that	  makes	   a	   smooth	   transition	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from	  1	  boundary	   to	   the	  other.	  The	   gradient	   of	   this	   field	   at	   each	  point	  forms	   a	   unique	   trajectory	   connecting	   the	   two	   boundaries,	   and	   the	  thickness	   at	   each	   point	   is	   calculated	   by	   integrating	   along	   these	  trajectories.	   The	   resulting	   VBCT	  maps	   are	   created	   in	   the	   space	   of	   the	  original	   input	   images	   which	   contain	   cortical	   thickness	   values	   within	  voxels	   identified	  as	   cortical	  GM	  and	  zeros	  outside	   the	  cortex.	  DARTEL	  (Ashburner	   2007),	   an	   algorithm	   for	   diffeomorphic	   image	   registration	  which	   is	   implemented	   as	   a	   toolbox	   for	   SPM8,	   was	   used	   to	   warp	   the	  VBCT	  maps	   into	  a	  new	  group-­‐specific	  reference	  space	  representing	  an	  average	   of	   all	   the	   subjects.	   This	   procedure	   uses	   the	   GM	   and	   WM	  segments	  estimated	  from	  the	  original	  T1-­‐weighted	  images	  to	  calculate	  a	  group-­‐specific	   template	   and	   the	   deformation	   fields	   required	   to	   warp	  data	   from	   each	   subject	   to	   the	   new	   template.	   Each	   VBCT	   map	   was	  warped	   to	   the	   new	   template	   using	   the	   corresponding	   subject	   specific	  deformation	   field	   and	  was	   resampled	   to	   an	   isotropic	   voxel	   size	   of	   1.5	  mm3	  using	  trilinear	  interpolation.	  The	  warped	  VBCT	  maps	  were	  scaled	  by	   the	   Jacobian	   determinant	   of	   the	   deformations	   to	   account	   for	  stretching	  and	   compression	  and	   subsequently	   smoothed	  with	  a	  6-­‐mm	  Gaussian	   kernel	   then	  divided	  by	   a	   binary	  mask	   of	   each	   original	  VBCT	  map	   which	   had	   been	   identically	   warped,	   scaled,	   and	   smoothed.	   A	  Gaussian	   kernel	   of	   6-­‐mm	   was	   chosen	   because,	   when	   investigating	  cortical	   thickness,	   it	   is	   important	   to	  keep	  smoothing	   to	  a	  minimum	  so	  that	  any	  abrupt	  changes	  in	  thickness	  that	  may	  occur	  at	  the	  boundaries	  between	  cortical	   areas	  are	  not	  obscured	   (Hutton,	  De	  Vita	  et	  al.	  2008).	  This	  procedure	  results	   in	  smoothed	  warped	  VBCT	  maps	   for	  which	  the	  Gaussian	   smoothing	   kernel	   applied	   in	   the	   warped	   space	   has	   been	  projected	  into	  the	  native	  space	  of	  the	  subject,	  and	  the	  cortical	  thickness	  values	   are	   preserved	   over	   a	   region	   the	   size	   of	   the	   smoothing	   kernel.	  Before	   performing	   the	   statistical	   analysis	   on	   the	   smoothed	   warped	  VBCT	  maps,	  I	  checked	  for	  homogeneity	  across	  the	  sample.	  	  
	   66	  
4.2.4.	  Statistical	  analyses	  	  The	   statistical	   analysis	   was	   performed	   using	   SPM8	   software	   on	   the	  smoothed	   warped	   VBCT	   maps.	   An	   analysis	   of	   variance	   was	   used	   to	  compare	   cortical	   thickness	  in	   UHR-­‐T,	   UHR-­‐NT	   and	   healthy	   controls.	  Scanner	  site	  was	  modeled	  as	  an	  additional	  factor,	  resulting	  in	  a	  total	  of	  12	   experimental	   groups.	   Including	   scanner	   site	   as	   a	   factor	   in	  the	  statistical	  analysis	  allowed	  us	  to	  model	  scanner-­‐related	  variance	  in	  the	  data,	   which	   had	   the	   effect	   of	   reducing	   error	  variance	   and	   increasing	  statistical	  sensitivity.	  Age,	  gender,	  ethnicity	  and	  handedness	  were	  also	  modelled	   as	  covariates	   of	   no	   interest	   to	   minimize	   any	   confounding	  effect	   of	  these	   variables	   on	   the	   findings.	   A	   region	   of	   interest	   (ROI)	  approach	   was	   used	   to	   examine	   between	   group	   differences	   in	   areas	  where	   abnormalities	   in	   cortical	   thickness	  have	  been	   identified	   in	  MRI	  studies	   of	   individuals	   at	   UHR	   or	   with	   a	   first	   episode	   of	   psychosis,	  excluding	  studies	  that	  included	  data	  from	  subjects	  who	  participated	  in	  the	  present	  investigation.	  	  These	  comprised	  the	  parahippocampal	  gyrus,	  inferior	   frontal	   gyrus,	   anterior	   cingulate,	   superior	   temporal	   gyrus,	  inferior	   parietal	   gyrus,	   and	   the	   precuneus	   (Narr,	   Bilder	   et	   al.	   2005,	  Schultz,	  Koch	  et	  al.	  2010,	  Jung,	  Kim	  et	  al.	  2011,	  Ziermans,	  Schothorst	  et	  al.	   2012).	   Using	   WFU	   PickAtlas	  (http://www.nitrc.org/projects/wfu_pickatlas/)	   a	   mask	   was	   created	  that	  included	  the	  six	  chosen	  regions	  of	  interest	  and	  comprised	  a	  total	  of	  11,700	  voxels.	  Within	  this	  mask,	  statistical	  inferences	  were	  made	  using	  a	   statistical	   threshold	   of	   p	   <	   0.05	   after	   familywise	   error	   (FWE)	  correction	  for	  multiple	  comparisons	  as	  calculated	  in	  SPM8.	  Trends	  that	  did	   not	   survive	   correction	   for	   multiple	   comparisons	   (p	   <	   0.001	  uncorrected)	   are	   reported	   but	   not	   discussed.	   For	   completeness	   I	   also	  performed	   a	   whole-­‐brain	   analysis	   using	   a	   statistical	   threshold	   of	   p	  <	  0.05	  after	  FWE	  correction	  for	  multiple	  comparisons.	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4.3.	  Results	  
4.3.1.Sociodemographic	  data	  No	   statistically	   significant	   differences	   were	   noted	   among	   the	   UHR-­‐T,	  UHR-­‐NT,	   and	   control	   groups	   in	   age,	   sex,	   ethnicity	   and	   handedness	  (Table	  4.2.).	  	  	  
Table	  4.2.	  Sociodemographic	  characteristics	  of	  the	  study	  samples	  	  
	  
Characteristics	   Healthy	  Controls	  	  (n=	  150)	   UHR-­‐T	  (n=	  50)	   UHR-­‐NT	  (n=	  117)	   	  Significance	  
Age	  (mean,	  SD)	   23.4	  ±	  4.3	   22.9	  ±	  4.6	   23.3	  ±	  5.3	   F(2,	  315)	  =	  0.221	  
p	  =	  0.801	  
Gender	  (Female/Male)	   51/99	  	   36/14	  	   83/51	  	   χ22	  =	  2.927	  p	  =	  0.231	  
Ethnicity	  Caucasian	  Black	  	  Asian	  Mixed	  
	  128/150	  7/150	  9/150	  6/150	  
	  43/50	  1/50	  0/50	  6/50	  
	  96/117	  5/117	  5/117	  11/117	  
	  χ26	  =	  8.320	  
p	  =	  0.216	  
Handedness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Right	  Left	  Ambidextrous	  
	  132/150	  12/150	  6/150	  
	  45/50	  4/50	  1/50	  
	  111/117	  4/117	  2/117	  
	  χ24	  =	  4.164	  
p	  =	  0.384	  
Medication	  	  	  (number	  of	  subjects	  receiving	  antipsychotics)	  	  	  	  	  	  	  	  	  	  	  	  	  	  n/a	   5/50	   21/117	  
χ21	  =	  1.684	  
p	  =	  0.194	  	  
4.3.2.	  Differences	  between	  the	  UHR	  and	  control	  groups	  	  Within	  the	  regions	  of	  interest,	  the	  cortex	  was	  thinner	  in	  the	  UHR	  group	  than	   in	   controls	   in	   the	   right	   parahippocampal	   gyrus	   (p	   <	   0.05	   FWE	  corrected;	   z-­‐score=	   4.06;	   MNI	   coordinates	   x=	   25,	   y=	   -­‐4,	   z=	   -­‐13	   see	  
Figure	   4.1).	   There	   was	   also	   a	   trend	   (p	   <	   0.001	   uncorrected)	   for	   a	  thinner	   cortex	   in	   the	  UHR	   group	   compared	   to	   controls	   in	   the	   inferior	  part	  of	  the	  left	  parahippocampal	  gyrus	  (z-­‐score	  =3.42:	  MNI	  coordinates	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x=	  -­‐20,	  y=	  -­‐7	  z=	  -­‐30).	  Plotting	  of	   the	  cortical	   thickness	  values	  revealed	  that	   the	  reduction	   in	   right	   parahippocampal	   cortical	   thickness	   was	  evident	  in	  the	  data	  from	  each	  of	  the	  four	  sites	  (Figure	  4.1).	  In	  contrast,	  there	  were	  no	  areas	   in	  which	  UHR	   individuals	  had	   thicker	  cortex	   than	  healthy	   controls.	   The	  whole-­‐brain	   analysis	   did	   not	   identify	   significant	  differences	   in	   cortical	   thickness	   between	   the	   UHR	   group	   and	   healthy	  controls	  at	  p	  <	  0.05	  (FWE	  corrected).	  	  	  
Figure	  4.1.	  
	  
Figure	   4.1.	   Cortical	   thickness	   differences	   between	   the	   UHR	   and	   HC	  
groups.	   Right	   parahippocampal	   region	  where	   the	   total	  UHR	   sample	   showed	  cortical	   thinning	   relative	   to	   healthy	   controls	   (HC);	   (p	   <	   0.05	   after	   FWE	  correction).	   For	   visualization	   purposes,	   effects	   are	   displayed	   at	   p	   <	   0.001	  uncorrected.	  The	  plot	  shows	  cortical	   thickness	  values	   for	   the	  healthy	  control	  group	   and	   two	   UHR	   subgroups	   at	   each	   site	   (x	   axis:	   1=	   London,	   2=Basel,	  3=Melbourne,	   4=Munich);	   values	   on	   the	   y	   axis	   refer	   to	   millimeters	   (mm).	  Error	  bars	  represent	  SD.	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4.3.3.	   Differences	   between	   UHR	   subjects	   who	   did	   and	   did	   not	  
develop	  psychosis	  No	  differences	  were	  observed	  for	  the	  comparison	  between	  UHR-­‐T	  and	  UHR-­‐NT	   at	  p	   <	   0.05	  after	   FWE	   correction.	   At	   a	   less	   conservative	  statistical	   threshold	   (p	   <	   0.001	   uncorrected),	   there	   was	   a	   trend	   for	  cortical	   thinning	   in	   the	   UHR-­‐T	   group	   in	   the	   orbital	   part	   of	   the	   left	  inferior	  frontal	  gyrus	  (z-­‐score=3.32;	  MNI	  coordinates	  x=	  -­‐33,	  y=	  32,	  z=	  -­‐15).	   The	   whole-­‐brain	   analysis	   revealed	   no	   significant	   differences	  between	  the	  UHR-­‐T	  and	  UHR-­‐NT	  groups	  at	  p	  <	  0.05	  (FWE	  corrected).	  	  
4.4.	  Discussion	  Previous	   neuroimaging	   studies	   have	   reported	   cortical	   thinning	   in	  schizophrenia,	  as	  well	  as	  in	  first	  episode	  psychosis	  and	  in	  UHR	  subjects	  (Narr,	  Bilder	  et	  al.	  2005,	  Fornito,	  Yucel	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	   Schultz,	   Koch	   et	   al.	   2010,	   Jung,	   Kim	   et	   al.	   2011,	   Ziermans,	  Schothorst	  et	  al.	  2012).	  However,	   the	  results	  of	  these	  studies	  have	  not	  always	   been	   consistent;	   this	  may	   reflect	   the	   recruitment	   of	   relatively	  small	  samples,	  the	  use	  of	  different	  study	  designs,	  and	  the	  investigation	  of	   samples	   that	   were	   heterogeneous	   with	   respect	   to	   age,	   duration	   of	  illness	   and	   exposure	   to	   treatment.	   In	   the	   present	   doctoral	   work,	   the	  impact	   of	   these	   potential	   methodological	   pitfalls	   was	   reduced	   by	  assessing	  cortical	  thickness	  in	  a	  relatively	  large	  sample	  of	  individuals	  at	  UHR	   for	   psychosis,	   all	   of	   whom	   were	   scanned	   at	   a	   similar	   stage	   of	  illness,	   when	   they	   first	   presented	   with	   clinical	   high	   risk	   symptoms.	  Most	   of	   the	   sample	   had	   not	   been	   treated	   before.	   The	   first	   hypothesis	  was	  that	  the	  UHR	  group	  as	  a	  whole	  would	  show	  differences	  in	  regional	  cortical	   thickness	   relative	   to	   controls,	   and	   that	   these	   would	   be	   most	  evident	  in	  areas	  that	  have	  previously	  been	  identified	  as	  sites	  of	  cortical	  thickness	  or	  volume	  abnormalities	   in	  studies	  of	  UHR	  and	   first	  episode	  subjects	   (i.e.	   the	   temporal,	   frontal,	   parietal,	   anterior	   cingulate,	  parahippocampal	   cortices	   and	   the	  precuneus).	  This	  hypothesis	  was	   in	  part	   confirmed,	   in	   that	   it	   was	   found	   that	   the	   right	   parahippocampal	  cortex	  was	   thinner	   in	   the	  UHR	   group	   than	   in	   controls.	   This	   finding	   is	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consistent	   with	   those	   of	   a	   recent	   investigation	   which	   also	   found	  reductions	   in	   thickness	   in	  other	   cortical	   areas	   (Jung,	  Kim	  et	   al.	   2011).	  This	   result	   is	   also	   in	   line	   with	   evidence	   that	   the	   density	   of	   the	  parahippocampal	  gyrus	  is	  altered	  in	  UHR	  and	  familial	  high	  risk	  subjects	  (Job,	  Whalley	  et	  al.	  2003).	  Furthermore,	  in	  first	  episode	  schizophrenia,	  altered	   right	   parahippocampal-­‐lingual	   cortical	   folding	   and	   reduced	  cortical	   thickness	  have	  been	   found	  (Schultz,	  Koch	  et	  al.	  2010).	  Finally,	  this	  region	  has	  also	  been	  identified	  as	  a	  site	  of	  functional	  (Allen,	  Seal	  et	  al.	  2011)	  alterations	  in	  UHR	  subjects	  and	  is	  one	  of	  the	  most	  robust	  site	  of	   volume	   reduction	   (Seidman,	   Pantelis	   et	   al.	   2003)	   and	  neuropathological	   abnormalities	   (Shenton,	   Dickey	   et	   al.	   2001)	   in	  schizophrenia.	  In	  the	  study	  described	  in	  Chapter	  3,	  differences	  between	  the	  UHR	  sample	  and	  controls	  were	  described	   in	  the	  ventral	  prefrontal	  and	   anterior	   cingulate	   cortex,	   but	   not	   in	   the	   parahippocampal	   cortex	  (Mechelli,	   Riecher-­‐Rossler	   et	   al.	   2011).	   However,	   in	   that	   study	   the	  subgroup	  of	  UHR	  subjects	   that	   subsequently	  developed	  psychosis	  had	  smaller	   left	  parahippocampal	  volumes	   than	   the	  UHR	  subjects	  who	  did	  not	   make	   a	   transition	   to	   psychosis.	   This	   volumetric	   finding	   was	   in	   a	  similar	  part	  of	  the	  parahippocampal	  gyrus	  to	  the	  site	  of	  the	  difference	  in	  cortical	  thickness	  between	  all	  UHR	  subjects	  and	  controls	  in	  the	  present	  work,	  although	  in	  the	  opposite	  hemisphere.	  Differences	  in	  the	  location	  of	  alterations	   in	  cortical	   thickness	  and	  cortical	  volume	  may	  reflect	   the	  fact	   that	   abnormalities	   in	   these	   two	   measures	   are	   not	   necessarily	  manifestations	   of	   the	   same	  underlying	  neuroanatomical	   changes.	   This	  would	   be	   consistent	   with	   recent	   evidence	   that	   cortical	   thickness	   and	  surface	   area	   are	   genetically	   and	   phenotypically	   independent	   and	   that	  the	  local	  cortical	  volume	  is	  more	  closely	  related	  to	  surface	  area	  than	  to	  cortical	   thickness	   (Winkler,	   Kochunov	   et	   al.	   2010).	   Therefore	  differences	   between	   the	   results	   of	   the	  present	  work	   and	   the	  previous	  VBM	   study	   may	   be	   partially	   explained	   by	   the	   fact	   that	   the	   cortical	  thickness	  method	  does	  not	   take	  surface	   information	   into	  account.	  The	  volumetric	  reduction	  of	  the	  left	  parahippocampal	  gyrus	  reported	  in	  the	  study	   described	   in	   Chapter	   3	   (Mechelli,	   Riecher-­‐Rossler	   et	   al.	   2011)	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may	   denote	   a	   marker	   of	   progression	   consistent	   with	   the	   results	   of	  earlier	  investigations	  (Pantelis,	  Velakoulis	  et	  al.	  2003,	  Job,	  Whalley	  et	  al.	  2005),	  whereas	   the	   thinning	   of	   the	   right	   parahippocampal	   gyrus	  may	  represent	   either	   a	   vulnerability	  marker	   (evident	   not	   only	   in	   the	   UHR	  stage	  but	  also	  in	  the	  earlier	  asymptomatic	  stage)	  or	  a	  specific	  marker	  of	  the	  UHR	   stage	   (not	   evident	   in	   the	   earlier	   asymptomatic	   stage).	   These	  two	  alternative	  options	  could	  be	  investigated	  by	  acquiring	  longitudinal	  neuroimaging	  data	  from	  individuals	  at	  high	  genetic	  risk.	  	  	  The	  second	  hypothesis	  was	  that	  UHR	  subjects	  who	  went	  on	  to	  develop	  psychosis	   would	   already	   at	   baseline	   show	   more	   pronounced	   cortical	  thickness	  abnormalities	  than	  UHR	  subjects	  who	  did	  not.	  No	  significant	  	  differences	   that	   survived	   correction	   for	   multiple	   comparisons	   were	  observed.	  Two	  previous	  studies	  have	  investigated	  cortical	  thickness	  in	  UHR	   subjects	   in	   relation	   to	   clinical	   outcome.	   One	   study,	   which	  restricted	  its	  analysis	  to	  the	  anterior	  cingulate	  cortex,	  reported	  cortical	  thinning	   in	   this	   region	   in	   the	   UHR-­‐T	   group	   compared	   to	   the	   UHR-­‐NT	  (Fornito,	  Yung	  et	  al.	  2008).	  The	  anterior	  cingulate	  cortex	  was	  included	  as	  one	  of	  the	  regions	  of	  interest	  based	  on	  previous	  studies	  (Narr,	  Toga	  et	   al.	   2005,	   Jung,	   Kim	   et	   al.	   2011,	   Ziermans,	   Schothorst	   et	   al.	   2012),	  however	  an	  effect	  in	  this	  regions	  was	  not	  detected;	  this	  may	  be	  in	  part	  explained	   by	   methodological	   differences	   in	   thickness	   measurements	  and	   in	   ROIs	   investigated.	   The	   second	   study	   used	   MRI	   to	   scan	   UHR	  subjects	   at	   two	   time-­‐points	   and	   compared	   longitudinal	   changes	   in	  cortical	   thickness	   in	   UHR	   individuals	   who	   did	   and	   did	   not	   make	   a	  transition	   to	   psychosis.	   The	   UHR-­‐T	   group	   showed	   longitudinal	  reductions	   in	   several	   regions	   including	   anterior	   cingulate,	   precuneus	  and	  temporo-­‐parietal-­‐occipital	  areas	  compared	  to	  controls,	  whereas	  the	  UHR-­‐NT	  group	  did	  not	  (Ziermans,	  Schothorst	  et	  al.	  2012).	  In	  contrast	  no	  differences	   in	   cortical	   thickness	   were	   reported	   between	   UHR-­‐T	   and	  UHR-­‐NT	   at	   baseline.	   The	   inconsistency	   between	   previous	   studies	   and	  the	   present	   investigation	   could	   be	   in	   part	   explained	   by	   the	   use	   of	  different	   techniques	   to	   measure	   cortical	   thickness.	   In	   particular,	   the	  
	   72	  
studies	   by	   Fornito	   and	   colleagues	   and	   Ziermans	   and	   colleagues	   used	  two	  different	  surface-­‐based	  methods	  (Fischl	  and	  Dale	  2000,	  Kim,	  Singh	  et	  al.	  2005,	  Fornito,	  Yung	  et	  al.	  2008,	  Ziermans,	  Schothorst	  et	  al.	  2012)	  while	   in	   the	  present	  work,	  a	  voxel-­‐based	  method	  was	  used	   to	  derived	  cortical	   thickness	   values	   (Hutton,	   De	   Vita	   et	   al.	   2008).	   Another	   study	  reported	  no	  baseline	  differences	  in	  cortical	  thickness	  between	  UHR	  and	  first	   episode	   psychosis	   and	   healthy	   controls,	   although	   the	   analysis	   of	  cortical	   asymmetry	   revealed	   significant	   group	   differences	   (Haller,	  Borgwardt	   et	   al.	   2009).	   The	   lack	   of	   significant	   differences	   between	  UHR-­‐T	  and	  UHR-­‐NT	  may	  seem	  surprising,	  given	  that	  the	  present	  sample	  was	   relatively	   large,	   and	   abnormalities	   in	   functional	   and	   in	   other	  structural	   measures	   between	   these	   subgroups	   have	   previously	   been	  identified	   (Pantelis,	   Velakoulis	   et	   al.	   2003,	   Borgwardt,	   McGuire	   et	   al.	  2008,	  Mechelli,	  Riecher-­‐Rossler	   et	   al.	   2011,	  Allen,	  Luigjes	   et	   al.	   2012).	  One	   possible	   explanation	   for	   the	   absence	   of	   significant	   differences	   in	  the	   present	   study	   is	   that	   there	   was	   some	   heterogeneity	   within	   the	  present	   UHR	   sample.	   Individuals	   can	  meet	   the	   UHR	   inclusion	   criteria	  through	  different	  patterns	  of	  clinical	  and	  cognitive	  symptoms,	  and	  it	  is	  unknown	   if	   these	   reflect	   distinct	   pathophysiological	   processes.	  Unfortunately,	  a	  stratification	  of	  the	  statistical	  analysis	  by	  type	  of	  UHR	  inclusion	   criteria	   was	   not	   possible	   in	   the	   present	   investigation	   as	  incorporating	   this	   additional	   factor	  would	   require	  much	   larger	   single	  centre	   sample	   sizes.	   The	   sample	   may	   also	   have	   been	   clinical	  heterogeneous	  with	   respect	   to	   the	   co-­‐morbid	   anxiety,	   depression	   and	  substance	   abuse	   that	   are	   often	   present	   in	   UHR	   subjects	   (Svirskis,	  Korkeila	  et	  al.	  2005).	  	  	  Another	   possibility	   is	   that	   some	   subjects	   who	   met	   transition	   criteria	  subsequently	  have	  returned	  to	  lower	  levels	  of	  psychotic	  symptoms	  and	  higher	   levels	  of	   functioning,	  while	   some	  who	  did	  not	  meet	   criteria	   for	  transition	   actually	   have	   deteriorated	   in	   functioning	   over	   time.	   This	  latter	   group	   may	   be	   more	   likely	   to	   develop	   schizophrenia	   than	   the	  former	  group	  (Yung,	  Nelson	  et	  al.	  2010).	  Thus	  the	  non-­‐transitioned	  but	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low	  functioning	  group	  may	  show	  brain	  imaging	  changes	  consistent	  with	  the	   ones	   observed	   in	   schizophrenia,	   but	   the	   high	   functioning	  transitioned	  cases	  may	  not.	  	  The	   age	   range	   of	   the	   present	   sample	   of	   UHR	   individuals	   varied	  considerably	   across	   the	   four	   sites	   (age	   range	   15-­‐37,	   see	   Table	   A3.2.,	  Appendix	   3).	   Previous	   works	   indicates	   that	   the	   pattern	   of	  neuroanatomical	  findings	  in	  schizophrenia	  with	  a	  relatively	  early	  onset	  (e.g.	  before	  the	  age	  of	  18)	  differs	  from	  that	  in	  schizophrenia	  with	  onset	  in	  adulthood	  and	  that	  the	  longitudinal	  trajectory	  of	  brain	  abnormalities	  varies	  with	  the	  age	  of	  onset	  (Gogtay,	  Vyas	  et	  al.	  2011).	  Although	  age	  was	  modelled	  as	  a	  covariate	  of	  no	  interest	  in	  the	  statistical	  analysis,	  the	  fact	  that	  the	  UHR	  sample	  comprised	  individuals	  at	  different	  stages	  of	  brain	  development	   might	   have	   reduced	   the	   likelihood	   of	   detecting	   reliable	  differences.	  	  	  A	   further	   potential	   contributory	   factor	   is	   that	   the	   MRI	   data	   were	  collected	   on	   different	   scanners,	   using	   different	   acquisition	   sequences.	  However,	   the	  present	   results	  are	  not	   likely	   to	  be	   significantly	  affected	  by	  the	  use	  of	  different	  scanners	  for	  several	  reasons.	  First,	  only	  MRI	  data	  collected	  with	  T1-­‐weighted	  sequences	  were	  used	  and	  scanner	  site	  was	  modelled	  as	  an	  independent	  factor	  in	  the	  statistical	  analysis.	  Second,	  a	  comparable	  proportion	  of	   controls,	  UHR-­‐NT	  and	  UHR-­‐T	  were	  scanned	  at	   each	   scanning	   site.	   Third,	   plotting	   of	   gray	  matter	   values	   suggested	  that	   the	   differences	   between	   UHR	   and	   healthy	   control	   groups	   were	  evident	   also	   within	   each	   site	   and	   therefore	   cannot	   be	   explained	   by	  inter-­‐scanner	   differences	   (Figure	   4.1).	   Fourthly,	   when	   the	   impact	   of	  scanner	  site	  was	  examined,	  no	  evidence	  of	  scanner	  x	  group	  interactions	  was	   found	   in	   the	   region	   that	   differed	   between	   groups,	   even	   when	  lowering	  the	  statistical	  threshold	  to	  p	  <	  0.05	  (uncorrected).	  A	  scanner	  x	  group	   interaction	  was	   observed	   in	   the	   superior	   temporal	   gyrus	   (MNI	  coordinates	   x;	   y;	   z:	   -­‐46;	   18;	   -­‐12	   p	   =	   0.022),	   which	   however	   did	   not	  significantly	  differ	  between	  HC	  and	  UHR	  or	  between	  UHR-­‐T	  and	  UHR-­‐
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NT.	   Finally,	   the	   present	   approach	   to	   the	   integration	   of	   multi-­‐scanner	  data	   has	   been	   employed	   successfully	   in	   previous	   studies	   that	   also	  combined	   different	   scanners	   and	   acquisition	   sequences	   (Stonnington,	  Tan	  et	  al.	  2008,	  Segall,	  Turner	  et	  al.	  2009,	  Suckling,	  Barnes	  et	  al.	  2010).	  Nevertheless,	   it	  cannot	  be	  completely	  excluded	  an	  effect	  of	  scanner	  on	  the	   findings,	   and	   ideally	  multi-­‐centre	   studies	   should	   employ	   the	   same	  acquisition	   sequence,	   and	   calibrate	   data	   across	   scanners	   using	  phantoms	  and	  common	  subjects	  to	  minimize	  the	  risk	  of	  scanner-­‐related	  effects	  (Jack,	  Bernstein	  et	  al.	  2008).	  	  	  The	   whole-­‐brain	   analysis	   did	   not	   identify	   significant	   differences	   in	  cortical	   thickness	   between	   the	   UHR	   group	   and	   healthy	   controls	   or	  between	  UHR-­‐T	  and	  UHR-­‐NT	  at	  p	  <	  0.05	  (FWE	  corrected).	  This	  could	  be	  in	   part	   explained	   by	   the	   heterogeneity	   of	   the	   UHR	   sample	   (e.g.	  symptoms,	  level	  of	  functioning,	  age),	  or	  by	  the	  use	  of	  different	  scanners	  and	  sequences.	  Nevertheless,	  when	  restricting	  the	  analysis	  to	  regions	  of	  interest,	  the	  method	  employed	  was	  able	  to	  detect	  a	  thickness	  reduction	  in	   the	   right	   parahippocampal	   gyrus	   in	   UHR	   group	   compared	   to	   the	  control	  group	  at	  a	  statistical	  threshold	  of	  p	  <	  0.05	  corrected	  (FWE).	  The	  reduction	  was	  evident	  across	  all	  the	  different	  scanning	  sites.	  Using	  the	  whole-­‐brain	   approach	   did	   not	   enable	   to	   detect	   differences	   at	   a	  corrected	   level,	   this	  might	   indicate	   that	   group	   differences	   in	   the	  UHR	  population	  are	  distributed	  and	  diluted	  across	  the	  brain	  cortex.	  
4.4.1.	  Conclusions	  In	  conclusion	  right	  parahippocampal	  thinning	  was	  observed	  in	  subjects	  at	  UHR	  for	  psychosis	  suggesting	  that	  thickness	  reduction	  in	  this	  region	  is	   related	   to	   the	   UHR	   symptomatology	   rather	   than	   the	   onset	   of	  psychosis.	   This	   cortical	   alteration	   could	   represent	   a	   marker	   of	  vulnerability	   to	   psychosis	   or,	   alternatively,	   a	   specific	   and	   distinctive	  marker	   of	   the	  UHR	   stage.	   No	   reliable	   differences	   in	   cortical	   thickness	  were	   found	   between	   subjects	   who	   did	   and	   did	   not	   go	   on	   to	   develop	  psychosis.	  	  Future	  multi-­‐centre	  work	  in	  this	  area	  would	  benefit	  from	  the	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subcharacterization	   of	   UHR	   individuals	   with	   different	   clinical	   and	  cognitive	  profiles,	   the	  recruitment	  of	  participants	  at	   the	  same	  stage	  of	  neurodevelopment	   and	   the	   use	   of	   a	   standardised	   image	   acquisition	  sequence.	  	   	  
	   76	  
5.	   Pattern	   classification	   analysis	   of	   structural	   data	   in	   a	   multi-­‐
centre	  sample	  of	  individuals	  at	  ultra	  high	  risk	  for	  psychosis	  
5.1.	  Introduction	  In	   the	   last	   two	   decades,	   there	   has	   been	   growing	   interest	   in	   trying	   to	  identify	   those	   individuals	   in	   the	   prodromal	   stages	   of	   psychosis	   to	  provide	   immediate	   and	   targeted	   psychological	   and	   pharmacological	  interventions.	  To	  date,	  the	  identification	  of	  individuals	  at	  increased	  risk	  for	  psychosis	  relies	  mainly	  on	  clinical	  high	  risk	  criteria	  (Yung,	  Yuen	  et	  al.	   2005,	   Schultze-­‐Lutter	   2007,	   Riecher-­‐Rossler,	   Aston	   et	   al.	   2008,	  Schultze-­‐Lutter	   2009,	   Schultze-­‐Lutter,	   Klosterkotter	   et	   al.	   2014).	  However,	   based	  on	   these	   sets	   of	   criteria,	   it	   is	   only	  possible	   to	  predict	  transition	   to	   psychosis	   in	   18%	   of	   cases	   after	   6	   months	   of	   follow-­‐up,	  22%	   after	   12	   months,	   29%	   after	   24	   months,	   and	   36%	   after	   3	   years	  (Fusar-­‐Poli,	  Bonoldi	  et	  al.	  2012).	  Therefore	  additional	  biomarkers	  that	  can	   aid	   the	   identification	   of	   prodromal	   individuals	   are	   necessary	   to	  improve	   the	  predictive	  value	  of	   clinical	  high-­‐risk	   criteria	  and	   to	  assist	  the	   diagnosis	   and	   prognosis	   in	   the	   initial	   stages	   of	   psychosis.	  Neuroimaging	   studies	   have	   tried	   to	   address	   this	   issue	   by	   examining	  structural	   abnormalities	   in	   the	   UHR	   individuals.	   Neuroimaging	  evidence	   suggests	   that	   some	   neuroanatomical	   alterations	   are	   already	  present	  in	  people	  at	  UHR	  for	  psychosis	  whereas	  others	  occur	  during	  the	  time	   of	   transition,	   supporting	   the	   idea	   of	   “late	   neurodevelopmental	  disturbance”	   that	   occurs	   during	   late-­‐adolescence	   or	   early	   adulthood	  (Pantelis,	  Yucel	  et	  al.	  2005).	  	  	  The	   results	   so	   far	   are	   not	   conclusive	   due	   to	   their	   heterogeneity;	   this	  may	  at	  least	  in	  part	  be	  explained	  by	  differences	  in	  the	  samples	  features	  (such	   as	   socio-­‐demographic	   characteristics	   e.g.	   age,	   gender),	   by	   the	  diverse	   inclusion	   criteria	   adopted	   by	   the	   different	   studies,	   including	  symptomatology	  and	   comorbidities,	   and	  by	   the	  use	  of	   relatively	   small	  samples	  which	  may	  have	  resulted	  in	  type	  I	  errors	  (Button,	  Ioannidis	  et	  al.	   2013).	   One	   of	   the	   key	   problems	   in	   the	   study	   of	   the	   high	   risk	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population	  is	  the	  difficulty	  in	  recruiting	  relatively	  large	  samples,	  which	  is	  even	  more	  challenging	  when	  comparing	   those	  UHR	   individuals	  who	  make	   transition	   to	  psychosis	   (UHR-­‐T,	   transition)	   to	   those	  who	  do	  not	  (UHR-­‐NT,	  non-­‐transition).	  	  	  Another	   characteristic	   of	   past	   neuroimaging	   studies	   investigating	  structural	  abnormalities	  in	  the	  UHR	  population,	  is	  that	  the	  vast	  majority	  of	   them	  have	  used	  univariate	   analytical	  methods	   that	   allow	   statistical	  inferences	   at	   group	   level.	   However	   clinicians	   have	   to	   take	   decisions	  based	  on	  the	  single	  individual	   in	  their	  day-­‐to-­‐day	  clinical	  practice,	  and	  therefore	  the	  translational	  impact	  of	  these	  results	  is	  limited.	  Univariate	  approaches	   are	  well	   suited	   to	   detect	   focal	   abnormalities	   at	   the	   group	  level;	  however,	  differences	  in	  brain	  anatomy	  in	  the	  high	  risk	  population	  are	  likely	  to	  be	  relatively	  subtle	  and	  widespread.	  Interestingly,	  findings	  from	   past	   studies	   suggest	   that	   structural	   alterations	   in	   the	   UHR	  population	  are	  not	  confined	  to	  single	  cortical	  regions	  nor	  spread	  in	  the	  entire	  brain	  but	  they	  are	  expressed	  within	  a	  distributed	  network,	  which	  mainly	   encompasses	   prefrontal	   and	   temporal	   regions	   (Smieskova,	  Fusar-­‐Poli	   et	   al.	   2010,	   Egerton	   2011,	   Fusar-­‐Poli,	   Radua	   et	   al.	   2012).	  Univariate	  approaches	  also	  involve	  multiple	  testing	  and	  the	  subsequent	  correction	   for	   multiple	   comparisons;	   therefore	   they	   may	   be	   too	  conservative	   and	   not	   sensitive	   enough	   to	   detect	   alterations	   that	   are	  expressed	   at	   network	   level	   rather	   than	   in	   distinct	   areas.	   Multivariate	  approaches,	  such	  as	  Support	  Vector	  Machines	  (SMV),	  consider	  multiple	  voxels	   simultaneously	   and	   between-­‐voxels	   correlations	   rather	   then	  each	   voxel	   independently,	   and	   as	   such	  may	   be	   better	   suited	   to	   detect	  network	   abnormalities	   in	   the	   population	   at	   risk	   for	   psychosis	   (Lao,	  Shen	  et	   al.	  2004,	  Norman,	  Polyn	  et	   al.	  2006).	   In	  addition,	  multivariate	  approaches	   allow	   inferences	   to	   be	   made	   at	   the	   individual	   level,	   and	  therefore	   they	   carry	   greater	   translational	   potential	   in	   day-­‐to-­‐day	  clinical	  practice.	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SVM	  is	  a	  ‘supervised’	  multivariate	  classification	  method	  that	  allows	  the	  binary	   categorization	   of	   individuals	   in	   distinct	   groups	   or	   classes	   (e.g.	  patients	   and	   healthy	   controls)	   based	   on	   the	   detection	   of	   patterns	   in	  high-­‐dimensional	   data,	   such	   as	   structural	   brain	   images.	   The	   term	  ‘supervised’	  refers	  to	  the	  training	  step	  in	  which	  the	  algorithm	  learns	  to	  differentiate	   between	   two	   groups	   or	   classes	   (Vapnik	   1999).	   SVM	  comprises	   a	   training	   phase	   and	   a	   testing	   phase.	   During	   the	   training	  phase,	   an	   algorithm	   that	   identifies	   the	   brain	   regions	   that	   better	  distinguish	   the	   two	   groups	   under	   investigation	   (e.g.	   patients	   and	  healthy	  controls)	   is	  developed.	  The	  aim	   is	   for	   the	  algorithm	  to	  predict	  the	   labels	   from	  a	   set	   of	   previously	   unseen	  data	   (Burges	   1998).	   In	   the	  testing	   phase,	   a	   new	   subject	   is	   recognised	   as	   belonging	   to	   one	   of	   the	  classes	  based	  on	  the	  decision	  function	  previously	  learnt	  (Schrouff,	  Rosa	  et	  al.	  2013).	  	  
	  During	  the	  last	  two	  decades,	  machine	  learning	  multivariate	  approaches	  have	  been	  successfully	  applied	  to	  the	  investigation	  of	  neuroanatomical	  abnormalities	   in	   a	   number	   of	   psychiatric	   and	   neurological	   disorders	  (Orru,	   Pettersson-­‐Yeo	   et	   al.	   2012).	   In	   particular,	   SVM	   has	   been	  employed	   in	   diagnostic	   studies,	   studies	   on	   prediction	   of	   treatment	  response	  and	  studies	  on	  prediction	  of	  disease	  onset	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012).	  SVM	  has	  been	  employed	  with	  the	  UHR	  population	  both	  to	  test	   its	  ability	  to	  discriminate	  UHR	  and	  healthy	  controls,	  and	  within	  the	   UHR	   group,	   UHR-­‐T	   and	   UHR-­‐NT.	   Relatively	   recent	   studies	   have	  reported	  high	  levels	  of	  accuracy	  in	  the	  prediction	  of	  group	  membership,	  effectively	  distinguishing	  UHR	   from	  healthy	   controls,	   and	  UHR-­‐T	   from	  UHR-­‐NT	   subjects	   (Koutsouleris,	   Meisenzahl	   et	   al.	   2009,	   Koutsouleris,	  Borgwardt	   et	   al.	   2012).	   For	   instance,	   Koutsouleris	   and	   colleagues	  (2009)	  using	  structural	  MRI	  have	  successfully	  distinguished	  the	  UHR-­‐T	  group	  from	  the	  healthy	  control	  group	  with	  an	  accuracy	  of	  94%,	  UHR-­‐NT	  from	  healthy	  controls	  with	  an	  accuracy	  of	  86%	  and	  UHR-­‐T	  from	  UHR-­‐NT	   with	   an	   accuracy	   of	   82%	   (Koutsouleris,	   Meisenzahl	   et	   al.	   2009).	  Similar	   results	   from	   an	   independent	   data	   set	   study	   showed	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classification	   accuracy	   respectively	   of	   92.3%	   for	   healthy	   controls	   and	  UHR-­‐T,	   of	   66.9%,	   for	   healthy	   controls	   and	  UHR-­‐NT	   and	   of	   84.2%,	   for	  UHR-­‐T	  and	  UHR-­‐NT	  (Koutsouleris,	  Borgwardt	  et	  al.	  2012).	  In	  addition,	  UHR-­‐T	  could	  be	  successfully	  distinguished	  from	  first	  episode	  psychosis	  with	   a	   80%	   accuracy	   (Borgwardt,	   Koutsouleris	   et	   al.	   2013).	   Finally,	  when	   combining	   two	   independent	   data	   sets,	   SVM	   could	   successfully	  distinguish	   UHR-­‐T	   from	   UHR-­‐NT	   with	   80.3%	   accuracy	   (Koutsouleris,	  Riecher-­‐Rossler	   et	   al.	   2014).	   No	   studies	   so	   far	   have	   assessed	   the	  predictive	   value	   of	   cortical	   thickness	   in	   the	   UHR	   population.	   While	  these	   initial	   results	   suggest	   this	   approach	   holds	   some	   promise,	   the	  studies	  published	  so	  far	  have	  used	  relatively	  small	  and	  selected	  groups	  of	  subjects;	  more	  evidence	  must	  therefore	  be	  collected	  from	  larger	  and	  more	  representative	  samples	  in	  order	  to	  evaluate	  the	  generalizability	  of	  the	  findings	  and	  their	  translational	  potential	  in	  clinical	  practice.	  	  	  In	  the	  work	  presented	  in	  this	  chapter,	  Support	  Vector	  Machines	  (SVM)	  was	   applied	   to	   a	   large	   multi-­‐centre	   sample	   of	   UHR	   individuals	   and	  matched	   healthy	   controls.	   Whole-­‐brain	   magnetic	   resonance	   images	  were	   acquired	   from	   individuals	   at	   UHR	   for	   psychosis	   and	   healthy	  controls	   at	   four	   psychiatric	   research	   centres	   in	   London,	   Basel,	  Melbourne	   and	   Munich.	   At	   each	   site,	   subjects	   were	   scanned	   at	   first	  clinical	   presentation,	   and	   followed	   clinically	   for	   an	   average	   of	   at	   least	  two	  years,	  so	  that	  they	  could	  be	  subcategorized	  according	  to	  the	  clinical	  outcome	   (i.e.	  UHR-­‐T	  and	  UHR-­‐NT).	  The	  MRI	  data	   from	  each	   site	  were	  combined	   to	   form	   a	   large	   UHR	   sample,	   which	   was	   subdivided	   into	  subjects	  who	  had	  developed	  psychosis	  and	  subjects	  who	  had	  not.	  	  	  The	  main	  objective	  of	  this	  work	  was	  to	  investigate	  the	  predictive	  value	  of	  neuroanatomical	  MRI	  scans	  in	  a	  relatively	  large	  sample	  of	  individuals	  at	  UHR	  for	  psychosis	  and	  matched	  healthy	  controls.	  The	  first	  aim	  of	  the	  work	   described	   in	   this	   chapter	   was	   to	   assess	   whether	   a	   multivariate	  pattern	  classification	  approach,	  such	  as	  SVM,	  is	  able	  to	  distinguish	  with	  a	   statistically	   significant	   level	   of	   accuracy,	   between	   UHR	   and	   healthy	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controls,	   using	  neuroanatomical	  data	   such	  as	  gray	  matter	  volume	  and	  cortical	  thickness.	  The	  second	  aim	  was	  to	  assess	  whether	  SVM	  is	  able	  to	  distinguish	   with	   a	   significant	   level	   of	   accuracy,	   between	   UHR-­‐T	   and	  UHR-­‐NT,	  using	  gray	  matter	  volume	  and	  cortical	  thickness	  information.	  	  	  
Hypothesis:	  	  1) Structural	  imaging	  data	  (i.e.	  gray	  matter	  volume	  and	  cortical	  thickness)	  can	   be	   used	   to	   discriminate	   between	   UHR	   participants	   and	   healthy	  controls	  with	  statistically	  significant	  accuracy.	  	  2) 	  Structural	   imaging	   data	   can	   be	   used	   to	   discriminate	   between	   UHR	  individuals	   who	   did	   and	   did	   not	  make	   a	   transition	   to	   psychosis	   with	  statistically	  significant	  accuracy.	  	  
5.2.	  Methods	  
5.2.1.	  Design	  A	  multi-­‐centre	   cross-­‐sectional	   study	   design	  was	   employed	   comparing	  167	  individuals	  at	  UHR	  for	  psychosis	  and	  150	  matched	  healthy	  controls	  and,	  within	  the	  UHR	  group,	  50	  individuals	  who	  developed	  psychosis	  at	  follow-­‐up	  and	  117	  who	  did	  not.	  	  	  
5.2.2.	  Inclusion	  criteria	  Inclusion	  and	  exclusion	  criteria	  for	  UHR	  and	  HC	  groups	  were	  reported	  in	  Chapter	  2,	  sections	  2.2.	  and	  2.2.2.	  	  	  
5.2.3.	  Sample	  All	   the	   UHR	   subjects	   were	   recruited	   from	   four	   specialised	   clinical	  services	   for	  young	   individuals	  at	  high	  risk	  of	  psychosis	   in	  London	  (i.e.	  1.5T),	  Basel,	  Melbourne	  and	  Munich.	  Recruitment	  details	  are	   reported	  in	   Chapter	   2,	   sections	   2.2.	   and	   2.2.2.	   MRI	   structural	   data	   were	   thus	  combined	  using	  the	  four	  samples	  employed	  also	  for	  the	  study	  described	  in	   Chapter	   4.	   Individuals	   at	   UHR	   were	   followed	   up	   for	   about	   30.6	  months	  (mean	  follow	  up	  period;	  SD=10.4)	  subsequent	  to	  scanning,	  and	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50	  of	  the	  original	  group	  (29.5%)	  of	  UHR	  developed	  psychosis	  (UHR-­‐T),	  while	   117	   did	   not	   (UHR-­‐NT).	   At	   each	   site,	   healthy	   controls	   from	   the	  same	   geographical	   area	   as	   the	   UHR	   subjects	   were	   recruited	   through	  local	  advertisement.	  Each	  site	  yielded	  a	  dataset	  that	  included	  an	  UHR-­‐T	  group,	  an	  UHR-­‐NT	  group	  and	  a	  healthy	  control	  group.	  	  
5.2.4.	  Image	  acquisition	  At	   all	   four	   sites,	   volumetric	   MR	   images	   were	   acquired	   using	   scanner	  field	   strength	   of	   1.5T	   and	   a	   T1-­‐weighted	   protocol.	   Two	   sites	   used	  General	  Electric	  scanners,	  and	  two	  used	  Siemens	  scanners.	  The	  details	  of	   the	   image	   acquisition	   sequences	   varied	   between	   scanners,	   as	  reported	  in	  Chapter	  2,	  section	  2.3.2.	  	  
5.3.	  Data	  analysis	  
5.3.1.	  Sociodemographic	  data	  Differences	   in	  demographics	  and	  clinical	  profile	  between	  groups	  were	  examined	  using	  one-­‐way	  analysis	  of	  variance	   (ANOVA)	   for	  parametric	  data,	  and	  a	  chi	  square	  test	  for	  non-­‐parametric	  data,	  as	  implemented	  in	  the	  Statistical	  Package	  for	  the	  Social	  Sciences	  (SPSS	  17.0	  for	  Windows,	  IBM	   SPSS	   statistics	   18.0	   and	   19.0	   for	   windows	   and	  mac),	   (see	  Table	  
4.2.,	  Chapter	  4).	  Sociodemographic	  characteristics	  of	  the	  study	  samples	  by	  site	  are	  reported	  in	  Appendix	  3	  (Table	  A3.2.).	  
5.3.2.	  Analysis	  of	  neuroanatomical	  data	  The	   analysis	   of	   the	   MRI	   data	   comprised	   of	   three	   main	   components.	  Firstly,	   the	   unified	   segmentation	   procedure	   (Ashburner	   and	   Friston	  2005)	   implemented	   in	   SPM8	   (http://www.fil.ion.ucl.ac.uk/spm)	   was	  used	   to	   segment	   all	   the	   images	   into	   gray	   matter	   (GM),	   white	   matter	  (WM)	   and	   cerebrospinal	   fluid	   (CSF)	   partitions.	   Secondly,	   the	   images	  were	  then	  pre-­‐processed	  using	  two	  alternative	  approaches	  that	  allowed	  the	   extraction	   of	   information	   on	   gray	   matter	   volume	   and	   cortical	  thickness	   respectively.	   Thirdly,	   Support	   Vector	   Machine	   (SVM)	   was	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used	   as	   implemented	   in	   the	   Pattern	   Recognition	   for	   Neuroimaging	  Toolbox	   (PRoNTo;	   http://www.mlnl.cs.ucl.ac.uk/pronto/)	   (Schrouff,	  Rosa	  et	  al.	  2013).	  A	  detailed	  description	  of	  each	  component	  is	  reported	  below,	  in	  Chapter	  3,	  section	  3.2.3.2.,	  and	  Chapter	  4,	  section	  4.2.3.2.	  
5.3.2.1.	  Creation	  of	  voxel-­‐based	  gray	  matter	  volume	  maps	  Preprocessing	  of	  gray	  matter	   images	   is	  described	  in	  details	   in	  Chapter	  3,	   section	   3.2.3.2.	   After	   the	   preprocessing	   smoothed,	   modulated,	  normalised	   data	   were	   obtained	   and	   were	   subsequently	   used	   for	   the	  statistical	  analyses.	  	  
5.3.2.2.	  Creation	  of	  voxel-­‐based	  cortical	  thickness	  maps	  Preprocessing	  for	  the	  creation	  of	  cortical	  thickness	  maps	  is	  described	  in	  details	  in	  Chapter	  4,	  section	  4.2.3.2.	  The	  procedure	  results	  in	  smoothed,	  wraped,	   voxel-­‐based	   cortical	   thickness	   (VBCT)	   maps	   that	   were	  subsequently	  used	  for	  the	  statistical	  analyses.	  	  
5.3.2.3.Multivariate	  SVM	  analyses	  A	   linear	   SVM	   was	   used	   to	   classify	   UHR	   participants	   and	   healthy	  controls,	  and	  within	  the	  UHR	  group,	  UHR-­‐T	  and	  UHR-­‐NT,	  on	  the	  basis	  of	  their	   brain	   structure.	   After	   the	   preprocessing,	   the	   segmented	   images	  were	   entered	   (gray	  matter	   volume	   and	   cortical	   thickness	   separately)	  into	   SVMs	   as	   implemented	   in	   the	   PRoNTo	   software	   package	   running	  under	   Matlab	   7.1	   (Math	   Works,	   Natick,	   MA,	   USA)	   to	   assess	   the	  diagnostic	  value	  of	  whole	  brain	  structural	  images	  (Schrouff,	  Rosa	  et	  al.	  2013).	   For	   each	   comparison	   subjects	  were	   used	   to	   construct	   samples	  for	   the	   classifier,	   with	   each	   individual	   scan	   treated	   as	   a	   data	   point	  located	   in	   high	   dimensional	   space	   and	   assigned	   the	   operator	   a	   given	  class.	  Each	  classifier	  was	  embedded	  in	  a	  leave-­‐one-­‐out-­‐cross-­‐validation	  (LOOCV)	  framework,	  where	  all	  but	  one	  pair	  of	   images	  (i.e.	  one	  subject	  for	   each	   class)	   were	   excluded	   from	   the	   overall	   group	   and	   used	   as	  training	   data	   for	   the	   classifier	   and	   the	   remaining	   images	   as	   test	   data.	  During	   the	   training	   phase	   the	   algorithm	   finds	   the	   optimal-­‐separating-­‐hyperplane	   (OSH)	   that	   divides	   the	   examples	   in	   the	   input	   space	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according	   to	   their	   class	   labels.	   The	   OSH	   is	   constructed	   by	   finding	   the	  hyperplane	   that	  maximizes	   the	  distance	  between	  the	  samples	   that	  are	  the	   most	   difficult	   to	   classify.	   The	   rationale	   is	   that	   maximizing	   the	  separation	   between	   ambiguous	   data	   points,	   the	   classifier	   will	   also	  accurately	   classify	   previously	   unseen	   data.	   The	   decision	   function	  was	  used	  to	  classify	  the	  test	  set	  of	  images.	  Results	  are	  reported	  in	  the	  terms	  of	   balanced	   accuracy	   that	   takes	   into	   account	   unbalanced	  designs.	   The	  balanced	  accuracy	  of	  the	  classifier	  was	  calculated	  by	  taking	  the	  mean	  of	  its	   sensitivity	   (i.e.	   proportion	   of	   subjects	   correctly	   classified	   as	  belonging	  to	  a	  certain	  class)	  and	  specificity	  (i.e.	  proportion	  of	  subjects	  correctly	  classify	  as	  not	  belonging	   to	  a	  certain	  class)	  across	  all	  LOOCV	  folds.	  In	  order	  to	  determine	  the	  statistical	  significance	  of	  the	  accuracy,	  a	  permutation	   test	   was	   performed	   whereby	   subjects	   were	   randomly	  assigned	   to	   a	   class	   and	   the	   LOOCV	   cycle	   repeated.	   A	   1000-­‐time	  repetition	   provides	   a	   distribution	   of	   accuracies	   reflecting	   the	   null	  hypothesis	   that	   the	   classifier	   to	   not	   exceed	   the	   chance.	   This	   is	  subsequently	   used	   to	   estimate	   the	   p-­‐value	   for	   the	   significance	   of	   the	  classification	  algorithm,	  by	  counting	  the	  number	  of	  times	  the	  permuted	  accuracy	  was	  greater	  than	  or	  equal	  to	  the	  true	  accuracy	  and	  dividing	  it	  by	  1000.	   For	   each	   comparison	   a	  multivariate	  discrimination	  map	  was	  produced	   visualizing	   each	   voxel’s	   vector	   score	   (wi),	   representing	   its	  relative	   contribution	   in	   defining	   the	   OSH,	   displaying	   the	   pattern	   of	  regions	   able	   to	   discriminate	   each	   group.	   Consistently	   with	   previous	  studies	  an	  arbitrary	   threshold	  was	  also	  applied	   to	  each	  map	  such	  that	  only	  voxels	  with	  a	  wi	  value	  above	  30%	  of	  the	  maximum	  absolute	  value	  were	   shown	   (Gong,	   Wu	   et	   al.	   2011,	   Gong,	   Li	   et	   al.	   2013).	   For	   all	  classifiers,	  a	  linear	  kernel	  was	  used	  and	  the	  SVM	  parameter	  C	  was	  fixed	  to	  unity.	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5.4.	  Results	  
5.4.1.	  Sociodemographic	  data	  	  No	   statistically	   significant	   differences	   were	   noted	   among	   the	   UHR-­‐T,	  UHR-­‐NT,	  and	  control	  groups	   in	  age,	  gender,	  ethnicity,	  handedness	  and	  medication	  (Table	  4.2.	  Chapter	  4).	  	  	  	  
5.4.2.	  Multivariate	  SVM	  analyses	  	  Results	   from	   each	   comparison	   are	   reported	   below.	   For	   ease	   of	  visualisation,	   tables	   and	   figures	  were	   created	   using	   an	   arbitrary	   70%	  threshold	  for	  all	  SVM	  derived	  weight	  maps,	  showing	  those	  regions	  with	  weight	  vector	  values	   in	   the	   top	  30%	  of	   the	  absolute	  maximum	  weight	  vector	   values	   across	   all	   regions.	   These	   values	   represent	   the	   relative	  contribution	   of	   each	   voxel	   to	   the	   decision	   function,	   in	   the	   context	   of	  every	  other	  voxel.	  	  
5.4.2.1.	  SVM	  classification	  of	  HC	  and	  UHR	  Using	   gray	  matter	   volume	   information,	   SVM	  was	   able	   to	   discriminate	  between	   UHR	   individuals	   and	   healthy	   controls	   with	   a	   balanced	  accuracy	   of	   56.8%	   (specificity:	  54%;	   sensitivity:	   59.6%),	   which	   was	  statistically	   significant	   (p	  =	  0.0310).	  The	  use	  of	  an	  arbitrary	   threshold	  corresponding	   to	   30%	   of	   the	   maximum	   weight	   vector	   score	   showed	  that	   the	   prediction	   appeared	   to	   be	   based	   on	   a	   distributed	   pattern	   of	  gray	  matter	   regions	   including,	   in	  particular,	   the	   inferior,	   superior	   and	  middle	   frontal	  gyrus,	  middle	  temporal	  gyrus,	   lingual	  gyrus,	  precuneus,	  cuneus,	   inferior	  parietal	   lobule	  and	  angular	  gyrus	   (see	  Table	   5.1.	   and	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Figure	  5.1.	  	  
	  
Figure	   5.1.	   Multivariate	   map	   SVM	   classification	   of	   HC	   and	   UHR.	   Gray	  matter	   regions	   that	   showed	   the	   highest	   discriminative	   value	   for	   the	  comparison	   between	   UHR	   and	   healthy	   controls.	   Regions	   were	   identified	   by	  setting	  the	  threshold	  to	  the	  top	  30%	  of	  the	  maximum	  absolute	  weight	  vector	  score.	   Red	   indicates	   higher	   values	   in	   UHR	   group	   and	   blue	   indicates	   higher	  values	  in	  the	  HC	  group.	  	  	  




MNI	  Coordinate	  	  
(x,	  y,	  z)	  
wi	  	  	  
Gray	  Matter	  Regions	  with	  Positive	  wi	  Scores	  Inferior	  Frontal	  Gyrus	   37	   48	  12	  19.5	   0.00755	  Middle	  Temporal	  Gyrus	   21	   -­‐51	  -­‐58.5	  -­‐6	   0.00751	  6	   -­‐46.5	  4.5	  -­‐28.5	   0.0065	  
Lingual	  Gyrus	   14	   21	  -­‐85.5	  -­‐7.5	   0.00677	  5	   12	  -­‐73.5	  -­‐4.5	   0.00636	  Superior	  Frontal	  Gyrus	   8	   -­‐19.5	  54	  -­‐16.5	   0.0065	  Precuneus	   3	   15	  -­‐66	  42	   0.0062	  Inferior	  Parietal	  Lobule	   2	   -­‐52.5	  -­‐42	  27	   0.0062	  
Gray	  Matter	  Regions	  with	  Negative	  wi	  Scores	  Middle	  Temporal	   50	   33	  -­‐78	  18	   0.00965	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Gyrus	  Middle	  Frontal	  Gyrus	   33	   31.5	  -­‐3	  48	   0.00843	  1	   33	  19.5	  43.5	   0.00692	  Middle	  Occipital	  Gyrus	   27	   -­‐33	  -­‐81	  13.5	   0.00771	  4	   28.5	  -­‐93	  -­‐3	   0.00693	  Angular	  Gyrus	   8	   -­‐40.5	  -­‐61.5	  31.5	   0.00724	  Cuneus	   2	   13.5	  -­‐94.5	  1.5	  	   0.00684	  
	  
Table	  5.1.	  Neuroanatomical	  regions	  with	  a	  weight	  vector	  score	  in	  the	  30%	  of	  the	  maximum	  weight	  vector	  score	  across	  all	   regions	   for	  gray	  matter	  volume.	  
wi,	  and	  MNI	  coordinates	  refer	  to	  the	  peak	  weight	  vector	  score	  in	  each	  cluster.	  Abbreviations:	  MNI,	  Montreal	  Neurological	   Institute:	  wi,	  weight	   vector	   score	  indicating	  the	  relative	  contribution	  of	  each	  voxel	  to	  the	  decision	  function.	  	  	  
5.4.2.2.	  SVM	  classification	  of	  HC	  and	  UHR-­‐T	  Using	   gray	  matter	   volume	   information,	   SVM	  was	   able	   to	   discriminate	  between	   UHR	   individuals	   who	   develop	   psychosis	   at	   follow	   up	   and	  healthy	  controls	  with	  a	  balanced	  accuracy	  of	  51.3%	  (specificity:	  84.7%;	  sensitivity:	   18%),	   which	   did	   not	   reach	   statistical	   significance	   (p	   =	  0.3430).	   Using	   cortical	   thickness	   information,	   SVM	   was	   able	   to	  discriminate	  between	  UHR	  individuals	  who	  develop	  psychosis	  at	  follow	  up	   and	   healthy	   controls	   with	   a	   balanced	   accuracy	   of	   53.9%	  (specificity:	  89.9%;	   sensitivity:	   18%;),	   which	   did	   not	   reach	   statistical	  significance	  (p	  =	  0.1080).	  	  
5.4.2.3.	  SVM	  classification	  of	  HC	  and	  UHR-­‐NT	  	  Using	   gray	  matter	   volume	   information,	   SVM	  was	   able	   to	   discriminate	  between	  UHR	   individuals	  who	   did	   not	   develop	   psychosis	   and	   healthy	  controls	   with	   a	   balanced	   accuracy	   of	   59.8%	   (specificity:	  67.3%;	  sensitivity:	  52.3%),	  which	  was	  statistically	  significant	  (p	  =	  0.0050).	  The	  use	   of	   an	   arbitrary	   threshold	   corresponding	   to	   the	   30%	   of	   the	  maximum	  weight	  vector	  score	  showed	  that	  the	  prediction	  appeared	  to	  be	  based	  on	  a	  distributed	  pattern	  of	   gray	  matter	   regions	   including,	   in	  particular,	   the	   middle	   frontal	   gyrus,	   lingual	   gyrus,	   middle	   occipital	  
	   87	  
gyrus,	  cuneus,	  precentral	  and	  postcentral	  gyrus,	  angular	  gyrus,	  middle	  and	  superior	  temporal	  gyrus	  and	  sub-­‐gyral	  region	  (see	  Table	  5.2.	  and	  
Figure	   5.2.).	   Using	   cortical	   thickness	   information,	   SVM	   was	   able	   to	  discriminate	  between	  UHR	   individuals	  who	  did	  not	  develop	  psychosis	  and	   healthy	   controls	   with	   a	   balanced	   accuracy	   of	   51.06	   %	  (specificity:	  62.2%;	   sensitivity:	   41%),	   which	   did	   not	   reach	   statistical	  significance	  (p	  =	  0.3330).	  	  	  
Figure	  5.2.	  	  
	  
Figure	  5.2.	  Multivariate	  map	  SVM	  classification	  of	  HC	  and	  UHR-­‐NT.	  Gray	  matter	   regions	   that	   showed	   the	   highest	   discriminative	   value	   for	   the	  comparison	   between	   UHR-­‐NT	   and	   healthy	   controls.	   Regions	  were	   identified	  by	   setting	   the	   threshold	   to	   the	   top	   30%	   of	   the	   maximum	   absolute	   weight	  vector	  score.	  Red	  indicates	  higher	  values	  in	  UHR-­‐NT	  group	  and	  blue	  indicates	  higher	  values	  in	  the	  HC	  group.	  
	  




MNI	  Coordinate	  	  
(x,	  y,	  z)	  
wi	  	  	  
Gray	  Matter	  Regions	  with	  Positive	  wi	  Scores	  Middle	  Frontal	  Gyrus	   42	   33	  30	  33	   0.0088	  Lingual	  Gyrus	   1	   21	  -­‐87	  -­‐7.5	   0.00665	  
Gray	  Matter	  Regions	  with	  Negative	  wi	  Scores	  Middle	  Occipital	  Gyrus	   74	   -­‐33	  -­‐81	  13.5	   0.0089	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Cuneus	   42	   15	  -­‐96	  0	   0.00739	  Precentral	  Gyrus	   39	   33	  19.5	  45	   0.00796	  Angular	  Gyrus	   38	   -­‐40.5	  -­‐61.5	  30	   0.00768	  Middle	  Temporal	  Gyrus	   7	   42	  -­‐60	  9	   0.00687	  4	   33	  -­‐78	  18	   0.00677	  
Sub-­‐Gyral	   5	   -­‐37.5	  40.5	  9	   0.00673	  1	   -­‐31.5-­‐43.5	  40.5	   0.00649	  Superior	  Temporal	  Gyrus	   4	   64.5	  -­‐22.5	  7.5	   0.00671	  Postcentral	  Gyrus	   2	   -­‐27	  -­‐37.5	  55.5	   0.00663	  
	  
Table	  5.2.	  Neuroanatomical	  regions	  with	  a	  weight	  vector	  score	  in	  the	  30%	  of	  the	  maximum	  absolute	  weight	  vector	  score	  across	  all	  regions	  for	  gray	  matter	  volume.	  wi,	  and	  MNI	  coordinates	  refer	  to	  the	  peak	  weight	  vector	  score	  in	  each	  cluster.	  Abbreviations:	  MNI,	  Montreal	  Neurological	  Institute:	  wi,	  weight	  vector	  score	   indicating	   the	   relative	   contribution	   of	   each	   voxel	   to	   the	   decision	  function.	  	  
5.4.2.4.	  SVM	  classification	  of	  UHR-­‐NT	  and	  UHR-­‐T	  Using	   gray	  matter	   volume	   information,	   SVM	  was	   able	   to	   discriminate	  between	   UHR	   individuals	   who	   developed	   psychosis	   at	   follow-­‐up	   and	  UHR	   individuals	   who	   did	   not	   with	   a	   balanced	   accuracy	   of	   52.7%	  (specificity:	  77.5%;	  sensitivity:	  28%),	  which	  did	  not	  reach	  the	  statistical	  significance	  (p	  =	  0.2410).	  Using	  cortical	  thickness	  information,	  SVM	  was	  able	  to	  discriminate	  between	  UHR	  individuals	  who	  developed	  psychosis	  at	   follow-­‐up	   and	   UHR	   who	   did	   not	   with	   a	   balanced	   accuracy:	   56.5%	  (specificity:	  82.9%;	  sensitivity:	  30%),	  which	  was	  statistically	  significant	  (p	   <	   0.0470).	   The	   use	   of	   an	   arbitrary	   threshold	   corresponding	   to	   the	  30%	  of	   the	  maximum	  weight	  vector	   score	   showed	   that	   the	  prediction	  appeared	   to	   be	   based	   on	   a	   distributed	   pattern	   of	   cortical	   regions	  including,	   in	   particular,	   the	  middle	   temporal	   gyrus,	   subcallosal	   gyrus,	  medial	  and	  inferior	  frontal	  gyrus,	  lingual	  gyrus,	  parahippocampal	  gyrus,	  orbital	  gyrus,	  fusiform	  gyrus	  and	  inferior	  occipital	  gyrus	  (see	  Table	  5.3.	  and	  Figure	  5.3.).	  	  
	   89	  
Figure	  5.3.	  	  
	  
Figure	   5.3.	   Multivariate	  map	   SVM	   classification	   of	   UHR-­‐NT	   and	   UHR-­‐T.	  Cortical	   regions	   that	   showed	   the	   highest	   discriminative	   value	   for	   the	  comparison	  between	  UHR-­‐T	  and	  UHR-­‐NT.	  Regions	  were	   identified	  by	  setting	  the	   threshold	   to	   the	   top	  30%	  of	   the	  maximum	  absolute	  weight	  vector	   score.	  Red	  indicates	  higher	  values	   in	  UHR-­‐T	  group	  and	  blue	   indicates	  higher	  values	  in	  the	  UHR-­‐NT	  group.	  	  	  




MNI	  Coordinate	  	  
(x,	  y,	  z)	  
wi	  	  	  
Cortical	  Thickness	  Regions	  with	  Positive	  wi	  Scores	  Middle	  Temporal	  Gyrus	   2	   -­‐60	  -­‐28.5	  -­‐18	   0.0327	  Subcallosal	  Gyrus	   1	   -­‐16.5	  16.5	  -­‐16.5	   0.028	  
Medial	  Frontal	  Gyrus	   1	   -­‐6	  18	  -­‐18	   0.0282	  1	   1.5	  15	  -­‐18	   0.0303	  1	   6	  10.5	  -­‐19.5	   0.0354	  
Inferior	  Frontal	  Gyrus	   1	   16.5	  18	  -­‐18	   0.0265	  1	   30	  10.5	  -­‐19.5	   0.0294	  1	   31.5	  13.5	  -­‐19.5	   0.0298	  Middle	  Temporal	  Gyrus	   1	   57	  -­‐27	  -­‐18	   0.0281	  Lingual	  Gyrus	   1	   10.5	  -­‐88.5	  -­‐18	   0.0263	  Parahippocampal	  Gyrus	   1	   -­‐31.5	  -­‐30	  -­‐19.5	   0.0368	  Orbital	  Gyrus	   1	   -­‐3	  40.5	  -­‐21	   0.0333	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Fusiform	  Gyrus	   1	   33	  -­‐40.5	  -­‐21	   0.0265	  1	   48	  -­‐43.5	  -­‐21	   0.0287	  
Cortical	  Thickness	  Regions	  with	  Negative	  wi	  Scores	  
Parahippocampal	  Gyrus	   1	   21	  -­‐27	  -­‐16.5	   0.0266	  1	   28.5	  0	  -­‐21	   0.0294	  1	   16.5	  -­‐1.5	  -­‐21	   0.0278	  Medial	  Frontal	  Gyrus	   1	   -­‐1.5	  15	  -­‐18	   0.0329	  Inferior	  Occipital	  Gyrus	   1	   -­‐33	  -­‐91.5	  -­‐18	   0.0258	  1	   -­‐27	  -­‐93	  -­‐18	   0.0366	  Inferior	  Frontal	  Gyrus	   1	   19.5	  9	  -­‐19.5	   0.0292	  Orbital	  Gyrus	  	   1	   -­‐6	  40.5	  -­‐21	   0.0282	  1	   -­‐1.4	  40.5	  -­‐1.4	   0.0289	  Middle	  Temporal	  Gyrus	   1	   51	  0	  -­‐21	   0.0266	  Fusiform	  Gyrus	   1	   39	  -­‐42	  -­‐21	   0.0258	  	  
Table	  5.3.	  Neuroanatomical	  regions	  with	  a	  weight	  vector	  score	  in	  the	  30%	  of	  the	  maximum	  weight	  vector	  score	  across	  all	  regions	  for	  cortical	  thickness.	  wi,	  and	   MNI	   coordinates	   refer	   to	   the	   peak	   weight	   vector	   score	   in	   each	   cluster.	  Abbreviations:	  MNI,	  Montreal	  Neurological	   Institute:	  wi,	  weight	   vector	   score	  indicating	  the	  relative	  contribution	  of	  each	  voxel	  to	  the	  decision	  function.	  	  
5.5.	  Discussion	  The	  assessment	  and	  detection	  of	   individuals	  at	  UHR	   for	  psychosis	   are	  complex	  due	  to	  the	  fact	  that	  many	  of	  the	  prodromal	  symptoms	  are	  non-­‐specific,	   since	   they	   overlap	   both	   with	   symptoms	   present	   in	   other	  psychiatric	   disorders	   (Ellison-­‐Wright	   and	   Bullmore	   2010,	   Tschoeke,	  Steinert	   et	   al.	   2014)	   and	  psychotic-­‐like-­‐experiences	   that	  may	  occur	   in	  the	  general	  population	  (van	  Os,	  Hanssen	  et	  al.	  2000,	  van	  Os,	  Linscott	  et	  al.	   2009).	   To	   date	   it	   is	   not	   possible	   to	   predict	  which	   individuals	  who	  meet	   the	   criteria	   for	   UHR	   for	   psychosis	   will	   make	   transition	   to	  psychosis	  based	  on	  their	  clinical	  presentation;	  therefore	  all	  individuals	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accessing	   early	   detection	   services	   are	   offered	   the	   same	   therapeutic	  options.	   However,	   the	   limited	   amount	   of	   available	   clinical	   resources	  highlights	   the	   need	   for	   alternative	   tools	   that	   can	   aid	   diagnostic	   and	  prognostic	  processes.	  Tools	  such	  as	  SVM	  offer	  the	  potential	  of	  assisting	  these	  processes.	  	  	  The	   first	   objective	   of	   this	   work	   was	   to	   determine	   whether	   machine	  learning	   and	   structural	   imaging	   data,	   specifically	   gray	  matter	   volume	  and	  cortical	  thickness,	  would	  allow	  classification	  of	  a	  large	  multi-­‐centre	  sample	   of	   UHR	   participants	   and	   healthy	   controls	   with	   statistically	  significant	   accuracy.	   UHR	   individuals	   could	   be	   successfully	  distinguished	   from	   healthy	   controls	   using	   gray	   matter	   volume	  information	   (balanced	   accuracy	   =	   56.8%,	   p	   =	   0.0310).	   In	   contrast,	  cortical	  thickness	  information	  did	  not	  allow	  an	  accurate	  discrimination	  of	  UHR	   from	  healthy	   controls	   (balanced	  accuracy	  =	  54%,	  p	   =	  0.1240).	  The	   gray	   matter	   regions	   that	   held	   the	   highest	   discriminative	   values	  were	  distributed	  in	  a	  bilateral	  widespread	  network	  of	  regions	  including	  the	  inferior,	  superior	  and	  middle	  frontal	  gyrus,	  middle	  temporal	  gyrus,	  lingual	   gyrus,	   precuneus	   and	   cuneus,	   inferior	   parietal	   lobule	   and	  angular	  gyrus	  (Table	  5.1.	  and	  Figure	  5.1.).	  	  	  The	   application	   of	   SVM	   to	   gray	   matter	   volume	   further	   allowed	   an	  accurate	   classification	   of	   UHR-­‐NT	   individuals	   from	   healthy	   controls	  (balanced	  accuracy	  =	  59.8%,	  p	  =	  0.0050).	  The	  gray	  matter	  regions	  that	  held	   the	   highest	   discriminative	   values	   were	   also	   distributed	   in	   a	  bilateral	   widespread	   network	   of	   regions	   including	   the	   middle	   frontal	  gyrus,	   lingual	   gyrus,	   middle	   occipital	   gyrus,	   cuneus,	   precentral	   and	  postcentral	   gyrus,	   angular	   gyrus,	  middle	   and	   superior	   temporal	   gyrus	  and	   sub-­‐gyral	   region	   (Table	   5.2.	   and	   Figure	   5.2.).	   In	   contrast,	   gray	  matter	  volume	  information	  did	  not	  allow	  a	  successful	  discrimination	  of	  UHR-­‐T	  from	  healthy	  controls	  (balanced	  accuracy	  =	  51.3%,	  p	  =	  0.3430).	  Cortical	   thickness	   did	   not	   allow	   a	   successful	   discrimination	   either	   of	  UHR-­‐T	   or	   of	   UHR-­‐NT	   from	   healthy	   controls	   (HC	   vs	   UHR-­‐T	   balanced	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accuracy	  53.9%,	  p	  =	  0.1080;	  HC	  vs	  UHR-­‐NT	  balanced	  accuracy	  51.06%,	  
p	  =	  0.3330).	  	  	  The	  second	  objective	  of	   this	  work	  was	   to	  determine	  whether	  machine	  learning	   and	   structural	   imaging	   data,	   specifically	   gray	  matter	   volume	  and	   cortical	   thickness,	   would	   allow	   discrimination	   between	   UHR	  individuals	   who	   did	   and	   did	   not	   make	   transition	   at	   follow-­‐up	   with	  statistically	  significant	  accuracy.	  Findings	  revealed	  that	  UHR-­‐T	  could	  be	  successfully	   distinguished	   from	   UHR-­‐NT	   using	   cortical	   thickness	  information	  (balanced	  accuracy	  =	  56.5%,	  p	  =	  0.0470).	  The	  cortical	  areas	  that	   held	   the	   highest	   discriminative	   values	   were	   distributed	   in	   a	  bilateral	  widespread	  network	  of	  regions	  including	  the	  middle	  temporal	  gyrus,	  subcallosal	  gyrus,	  medial	  and	  inferior	  frontal	  gyrus,	  lingual	  gyrus,	  parahippocampal	   gyrus,	   orbital	   gyrus	   and	   fusiform	   gyrus	   (Table	   5.3.	  and	   Figure	   5.3.).	   In	   contrast,	   gray	   matter	   volume	   did	   not	   allow	   a	  significant	   classification	   of	   UHR-­‐T	   and	   UHR-­‐NT	   (balanced	   accuracy	   =	  52.7%,	  p	  =	  0.2410).	  	  While	   the	   results	   of	   this	   work	   provide	   further	   evidence	   for	   the	  implication	   of	   the	   above	   regions	   in	   psychosis,	   it	   has	   to	   be	   noted	   that	  when	   structural	   data	   are	   analysed	   using	   a	   multivariate	   approach	   the	  findings	  cannot	  be	   interpreted	   in	   terms	  of	  greater	  or	   lower	  volume	  or	  thickness	   in	   one	   group	   compared	   to	   the	   other.	   This	   is	   because	   the	  regions	  identified	  in	  each	  group	  are	  those	  that	  are	  the	  most	  important	  in	  defining	  group	  membership;	  this	  can	  be	  the	  case	  either	  because	  of	  a	  difference	   in	   volume	   between	   groups	   in	   that	   region	   or	   because	   of	   a	  difference	  in	  the	  correlation	  between	  that	  region	  and	  other	  areas	  of	  the	  brain.	  Therefore,	   the	  regions	   identified	   in	   the	  present	  study	  should	  be	  interpreted	   as	   parts	   of	   a	   spatially	   distributed	   pattern	   of	  neuroanatomical	   alterations	   rather	   than	   as	   independent	   areas.	   In	  addition,	  it	  should	  be	  noted	  that	  these	  regions	  were	  identified	  using	  an	  arbitrary	  threshold	  of	  30%	  based	  on	  previous	  studies	  (Gong,	  Wu	  et	  al.	  2011,	  Gong,	  Li	  et	  al.	  2013),	  and	  that	  prediction	  of	  class	  membership	  was	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to	   some	   extent	   informed	   by	   all	   voxels	   in	   the	   brain	   since	   no	   feature	  extraction	  was	  employed.	  	  	  Interestingly,	   gray	   matter	   volume	   information	   allowed	   an	   accurate	  discrimination	   of	   UHR	   from	   healthy	   controls	   and	   UHR	   who	   did	   not	  make	   transition	   from	   healthy	   controls,	   whereas	   cortical	   thickness	  information	   allowed	   the	   discrimination	   of	   UHR	   who	   made	   transition	  from	   those	   who	   did	   not.	   These	   findings	   suggest	   that	   network	  abnormalities	   in	   gray	   matter	   volume	   could	   be	   more	   associated	   to	  vulnerability	   to	   psychosis	   while	   cortical	   network	   abnormalities	   could	  be	  more	  associated	  to	  transition	  to	  psychosis,	  supporting	  the	  idea	  that	  cortical	   thickness	   and	   gray	   matter	   volume	   offer	   distinct	   and	  complementary	   information.	   This	   is	   consistent	   with	   the	   notion	   that	  cortical	   thickness	   and	   surface	   area	   are	   genetically	   and	   phenotypically	  independent	   and	   that	   volume,	   that	   takes	   into	   account	   both	   cortical	  thickness	  and	  surface,	  is	  more	  closely	  related	  to	  surface	  than	  to	  cortical	  thickness	  (Winkler,	  Kochunov	  et	  al.	  2010).	  	  	  Neither	   gray	   matter	   volume	   nor	   cortical	   thickness	   allowed	   the	  identification	  of	  UHR-­‐T	   from	  healthy	   controls.	   Interestingly,	  both	  grey	  matter	  volume	  and	  cortical	  thickness	  showed	  very	  high	  specificity	  (i.e.	  proportion	   of	   healthy	   controls	   correctly	   classified	   as	   not	   having	   a	  condition)	   and	  on	   the	   contrary	   very	   low	   sensitivity	   (i.e.	   proportion	  of	  patients	  correctly	  classified	  as	  having	  a	  condition).	  The	  disproportion	  in	  specificity	   and	   sensitivity	   was	   also	   observed	   in	   the	   classification	   of	  UHR-­‐NT	   and	   UHR-­‐T,	   both	   for	   the	   successful	   classification	   obtained	  using	   cortical	   thickness	   information	   and	   for	   the	   unsuccessful	   one	  obtained	  using	  gray	  matter	  volume.	  This	  indicates	  that	  the	  two	  classes	  were	   not	   equally	   important	   for	   the	   classification	   and	   the	   model	  favoured	   respectively	   the	   healthy	   control	   class	   and	   the	   UHR-­‐NT	   class	  over	   the	   UHR-­‐T	   class.	   This	   could	   be	   partially	   explained	   by	   class	  imbalance;	  indeed	  the	  UHR-­‐T	  group	  has	  a	  lower	  number	  of	  subjects	  (n=	  50)	  compared	  to	  healthy	  controls	  (n	  =	  150)	  and	  UHR-­‐NT	  (n	  =	  117).	  SVM	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is	   accurate	   on	   moderately	   imbalanced	   samples	   as	   SVM	   uses	   only	  ‘support’	   vectors	   to	   generate	   the	   decision	   function,	   therefore	   several	  subjects	   that	   are	   far	   from	   the	   decision	   boundary	   can	   be	   potentially	  removed	  without	  affecting	   the	  classification	  (Tang,	  Zhang	  et	  al.	  2009).	  However	  SVM	  can	  be	  sensitive	  to	  high	  class	  imbalance	  and	  can	  generate	  a	   classifier	   that	   is	   biased	   towards	   the	   larger	   class,	   resulting	   in	   a	   high	  number	  of	  false	  negatives	  (Tang,	  Zhang	  et	  al.	  2009,	  Lin	  and	  Chen	  2013).	  	  	  The	   accuracy	   values	   reported	   in	   the	   preset	   work	   are	   below	   the	   90%	  mark	  that	  has	  been	  suggested	  for	  routine	  use	  of	  MRI	  in	  clinical	  setting	  (Kasparek,	   Thomaz	   et	   al.	   2011,	   Iwabuchi,	   Liddle	   et	   al.	   2013).	   While	  some	  of	  the	  classification	  accuracies	  obtained	  in	  the	  present	  work	  were	  statistically	   significant,	   it	   should	   be	   noted	   that	   their	   values	   remain	  relatively	   low	   also	   when	   compared	   to	   previous	   machine	   learning	  studies	  conducted	  in	  the	  same	  population	  (Koutsouleris,	  Meisenzahl	  et	  al.	   2009,	   Koutsouleris,	   Schmitt	   et	   al.	   2009,	   Koutsouleris,	   Riecher-­‐Rossler	   et	   al.	   2014).	   In	   particular,	   in	   a	   recent	   study	   Koutsouleris	   and	  colleagues	   (2014)	   combined	   two	  of	   the	  data	   sets	   also	   included	   in	   this	  work	   (Koutsouleris,	   Riecher-­‐Rossler	   et	   al.	   2014)	   and	   were	   able	   to	  correctly	   predict	   transition	   outcomes	   with	   a	   80%	   of	   accuracy.	   The	  relatively	   low	   level	   of	   accuracy	   in	   the	   present	   work	   could	   be	   in	   part	  explained	   by	   the	   challenging	   combination	   of	   more	   independent	   data	  sets.	  This	  is	  consistent	  with	  results	  reported	  in	  the	  literature	  suggesting	  that	  the	  discrimination	  performance	  can	  decrease	  when	  combining	  data	  across	   sites	   (Kloppel,	   Stonnington	   et	   al.	   2008).	   The	   present	   work	  employed	   four	   independent	   samples	   that	   were	   recruited	   using	  different,	  although	  comparable,	  clinical	  high	  risk	  criteria	  and	  examined	  using	   different	   MRI	   protocols.	   Increasing	   the	   number	   of	   independent	  samples	  could	  have	  contributed	  in	  increasing	  the	  overall	  variability	  and	  consequently	   in	   lowering	   the	   classification	  accuracy.	   In	  particular,	   the	  combination	  of	   samples	   acquired	  with	  different	   acquisition	   sequences	  can	  result	  in	  increased	  variability	  related	  to	  the	  images	  properties,	  such	  as	  contrast,	  signal	  to	  noise	  ratio	  and	  voxel	  size.	  For	  example,	  Kempton	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and	   colleagues	   have	   reported	   a	   between-­‐sequence	   variation	   of	   4%	   in	  total	  gray	  matter	  volume	  in	  six	  T1	  weighted	  MRI	  sequences	  (Kempton,	  Underwood	   et	   al.	   2011,	   Kempton	   and	   McGuire	   2014).	   Such	   a	   large	  variation	   in	   gray	   matter	   volume	   that	   is	   due	   to	   between-­‐centre/sequence	   differences	   could	   contribute	   to	   mask	   abnormalities	  observed	  in	  this	  group	  of	  patients.	  	  	  On	   the	   other	   hand,	   differences	   in	   the	   recruitment	   process	   across	  centres	  might	  have	  also	  contributed	  to	  increase	  the	  heterogeneity	  in	  the	  population	   itself.	   This	   in	   turn	   might	   have	   decreased	   the	   chance	   of	  finding	   reliable	   network	   differences	   that	   would	   allow	   discriminating	  between	   groups	  with	   a	   high	   level	   of	   accuracy.	   The	  UHR	  population	   is	  heterogeneous	  in	  nature.	  People	  identified	  as	  being	  at	  ultra	  high	  risk	  for	  psychosis	   might	   meet	   different	   UHR	   criteria	   and	   they	   might	   present	  with	   diverse	   symptomatology	   and	   comorbidities.	   For	   example,	   the	  prevalence	   of	   Axis	   I	   diagnoses,	   such	   as	   depression	   and	   anxiety	  disorders,	   has	   been	   estimated	   to	   be	   around	  73%	   in	   a	   large	   sample	   of	  individuals	   at	   risk	   for	   psychosis	   (Fusar-­‐Poli,	   Nelson	   et	   al.	   2014,	  Modinos,	   Allen	   et	   al.	   2014).	   Mood	   and	   anxiety	   disorders	   are	  characterized	   by	   a	   distinct	   neurobiology;	   therefore	   the	   prevalence	   of	  these	   symptoms	   in	   UHR	   individuals	   might	   further	   complicate	   the	  investigation	  and	  identification	  of	  neuroanatomical	  biomarkers	  that	  can	  predict	  transition	  outcomes.	  	  	  In	  addition,	  only	  a	  subsample	  of	  those	  individuals	  meeting	  criteria	  will	  go	   on	   to	   develop	   the	   full-­‐blown	   psychotic	   illness	   and	   among	   these	  individuals	  there	  are	  differences	  in	  the	  psychopathological	  trajectory.	  A	  recent	   meta-­‐analysis	   reported	   that	   among	   those	   individuals	   who	  progress	   to	   psychosis,	   73%	   will	   develop	   a	   disorder	   that	   lies	   on	   the	  schizophrenia	   spectrum,	  while	   the	  11%	  will	   develop	  a	  mood	  disorder	  with	  psychotic	   features	   (Fusar-­‐Poli,	  Bechdolf	  et	  al.	  2013).	  Psychosis	   is	  indeed	  an	  “umbrella”	   term	  that	   includes	  heterogeneous	   illnesses,	  each	  of	  them	  requiring	  different	  treatment	  approaches.	  This	  complicates	  the	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scenario	  further	  and	  potentially	  adds	  noise	  to	  the	  data.	  Thus,	  a	  way	  to	  improve	  the	  predictive	  value	  of	  neuroimaging	  tools	  such	  as	  SVM	  could	  be	   to	   adopt	   a	   stratification	   approach	  which	   involves	   sub-­‐categorising	  individuals	   that	  make	   transition	   according	   to	   their	   different	  diagnosis	  and	  then	  applying	  the	  resulting	  decision	  function	  to	  a	  new	  independent	  population	  to	  test	  its	  validity.	  	  	  Future	  studies	  should	  aim	  at	  combining	  not	  only	  different	  centres	  but	  also	   different	  modalities,	   and	   clinical,	   neuropsychological	   and	   genetic	  information,	   which	   is	   expected	   to	   increase	   the	   predictive	   accuracy,	  utility	   and	   validity	   of	   the	   method.	   Moreover,	   to	   overcome	  methodological	  disadvantages	  due	  to	  differences	  in	  MRI	  acquisition,	  the	  ADNI	  consortium	  developed	  a	   structural	  MRI	   sequence	   that	  generates	  an	   image	   with	   similar	   properties	   independently	   from	   the	   scanner	  model	   and	   manufacturer	   (Jack,	   Bernstein	   et	   al.	   2008).	   Multi-­‐centre	  projects	   such	  as	  EU-­‐GEI	   (European	  network	  of	  national	   schizophrenia	  networks	  studying	  gene-­‐environment	   interaction)	   (European	  Network	  of	  National	  Networks	   studying	  Gene-­‐Environment	   Interactions	   in,	   van	  Os	   et	   al.	   2014)	   and	   NAPLS	   (North	   American	   Prodrome	   Longitudinal	  Study),	   (Cannon,	   Cadenhead	   et	   al.	   2008)	   that	   have	   adopted	   this	  approach,	   will	   be	   able	   to	   optimize	   the	   investigation	   of	   large	   samples	  deriving	   form	   the	   data-­‐pooling	   and	   at	   the	   same	   time	   to	   minimise	  between-­‐centre	  differences.	  	  	  
5.5.1	  Limitations	  	  The	  first	  limitation	  of	  this	  work	  lies	  on	  the	  between-­‐centre	  differences	  that	   are	   likely	   to	   originate	   from	   scanner-­‐related	   differences.	   The	   field	  strength	  of	  the	  four	  scanning	  machines	  used	  was	  the	  same	  for	  all	  sites	  (i.e.	   1.5	   T),	   however	   the	   four	   sites	   have	   employed	   different	  machines	  and	  acquisition	  sequences	  that	  might	  have	  increased	  the	  heterogeneity	  in	  the	  sample.	  Secondly,	  the	  PRoNTo	  version	  used	  in	  this	  work	  did	  not	  allow	  regressing	  out	  covariates	  of	  no	  interest	  such	  as	  age,	  gender,	  and	  scanning	   site.	   UHR	   individuals	   and	   healthy	   controls	   do	   not	   differ	   in	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terms	  of	  socio-­‐demographic	  data,	  which	  therefore	  are	  not	  likely	  to	  have	  impacted	   on	   the	   results.	   However,	   given	   that	   it	   was	   not	   possible	   to	  remove	  the	  effect	  of	  scanning	  site,	  it	  cannot	  be	  excluded	  that	  this	  could	  have	  added	  noise	  and	  consequently	  lowered	  the	  algorithm	  accuracy	  in	  discriminating	   between	   classes.	   Future	   multi-­‐centre	   studies	   should	  ideally	   use	   the	   same	   acquisition	   sequence	   and	   calibrate	   data	   across	  centres	   using	   phantoms	   or	   common	   subjects	   to	   minimise	   scanner-­‐related	   differences	   (Jack,	   Bernstein	   et	   al.	   2008).	   	   Finally,	   the	   different	  researchers	  and	  clinicians	  at	  the	  four	  centres	  recruited	  UHR	  individuals	  using	   different	   screening	   instruments.	   Although	   the	   high-­‐risk	   criteria	  used	   in	   the	   four	   sites	   were	   comparable,	   it	   cannot	   be	   excluded	   that	  differences	   in	   the	   recruitment	   phase	   could	   have	   resulted	   in	   relatively	  different	   groups.	   Overall	   these	   differences	   might	   have	   increased	   the	  level	  of	  noise	  in	  the	  data	  that	  in	  turn	  might	  have	  significantly	  decreased	  the	  ability	  of	  SVM	  to	  find	  the	  optimal	  discrimination	  function.	  	  	  
5.5.2.	  Conclusions	  	  Developing	  an	  alternative	  tool	  that	  can	  assist	  the	  identification	  of	  UHR	  and	   within	   this	   group,	   the	   prediction	   of	   those	   more	   likely	   to	   make	  transition	  to	  psychosis,	  would	  allow	  a	  more	  selective	  and	  safe	  delivery	  of	   the	  available	  preventative	   treatments,	  which	   is	  desirable	  both	   from	  an	  ethical	  point	  of	  view	  and	  for	  a	  sensible	  use	  of	  the	  care	  resources.	  The	  results	   of	   the	   current	   work	   show	   that	   UHR	   and	   healthy	   controls	   are	  distinguishable	  at	  the	  individual	  level	  based	  on	  information	  on	  the	  gray	  matter	  volume.	  In	  addition,	  UHR	  who	  made	  transition	  to	  psychosis	  and	  those	  UHR	  who	  did	  not	  are	  distinguishable	  at	  the	  individual	  level	  using	  cortical	  thickness	  information.	  Nevertheless,	  the	  percentage	  of	  accuracy	  remains	  low	  to	  be	  meaningfully	  applied	  in	  a	  real-­‐world	  clinical	  setting.	  	  
	  Future	   multi-­‐centre	   projects,	   such	   as	   EU-­‐GEI	   (European	   Network	   of	  National	  Networks	  studying	  Gene-­‐Environment	  Interactions	   in,	  van	  Os	  et	   al.	   2014),	   that	   are	   acquiring	   environmental,	   genetic,	   clinical,	  neuropsychological	   and	   neuroimaging	   information	   using	   the	   same	  
	   98	  
instruments	   and	   the	   same	   protocols	   will	   be	   able	   to	   clarify	   the	  translational	   potential	   of	   machine	   learning	   techniques	   in	   this	  population.	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6.	   Using	   structural	   neuroimaging	   to	   make	   quantitative	  
predictions	   of	   symptom	   progression	   in	   individuals	   at	   ultra	  
high	  risk	  for	  psychosis	  
	  
(Adapted	  from	  published	  paper,	  Appendix	  1,	  A1.3.)	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6.1.	  Introduction	  As	   discussed	   in	   previous	   chapters,	   the	  majority	   of	   past	   neuroimaging	  studies	   employed	   univariate	   approaches	   and	   therefore	   reported	  significant	   effects	   only	   at	   a	   group	   level,	   whereas	   clinicians	   treating	  psychosis	  have	  to	  make	  decisions	  about	  the	  individual	  in	  front	  of	  them.	  Because	  effects	   that	  are	   significant	  at	  a	  group	   level	  do	  not	  necessarily	  permit	  accurate	  inferences	  about	  individuals,	  the	  translational	  potential	  of	   the	   above	   findings	   for	   everyday	   clinical	   practice	   is	   unclear.	   In	  addition,	   these	   studies	   were	   conducted	   using	   a	   standard	   univariate	  analytical	   approach	   in	  which	   each	   voxel	   is	   considered	   independently.	  This	   approach	   is	   well	   suited	   to	   detect	   effects	   that	   are	   robust	   and	  localised;	  however,	  it	  is	  not	  very	  sensitive	  to	  differences	  that	  are	  subtle	  and	  highly	  distributed	  across	  the	  brain.	  For	  these	  reasons,	  an	  increasing	  number	   of	   recent	   studies	   of	   psychiatric	   disorders	   have	   adopted	   an	  alternative	  approach	  based	  on	  multivariate	  machine	   learning	  methods	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012,	  Pettersson-­‐Yeo,	  Benetti	  et	  al.	  2013).	  A	  key	  benefit	  of	  multivariate	  machine	  learning	  methods	  is	  that	  they	  allow	  one	   to	  make	  predictions	   that	   are	   specific	   to	   a	   given	   individual,	   rather	  than	  providing	  an	  average	  estimate	   for	  a	  group.	  This	  greatly	   increases	  the	  likelihood	  that	  the	  results	  can	  be	  translated	  into	  a	  tool	  that	  is	  useful	  in	  a	  real	  world	  clinical	  setting.	  A	  further	  benefit	  of	  multivariate	  machine	  learning	  methods	   is	   that	   they	   take	   into	   account	   the	   inter-­‐relationship	  between	   different	  measures	   (e.g.	   gray	  matter	   volume	   across	   different	  voxels),	   and	   therefore	   are	   better	   suited	   for	   detecting	   subtle	   and	  spatially	   distributed	   patterns	   of	   alteration.	   The	   vast	   majority	   of	  multivariate	   machine	   learning	   studies	   of	   psychiatric	   disorders	  published	   so	   far	   have	   been	   limited	   to	   categorical	   decisions	   such	   as	  whether	  an	  individual	  belongs	  to	  a	  patient	  or	  control	  group;	  whether	  an	  individual	  will	   respond	   to	   treatment	   or	   not;	   or	  whether	   an	   individual	  will	  develop	  a	  disorder	  or	  not	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012).	  Within	  this	   context,	   studies	   of	   the	   UHR	   population	   employing	   multivariate	  machine	   learning	   methods	   have	   typically	   focused	   on	   prediction	   of	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clinical	  outcome	  in	  terms	  of	  transition/non-­‐transition	  to	  psychosis.	  For	  example,	   Koutsouleris	   and	   colleagues	   (2009)	   demonstrated	   that	   a	  distributed	   network	   of	   abnormalities	   in	   gray	   matter	   volume	   allows	  prediction	   of	   subsequent	   transition	   to	   psychosis	   with	   an	   accuracy	   of	  82%	   (Koutsouleris,	   Meisenzahl	   et	   al.	   2009).	   This	   notable	   finding	  was	  replicated	   in	   an	   independent	   cohort	   by	   a	   subsequent	   investigation	  (Koutsouleris,	   Borgwardt	   et	   al.	   2012).	   However,	   follow-­‐up	   studies	   of	  individuals	   at	  UHR	  have	   shown	   substantial	   heterogeneity	   in	   symptom	  progression	  both	   among	   those	  who	  develop	  psychosis	   and	   those	  who	  do	   not	   (Miller,	  McGlashan	   et	   al.	   2002,	   Velthorst,	   Nieman	   et	   al.	   2011).	  	  For	   instance,	   a	   recent	   investigation	   showed	   that	   about	   75%	   of	   those	  individuals	   who	   do	   not	   develop	   psychosis	   present	   with	   symptoms	  remission	  after	  three	  years	  while	  the	  remaining	  25%	  are	  still	  showing	  sub-­‐threshold	   symptoms	   (Velthorst,	   Nieman	   et	   al.	   2011).	   In	   addition,	  even	   those	   individuals	   at	   UHR	   who	   show	   full	   or	   partial	   remission	   of	  positive	  symptoms	  remain	  at	  a	   lower	  level	  of	   functioning	  compared	  to	  non-­‐psychiatric	   comparison	   individuals	   (Addington,	   Cornblatt	   et	   al.	  2011).	  Another	  study	  reported	  that	  only	  30%	  of	  those	  individuals	  who	  do	  not	  develop	  psychosis	  experience	  a	  full	  symptomatic	  and	  functional	  recovery	   (Schlosser,	   Jacobson	   et	   al.	   2012).	   Despite	   the	   high	   degree	   of	  heterogeneity	   in	   clinical	   outcome	   beyond	   and	   above	   transition	   of	  psychosis,	  none	  of	  the	  multivariate	  machine	  learning	  studies	  of	  the	  UHR	  population	   published	   so	   far	   have	   focussed	   on	   quantitative	   changes	   in	  symptomatology.	  	  	  Here	   I	   sought	   to	   expand	   the	   existing	   literature	   by	   investigating	   the	  potential	   of	   structural	   MRI	   for	   predicting	   the	   course	   of	   clinical	  symptomatology	   at	   2-­‐year	   follow-­‐up	   in	   UHR	   individuals	   using	  Relevance	   Vector	   Regression	   (Tipping	   2001).	   The	   advantage	   of	   RVR	  relative	   to	   other	   multivariate	   machine	   learning	   techniques,	   such	   as	  Support	   Vector	   Machine	   (Orru,	   Pettersson-­‐Yeo	   et	   al.	   2012),	   is	   that	   it	  allows	   the	   quantitative	   prediction	   of	   a	   variable	   of	   interest	   (e.g.	   a	  patient’s	  score	  on	  a	  clinical	  scale)	  at	   individual	   level,	  without	  the	  need	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for	  a	  discrete	  categorical	  decision	  (e.g.	  patients	  vs.	  controls).	   In	  recent	  years,	  RVR	  has	  been	  successfully	  used	  in	  several	  neuroimaging	  studies	  of	   healthy	   people	   (Franke,	   Ziegler	   et	   al.	   2010,	   Mwangi,	   Hasan	   et	   al.	  2013)	   and	   patients	   with	   psychiatric	   (Mwangi,	   Matthews	   et	   al.	   2012,	  Gong,	  Li	  et	  al.	  2014)	  or	  neurological	  disorders	  (Stonnington,	  Chu	  et	  al.	  2010).	   It	   is	   therefore	   hypothesised	   that	   the	   application	   of	   RVR	   to	  neuroanatomical	   data,	   particularly	   gray	   matter	   volume	   and	   cortical	  thickness,	  would	  allow	  quantitative	  prediction	  of	  symptom	  progression	  at	  individual	  level	  with	  statistically	  significant	  accuracy.	  
6.2.	  Methods	  
6.2.1.	  Sample	  The	   total	   sample	   consisted	   of	   40	   UHR	   subjects	   recruited	   at	   first	  presentation	  from	  consecutive	  referrals	  to	  the	  Outreach	  and	  Support	  in	  South	   London	   (OASIS)	   service	   in	   London,	   UK	   (Fusar-­‐Poli,	   Byrne	   et	   al.	  2013).	  Subsequent	  to	  MRI	  scanning,	  the	  UHR	  subjects	  were	  monitored	  for	   at	   least	   2	   years.	   Over	   the	   2-­‐year	   follow-­‐up,	   7	   UHR	   individuals	  developed	   psychosis	   and	   the	   remaining	   33	   did	   not.	   Transition	   to	  psychosis	  during	  the	  follow-­‐up	  period	  was	  established	  according	  to	  the	  Diagnostic	   and	   Statistical	  Manual	   of	  Mental	   Disorders,	   Fourth	   Edition	  (DSM-­‐IV)	   criteria	   based	   on	   clinical	   consensus	   between	   at	   least	   two	  experienced	   psychiatrists.	  Most	   of	   the	  UHR	   group	   (31/44	   70%)	  were	  naïve	  to	  antipsychotics	  at	  the	  time	  of	  scanning;	  the	  remaining	  13	  (30%)	  had	   been	   exposed	   to	   antipsychotics	   for	   an	   average	   of	   9.7	   weeks	  (SD=13.3).	  	  
6.2.2.	  Sociodemographic	  data	  and	  clinical	  measures	  Socio-­‐demographic	   measures	   included	   age,	   gender	   and	   years	   of	  education.	   Clinical	   symptoms	  were	   assessed	   in	   all	   participants	   at	   the	  time	   of	   scanning	   and	   at	   2-­‐year	   follow-­‐up	   using	   the	   Positive	   and	  Negative	  Syndrome	  Scale	  (PANSS)(Kay,	  Fiszbein	  et	  al.	  1987).	  Symptoms	  in	   the	   UHR	   participants	  were	   also	   assessed	   using	   the	   Comprehensive	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Assessment	   of	   At-­‐Risk	   Mental	   States	   (CAARMS)	   (Yung,	   Yuen	   et	   al.	  2005).	   Socio-­‐demographic	   and	   clinical	   variables	   were	   analysed	   using	  Student’s	   t-­‐test	   for	   continuous	   data	   and	   a	   chi	   square	   test	   for	   ordinal	  data.	   These	   statistical	   analyses	   were	   performed	   using	   the	   Statistical	  Package	   for	   the	  Social	  Sciences	  19.0	  (SPSS	  19.0	   for	  Windows,	  Chicago,	  Illinois,	  USA).	  
6.2.3.	  Acquisition	  of	  neuroanatomical	  data	  Neuroanatomical	  images	  were	  acquired	  using	  a	  1.5	  T	  GE	  NV/I	  Signa	  LX	  Horyzon	   system	   (General	   Electric,	   Milwaukee,	   WI,	   USA)	   at	   Mapother	  House,	  Maudsley	  Hospital.	  Details	  of	  the	  image	  acquisition	  sequence	  are	  reported	  in	  Chapter	  2,	  section	  2.3.2.	  
6.2.4.	  Analysis	  of	  neuroanatomical	  data	  The	  analysis	  of	  the	  MRI	  data	  comprised	  of	  3	  main	  components.	  Firstly,	  the	   unified	   segmentation	   procedure	   (Ashburner	   and	   Friston	   2005)	  implemented	   in	   SPM8	   (http://www.fil.ion.ucl.ac.uk/spm)	  was	   used	   to	  segment	  all	  the	  images	  into	  gray	  matter	  (GM),	  white	  matter	  (WM)	  and	  cerebrospinal	   fluid	   (CSF)	   partitions.	   I	   then	   pre-­‐processed	   the	   images	  using	   two	   alternative	   approaches	   that	   allowed	   me	   to	   extract	  information	  on	  gray	  matter	  volume	  and	  cortical	  thickness	  respectively.	  Secondly,	   I	   used	   multivariate	   Relevance	   Vector	   Regression	   (Tipping	  2001)	   as	   implemented	   in	   the	   Pattern	   Recognition	   for	   Neuroimaging	  Toolbox	   (PRoNTo;	   http://www.mlnl.cs.ucl.ac.uk/pronto/).	   Thirdly,	   I	  performed	  a	  standard	  univariate	  analysis	  as	  implemented	  in	  Statistical	  Parametric	   Mapping	   (SPM8)	   software.	   A	   detailed	   description	   of	   each	  component	  is	  reported	  below,	  in	  Chapter	  3,	  section	  3.2.3.2.,	  and	  Chapter	  4,	  section	  4.2.3.2.	  	  
6.2.4.1.	  Creation	  of	  voxel-­‐based	  gray	  matter	  volume	  maps	  Preprocessing	  of	  gray	  matter	   images	   is	  described	  in	  details	   in	  Chapter	  3,	   section	   3.2.3.2.	   After	   the	   preprocessing	   smoothed,	   modulated,	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normalised	   data	   were	   obtained	   and	   were	   subsequently	   used	   for	   the	  statistical	  analyses.	  	  
	  6.2.4.2.	  Creation	  of	  voxel-­‐based	  cortical	  thickness	  maps	  Preprocessing	  for	  the	  creation	  of	  cortical	  thickness	  maps	  is	  described	  in	  details	  in	  Chapter	  4,	  section	  4.2.3.2.	  The	  procedure	  results	  in	  smoothed,	  wraped,	   voxel-­‐based	   cortical	   thickness	   (VBCT)	   maps	   that	   were	  subsequently	  used	  for	  the	  statistical	  analyses.	  	  
6.2.4.3.	  Multivariate	  RVR	  analyses	  I	   examined	   the	   relationship	   between	   brain	   structure	   and	   changes	   in	  PANSS	   total	   score	   from	   baseline	   to	   two	   years	   follow-­‐up	   using	  multivariate	   RVR	   as	   implemented	   in	   PRoNTo	  (http://www.mlnl.cs.ucl.ac.uk/pronto/)	   running	   under	   Matlab	  (Mathworks,	   2010	   release),	   (Schrouff,	   Rosa	   et	   al.	   2013).	   This	  method	  has	  been	  described	  elsewhere	  (Gong,	  Li	  et	  al.	  2014).	   In	  brief,	  RVR	   is	  a	  sparse	   kernel	   learning	   multivariate	   regression	   method	   set	   in	   a	   fully	  probabilistic	  Bayesian	  framework.	  Under	  this	   framework,	  a	  zero-­‐mean	  Gaussian	  prior	  is	  introduced	  over	  the	  model	  weights,	  governed	  by	  a	  set	  of	   hyperparameters	   –	   one	   for	   each	  weight.	   The	  most	   probable	   values	  for	   these	   hyperparameters	   are	   then	   iteratively	   estimated	   from	   the	  training	   data,	   with	   sparseness	   achieved	   due	   to	   the	   posterior	  distributions	  of	  many	  of	  the	  weights	  peaking	  sharply	  around	  zero;	  those	  training	   vectors	   associated	   with	   non-­‐zero	   weights	   are	   referred	   to	   as	  ‘relevance’	   vectors.	   The	   optimised	   posterior	   distribution	   over	   the	  weights	  can	  then	  be	  used	  to	  predict	  the	  target	  value	  (e.g.	  PANSS	  score)	  for	   a	   previously	   unseen	   input	   vector	   (e.g.	   cortical	   thickness	   map)	   by	  computing	  the	  predictive	  distribution	  (for	  a	  more	  in-­‐depth	  and	  detailed	  description	  see	  Tipping,	  2001	  (Tipping	  2001).	  	  	  In	   the	   current	   study,	   the	   input	   vectors	   (i.e.	   each	   subjects	   gray	  matter	  volume	  and	   cortical	   thickness	  maps,	   respectively)	  were	  mean	   centred	  using	  the	  training	  data,	  and	  an	  estimate	  for	  the	  model’s	  generalizability	  obtained	  via	  leave-­‐one-­‐out	  cross	  validation,	   indexed	  using	  the	  Pearson	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correlation	   coefficient	   and	   mean	   square	   error	   (MSE)	   between	   actual	  and	   predicted	   difference	   between	   baseline	   and	   follow–up	   on	   PANSS	  total	  scores.	  The	  significance	  of	  both	  the	  correlation	  coefficient	  and	  the	  MSE	  score	  was	  estimated	  using	  a	  permutation	  test	  whereby	  the	  input-­‐target	  data	  were	  randomly	  paired	  and	  the	  RVR	  re-­‐run	  1000	  times.	  This	  created	  a	  distribution	  of	  correlation	  and	  MSE	  values	  reflecting	  the	  null	  hypothesis	  that	  the	  model	  did	  not	  exceed	  chance.	  The	  number	  of	  times	  the	   permuted	   value	  was	   greater	   than	   (or	  with	   respect	   to	  MSE	   values,	  less	   than),	   or	   equal	   to,	   the	   true	   value,	   was	   then	   divided	   by	   1000	  providing	  an	  estimated	  p-­‐value	  for	  both	  the	  correlation	  coefficient	  and	  observed	  MSE.	  For	  ease	  of	  visualisation,	  a	  table	  was	  also	  created	  using	  an	  arbitrary	  70%	  threshold	  for	  all	  successful	  RVR	  derived	  weight	  maps,	  showing	  those	  regions	  with	  weight	  vector	  values	  in	  the	  top	  30%	  of	  the	  absolute	   maximum	   weight	   vector	   values	   across	   all	   regions.	   These	  values	   represent	   the	   relative	   contribution	   of	   each	   voxel	   to	   the	  regression	  function,	  in	  the	  context	  of	  every	  other	  voxel.	  
6.2.4.4.	  Univariate	  SPM	  analyses	  I	  also	  examined	   the	  relationship	  between	  brain	  structure	  and	  changes	  in	   PANSS	   total	   score	   from	   baseline	   to	   follow-­‐up	   using	   a	   standard,	  univariate	   approach.	   A	   multiple	   regression	   model	   was	   performed	   in	  SPM8	   software	   to	   identify	   any	   voxels	   in	   the	   gray	  matter	   volume	   and	  cortical	   thickness	   maps	   respectively	   that	   showed	   a	   significant	  association	  with	  PANSS	  total	  scores.	  Statistical	  inferences	  were	  made	  at	  
p	  <	  0.05	   (corrected	   for	  multiple	  comparisons	  using	  Family-­‐Wise	  Error	  (FWE)).	   For	   completeness,	   when	   no	   significant	   effects	   were	   found,	   I	  also	  examined	  trends	  at	  p	  <	  0.001uncorrected.	  	  
6.3.	  Results	  
6.3.1.	  Sociodemographic	  data	  and	  clinical	  measures	  Socio-­‐demographic	  and	  clinical	  variables	  are	  reported	  in	  Table	  6.1.	  for	  all	  participants	  as	  well	  as	  for	  the	  sub-­‐groups	  that	  did	  and	  did	  not	  make	  transition	   to	   psychosis	   separately.	   It	   can	   be	   seen	   that,	   on	   average,	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participants	   showed	   clinical	   improvement	   at	   follow-­‐up	   relative	   to	  baseline	   (t	   =	   -­‐2.555;	   p	  =	   0.015;	   df	   =39).	   Examination	   of	   the	   subject-­‐specific	   scores	   revealed	   that	   26	   individuals	   improved,	   3	   remained	  stable	   and	   11	   worsened	   over	   the	   two	   years	   follow-­‐up	   time.	   No	  significant	  association	  were	   found	  between	   the	   change	   in	  PANSS	   total	  scores	   from	  baseline	   to	   follow-­‐up	   and	   antipsychotic	  medication	   (t	   =	   -­‐0.269,	  df	  =	  38,	  p	  =	  0.789).	  	  	  
Table	  6.1.	  Demographic	  and	  clinical	  variables	  by	  group	  	  	  	  	  
Characteristics	   UHR	  (N	  =	  40)	   UHR-­‐NT	  	  	  	  (N	  =	  33)	   UHR-­‐T	  (N	  =	  7)	   Group	  Comparison	  	  
Age	  (mean,	  SD)	   23.90	  (4.50)	   24.06	  (4.61)	   23.14	  (4.18)	   t(38)	  =	  0.48	  p	  =	  0.63	  	  
Gender	  (Male	  /	  Female)	  	   25/15	   20/13	   5/2	   Χ21	  =	  0.29	  p	  =	  0.59	  	  Years	  of	  
Education	   12.82	  (2.31)	   12.88	  (2.31)	   12.50	  (2.51)	   t(36)	  =	  0.36	  	  p	  =	  0.72	  
PANSS	  total	  
baseline	  
53.30	  (14.95)	   50.27	  (12.02)	   67.57	  (19.85)	   t(38)	  =	  -­‐3.06	  	  p	  =	  0.004	  
PANSS	  total	  
follow-­‐up	  





-­‐6.80	  (16.83)	  	  t(39)	  =	  	  -­‐2.555	  	  
p	  =	  0.015	  	   6.67	  (15.16)	   7.43	  (24.78)	   t(38)	  =	  -­‐0.10	  	  p	  =	  0.91	  
	  	  	  	  
	  	  Table	  6.1.	  Data	  reflect	  mean	  (and	  standard	  deviation).	  Abbreviations:	  PANSS,	  Positive	  and	  Negative	  Syndrome	  Scale	  
6.3.2.	  Multivariate	  RVR	  analyses	  The	   application	   of	   RVR	   to	   whole-­‐brain	   cortical	   thickness	   images	  allowed	   quantitative	   prediction	   of	   symptom	   progression	   with	  statistically	   significant	   accuracy	   (correlation	   =	   0.34,	   p-­‐value	   =	   0.026;	  Mean	   Squared-­‐Error	   =	   249.63,	  p	   =	   0.024,	  Figure	   6.1.).	   The	   use	   of	   an	  arbitrary	  threshold	  corresponding	  to	  the	  30%	  of	  the	  maximum	  weight	  vector	   score	   showed	   that	   the	   prediction	   appeared	   to	   be	   based	   on	   a	  distributed	  pattern	  of	  cortical	  thickness	  including,	  in	  particular,	  the	  left	  insular	   cortex	   and	   lateral	   and	   medial	   regions	   of	   the	   right	   temporal	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cortex	  (Table	  6.2.	  and	  Figure	  6.1.).	  In	  contrast,	  the	  application	  of	  RVR	  to	   the	  whole-­‐brain	  gray	  matter	   volume	   images	  did	  not	   allow	  accurate	  prediction	   of	   symptoms	   progression	   (correlation	   =	   0.14,	   p	   =	   0.627;	  Mean	  Sum	  of	  Squares	  =	  369.50,	  p	  =	  0.621).	  
Figure	  6.1.	  	  
	  
Figure	   6.1.	  Red/Blue	  circles	   show	  voxels	  with	  a	  weight	   score	   in	   the	  30%	  of	  the	  maximum	   (range	   -­‐0.011608	  –	  0.026588).	  Axial	   Slices	   (MNI)	  Left-­‐Right:	   -­‐65,	   -­‐49,	   -­‐40,	   -­‐23,	   -­‐17,	   16,	   25.	   Scatter	   plot	   showing	   the	   predicted	   difference	  between	   baseline	   and	   follow	   up	   total	   PANSS	   score	   for	   each	   subject	   derived	  from	  their	  cortical	  thickness	  data	  using	  RVR,	  versus	  the	  actual	  difference.	  	  	  
Table	  6.2.	  MNI	  coordinates	  
Region	   Number	  of	  Voxels	  
MNI	  Coordinate	  	  
(x,	  y,	  z)	   wi	  	  	  
Regions	  with	  Positive	  wi	  Scores	  Temporal	  Right	  Temporal	  Fusiform	  Cortex	  	   42	   28.5	  -­‐9	  -­‐46.5	   0.00139	  Right	  Temporal	  Pole	   12	   22.5	  9	  -­‐46.5	   0.0111	  
Regions	  with	  Negative	  wi	  Scores	  Subcortical	  Left	  Thalamus	   24	   -­‐15	  -­‐6	  15	   -­‐0.00941	  Right	  Posterior	  Limb	  of	  Internal	  Capsule	   19	   18	  -­‐7.5	  16.5	   	  	  
Table	  6.2.	  Neuroanatomical	  regions	  with	  a	  weight	  vector	  score	  in	  the	  30%	  of	  the	  maximum	  weight	  vector	  score	  across	  all	  regions	  for	  the	  cortical	  thickness	  based	   RVR	   used	   to	   accurately	   predict	   the	   difference	   between	   baseline	   and	  follow	  up	  total	  PANSS	  score.	  wi,	  and	  MNI	  coordinates	  refer	  to	  the	  peak	  weight	  vector	   score	   in	   each	   cluster.	   Abbreviations:	   MNI,	   Montreal	   Neurological	  Institute:	   RVR,	   relevance	   rector	   regression;	   PANSS,	   Positive	   and	   Negative	  Syndrome	  Scale;	  wi,	  weight	  vector	  score	  indicating	  the	  relative	  contribution	  of	  each	  voxel	  to	  the	  regression	  function.	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6.3.3.	  Univariate	  SPM	  analyses	  Whole	  brain	  analysis	  of	   the	  gray	  matter	  volume	  and	  cortical	   thickness	  data	   did	   not	   detect	   any	   regions	   that	   showed	   a	   significant	   positive	   or	  negative	   association	   with	   the	   change	   in	   PANSS	   total	   scores	   from	  baseline	   to	   follow-­‐up	   at	   p	   <	   0.05	   (FWE	   corrected).	   With	   a	   less	  conservative	  statistical	  threshold	  (p	  <	  0.001	  uncorrected),	  a	  number	  of	  regions	  showing	  a	  positive	  association	  with	  the	  change	   in	  PANSS	  total	  scores	   were	   detected.	   With	   respect	   to	   gray	   matter	   volume,	   the	   right	  middle	  frontal	  gyrus	  (MNI	  coordinates:	  39,	  15,	  37.5;	  p	  =	  0.929;	  z-­‐score	  =	  3.266)	  was	   associated	  with	   changes	   in	   PANSS	   scores.	  With	   respect	   to	  cortical	   thickness,	   the	   right	   inferior	   parietal	   lobule	   (MNI	   coordinates:	  61.5,	   -­‐34.5,	  25.5;	  p	  =	  0.802;	  z-­‐score	  =	  3.659),	   left	  cingulate	  gyrus	  (MNI	  coordinates:	   -­‐9,	   1.5,	   46.5;	   p	   =	   0.986;	   z-­‐score	   =	   3.340),	   right	   middle	  temporal	   gyrus	   (MNI	   coordinates:	   49.5,	   -­‐63,	   4.5;	   p	   =	   0.992;	   z-­‐score	   =	  3.295)	  and	   left	   insula	   (MNI	   coordinates:	   -­‐34.5,	   -­‐15,	  16.5;	  p	  =	  0.998;	   z-­‐score	  =	  3.197)	  were	  associated	  with	  changes	  in	  PANSS	  scores.	  	  
6.4.	  Discussion	  At	   present	   it	   is	   difficult	   to	   use	   clinical	   data	   acquired	   at	   first	   clinical	  presentation	   to	   predict	   subsequent	   progression	   of	   symptoms	   in	  individuals	  at	  UHR	  for	  psychosis.	  This	  prevents	  the	  selective	  delivery	  of	  potentially	  preventative	   interventions	   to	   those	  who	  are	  most	   likely	   to	  develop	   persistent	   symptoms.	   Recent	   studies	   have	   shown	   that	   the	  application	   of	   multivariate	   machine	   learning	   methods	   to	   structural	  neuroimaging	   data	   allows	   accurate	   categorical	   prediction	   of	   which	  individuals	   at	   UHR	   will	   and	   will	   not	   make	   transition	   to	   psychosis	  (Koutsouleris,	   Meisenzahl	   et	   al.	   2009).	   However,	   as	   discussed	   in	   the	  introduction,	   within	   the	   UHR	   population	   there	   is	   a	   substantial	  heterogeneity	  in	  symptom	  progression	  above	  and	  beyond	  transition	  to	  psychosis	   (Addington,	   Cornblatt	   et	   al.	   2011,	   Velthorst,	   Nieman	   et	   al.	  2011,	  Schlosser,	  Jacobson	  et	  al.	  2012).	  I	  therefore	  examined	  for	  the	  first	  time	  whether	  it	  is	  possible	  to	  use	  neuroanatomical	  information	  to	  make	  accurate	   quantitative	   predictions	   of	   symptom	   progression	   in	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individuals	  at	  UHR.	  The	  present	  results	  indicate	  that	  the	  application	  of	  RVR	   to	   whole-­‐brain	   cortical	   thickness	   MRI	   data	   allows	   quantitative	  prediction	   of	   symptom	   progression	   (i.e.	   both	   the	   magnitude	   and	  direction	   of	   change	   for	   each	   individual)	   at	   2-­‐year	   follow-­‐up	   with	  statistically	   significant	   accuracy.	   This	   is	   the	   first	   evidence	   that	  neuroimaging	   techniques	   may	   inform	   the	   clinical	   assessment	   of	   UHR	  individuals	  by	  allowing	  quantitative	  estimation	  of	  the	  course	  of	  clinical	  psychopathology.	   In	   contrast,	   gray	   matter	   volume	   did	   not	   allow	  accurate	  prediction	  of	  symptoms	  progression	  at	  individual	  level	  despite	  two	  previous	  reports	  that	  this	  information	  allows	  categorical	  prediction	  of	   transition	   to	   psychosis	   (Koutsouleris,	   Meisenzahl	   et	   al.	   2009,	  Koutsouleris,	  Borgwardt	  et	  al.	  2012).	  	  
	  What	  is	  the	  implication	  of	  the	  differential	  finding	  for	  cortical	  thickness	  and	  gray	  matter	  volume?	  Gray	  matter	  volume	  is	  thought	  to	  depend	  on	  local	   cortical	   thickness	   as	  well	   as	   cortical	   folding	   and	   gyrification	   (i.e.	  cortical	   surface	   area),	   while	   cortical	   thickness	   does	   not	   include	  measures	   of	   local	   surface	   (Hutton,	   De	   Vita	   et	   al.	   2008).	   A	   recent	  investigation	  has	  also	  shown	  that	  cortical	  thickness	  and	  cortical	  surface	  area	  are	  genetically	  and	  phenotypically	  independent,	  and	  that	  regional	  gray	  matter	  volume	  is	  more	  closely	  related	  to	  the	  latter	  than	  the	  former	  (Winkler,	   Kochunov	   et	   al.	   2010).	   It	   follows	   that	   the	   two	   approaches	  provide	  complementary	  information,	  and	  that	  one	  can	  be	  more	  or	  less	  than	  the	  other	  depending	  on	  the	  nature	  of	  the	  neuroanatomical	  changes	  being	  examined.	  In	  the	  context	  of	  the	  present	  investigation,	  the	  fact	  that	  symptom	  progression	  was	  predicted	  by	  cortical	  thickness	  but	  not	  gray	  matter	   volume	   indicates	   that	   changes	   in	   symptomatology	   are	  specifically	  associated	  with	  differences	  in	  cortical	  thickness	  as	  opposed	  to	  cortical	  folding	  and	  gyrification.	  	  	  Examination	   of	   the	   regions	   that	   provided	   the	   greatest	   contribution	   to	  prediction	   of	   symptom	   progression	   identified	   specific	   areas	   amongst	  others	   traditionally	   associated	   with	   schizophrenia,	   namely	   the	   right	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temporal	   fusiform	   cortex,	   the	   right	   temporal	   pole,	   the	   right	  parahippocampal	  gyrus,	  the	  inferior	  temporal	  gyrus	  and	  the	  left	  insular	  cortex	  (Table	  6.2.	  and	  Figure	  6.1.).	  The	  temporal	  fusiform	  cortex	  and	  temporal	   pole	   have	   been	   reported	   to	   show	   cortical	   thickness	  differences	   over	   time	   between	   UHR-­‐T	   and	   controls	   but	   not	   between	  UHR-­‐NT	  and	  controls	  (Ziermans,	  Schothorst	  et	  al.	  2012).	  The	  temporal	  pole	  is	  thought	  to	  be	  implicated	  in	  different	  cognitive	  functions	  such	  as	  emotion,	   attention,	   behaviour,	   and	   memory	   (Blaizot,	   Mansilla	   et	   al.	  2010).	   In	  people	  with	  schizophrenia,	  abnormalities	   in	  this	  region	  have	  been	  associated	  with	   a	   range	  of	   clinical	   symptoms	   including,	   amongst	  others,	  auditory	  hallucinations	  and	  thought	  disorder	  (Barta,	  Pearlson	  et	  al.	   1990,	   Shenton,	   Kikinis	   et	   al.	   1992).	   The	   temporal	   fusiform	   cortex	  plays	   a	   central	   role	   in	   facial	   configuration	   processing	   in	   the	   healthy	  brain	   (LaBar,	   Crupain	   et	   al.	   2003).	   Deficits	   in	   this	   domain	   have	   been	  recently	  reported	  in	  the	  UHR	  population,	  and	  may	  be	  one	  of	  the	  factors	  that	  underlie	  social	  dysfunction	  in	  schizophrenia	  (Kim,	  Shin	  et	  al.	  2010).	  The	   parahippocampal	   gyrus	   has	   also	   been	   reported	   to	   show	   reduced	  thickness	   both	   in	   the	   UHR	   (Jung,	   Kim	   et	   al.	   2011,	   Tognin,	   Riecher-­‐Rossler	   et	   al.	   2013)	   and	   first	   episode	   psychosis	   (Schultz,	   Koch	   et	   al.	  2010).	   Specifically,	   this	   area	   has	   been	   identified	   as	   a	   site	   of	   robust	  structural	  and	  functional	  alteration	  in	  UHR	  individuals	  (Allen,	  Seal	  et	  al.	  2011)	  and	  those	  who	  have	  developed	  the	  disorder	  (Shenton,	  Dickey	  et	  al.	   2001,	   Seidman,	   Pantelis	   et	   al.	   2003).	   The	   right	   inferior	   temporal	  gyrus	  volume	  has	  also	  been	  reported	  as	  progressively	  reduced	  overtime	  in	   UHR-­‐T	   compared	   to	   UHR-­‐NT	   (Borgwardt,	   McGuire	   et	   al.	   2008).	  Finally	   the	   left	   insular	  cortex	  plays	  a	  key	  role	   in	  emotional	   regulation,	  which	   is	   typically	   altered	   in	   psychosis,	   and	   has	   been	   found	   to	   show	  reduced	  volume	   in	  UHR-­‐T	   compared	   to	  UHR-­‐NT	   (Borgwardt,	  McGuire	  et	  al.	  2008,	  Takahashi,	  Wood	  et	  al.	  2009).	  	  	  While	  the	  results	  of	  the	  present	  investigation	  provide	  further	  evidence	  for	   the	   implication	  of	   the	  above	  regions	   in	   schizophrenia,	   it	   should	  be	  noted	   that	   in	   multivariate	   methods	   an	   individual	   region	   may	   display	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high	  discriminative	  power	  due	  to	  two	  possible	  reasons:	  (i)	  a	  difference	  in	   volume	   between	   groups	   in	   that	   region;	   (ii)	   a	   difference	   in	   the	  correlation	  between	  that	  region	  and	  other	  areas	  between	  groups.	  Thus,	  the	   regions	   identified	   in	   this	  work	  should	  be	   interpreted	  as	  parts	  of	  a	  spatially	   distributed	   pattern	   rather	   than	   as	   independent	   areas.	   In	  addition,	  it	  should	  be	  noted	  that	  these	  regions	  were	  identified	  using	  an	  arbitrary	  threshold	  of	  30%	  based	  on	  previous	  studies	  (Gong,	  Wu	  et	  al.	  2011,	  Gong,	  Li	  et	  al.	  2013),	  and	  that	  prediction	  of	  symptom	  progression	  was	  to	  some	  extent	  informed	  by	  all	  voxels	  in	  the	  brain	  since	  no	  feature	  extraction	  was	  employed.	  	  	  In	  contrast	  to	  the	  results	  obtained	  using	  RVR,	  the	  univariate	  analysis	  of	  the	  structural	  MRI	  data,	  in	  which	  each	  voxel	  is	  considered	  as	  a	  spatially	  independent	  unit,	  did	  not	  detect	  any	  regions	  that	  showed	  a	  significant	  association	  with	  progression	  of	  symptoms	  after	  correction	  for	  multiple	  comparisons.	  This	  supports	  the	  idea	  that	  multivariate	  methods	  such	  as	  RVR	   are	  more	   sensitive	   to	   the	   subtle	   and	   spatially	   diffuse	   alterations	  typically	  observed	  in	  psychiatric	  disorders,	  and	  therefore	  may	  be	  better	  suited	   to	   the	   possible	   development	   of	   clinical	   diagnostic	   tools,	   than	  standard	  mass-­‐univariate	  techniques	  (Brammer	  2009).	  	  
	  The	   present	   work	   has	   four	   main	   limitations.	   Firstly,	   the	   number	   of	  subjects	   included	   in	   the	   study	   was	   relatively	   small	   and	   therefore	   the	  generalizability	  of	  the	  results	  is	  unclear.	  Multi-­‐centre	  studies	  would	  be	  needed	  in	  order	  to	  better	  characterize	  the	  predictive	  value	  of	  structural	  neuroimaging	   for	   predicting	   symptom	   progression	   in	   real-­‐life	   clinical	  practice.	   Secondly,	   30%	   of	   the	   participants	   had	   been	   exposed	   to	  antipsychotic	   medication	   which	   might	   have	   influenced	   the	   present	  results	  for	  instance	  by	  resulting	  in	  changes	  in	  brain	  structure	  while	  also	  influencing	   symptom	   progression.	   Nevertheless,	   as	   reported	   in	   the	  Results	   section	  of	   this	  chapter,	   there	   is	  no	  evidence	   for	  an	  association	  between	   antipsychotic	   medication	   at	   first	   clinical	   presentation	   (i.e.	  yes/no)	   and	   progression	   of	   illness.	   Thirdly,	   there	   are	   a	   number	   of	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potential	  sources	  of	  individual	  variability	  in	  symptom	  progression	  that	  were	  not	   included	   in	   the	   statistical	  model;	   these	   include,	   for	   example,	  sociodemographic	   variables	   such	   as	   age,	   gender	   and	   ethnicity,	   and	  treatment	   course	   variables	   such	   as	   life	   events	   and	   psychosocial	  interventions	   during	   the	   follow-­‐up	   period.	   It	   is	   expected	   that	   the	  integration	  of	  this	  information	  within	  the	  same	  statistical	  model	  would	  improve	   prediction	   of	   symptom	   progression.	   Fourthly,	   in	   the	   present	  investigation	  I	  examined	  the	  predictive	  value	  of	  gray	  rather	  than	  white	  matter	   as	   the	   former	   could	   be	   estimated	   more	   accurately	   than	   the	  latter.	  However,	   given	   the	  number	   of	   studies	   reporting	   an	   association	  between	   white	   matter	   integrity	   and	   clinical	   outcome	   in	   the	   UHR	  population	  (Walterfang,	  McGuire	  et	  al.	  2008,	  Karlsgodt,	  Niendam	  et	  al.	  2009,	   Bloemen,	   de	   Koning	   et	   al.	   2010,	   Carletti,	   Woolley	   et	   al.	   2012,	  Ziermans,	   Schothorst	   et	   al.	   2012),	   it	   would	   be	   interesting	   to	   use	   DTI	  scans	  in	  future	  studies.	  	  	  	  In	  conclusion,	  the	  results	  of	  the	  present	  study	  provide	  proof-­‐of-­‐concept	  that	   it	   might	   be	   possible	   to	   use	   structural	   neuroimaging	   to	   inform	  quantitative	   prediction	   of	   subsequent	   progression	   of	   symptoms	   in	  individuals	  at	  UHR	  for	  psychosis.	  This	  would	  enable	  clinicians	  to	  target	  those	  individuals	  at	  greatest	  need	  of	  preventative	  interventions	  thereby	  resulting	   in	  a	  more	  efficient	  use	  of	  health	  care	   resources.	   It	   should	  be	  noted,	  however,	   that	  daily	   clinical	  practice	  often	   requires	   clinicians	   to	  make	  prompt	  treatment	  decisions,	  and	  delaying	  the	  decisional	  process	  in	  order	  to	  acquire	  and	  analyse	  structural	  neuroimaging	  data	  could	  be	  impractical	   and	   potentially	   harmful	   to	   a	   patient.	   A	   possible	   solution	  would	  be	  the	  development	  of	  a	  practical	  and	  flexible	  analytical	  tool	  for	  clinical	   use	   that	   does	   not	   require	   the	   manual	   implementation	   of	   a	  lengthy	   pipeline.	   In	   addition,	   it	   is	   likely	   that	   the	   use	   of	   structural	  neuroimaging	   in	   everyday	   clinical	   practice	  would	  ultimately	   require	   a	  greater	   accuracy	   of	   prediction	   than	   that	   found	   in	   the	   present	   study.	  Such	  accuracy	  might	  be	  improved,	  for	  example,	  by	  combining	  structural	  neuroimaging	  with	  other	   types	  of	  data,	  an	   integrative	  approach	  which	  
	   113	  
was	   successfully	   applied	   to	   an	   investigation	   of	   mild	   cognitive	  impairment	  (Fan,	  Resnick	  et	  al.	  2008).	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7.	  Conclusions	  
7.1.	  	  Summary	  of	  hypotheses	  and	  main	  findings	  	  The	   main	   aim	   of	   the	   present	   doctoral	   work	   was	   to	   (i)	   investigate	  neuroanatomical	   abnormalities	   in	   individuals	   at	   ultra	   high	   risk	   for	  psychosis	   and	   (ii)	   compare	   those	   individuals	  who	   subsequently	  made	  transition	   to	   psychosis	  with	   those	  who	  did	  not	   using	   a	   sample	   that	   is	  larger	  and	  more	  representative	  of	  the	  general	  population	  compared	  to	  previous	   studies.	   I	   therefore	   combined	   structural	  magnetic	   resonance	  imaging	   data	   collected	   at	   four	   different	   research	   centres:	   London,	  United	  Kingdom;	  Basel,	  Switzerland;	  Melbourne,	  Australia;	  and	  Munich,	  Germany.	   Each	   centre	   provided	   imaging	   data	   in	   an	   UHR	   group	   and	   a	  group	  of	  healthy	  controls.	  At	  each	  site	  UHR	  individuals	  were	  scanned	  at	  first	   clinical	   presentation	   and	  were	   then	   followed	   up	   for	   at	   least	   two	  years	  to	  allow	  further	  sub-­‐categorisation	  according	  to	  clinical	  outcome	  (i.e.	   UHR-­‐T	   and	   UHR-­‐NT	   sub	   groups).	   The	   MRI	   data	   collected	   at	   the	  different	   sites	  were	   combined	   to	   form	   groups	   of	   UHR-­‐T,	   UHR-­‐NT	   and	  healthy	   control	   subjects	   larger	   than	   any	   previous	   UHR	   neuroimaging	  study.	   I	   analysed	   the	   MRI	   structural	   data	   using	   different	   analytic	  techniques:	   two	   univariate	   techniques,	   voxel-­‐based	   morphometry	  (VBM),	   voxel	   based	   cortical	   thickness	   (VBCT),	   and	   two	   multivariate	  machine	   learning	  analytic	   techniques,	  Support	  Vector	  Machines	  (SVM)	  and	  Relevance	  Vector	  Regression	  (RVR).	  	  	  My	   first	   objective	   was	   to	   use	   VBM	   and	   VBCT	   to	   investigate	   whether	  there	   are	   volumetric	   and	   cortical	   thickness	   abnormalities	   that	  distinguish	   UHR	   individuals	   from	   healthy	   controls	   at	   the	   group	   level.	  This	  first	  objective	  led	  me	  to	  test	  the	  following	  two	  hypotheses:	  
	  
Hypothesis	  1,	  Chapter	  3	  My	   first	   hypothesis	  was	   that	  UHR	   individuals	  would	   show	   volumetric	  abnormalities	   relative	   to	   healthy	   controls,	   and	   that	   these	   would	   be	  qualitatively	   similar	   to	   those	   observed	   in	   patients	   with	   established	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schizophrenia	   (i.e.	   volumetric	   reductions).	   This	   first	   hypothesis	   was	  confirmed	  as	  the	  UHR	  group	  showed	  significant	  volumetric	  reductions	  in	   the	   prefrontal	   and	   anterior	   cingulate	   regions,	   areas	   that	   have	   been	  previously	   reported	   to	   be	   affected	   in	   patients	   with	   first	   episode	   and	  established	  psychosis	   (Steen,	  Mull	   et	   al.	   2006,	  Olabi,	   Ellison-­‐Wright	   et	  al.	  2011,	  Vita,	  De	  Peri	  et	  al.	  2012).	  	  	  
Hypothesis	  2,	  Chapter	  4	  My	   second	   hypothesis	   was	   that	   the	   UHR	   group	   would	   show	   cortical	  thickness	  abnormalities	   relative	   to	  healthy	  controls	   in	  areas	   that	  have	  been	  reported	  in	  previous	  studies	  of	  cortical	  thickness	  in	  UHR	  subjects	  and	   patients	   with	   a	   first	   episode	   of	   psychosis	   such	   as	   the	   frontal,	  anterior	  cingulate,	  parahippocampal,	  temporal,	  parietal	  cortices	  and	  the	  precuneus	  (Narr,	  Bilder	  et	  al.	  2005,	  Fornito,	  Yucel	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Schultz,	  Koch	  et	  al.	  2010,	  Ziermans,	  Schothorst	  et	  al.	  2012).	  A	  mask,	  including	  these	  regions	  of	  interest	  (ROIs),	  was	  employed	  in	   the	   analysis	   of	   cortical	   thickness.	   This	   hypothesis	   was	   in	   part	  confirmed	   as	   the	   UHR	   group	   showed	   cortical	   thinning	   of	   the	   right	  parahippocampal	   cortex	   compared	   to	   the	  healthy	   controls	  group.	  At	   a	  less	  conservative	  threshold	  (p	  <	  0.001	  uncorrected),	  a	  trend	  for	  cortical	  thinning	  in	  the	  inferior	  part	  of	  the	  left	  parahippocampal	  gyrus	  was	  also	  detected.	  	  My	  second	  objective	  was	  to	  use	  VBM	  and	  VBCT	  to	  investigate	  whether	  there	   are	   volumetric	   and	   cortical	   abnormalities	   that	   can	   help	  distinguish	   between	   UHR	   individuals	   who	   subsequently	   made	  transition	   to	  psychosis	  and	   those	  who	  did	  not	  at	   the	  group	   level.	  This	  second	  objective	  led	  me	  to	  test	  the	  following	  two	  hypotheses:	  	  
Hypothesis	  3,	  Chapter	  3	  My	   third	   hypothesis	   was	   that	   individuals	   at	   UHR	   who	   subsequently	  made	   transition	   to	   psychosis	   would	   show	   differences	   in	   gray	   matter	  volume	  relative	  to	  those	  who	  did	  not	  become	  ill	  at	  presentation.	  Areas	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identified	   in	   previous	   neuroimaging	   studies	   of	   first	   episode	   and	  established	   psychosis,	   such	   as	   the	   inferior	   frontal,	   parahippocampal	  and	   superior	   temporal	   regions	   (Job,	   Whalley	   et	   al.	   2003,	   Farrow,	  Whitford	  et	  al.	  2005,	  Job,	  Whalley	  et	  al.	  2005)	  were	  used	  as	  regions	  of	  interest.	  A	  mask,	  including	  these	  ROIs,	  was	  employed	  in	  the	  analysis	  of	  gray	  matter	  volume.	  This	  hypothesis	  was	  in	  part	  confirmed	  as	  the	  UHR-­‐T	  group	  showed	  relatively	  reduced	  gray	  matter	  volume	  in	  the	  anterior	  part	  of	  the	  left	  parahippocampal	  gyrus,	  bordering	  with	  the	  hippocampal	  uncus	  compared	  to	  UHR-­‐NT.	  	  	  
Hypothesis	  4,	  Chapter	  4	  My	   forth	   hypothesis	   was	   that	   the	   UHR-­‐T	   group	   would	   show	   more	  pronounced	   cortical	   thickness	   abnormalities	   in	   the	   frontal,	   anterior	  cingulate,	   parahippocampal,	   temporal,	   parietal	   cortices	   and	   the	  precuneus	  areas	  than	  UHR-­‐NT	  (Narr,	  Bilder	  et	  al.	  2005,	  Fornito,	  Yucel	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Schultz,	  Koch	  et	  al.	  2010,	  Ziermans,	  Schothorst	   et	   al.	   2012).	   A	   mask,	   including	   these	   ROIs,	   was	   therefore	  employed	  in	  the	  analysis	  of	  cortical	  thickness.	  This	  hypothesis	  was	  not	  confirmed,	  as	  there	  were	  no	  cortical	  thickness	  differences	  between	  the	  UHR-­‐T	  and	  UHR-­‐NT	  that	  survived	  correction	  for	  multiple	  comparisons.	  However,	   at	   a	   less	   conservative	   threshold	   (p	   <	   0.001	   uncorrected),	  there	   was	   a	   trend	   for	   cortical	   thinning	   in	   the	   orbital	   part	   of	   the	   left	  inferior	  frontal	  gyrus	  in	  the	  UHR-­‐T	  group	  compared	  to	  the	  UHR-­‐NT.	  	  	  My	   third	   objective	   was	   to	   use	   a	   multivariate	   pattern	   classification	  approach,	   such	   as	   Support	   Vector	   Machines	   (SVMs),	   to	   investigate	  whether	  it	  is	  possible	  to	  distinguish	  between	  UHR	  and	  healthy	  controls	  at	   the	   individual	   level	   using	   structural	   imaging	  data.	   Therefore	   I	   used	  the	  images	  pre-­‐processed	  for	  the	  first	  two	  studies	  described	  in	  Chapters	  3	   and	   4	   to	   investigate	   whether	   gray	   matter	   volume	   and	   cortical	  thickness	   information	   would	   allow	   an	   accurate	   and	   significant	  classification	  of	  UHR	  and	  healthy	  controls.	  This	  third	  objective	  led	  me	  to	  test	  the	  following	  hypothesis:	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Hypothesis	  5,	  Chapter	  5	  My	  fifth	  hypothesis	  was	  that	  gray	  matter	  volume	  and	  cortical	  thickness	  would	  allow	  an	  accurate	  classification	  discerning	  UHR	  individuals	  from	  healthy	   controls.	   This	   hypothesis	   was	   in	   part	   confirmed	   as	   the	  application	  of	  SVM	  allowed	  UHR	  to	  be	  successfully	  distinguished	   from	  healthy	   controls	   at	   the	   individual	   level	   based	   on	   gray	  matter	   volume	  information	   (balanced	   accuracy	   56.8%,	   p	   =	   0.0310).	   On	   the	   contrary,	  cortical	  thickness	  information	  did	  not	  allow	  accurate	  discrimination	  of	  UHR	   from	   healthy	   controls.	   The	   gray	   matter	   regions	   that	   held	   the	  highest	   discriminative	   values	   were	   distributed	   in	   a	   relatively	  widespread,	   bilateral	   network	   that	   include	   the	   inferior,	   superior,	   and	  middle	   frontal	   gyrus,	  middle	   temporal	   gyrus,	   lingual	   gyrus,	  precuneus	  and	  cuneus,	  inferior	  parietal	  lobule	  and	  angular	  gyrus.	  	  The	  application	  of	   SVM	   to	   gray	   matter	   volume	   further	   allowed	   an	   accurate	  discrimination	  of	  UHR-­‐NT	   from	  healthy	   controls	   (balanced	  accuracy	  =	  59.8%,	   p	   =	   0.0050).	   The	   areas	   that	   held	   the	   highest	   discriminative	  values	  were	  distributed	  in	  a	  bilateral	  network	  of	  regions,	  including	  the	  middle	   frontal	   gyrus,	   lingual	   gyrus,	   middle	   occipital	   gyrus,	   cuneus,	  precentral	   and	   postcentral	   gyrus,	   angular	   gyrus,	   middle	   and	   superior	  temporal	   gyrus	   and	   sub-­‐gyral	   region.	   In	   contrast,	   gray	  matter	   volume	  did	   not	   allow	   an	   accurate	   discrimination	   of	   UHR-­‐T	   individuals	   from	  healthy	  controls.	  Cortical	  thickness	  did	  not	  allow	  the	  discrimination	  of	  either	  UHR-­‐T	  or	  UHR-­‐NT	  from	  healthy	  controls.	  	  	  My	  forth	  objective	  use	  SVM	  to	  distinguish	  between	  UHR-­‐T	  and	  UHR-­‐NT	  using	   gray	   matter	   volume	   and	   cortical	   thickness	   information,	   as	   this	  would	  be	   the	  most	  clinically	  useful	  application.	   I	  used	  the	   images	  pre-­‐processed	  for	  the	  VBM	  and	  VBCT	  analyses	  to	  investigate	  whether	  gray	  matter	   volume	   and	   cortical	   thickness	   would	   allow	   an	   accurate	   and	  significant	   classification	  of	  UHR-­‐T	  and	  UHR-­‐NT	  at	   the	   individual	   level.	  This	  fourth	  objective	  led	  me	  to	  test	  the	  following	  hypothesis:	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Hypothesis	  6,	  Chapter	  5	  My	  sixth	  hypothesis	  was	  that	  gray	  matter	  volume	  and	  cortical	  thickness	  would	  allow	  an	  accurate	  classification	  discerning	  UHR-­‐T	  from	  UHR-­‐NT.	  This	   hypothesis	   was	   in	   part	   confirmed	   as	   the	   application	   of	   SVM	  allowed	  UHR-­‐T	  to	  be	  successfully	  distinguished	  from	  UHR-­‐NT	  based	  on	  cortical	   thickness	   information	   (balanced	  accuracy	  56.5%,	  p	   =	  0.0470).	  The	   regions	   that	   held	   the	   highest	   discriminative	   values	   were	  distributed	  in	  a	  relatively	  widespread	  bilateral	  network	  of	  regions	  that	  includes	   the	   middle	   temporal	   gyrus,	   subcallosal	   gyrus,	   medial	   and	  inferior	   frontal	   gyrus,	   lingual	   gyrus,	   parahippocampal	   gyrus,	   orbital	  gyrus	   and	   fusiform	   gyrus.	   In	   contrast,	   gray	   matter	   volume	   did	   not	  allowed	  significant	  discrimination.	  	  My	   fifth	   objective	  was	   to	  use	   a	  multivariate	   classification	   approach	   to	  predict	  symptom	  progression	  at	  the	  individual	  level	  in	  UHR	  individuals	  using	   structural	   imaging	   data.	   This	   analysis	   was	   performed	   in	   a	  subsample	   of	   UHR	   individuals	   recruited	   at	   the	   London	   site	   for	  which	  baseline	   and	   two	   years	   follow-­‐up	   information	   of	   clinical	   scores	   (i.e.	  PANSS)	  were	  available.	  	  This	  fifth	  objective	  led	  me	  to	  test	  the	  following	  hypothesis:	  	  
Hypothesis	  7,	  Chapter	  6	  I	   hypothesized	   that	   gray	   matter	   volume	   and	   cortical	   thickness	  respectively,	   would	   allow	   quantitative	   prediction	   of	   symptom	  progression	  at	  the	  individual	  level	  with	  statistically	  significant	  accuracy.	  This	  hypothesis	  was	  in	  part	  confirmed	  as	  cortical	  thickness	  information	  allowed	  accurate	  prediction	  of	  symptom	  progression	  at	  individual	  level	  (correlation	  =	  0.34,	  p	  =	  0.026,	  Mean	  Squared-­‐Error	  =	  249.63,	  p	  =	  0.024).	  The	  cortical	  regions	  that	  held	  the	  highest	  weight	  vector	  score	  included	  the	   left	   insular	   cortex	   and	   lateral	   and	   medial	   regions	   of	   the	   right	  temporal	   cortex.	   In	   contrast,	   the	   application	   of	   RVR	   to	   gray	   matter	  volume	   information	   did	   not	   allow	   accurate	   prediction	   of	   symptom	  progression.	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7.2.	  	  Discussion	  	  
7.2.1.	  Implications	  for	  the	  neurobiological	  models	  of	  psychosis	  	  The	  neurodevelopmental	  model	  of	  psychosis	  postulate	  that	  the	  onset	  of	  the	  illness	  is	  the	  end	  stage	  of	  an	  abnormal	  neurodevelopmental	  process	  that	   started	   several	   years	   earlier	   (Weinberger	   1987,	   Murray	   1994,	  Rapoport,	   Giedd	   et	   al.	   2012).	   In	   the	   last	   two	   decades,	   neuroimaging	  studies	  conducted	  in	  young	  individuals	  at	  ultra	  high	  risk	  for	  psychosis,	  first	   episode	   of	   psychosis	   and	   relatives	   of	   patients	   with	   established	  schizophrenia,	  have	  provided	  strong	  evidence	  that	  brain	  abnormalities	  associated	   with	   schizophrenia	   are	   indeed	   already	   present	   before	   the	  illness	  onset.	  These	  brain	  abnormalities	  are	  thought	  to	  result	  from	  early	  brain	   insults	   that	   can	   arise	   as	   early	   as	   the	   pre	   or	   perinatal	   period	  (Weinberger	   1987,	  Murray	   1994,	   Rapoport,	   Giedd	   et	   al.	   2012).	  While	  evidence	   from	   neuroimaging	   studies	   in	   early	   psychosis	   and	   high-­‐risk	  cohorts	   is	   largely	   consistent	   with	   the	   neurodevelopmental	   model	   of	  psychosis,	  the	  delay	  between	  the	  early	  brain	  insults	  and	  the	  onset	  of	  the	  symptoms	  remained	  poorly	  understood.	  A	  possible	  explanation	  that	  has	  been	   proposed	   is	   that	   behavioural	   abnormalities	   resulting	   from	   non-­‐progressive	   early	   brain	   insults	   would	   become	   evident	   in	  adolescence/early	   adulthood,	  when	   there	   is	   an	  acceleration	  of	  normal	  brain	   maturation	   and	   the	   brain	   circuits	   are	   placed	   under	   higher	  functional	   demand	   (Weinberger	   1987).	   Throughout	   the	   years,	   the	  original	  neurodevelopmental	  model	  has	  been	  expanded	  to	  include	  new	  findings	   that	   may	   help	   explain	   the	   delay	   in	   the	   manifestation	   of	   the	  psychotic	   symptoms.	   For	   example,	   several	   studies	   have	   provided	  evidence	  for	  the	  mediating	  effect	  of	  environmental	  risk	  factors	  or	  social	  stressors	   (Corcoran,	   Walker	   et	   al.	   2003),	   such	   as	   urbanicity	  (Thornicroft,	  Bisoffi	  et	  al.	  1993,	  March,	  Hatch	  et	  al.	  2008,	  van	  Os,	  Kenis	  et	   al.	   2010),	   childhood	   trauma	   and	   abuse	   (Morgan	   and	   Fisher	   2007,	  Arseneault,	   Cannon	   et	   al.	   2011),	   ethnic	  minority	   status	   (Bourque,	   van	  der	   Ven	   et	   al.	   2011),	   and	   social	   adversity	   (Wicks,	   Hjern	   et	   al.	   2005).	  Although	   the	   pathophysiology	   of	   the	   disorder	   remains	   poorly	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understood,	   the	   mechanisms	   underlining	   the	   abnormal	  neurodevelopment	   are	   likely	   to	   result	   from	   an	   interaction	   between	  early	  brain	   insults	  and	  environment-­‐dependent	  dynamic	  changes	  such	  as	   an	   excessive	   elimination	   of	   synapses	   as	   well	   as	   loss	   of	   plasticity	  during	   adolescence	   (Keshavan	   1999,	   Keshavan	   and	   Hogarty	   1999).	  Findings	   from	   neuroimaging	   studies	   have	   also	   suggested	   that	   brain	  abnormalities	   that	   are	   presents	   before	   the	   disorder	   becomes	   frank,	  become	  more	   pronounced	   around	   the	   time	   of	   transition	   to	   psychosis	  (Steen,	  Mull	  et	  al.	  2006).	  Thus,	  the	  brain	  abnormalities	  that	  are	  typically	  observed	  in	  chronic	  schizophrenia	  result	  from	  a	  combination	  of	  neural	  deficits	   that	   are	   expressed	   during	   brain	   development,	   neural	   deficits	  that	  become	  evident	  around	  the	  time	  of	  the	  first	  psychotic	  episode	  and	  alterations	   associated	   with	   psychotropic	   medication	   (Keshavan	   1999,	  Keshavan	  and	  Hogarty	  1999,	  Pantelis,	  Yucel	  et	  al.	  2003,	  Ho,	  Andreasen	  et	  al.	  2011).	  	  Over	  the	  past	  two	  decades,	  neuroimaging	  studies	  have	  provided	  a	  rich	  body	   of	   evidence	   in	   support	   of	   the	   neurodevelopmental	   model.	   In	  particular,	  studies	  of	  the	  UHR	  population	  have	  demonstrated	  that	  there	  is	   evidence	   for	   the	   presence	   of	   early	   brain	   abnormalities	   before	   the	  onset	   of	   full-­‐blown	   psychosis	   and	   that	   the	   areas	   most	   affected	   are	  fronto-­‐temporal	   regions,	   similar	   to	   abnormalities	   reported	   in	   first	  episode	  psychosis	  and	  established	  schizophrenia	  cohorts	  (Steen,	  Mull	  et	  al.	  2006,	  Olabi,	  Ellison-­‐Wright	  et	  al.	  2011,	  Vita,	  De	  Peri	  et	  al.	  2012).	  	  	  
Univariate	  analyses	  Consistent	   with	   the	   neurodevelopmental	   model	   of	   psychosis,	   this	  doctoral	  work	  provides	  evidence	   for	   the	  existence	  of	  neuroanatomical	  abnormalities	   in	   the	   UHR	   population	   compared	   to	   healthy	   controls.	  Volumetric	   reductions	  were	  observed	   in	   the	  UHR	  group	   in	   the	   frontal	  regions	   bilaterally,	   in	   areas	   previously	   reported	   to	   be	   affected	   in	  patients	  with	  first	  episode	  and	  established	  psychosis	  (Steen,	  Mull	  et	  al.	  2006,	   Olabi,	   Ellison-­‐Wright	   et	   al.	   2011,	   Vita,	   De	   Peri	   et	   al.	   2012).	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Additionally,	   VBCT	   analysis	   revealed	   cortical	   thinning	   in	   the	   right	  parahippocampal	  gyrus,	  and	  at	  a	  less	  conservative	  threshold	  (p	  <	  0.001	  uncorrected)	   in	   the	   left	   parahippocampal	   gyrus,	   in	   UHR	   compared	   to	  healthy	   control	   subjects.	   These	   observations	   are	   consistent	   with	  previous	   structural	   imaging	   studies	   that	   have	   reported	   gray	   matter	  abnormalities	  in	  frontal,	  temporal,	  and	  midline	  limbic	  structures	  in	  high	  risk	   individuals,	   first	   episode	   and	   established	   schizophrenia	   (Job,	  Whalley	  et	  al.	  2003,	  Steen,	  Mull	  et	  al.	  2006,	  Jung,	  Kim	  et	  al.	  2011,	  Olabi,	  Ellison-­‐Wright	  et	  al.	  2011,	  Vita,	  De	  Peri	  et	  al.	  2012).	  The	  fact	  that	  both	  volumetric	   and	   cortical	   structural	   alterations	   were	   also	   present	   in	  individuals	   that	   did	   not	   develop	   psychosis,	   suggests	   that	   these	   may	  represent	  neurobiological	  markers	  of	  vulnerability	   to	  psychosis	  rather	  than	  markers	  of	  the	  disease	  emergence.	  Another	  possibility	  is	  that	  some	  of	  the	  individuals	  that	  have	  not	  made	  transition	  to	  psychosis	  at	  the	  time	  of	  the	  last	  follow-­‐up	  within	  the	  research	  study	  will	  make	  transition	  at	  a	  later	   time	   or	   they	   might	   develop	   or	   have	   already	   developed	   another	  Axis	   I	   disorder.	   The	   structural	   abnormalities	   detected	   in	   this	   sample	  appear	   to	   support	   the	  neurodevelopmental	  model	  of	  psychosis,	  which	  states	  that	  neuroanatomical	  abnormalities	  are	  present	  before	  the	  onset	  of	  the	  disorder.	  These	  abnormalities	  might	  reflect	  neurodevelopmental	  lesions	  that	  occur	   in	  the	  peri-­‐natal	  phase;	  however,	   they	  could	  also	  be	  the	   result	   of	   an	   interaction	   between	   early	   insults	   of	   the	   brain	   and	  dynamic	  processes	  undergoing	  during	  adolescence	  and	  early	  adulthood.	  	  As	  part	  of	   this	  doctoral	  work	   I	  also	  examined	  whether	   the	  analyses	  of	  gray	   matter	   volume	   and	   cortical	   thickness	   would	   have	   provided	  complementary	   information	   about	   neuroanatomical	   differences	  between	   people	   at	   high	   risk	   for	   psychosis	   and	   healthy	   controls.	   VBM	  and	   VBCT	   identified	   structural	   abnormalities	   in	   UHR	   compared	   to	  controls	  in	  different	  locations	  of	  the	  brain.	  The	  fact	  that	  VBM	  and	  VBCT	  identified	   different	   frontal	   and	   temporal	   abnormalities	   appears	   to	  suggest	   that	   these	   are	   the	   result	   of	   distinct	   pathological	   and	  neurobiological	   mechanisms.	   Consistent	   with	   this,	   recent	   evidence	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suggests	  that	  cortical	  surface	  and	  thickness	  are	  relatively	   independent	  from	  a	   genetic	   and	  phenotypic	   perspective,	   and	   that	   the	   local	   cortical	  volume	  is	  more	  closely	  related	  to	  surface	  area	  (i.e.	  gyrification)	  than	  to	  cortical	   thickness	   (Winkler,	   Kochunov	   et	   al.	   2010).	   Thus,	   the	   frontal	  abnormalities	   observed	   in	   the	   UHR	   population	   could	   be	   more	  associated	  to	  sulcal	  and	  gyral	  anomalies	  while	   temporal	  abnormalities	  could	  depend	  more	  on	  cortical	  atrophy.	  We	  know	  that	  sulcal	  and	  gyral	  folding	  is	  almost	  complete	  during	  the	  third	  trimester	  of	  gestation	  (Chi,	  Dooling	   et	   al.	   1977,	   Worthen,	   Gilbertson	   et	   al.	   1986)	   and	   remains	  relatively	   stable	   after	   birth	   (Zilles,	   Armstrong	   et	   al.	   1988,	   Armstrong,	  Schleicher	   et	   al.	   1995),	   consequently	   the	   volumetric	   reductions	  observed	   in	   the	   frontal	   regions	   are	   more	   likely	   to	   reflect	   early	  neurodevelopmental	  abnormalities.	  In	  contrast,	  cortical	  thinning	  of	  the	  right	   parahippocampal	   region	   observed	   in	   the	   UHR	   population	   could	  could	   be	   the	   result	   of	   early	   brain	   insults	   that	   occurred	   during	   brain	  development	   or,	   alternatively,	   neurodevelopmental	   changes	   taking	  place	  around	  adolescence/early	  adulthood.	  	  The	  neurodevelopmental	  model	  also	  supports	  the	  idea	  of	  the	  presence	  of	  more	  marked	  structural	  abnormalities	   in	  those	  UHR	  who	  will	  go	  on	  to	   develop	   psychosis	   compared	   to	   those	   who	   will	   not.	   This	   doctoral	  work	   demonstrated	   that	   volumetric	   reductions	   are	   present	   in	   UHR-­‐T	  individuals	   in	   the	   anterior	   part	   of	   the	   left	   parahippocampal	   gyrus,	  bordering	   with	   the	   hippocampal	   uncus	   compared	   to	   UHR-­‐NT.	   The	  analysis	  of	  cortical	  thickness	  did	  not	  provide	  further	  evidence,	  as	  there	  were	  no	  cortical	  thickness	  differences	  between	  the	  UHR-­‐T	  and	  UHR-­‐NT	  that	   survived	   correction	   for	  multiple	   comparisons.	   The	   fact	   that	   VBM	  but	  not	  VBCT	  was	  able	  to	  detect	  neuroanatomical	  abnormalities	  in	  the	  comparisons	   between	   UHR-­‐T	   and	   UHR-­‐NT	   groups	   suggests	   that	  alterations	  observed	  in	  this	  area	  of	  the	  left	  parahippocampal	  gyrus	  are	  likely	  to	  reflect	  abnormalities	   in	  sulcal	  and	  gyral	   folding	  and	  therefore	  arising	   early	   in	   life	   in	   the	   pre-­‐natal	   phase	   constituting	   a	   marker	   of	  vulnerability	  rather	  than	  a	  marker	  of	  the	  emergence	  of	  the	  disease.	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  The	   structural	   abnormalities	   observed	   in	   the	   fronto-­‐temporal	   regions	  are	  also	   in	   line	  with	   studies	   that	   focussed	  on	  healthy	   individuals	  with	  high	  scores	   in	  psychometric	  schizotypy	  (Ettinger,	  Williams	  et	  al.	  2012,	  DeRosse,	   Nitzburg	   et	   al.	   2015),	   further	   supporting	   the	   idea	   of	   a	  phenomenological	   and	   phonotypical	   continuum	   with	   schizophrenia	  spectrum	  disorders.	  	  Taken	  together,	   these	   findings	  support	   the	   idea	  that	   the	  abnormalities	  observed	  in	  UHR	  for	  psychosis	  represent	  an	  interconnected	  network	  of	  fronto-­‐temporal	   regions	   rather	   than	   being	   isolated	   abnormal	   areas	   in	  the	  brain	  (Insausti,	  Amaral	  et	  al.	  1987,	  Cavada,	  Company	  et	  al.	  2000).	  	  	  
Multivariate	  analyses	  	  	  Previous	   neuroimaging	   studies	   of	   UHR	   for	   psychosis	   suggest	   that	   the	  neuroanatomical	  abnormalities	  observed	  in	  this	  population	  are	  neither	  necessarily	  focal	  nor	  spread	  in	  the	  entire	  brain	  but	  seem	  to	  be	  involved	  in	  an	   interconnected	  network	  of	   fronto-­‐temporal	   regions.	  Multivariate	  machine	   learning	   approaches	   that	   take	   into	   account	   the	   inter-­‐relationship	   between	   different	   measures	   (e.g.	   gray	   matter	   volume	  across	  different	  voxels)	  are	  better	  suited	  to	  detect	  subtle	  and	  spatially	  distributed	   patterns	   of	   network	   alterations.	   Therefore,	   I	   employed	   a	  multivariate	   machine	   learning	   technique,	   Support	   Vector	   Machine	  (SVM),	   to	   investigate	   whether	   volumetric	   or	   cortical	   network	  information	  would	  allow	  an	  accurate	  prediction	  of	  group	  membership	  at	  the	  individual	  level.	  	  	  The	   hypotheses	   were	   partially	   confirmed	   as	   volumetric	   information	  allowed	   accurate	   classification	   of	   group	   membership	   for	   UHR	   and	  healthy	   controls,	   whilst	   cortical	   thickness	   information	   allowed	   an	  accurate	   prediction	   of	   group	   membership	   of	   UHR-­‐T	   and	   UHR-­‐NT.	  Interestingly,	   the	   frontal	   regions	   that	   showed	   significant	   volumetric	  reductions	  in	  the	  univariate	  analyses	  of	  gray	  matter	  volume	  (i.e.	  VBM)	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are	   also	   contributing	   to	   the	   accurate	   classification	   in	   the	  multivariate	  analysis.	   Conversely,	   cortical	   thickness	   data	   did	   not	   allow	   accurate	  discrimination	  between	  UHR	  and	  healthy	  controls.	  On	   the	  other	  hand,	  the	   application	   of	   SVM	   to	   cortical	   thickness	   information	   rather	   than	  volume,	  did	  allowed	   the	  successful	  discrimination	  of	  UHR-­‐T	  and	  UHR-­‐NT.	  Interestingly,	  the	  parahippocampal	  cortical	  thickness,	  identified	  by	  the	  univariate	  analysis,	  was	  among	  the	  areas	  that	  were	  determinant	  in	  the	   discrimination.	   The	   VBCT	   analysis	   revealed	   that	   there	   were	   no	  cortical	   thickness	   differences	   between	   the	   UHR-­‐T	   and	   UHR-­‐NT	   that	  survived	   correction	   for	   multiple	   comparisons.	   However,	   using	   a	   less	  conservative	   threshold	   (p	   <	   0.001	  uncorrected)	   there	  was	   a	   trend	   for	  cortical	   thinning	   in	   the	  UHR-­‐T	   group	   compared	   to	   the	  UHR-­‐NT	   in	   the	  orbital	  part	  of	  the	  left	  inferior	  frontal	  gyrus,	  area	  that	  also	  appear	  to	  be	  determinant	   in	   the	   multivariate	   classification.	   The	   fact	   that	   cortical	  thickness	   information	   but	   not	   volumetric	   information	   allowed	  successful	   classification	   of	   UHR-­‐T	   and	   UHR-­‐NT	   at	   the	   individual	   level	  might	  suggest	  that	  cortical	  thickness	  abnormalities	  in	  UHR-­‐T	  are	  more	  subtle	  and	  widespread	  rather	  than	  focal,	  this	  could	  in	  part	  explain	  why	  these	  were	  not	  detected	  by	  the	  univariate	  analysis	  of	  cortical	  thickness.	  On	  the	  other	  hand,	  volumetric	  difference	  may	  be	  more	  pronounced	  but	  also	  more	  focal	  consistent	  with	  findings	  from	  the	  VBM	  study	  reported	  in	  Chapter	   3.	   These	   findings	   suggest	   that	   network	   abnormalities	   in	   gray	  matter	   volume	   could	  be	  more	   associated	   to	   vulnerability	   to	  psychosis	  or	   alternatively	   the	   UHR	   stage	   within	   the	   staging	   model	   (McGorry,	  Keshavan	   et	   al.	   2014),	  whilst	   cortical	   network	   abnormalities	   could	  be	  more	   associated	   to	   transition	   to	   psychosis.	   The	   results	   of	   this	   work	  provide	   further	   evidence	   for	   the	   implication	   of	   the	   above	   regions	   in	  psychosis;	  however,	  as	  discussed	  in	  Chapter	  5,	  the	  regions	  identified	  in	  the	   present	   study	   should	   be	   interpreted	   as	   parts	   of	   a	   spatially	  distributed	   pattern	   of	   neuroanatomical	   alterations	   rather	   than	   as	  independent	  areas.	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A	   recent	   follow-­‐up	   study	   on	   the	   outcome	   of	   young	   people	   initially	  identified	   as	   being	   at	   ultra	   high	   risk	   for	   psychosis,	   showed	   that	   only	  30%	   of	   those	   who	   do	   not	   make	   transition	   to	   psychosis	   reach	   full	  symptomatic	   and	   functional	   recovery,	   26%	   reach	   symptom	   remission	  without	   functional	   recovery	   and	   26%	   meet	   criteria	   for	   functional	  recovery	  without	  symptom	  remission	  (Schlosser,	  Jacobson	  et	  al.	  2012).	  Another	   follow-­‐up	   study	   reported	   that	   25%	   of	   these	   individuals	   still	  present	   symptoms	   that	   qualify	   them	   as	   being	   at	   risk	   for	   psychosis	  (Velthorst,	   Nieman	   et	   al.	   2011).	   This	   provides	   a	   rationale	   for	  investigating	   not	   only	   predictors	   of	   transition	   to	   psychosis	   but	   also	  predictors	   of	   symptom	   progression	   above	   and	   beyond	   psychosis	  outcome.	   I	   have	   therefore	   applied	   a	   multivariate	   machine	   learning	  method,	  RVR	  to	  investigate	  whether	  structural	  information	  would	  have	  allowed	  the	  quantitative	  prediction	  of	  symptom	  progression	  (i.e.	  PANSS	  total	  scores)	  at	  the	  individual	  level	  in	  a	  subsample	  of	  UHR	  recruited	  at	  the	  London	  site.	  The	  application	  of	  RVR	  revealed	  that	  cortical	  thickness	  but	   not	   volumetric	   information	   allowed	   the	   quantitative	   prediction	   of	  symptom	  progression	  in	  UHR	  individuals	  above	  and	  beyond	  transition	  to	   psychosis.	   This	   provides	   preliminary	   evidence	   that	   symptom	  progression	   in	   UHR	   people	   is	   associated	   with	   differences	   in	   cortical	  thickness	  rather	  than	  volumetric	  abnormalities.	  	  
7.2.2.	  Clinical	  implications	  The	   possibility	   of	   elucidating	   neuroanatomical	   abnormalities	   in	   the	  early	   stages	   of	   psychosis	   has	   important	   implications	   both	   for	   the	  understanding	   of	   pathophysiological	   mechanisms	   underlining	   this	  disorder	  and	  for	  the	  identification	  of	  neuromarkers	  that	  can	  be	  used	  to	  inform	   clinical	   practice.	   To	   date,	   all	   the	   UHR	   individuals	   entering	   the	  early	   intervention	  pathways	   are	   offered	   the	   same	   therapeutic	   options	  as	   it	   is	   not	   possible	   to	   predict	   which	   of	   them	   will	   go	   on	   to	   develop	  psychosis	   only	   based	   on	   the	   clinical	   presentation	   (Nelson	   2010).	  Neuroimaging	   studies	   of	   UHR	   hold	   the	   potential	   of	   elucidating	   the	  mechanisms	   underlining	   psychosis	   onset	   and	   at	   the	   same	   time	   of	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informing	   the	   early	   detection	   and	   the	   diagnosis	   of	   transition	   to	  psychosis.	   The	   present	   multi-­‐centre	   investigation	   revealed	   that	   there	  are	   volumetric	   and	   cortical	   differences	   between	   UHR	   individuals	   and	  healthy	  controls	  and	  volumetric	  differences	  between	  UHR-­‐T	  and	  UHR-­‐NT.	   Although	   the	   observed	   volumetric	   and	   cortical	   differences	  contribute	  to	  the	  understanding	  of	  the	  pathophysiology	  of	  the	  disease,	  their	   clinical	   applicability	   is	   unclear	   as	   these	   results	   are	   statistically	  significant	  only	  at	  the	  group	  level.	  	  	  Neuroimaging,	   that	   allows	   the	   study	   of	   the	   brain	   in	   vivo,	   holds	   the	  promise	   of	   elucidating	   the	   pathophysiological	   mechanisms	   underling	  the	  emergence	  of	  psychosis	  and	  providing	  information	  that	  can	  help	  to	  predict	   psychosis	   outcome.	   This	   would	   potentially	   allow	   a	   more	  targeted	  and	  ethically	  safer	  approach	  to	  the	  treatment	  of	  individuals	  at	  ultra	   high	   risk	   of	   psychosis.	  Multivariate	  machine	   learning	   techniques	  can	   employ	   information	   derived	   from	   any	   kind	   of	   multivariate	   data,	  including	   brain	   scans,	   to	   potentially	   predict	   the	   psychosis	   outcome	   at	  the	   individual	   level.	   Although	   the	   results	   from	   the	   present	   doctoral	  work	  were	   statistically	   significant,	   accuracy	   remains	   relatively	   low	   to	  be	   usefully	   applied	   in	   real-­‐world	   clinical	   settings.	   For	   example,	   the	  accuracies	  obtained	  in	  the	  present	  work	  are	  below	  the	  90%	  mark	  that	  was	  suggested	  for	  routine	  clinical	  use	  of	  MRI	  (Kasparek,	  Thomaz	  et	  al.	  2011,	   Iwabuchi,	   Liddle	   et	   al.	   2013).	   Furthermore,	   recent	   studies	   have	  emphasized	  the	  need	  to	  report	  additional	  measures	  such	  as	  Diagnostic	  Odd	  Ratio	   (DOR),	  which	   provides	   a	  mean	   for	   synthesising	   SVM-­‐based	  findings	  in	  a	  meta-­‐analytical	  framework,	  and	  Number	  Needed	  to	  Predict	  (NNP),	   that	  provides	  a	  summary	  value	  for	  measuring	  economic	  effects	  and	  resources	  allocation	  required	  to	  deploy	  SVM-­‐based	  diagnostic	  tools	  at	   a	   service	   level	   (Iwabuchi,	   Liddle	   et	   al.	   2013).	   The	   use	   of	   these	  alternative	   measures	   may	   be	   particularly	   useful	   given	   that	   different	  studies	   investigating	   the	   same	   populations	   have	   reported	   different	  levels	   of	   accuracy	   (Orru,	   Pettersson-­‐Yeo	   et	   al.	   2012).	   In	   order	   to	  facilitate	  the	  application	  of	  these	  approaches	  in	  clinical	  settings	  it	  would	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be	   therefore	   essential	   to	   report	   measures	   that	   empathise	   the	   clinical	  significance	  of	  the	  results	  (Iwabuchi,	  Liddle	  et	  al.	  2013).	  During	  the	  last	  two	   decades	   neuroimaging	   studies	   have	   provided	   a	   large	   amount	   of	  data	   that	   up	   till	   now	   failed	   to	   have	   a	   real	   clinical	   impact.	   In	   order	   to	  evaluate	   the	   clinical	   utility	   of	   a	   potential	   biomarker	   or	  diagnostic/prognostic	   approach,	   several	   factors	   should	   be	   considered.	  In	  particular,	  the	  relevance	  of	  the	  outcome	  and	  the	  number	  of	  patients	  that	   needs	   to	   be	   assessed	   in	   order	   to	  make	   one	   successful	   prediction	  have	  to	  be	  balanced	  against	  potential	  risks	  and	  side	  effects,	  burden	  and	  delays	  associated	  to	  the	  marker	  testing,	  costs	  and	  ethical	  issues	  (Perlis,	  Patrick	  et	  al.	  2009,	  Perlis	  2011,	  Prata,	  Mechelli	  et	  al.	  2014).	  	  	  	  The	   UHR	   population	   is	   clinically	   more	   heterogeneous	   than	   first	  episodes	   or	   schizophrenia	   populations	   (Fusar-­‐Poli,	   Bechdolf	   et	   al.	  2013).	  Indeed,	  the	  majority	  of	  the	  individuals	  does	  not	  make	  transition	  to	  psychosis,	   and	   those	  who	  do	  become	   ill	   can	  develop	  schizophrenia,	  affective	  or	  other	  psychotic	  disorders	  (Fusar-­‐Poli,	  Bechdolf	  et	  al.	  2013).	  Among	  those	  individuals	  that	  will	  not	  develop	  psychosis,	  about	  the	  25%	  will	  not	  reach	   full	  symptomatic	  remission	  after	   three	  years	  (Velthorst,	  Nieman	   et	   al.	   2011)	   and	   among	   those	   who	   reach	   full	   or	   partial	  remission	   of	   positive	   symptoms	   a	   portion	   will	   still	   present	   with	  relatively	  low	  social	  and	  occupational	  functioning	  (Addington,	  Cornblatt	  et	  al.	  2011).	  This	  partially	  shifts	  the	  focus	  from	  prediction	  of	  outcome	  to	  prediction	   of	   symptom	   progression	   and	   functioning	   over	   time.	   While	  preventing	   transition	   to	   psychosis	   remains	   a	   critical	   goal	   of	   early	  intervention	   services,	   there	   is	   growing	   appreciation	   that	   some	  individuals	  who	  never	  develop	  psychosis	  show	  disabling	  symptoms	  and	  poor	  functioning	  that	  have	  a	  detrimental	  impact	  on	  their	  quality	  of	  life.	  Neuroimaging	  and	  machine	   learning	  applications	  hold	   the	  potential	  of	  predicting	   functional	   outcome	   and	   symptom	   progression	   overtime	  (Allen,	   Chaddock	   et	   al.	   2014).	   Results	   form	   the	   present	   work	  demonstrated	   that	   cortical	   thickness	   information	   allows	   quantitative	  prediction	  of	  symptom	  progression	  in	  UHR	  for	  psychosis	  regardless	  of	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the	   psychosis	   outcome.	   This	   application	   of	   machine	   learning	   would	  potentially	   inform	   clinical	   practice	   and	   the	   selective	   delivery	   of	   early	  interventions,	   for	   example	   by	   providing	   further	   support	   to	   those	  individuals	   more	   likely	   to	   present	   with	   functional	   impairment	   and	  disabling	  symptoms	  overtime.	  However,	  this	  analysis	  was	  performed	  in	  a	   relatively	   small	   subsample	   of	   UHR	   for	   psychosis,	   replication	   of	   this	  finding	   in	   a	   larger,	   independent	   sample	   is	   required	   to	   draw	   more	  definitive	  conclusions.	  	  	  
7.3.	  Strengths	  The	   work	   presented	   here	   has	   a	   number	   of	   strengths.	   Firstly,	   it	  employed	   a	   multi-­‐centre	   approach	   for	   the	   investigation	   of	   structural	  abnormalities	   in	   individuals	   at	   high	   risk	   for	   psychosis.	   Relative	   to	   a	  single-­‐centre	   study,	   this	   approach	   has	   several	   advantages.	   Firstly,	   it	  increases	   sample	   size	  by	  pooling	  MRI	  data	   collected	   at	  different	   sites;	  this	   is	   particularly	   important	   for	   analyses	   of	   clinical	   outcome	   (i.e.	  statistical	  comparisons	  between	  UHR-­‐T	  and	  UHR-­‐NT	  subjects)	  as	  UHR-­‐T	  samples	  sizes	  tend	  to	  be	  small	  at	  a	  single	  site	  level.	  In	  addition	  to	  the	  increased	  statistical	  power	  and	  the	  reduced	  probability	  of	  type	  I	  errors	  (Button,	   Ioannidis	   et	   al.	   2013),	   combining	   data	   from	  different	   centres	  has	  the	  advantage	  of	  enhancing	  the	  generalizability	  of	  the	  results.	  Data	  collected	   from	   single	   research	   centres	  may	  differ	   due	   to	   variability	   in	  genetic,	  socio-­‐demographic	  and	  environmental	   factors;	   in	  contrast,	   the	  results	  presented	   in	   this	  doctoral	  work	  are	  based	  on	  data	   collected	   in	  the	  UK,	  Germany,	  Switzerland	  and	  Australia	  and	  therefore	  should	  have	  greater	  generalizability.	  	  	  	  Secondly,	   the	   sample	   reported	   here	   are	   individuals	  who	  were	   at	   high	  risk	  of	  developing	  a	  psychotic	  illness	  but	  still	  considered	  not	  psychotic.	  The	   study	   of	   the	   high	   risk	   population	   offers	   a	   window	   in	   which	   the	  mechanisms	  underling	  the	  emergence	  of	  psychosis	  can	  be	  studied	  with	  a	  relatively	  limited	  impact	  of	  confounding	  factors	  such	  as	  chronicity	  and	  psychotropic	  medications.	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  Thirdly,	  different	  analytic	  techniques	  have	  been	  used	  to	  investigate	  the	  pathophysiology	   of	   the	   illness.	   	   Specifically,	   in	   order	   to	   examine	   gray	  matter	   volume	   and	   cortical	   thickness,	   two	   voxel-­‐based	   analytic	  techniques	  have	  been	  employed:	  VBM	  and	  VBCT.	  Both	  techniques	  allow	  the	  investigation	  of	  volume	  and	  cortical	  thickness	  abnormalities	  at	  the	  voxel	  level.	  Previous	  studies	  investigating	  cortical	  thickness	  in	  the	  UHR,	  first	   episode	   and	   established	   schizophrenia	   have	   used	   surface-­‐based	  analytical	   techniques,	   which	   complicates	   the	   direct	   comparison	   of	  regional	  volumetric,	  or	  thickness	  abnormalities.	  VBM	  and	  VBCT	  use	  the	  same	  spatial	  preprocessing	  methods	  therefore	  it	  is	  possible	  to	  compare	  the	  patterns	  of	  alterations	  in	  gray	  matter	  volume	  and	  cortical	  thickness,	  minimising	  possible	  methodological	  differences.	  	  	  Fourthly,	  multivariate	  machine	  learning	  techniques,	  including	  SVM	  and	  RVR,	   were	   applied	   to	   a	   relatively	   large	   sample	   of	   UHR.	   Multivariate	  machine	   learning	   techniques	   allow	   inferences	   at	   the	   level	   of	   the	  individual,	   and	   therefore	   have	   greater	   translational	   potential	   in	  everyday	  clinical	  practice	  than	  standard	  analytical	  approaches	  based	  on	  group-­‐level	  statistics.	  	  	  Fifthly,	  in	  this	  doctoral	  work	  I	  examined	  for	  the	  first	  time	  whether	  it	  is	  possible	   to	   use	   neuroanatomical	   information	   to	   make	   accurate	  quantitative	  predictions	  of	  symptom	  progression	  in	  individuals	  at	  UHR	  for	   psychosis.	   Although	   the	   analysis	   was	   performed	   only	   on	   a	  subsample	  of	  UHR,	  for	  which	  the	  clinical	  information	  were	  available	  at	  baseline	  and	  two-­‐years	  follow-­‐up,	  the	  results	  provide	  proof-­‐of-­‐concept	  that	   it	  might	  be	  possible	   to	  use	  brain	  structural	   information	  to	   inform	  quantitative	   prediction	   of	   symptom	   progression	   in	   the	   population	   at	  high	  risk	  for	  psychosis.	  	  	  	  
7.4.	  Limitations	  A	  number	  of	   limitations	  also	  need	  to	  be	  considered	  when	   interpreting	  the	  results	  reported	  in	  this	  thesis.	  Firstly,	  the	  structural	  MRI	  data	  were	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collected	  using	  different	  scanners	  and	  acquisition	  sequences.	  Although	  this	   has	   been	   taken	   into	   account	   when	   the	   statistical	   analyses	   were	  preformed	  and	  this	  method	  has	  been	  previously	  successfully	  employed	  (Stonnington,	   Tan	   et	   al.	   2008,	   Segall,	   Turner	   et	   al.	   2009,	   Suckling,	  Barnes	   et	   al.	   2010),	   it	   cannot	   be	   completely	   ruled	   out	   that	   this	  might	  have	   had	   an	   impact	   on	   the	   findings.	   In	   particular,	   although	   it	   was	  possible	  to	  control	  for	  scanner	  effects	  in	  the	  VBM	  and	  VBCT	  analyses	  by	  modelling	   scanner	   as	   a	   factor	   in	   the	   statistical	   analyses,	   this	   was	   not	  possible	   in	   the	   SVM	  analyses.	   Therefore,	   the	  use	  of	   different	   scanners	  and	  acquisition	  sequences	  is	  most	  likely	  to	  have	  added	  noise	  to	  the	  data,	  increasing	   the	   unexplained	   variance	   in	   the	   statistical	   analysis	   and	  lowering	  the	  probability	  of	  finding	  statistically	  significant	  results.	  	  	  Secondly,	   although	   the	   four	   centres	   employed	   comparable	   inclusion	  criteria,	  different	  screening	  instruments	  and	  selection	  procedures	  were	  used	   to	   identify	   individuals	   at	   ultra	   high	   risk	   for	   psychosis.	   A	   recent	  meta-­‐analysis	   reported	   that	   different	   screening	   instruments	   are	  associated	   with	   different	   transition	   rates	   (Fusar-­‐Poli,	   Bonoldi	   et	   al.	  2012).	  In	  addition,	  variability	  could	  in	  part	  be	  due	  to	  different	  sampling	  selections	   procedures	   at	   the	   recruiting	   centres.	   When	   exploring	  between-­‐centre	   sociodemographic	   characteristics,	   a	   number	   of	  differences	   were	   detected.	   In	   particular,	   differences	   in	   age,	   ethnicity	  and	   total	   gray	   matter	   volume	   were	   observed	   between	   centres	   when	  comparing	  each	  sub-­‐sample	  (i.e.	  HC,	  UHR-­‐T	  and	  UHR-­‐NT)	  (Table	  A3.1.	  and	  A3.2.	  Appendix	  3).	  As	  discussed	  in	  previous	  chapters,	  these	  features	  were	   modelled	   as	   covariates	   of	   no	   interest	   when	   performing	   the	  statistical	   analyses	   in	   order	   to	   reduce	   their	   impact	   on	   the	   findings;	  however,	   it	   is	   not	   possible	   to	   exclude	   that	   the	   observed	   differences	  might	   have	   contributed	   noise	   to	   the	   data	  which,	   in	   turn,	   reduced	   the	  chance	   of	   finding	   reliable	   differences	   in	   brain	   structure.	   In	   addition,	  although	   nominally	   different	   transition	   rates	   were	   observed	   in	   the	  different	   centres,	   there	   was	   no	   significant	   effect	   of	   site	   on	   the	  percentage	   of	   those	   who	   transitioned	   to	   psychosis.	   This	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sociodemographic	  variability	  could	  be	  minimised	  in	  future	  multi-­‐centre	  studies	  by	  employing	  the	  same	  inclusion	  criteria,	  screening	  instruments	  and	  selection	  procedures	  at	  each	  site.	  	  Thirdly,	  the	  data	  analysed	  in	  the	  present	  doctoral	  work	  were	  collected	  at	  a	  single	  cross-­‐sectional	  time	  point.	  Therefore,	   it	  was	  not	  possible	  to	  assess	   the	   stage	   at	  which	   the	  observed	  differences	  had	   emerged.	  This	  issue	   could	   be	   addressed	   by	   using	   a	   longitudinal	   approach	   where	  individuals	   at	   high	   risk	   for	   psychosis	   are	   scanned	   and	   assessed	   at	  different	  time	  points	  not	  only	  in	  the	  prodromal	  phase	  but	  also	  after	  the	  onset	  of	  psychosis.	  	  	  Fourthly,	   the	   UHR	   population	   is	   heterogeneous	   in	   at	   least	   two	   ways.	  Firstly,	   UHR	   individuals	   can	   meet	   different	   inclusion	   criteria.	   The	  criteria	  require	  at	  least	  one	  of	  the	  following	  presentations:	  “attenuated”	  psychotic	   symptoms,	   brief	   limited	   intermittent	   psychotic	   symptoms	  (BLIPS)	   lasting	   less	   than	  a	  week	  and	   resolving	   spontaneously	  without	  the	   use	   of	   antipsychotic	   medication,	   or	   a	   significant	   decrease	   in	  functioning	  in	  the	  context	  of	  genetic	  risk	  for	  psychosis	  (Yung,	  Yuen	  et	  al.	  2005).	   Therefore	  UHR	   included	   in	   this	   and	   previous	   studies	   can	   have	  rather	   different	   clinical	   presentations,	   and	   they	   can	   follow	   different	  trajectories	   in	   terms	   of	   psychosis	   outcome,	   symptoms	   remission	   and	  functional	   recovery	   (Velthorst,	   Nieman	   et	   al.	   2011,	   Addington	   and	  Heinssen	  2012,	  Schlosser,	   Jacobson	  et	  al.	  2012,	  Fusar-­‐Poli,	  Bechdolf	  et	  al.	   2013).	   Secondly,	   UHR	   individuals	   can	   present	   with	   different	  comorbidities,	   the	  most	   common	  being	   anxiety,	   depression,	   substance	  misuse	  and	  personality	  disorders	   (Woods,	  Addington	  et	  al.	  2009)	   that	  can	   further	  complicate	   the	  picture.	  Recent	  studies	  reported	  that	  about	  69%	  of	  the	  UHR	  population	  had	  one	  or	  more	  mood/anxiety	  diagnoses,	  25%	  had	  substance	  abuse	  or	  dependence,	  44%	  had	  one	  or	  more	  Axis	  II	  diagnoses.	   Another	   recent	   study	   reported	   that	   73%	   of	   UHR	   had	   a	  comorbid	   Axis	   I	   diagnosis	   and	   40%	   of	   the	   cohort	   had	   a	   comorbid	  depressive	   disorder	   (Fusar-­‐Poli,	   Nelson	   et	   al.	   2014).	   The	   presence	   of	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Axis	  I	  or	  II	  comorbidities	  associated	  to	  the	  UHR	  state	  can	  correspond	  to	  potentially	   different	   trajectories	   in	   terms	   of	   outcome	   and	   therefore	  potentially	   different	   underlying	   psychophysiological	   mechanisms	  (Modinos,	  Allen	  et	  al.	  2014).	  Such	  heterogeneity	  within	  the	  UHR	  group	  was	   not	   modelled	   in	   the	   statistical	   analyses	   and	   may	   have	   reduced	  statistical	  sensitivity	  to	  neuroanatomical	  abnormalities.	  	  	  Fifthly,	  within-­‐centre	  analyses	  are	  not	  reported	  in	  the	  present	  doctoral	  work.	   I	   did	   not	   attempt	   to	   replicate	   within-­‐centre	   analyses	  (e.g.(Pantelis,	   Velakoulis	   et	   al.	   2003,	   Borgwardt,	   McGuire	   et	   al.	   2007,	  Borgwardt,	  McGuire	  et	  al.	  2008,	  Fornito,	  Yung	  et	  al.	  2008,	  Meisenzahl,	  Koutsouleris	   et	   al.	   2008,	   Koutsouleris,	   Meisenzahl	   et	   al.	   2009,	  Koutsouleris,	  Schmitt	  et	  al.	  2009)	  as	  this	  was	  not	  part	  of	  the	  objectives	  of	  the	  present	  doctoral	  work.	  This	  is	  because	  (i)	  different	  software	  (e.g.	  PRoNTo	   versus	   in-­‐house	   script	   used	   by	   Koutsouleris	   et	   al.	   2008)	   and	  different	  analytic	  methods	  (e.g.	  VBCT	  versus	  Freesurfer	  used	  by	  Fornito	  et	   al	   2008)	   were	   used	   in	   this	   work	   compared	   to	   other	   previously	  published	   studies;	   and	   (ii)	   the	   samples	   included	   in	   the	   present	   work	  overlapped	   but	   did	   not	   exactly	   match	   with	   those	   used	   in	   previous	  papers	  (e.g.	   (Pantelis,	  Velakoulis	  et	  al.	  2003,	  Fornito,	  Yung	  et	  al.	  2008,	  Koutsouleris,	  Schmitt	  et	  al.	  2009).	  
7.5.	  Future	  developments	  The	   present	   doctoral	   work	   provides	   further	   evidence	   supporting	   the	  feasibility	   and	   utility	   of	   using	   a	  multi-­‐centre	   approach	  when	   studying	  clinical	  populations	  that	  are	  difficult	  to	  recruit	  (e.g.	  the	  UHR	  population)	  and	   where	   the	   phenomenon	   of	   interest	   is	   rather	   infrequent	   (e.g.	  transition	   to	   psychosis	   is	   estimated	   to	   occur	   in	   around	   29%	   of	   those	  who	  meet	  criteria	  for	  UHR	  within	  24	  months	  although	  at	  some	  centres	  this	   transition	   rate	   may	   be	   even	   lower).	   	   To	   overcome	   limitations	  associated	  with	  cross-­‐sectional	  and	  prospective	  studies	  reported	  here,	  future	   multi-­‐centre	   studies	   should	   employ	   a	   longitudinal	   rather	   than	  cross-­‐sectional	   design;	   this	   would	   allow	   a	   better	   temporal	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characterization	   of	   the	   emergence	   of	   neuroanatomical	   abnormalities	  and	   how	   these	   trajectories	   varies	   depending	   on	   clinical	   outcome.	  Individuals	  at	  UHR	  for	  psychosis	  could	  be	  further	  stratified	  according	  to	  the	   inclusion	   criteria	   and	   symptomatology	   at	   baseline	   to	   investigate	  whether	   different	   subgroups	   are	   associated	   with	   distinct	   underling	  mechanisms.	   Moreover	   a	   retrospective	   stratification	   of	   UHR-­‐T	  according	   to	   different	   diagnosis	   at	   follow-­‐up	   such	   as	   schizophrenia,	  other	   psychosis,	   or	   affective	   disorders	   would	   allow	   one	   to	   further	  characterise	   the	   neuropathological	   pathways	   underlying	   the	   different	  illnesses.	  In	  addition,	  future	  studies	  would	  benefit	  from	  using	  the	  same	  scanning	   sequences.	   On	   this	   regard,	   the	   ADNI	   consortium	   has	  developed	   a	   structural	   MRI	   sequence	   that	   generates	   an	   image	   with	  similar	   properties	   independently	   of	   the	   scanner	   model	   and	  manufacturer	   (Jack,	  Bernstein	   et	   al.	   2008).	   Currently,	   there	   are	  multi-­‐centre	   projects	   such	   as	   EU-­‐GEI	   (European	   network	   of	   national	  schizophrenia	   networks	   studying	   gene-­‐environment	   interaction)	  (European	  Network	  of	  National	  Networks	  studying	  Gene-­‐Environment	  Interactions	   in,	   van	   Os	   et	   al.	   2014)	   and	   NAPLS	   (North	   American	  Prodrome	   Longitudinal	   Study),	   (Cannon,	   Cadenhead	   et	   al.	   2008)	   that	  have	  already	  adopted	  this	  approach,	  and	  that	  will	   therefore	  be	  able	  to	  pool	  different	  datasets	   into	  a	  single	   investigation	  with	  minimal	   impact	  of	   between-­‐centre	   differences.	   In	   order	   to	   promote	   the	   translational	  application	   of	   machine	   learning	   approaches	   in	   real-­‐world	   clinical	  practice,	   future	   studies	   should	   consider	   developing	   and	   testing	  predictive	   algorithm	   in	   large	   and	   independent	   datasets.	   In	   addition,	  given	   the	   inconsistent	   accuracies	   reported	   by	   studies	   that	   compared	  patients	  and	  controls	  (Orru,	  Pettersson-­‐Yeo	  et	  al.	  2012),	  future	  studies	  should	   aim	   to	   report	   measures	   that	   are	   clinically	   significant,	   such	   as	  NNP	  and	  DOR.	  	  
7.6.	  Conclusions	  The	  present	  multi-­‐centre	   investigation	  of	   individuals	  at	  ultra	  high	  risk	  for	   psychosis	   demonstrates	   that	   there	   are	   volumetric	   and	   cortical	  
	   134	  
differences	   in	   fronto-­‐temporal	  regions	  associated	  with	  vulnerability	   to	  psychosis,	  and	  that	  there	  are	  temporal	  volumetric	  abnormalities	  in	  UHR	  individuals	  who	  subsequently	  develop	  psychosis	  relative	  to	  those	  who	  do	  not.	  Using	  machine	  learning	  methods,	  I	  also	  showed	  that	  volumetric	  abnormalities	  allow	  the	  distinction	  between	  people	  at	  UHR	  and	  healthy	  controls	   at	   the	   level	   of	   the	   individual	   regardless	   of	   transition	   to	  psychosis.	  In	  contrast,	  cortical	  thickness	  measures	  appear	  to	  better	  able	  to	   classify	   according	   to	   clinical	   outcome	   and	   symptom	  progression	   at	  the	   level	   of	   the	   individual.	   However,	   the	   classification	   accuracies	  obtained	   from	  multivariate	   analyses,	   although	   statistically	   significant,	  were	  low	  and	  may	  not	  be	  suitable	  for	  clinical	  application.	  	  	  Taken	   together	   these	   findings	   suggest	   that,	   consistent	   with	   the	  neurodevelopmental	   model,	   there	   are	   neuroanatomical	   abnormalities	  that	   precede	   the	   emergence	   of	   psychosis	   within	   a	   distributed	   fronto-­‐temporal	  network.	  The	  results	  of	  the	  current	  work	  show	  that	  UHR	  and	  healthy	   controls	   are	   distinguishable	   at	   the	   individual	   level	   based	   on	  information	   on	   the	   gray	  matter	   volume,	   and	   UHR-­‐T	   and	   UHR-­‐NT	   are	  distinguishable	   at	   the	   individual	   level	   using	   cortical	   thickness	  information.	   Nevertheless,	   the	   accuracies	   found	   in	   the	   present	   work	  remain	  relatively	  low	  to	  be	  safely	  applied	  in	  real-­‐word	  clinical	  settings.	  The	   timing	   of	   the	   emergence	   of	   these	   abnormalities	   could	   not	   be	  established,	   and	   further	   research	   is	  needed	   to	  examine	  whether	   these	  have	  emerged	  early	  in	  life	  or	  around	  adolescence/early	  adulthood.	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Appendix	  1	  Publications	  derived	  from	  this	  thesis	  
	  
A1.1.	   	   Neuroanatomical	   abnormalities	   that	   predate	   the	   onset	   of	  
psychosis	  
	  Candidate’s	   contribution	   to	   the	   study:	   I	   have	   carried	   out	   the	   preprocessing	  and	  the	  statistical	  analyses	  of	  the	  MRI	  data.	  I	  have	  drafted	  the	  first	  version	  of	  the	  manuscript,	  I	  have	  implemented	  the	  suggestions	  made	  by	  the	  co-­‐authors	  and	   I	   have	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   the	   manuscript	   according	   to	   the	   reviewers’	   comments	  during	  the	  publication	  phase.	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Neuroanatomical Abnormalities That Predate
the Onset of Psychosis
A Multicenter Study
Andrea Mechelli, PhD; Anita Riecher-Ro¨ssler, MD; Eva M. Meisenzahl, MD; Stefania Tognin, BSc, MSc;
Stephen J. Wood, PhD; Stefan J. Borgwardt, MD; Nikolaos Koutsouleris, MD; Alison R. Yung, MB, BS, PhD, FRANZCP;
James M. Stone, BSc, MB, BS, MRCPsych, PhD; Lisa J. Phillips, MPsych, PhD;
Patrick D. McGorry, MB, BS, MD, PhD, FRANZCP; Isabel Valli, MD; Dennis Velakoulis, MB, BS, FRANZCP;
James Woolley, BSc, MBBS, MRCP, MRCPsych; Christos Pantelis, MB, BS, MD, MRCPsych, FRANZCP;
Philip McGuire, BSc, MB, ChB, MD, PhD, FRCPsych
Context: People experiencing possible prodromal symp-
toms of psychosis have a very high risk of developing the
disorder, but it is not possible to predict, on the basis of
their presenting clinical features, which individuals will
subsequently become psychotic. Recent neuroimaging
studies suggest that there are volumetric differences be-
tween individuals at ultra-high risk (UHR) for psycho-
sis who later develop psychotic disorder and those who
do not. However, the samples examined to date have been
small, and the findings have been inconsistent.
Objective: To assess brain structure in individuals at
UHR for psychosis in a larger and more representative
sample than in previous studies by combining magnetic
resonance imaging data from 5 different scanning sites.
Design: Case-control study.
Setting: Multisite.
Participants:A total of 182 individuals at UHR and 167
healthy controls. Participants were observed clinically for
a mean of 2 years. Forty-eight individuals (26.4%) in the
UHR group developed psychosis and 134 did not.
Main Outcome Measures: Magnetic resonance im-
ages were acquired from each participant. Group differ-
ences in gray matter volume were examined using opti-
mized voxel-based morphometry.
Results: The UHR group as a whole had less gray mat-
ter volume than did controls in the frontal regions bilat-
erally. The UHR subgroup who later developed psycho-
sis had less graymatter volume in the left parahippocampal
cortex than did the UHR subgroup who did not.
Conclusions: Individuals at high risk for psychosis show
alterations in regional gray matter volume regardless of
whether they subsequently develop the disorder. In the
UHR population, reduced left parahippocampal volume
was specifically associated with the later onset of psy-
chosis. Alterations in this region may, thus, be crucial
to the expression of illness. Identifying abnormalities that
specifically predate the onset of psychosis informs the
development of clinical investigations designed to pre-
dict which individuals at high risk will subsequently de-
velop the disorder.
Arch Gen Psychiatry. 2011;68(5):489-495
P SYCHOTIC DISORDERS AREusually preceded by a pro-dromal phase in which thereis a gradual deterioration ofglobal and social functioning
and the emergence of attenuated psy-
chotic symptoms.1,2 However, not all
people with these features progress to
develop a full-blown psychotic disorder;
20% to 50% develop psychosis, usually
within 24 months, but the remainder do
not.3-6 Individuals first seen with this
clinical syndrome are, thus, said to be at
ultra-high risk (UHR) for psychosis.7
Results of recent trials8-10 suggest that
clinical intervention in the UHR popula-
tion may reduce the risk of later transi-
tion to psychosis. However, it is difficult
on purely clinical grounds to distinguish
individuals who will later become psy-
chotic from those who will not.5,6,10 This
prevents the selective provision of poten-
tially preventive interventions to the sub-
groups most likely to become psychotic,
which is desirable from an ethical stand-
point and for the efficient use of health
care resources.
Recent studies11-20 usingmagnetic reso-
nance imaging (MRI) have examined
whether there are neuroanatomical dif-
ferences between UHR individuals who
subsequently develop psychosis and those
who do not. A variety of differences in re-
gional gray matter volume (GMV) have
Author Affiliations are listed at
the end of this article.
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been reported, but the findings have been inconsistent;
this may partly reflect the use of small samples. How-
ever, UHR individuals are hard to recruit, and it is diffi-
cult for any single center to scan a large sample. Sample
size is a particular problem for the key comparison be-
tween UHR individuals who later develop psychosis and
those who do not, which entails a further subdivision of
the UHR sample according to clinical outcome. A po-
tential solution is to conduct multicenter studies, with
the pooling of data to produce a relatively large total
sample. This approach has been successfully used in neu-
roimaging studies of other central nervous system dis-
orders in which patient recruitment is difficult.21,22
In the present study, whole-brain MRIs were ac-
quired from 5 MRI scanners in London, United King-
dom (2 sites); Basel, Switzerland;Munich, Germany; and
Melbourne, Australia. The objective was to identify the
most robust neuroanatomical abnormalities in individu-
als at UHR and to compare UHR participants who sub-
sequently made a transition to psychosis with those who
did not. At each site, participants were scanned at first
clinical presentation and were observed clinically for a
mean of 2 years so that they could then be subcatego-
rized according to clinical outcome. The MRI data from
each site were combined to form a large UHR sample,
which was subdivided into individuals who had devel-
oped psychosis (UHR-T) and those who had not (UHR-
NT). The MRI data from several matched healthy con-
trols were also acquired at each site.
The first prediction, based on data fromprevious stud-
ies,11,15,18,23-27 was that the UHR group as a whole would
show regional volumetric differences relative to con-
trols that were qualitatively similar to those seen in pa-
tients with schizophrenia. We then tested the main hy-
pothesis that UHR-T individuals would show differences
in GMV relative to UHR-NT individuals in the inferior
frontal, parahippocampal, and superior temporal corti-
ces, the areasmost frequently implicated in previous stud-
ies. Critically, these predictions were based on the re-
sults of previous single-center studies11,15,18,23-27 that used




All the UHR individuals were recruited from specialized clini-
cal services for people at high risk for psychosis. Individuals
at UHR scanned at the 2 London sites (Institute of Psychiatry
and Maudsley Hospital) were recruited via Outreach and Sup-
port in South London (OASIS). Individuals at UHR scanned
in Basel were recruited through the clinic for early detection
of psychosis (FEPSY) at the Psychiatric Outpatient Depart-
ment, University Hospital. Those scanned in Munich were re-
cruited through the Early Detection and Intervention Centre
for Mental Crisis of the Department of Psychiatry and Psycho-
therapy, Ludwig-Maximilians-University. The UHR individu-
als scanned inMelbourne were recruited from the Personal As-
sessment andCrisis Evaluation (PACE)Clinic. Data were, thus,
combined from 5 MRI scanners at the Institute of Psychiatry,
theMaudsley Hospital, the University Hospital Basel, the Lud-
wig-Maximilians-University (Munich), and the Royal Mel-
bourne Hospital. Some of the data from London, Basel, Mu-
nich, andMelbourne have been described separately in previous
single-center studies.12-14,17,19,20,28-30 Data were from 182 pa-
tients at UHR.
All the UHR individuals at all the sites met the Personal As-
sessment and Crisis Evaluation criteria for UHR. Inclusion re-
quired the presence of 1 or more of the following features: (1)
“attenuated” psychotic symptoms, (2) brief limited intermit-
tent psychotic symptoms, or (3) a first-degree relative with a
psychotic disorder, plus a marked decline in social or occupa-
tional functioning.2,7 None of the participants met the criteria
for additional psychiatric disorders or learning disabilities. De-
tails of the inclusion and exclusion criteria and clinical char-
acteristics of the UHR individuals are reported in eTables 1, 2,
3, 4, 5, 6, and 7 (http://www.archgenpsychiatry.com). Most of
theUHRgroup (168of 182 individuals [92.3%]) hadnever taken
antipsychotic agents or mood stabilizing drugs, and 14 (7.7%)
had been exposed to antipsychotic agents (mean [SD] expo-
sure time, 13.0 [19.3] months).
At each site, controls from the same geographic area as the
UHR individuals were recruited through local advertise-
ments. The control sample comprised 167 individuals and was
comparable with the total UHR group for sex, age, and race/
ethnicity. For all participants, the exclusion criteria were past
or present diagnosis of psychiatric illness, previous treatment
with antipsychotic drugs, medical illness, family history of psy-
chiatric illness, past or present diseases of the central nervous
system, alcohol or other substance abuse or dependence (de-
fined using DSM-IV criteria), and pregnancy (eTable 1).
During a mean (SD) of 30.6 (10.4) months of follow-up
subsequent to scanning, 48 of the UHR sample (26.4%)
developed psychosis (UHR-T) and 134 did not (UHR-NT).
Each site yielded a data set that included a UHR-T group, a
UHR-NT group, and a control group, except 1 of the London
data sets, from which the UHR-T group was too small (n=2)
to be included in the combined UHR-T vs UHR-NT compari-
son (eTable 8).
MRI ACQUISITION
At all 5 sites, volumetric MRIs were acquired using a T1-
weighted protocol. At 4 sites, the scanner field strength was 1.5
T, and at 1 site it was 3 T. Three sites used General Electric
scanners (Milwaukee, Wisconsin), and 2 used Siemens scan-
ners (Erlangen, Germany). The details of the MRI acquisition
sequence varied among scanners (eTable 9).
DATA ANALYSIS
Sociodemographic and Clinical Parameters
Differences in demographics and clinical profile between groups
were examined using 1-way analysis of variance for paramet-
ric data and a !2 test for nonparametric data using a commer-
cially available software program (SPSS, version 17.0 for Win-
dows; SPSS Inc, Chicago, Illinois) (Table 1).
Preprocessing
We examined group-related differences in GMV using voxel-
based morphometry, as implemented in SPM8 software (http:
//www.fil.ion.ucl.ac.uk/spm) running underMATLAB 7.1 (The
MathWorks, Inc, Natick, Massachusetts). First, T1-weighted
volumetric images were preprocessed using the DARTEL (dif-
feomorphic anatomical registration using exponentiated lie
algebra)31 SPM8 toolbox. This approach involves the creation
of a study-specific template and the segmentation of each in-
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dividual image using such a template, with the aim of maxi-
mizing accuracy and sensitivity.32 The following steps were fol-
lowed for voxel-basedmorphometry preprocessing: (1) checking
for scanner artifacts and gross anatomical abnormalities for each
subject, (2) setting the image origin to the anterior commis-
sure, (3) using the DARTEL toolbox to produce a high-
dimensional normalization protocol,31 (4) checking for homo-
geneity across the sample, and (5) using standard smoothing
(ie, 8 mm). A “modulation step” was also included in the nor-
malization to preserve the information about the absolute gray
matter values.33,34 After this preprocessing, we obtained
smoothed, modulated, normalized data that were used for the
statistical analysis.
STATISTICAL ANALYSIS
Weperformed 2 statistical analyses using SPM8 software. First,
an analysis of variance was used to compare gray matter im-
ages from UHR individuals (UHR-T and UHR-NT combined)
and controls. In this analysis, scanner site was modeled as a
factor, resulting in 10 experimental groups. Second, we per-
formed an analysis of variance to compare gray matter images
from UHR individuals who later became psychotic (UHR-T),
UHR individuals who did not become psychotic (UHR-NT),
and controls. In this analysis, scanner site was again modeled
as a factor, resulting in 14 experimental groups (1UHR-T group
was too small for analysis [n=2] compared with the UHR-NT
group [n=19]; see previously herein). Including scanner site
as a factor in the statistical analysis allowed us to (1) model
scanner-related variance in the data, which had the effect of
reducing error variance and increasing statistical sensitivity, and
(2) examine the impact of scanner site by testing for scanner
effects and scanner! group interactions. To assess howmuch
of the interindividual variance in regions that differed be-
tween UHR-T and UHR-NTwas explained by diagnostic group
and scanner site, respectively, we used the"p2 measure of effect
size in SPSS. In both analyses, we modeled age, sex, race/
ethnicity, and use of medication as covariates of no interest to
reduce the potential impact of these variables on the findings.
To identify regionally specific changes that were not con-
founded by global differences, we used the proportional scal-
ing option. Statistical inferencesweremade at P# .05 after fami-
lywise error (FWE) correction, with an extent threshold of 5
voxels.
REGION-OF-INTEREST ANALYSES
In addition to thewhole-brain analysis, regions of interest (ROIs)
were used to examine between-group differences in areas in
which volumetric abnormalities have previously been identi-
fied in studies of people at high risk for psychosis or patients
with first-episode psychosis.16,35,36 These ROIswere the left para-
hippocampal gyrus (MNI [Montreal Neurological Institute] co-
ordinates x, y, z, −23, 6, and −20),35 the right inferior frontal
gyrus (45, 37, and 0),36 and the left superior temporal gyrus
(−49, −31, and 2).16 We used the coordinates from the previ-
ous studies that had reported themost significant effects in these
regions; none of these previous studies had included data from
individuals who participated in the present investigation. Using
the SimpleROIBuilder toolbox (http://www.fil.ion.ucl.ac.uk
/spm/ext/), we created amask that included the 3 chosen ROIs.
This mask consisted of 3 spheres with a radius of 8 mm cor-
responding to the 3 ROIs and a total of 758.71 voxels. Within
themask, statistical inferences were made at P# .05 after FWE




No statistically significant differences were noted among
theUHR-T,UHR-NT, and control groups in age, sex, total
GMV, and race/ethnicity (Table 1).
DIFFERENCES BETWEEN THE UHR AND
CONTROL GROUPS
TheUHRgrouphad lessGMV thandid controls (atP# .05
after FWE correction) in 3 areas of the frontal cortex: the
medial orbital gyrus and the gyrus rectus bilaterally and
the right anterior cingulate gyrus (Figure 1 and
Table 2). In these regions, no significant effect of medi-
cation was noted even at trend level (P# .05 uncor-
rected). There were no areas in which UHR individuals
had more GMV than did controls.







(n = 134) Significance
Age, mean (SD), y 23.5 (4.2) 22.7 (4.5) 23.3 (5.3) F2 = 0.552
P = .58
Sex, No. $22 = 2.541
P = .28Male 104 15 51
Female 63 33 83
Race/ethnicity, No. $26 = 11.122
P = .09White 140 42 106
Black 11 1 7
Asian 10 0 6
Mixed 6 5 15
Handedness, No. $24 = 3.355
P = .50Right 147 44 126
Left 14 3 6
Ambidextrous 6 1 2
GMV, mean (SD), mm3 0.948 (0.11) 0.945 (0.08) 0.937 (0.10) F2 = 0.450
P = .64
Abbreviations: GMV, gray matter volume; UHR-NT, ultra-high risk without disease transition; UHR-T, ultra-high risk with disease transition.
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DIFFERENCES BETWEEN UHR INDIVIDUALS
WHO DID AND DID NOT DEVELOP PSYCHOSIS
Analysis by ROI revealed reduced gray matter volume in
the UHR-T group relative to the UHR-NT group in the
anterior part of the left parahippocampal gyrus (border-
ing the uncus) (MNI coordinates x=−21, y=6, and z=−27;
P =.03; z=3.35; and cluster size=6 voxels) (at P! .05 af-
ter FWE correction) (Figure 2), where the difference
between UHR-T and UHR-NT accounted for 14% of the
total variance. In this region, no significant effect ofmedi-
cation was noted even at trend level (P! .05 uncor-
rected). Plotting of gray matter values revealed that this
reduction was evident in each of the 4 sites examined for
this contrast (Figure 2). There were no significant dif-
ferences in the other ROIs (ie, in the right inferior fron-
tal gyrus and the left superior temporal gyrus).
To examine the predictive value of GMV in the left
parahippocampal gyrus, we extracted gray matter val-
ues from the peak voxel and performed a series of cross-
validation analyses using a predictive linearmodel in SPSS
software. This involved developing a predictive model
based on a data set from a single scanner site and testing
it in each of the other data sets; the average predictive
accuracy was 62% (sensitivity =61% and specific-
ity=65%). We also performed a 3-fold cross-validation
analysis irrespective of scanner site that involved devel-
oping a predictive model based on two-thirds of the total
sample and testing it in the remaining one-third; this
yielded an average accuracy of 67% (sensitivity=68% and
specificity=66%).
COMMENT
We used MRI to study a large sample of UHR individu-
als created by pooling data from 5 sites. The UHR indi-
viduals were observed clinically subsequent to scanning
and were subcategorized according to which individu-
als developed psychosis and which did not.
On the basis of previous MRI studies of smaller UHR
samples collected at single sites,11,15,18,23-27 we first tested
the hypothesis that theUHRgroup as awholewould show
volumetric abnormalities relative to controls that were
qualitatively similar to those seen in patients with schizo-
phrenia. Consistent with this prediction, the UHR group
expressed significant reductions in GMV in the prefron-
tal and anterior cingulate cortices (P! .05 after FWE cor-
rection), areas that have been consistently implicated in
volumetric neuroimaging studies of schizophrenia.37 In
contrast, we did not identify areas where there was more
GMV in the UHR sample than in controls.
The main prediction was that UHR individuals who
later developed psychosis would show differences in re-
gional GMV in the inferior frontal, parahippocampal, and
superior temporal cortices compared with those who did
not become psychotic. This hypothesis was, in part, con-
firmed: the UHR-T subgroup showed relatively reduced
GMV in the anterior part of the left parahippocampal gy-
rus, bordering the hippocampal uncus (P! .05 after FWE
correction). In this area, there was less gray matter in
UHR-T individuals than in controls (P! .05 corrected)
but no significant difference between the UHR-NT and
y = 40
HC > UHR




x  = 7
Figure 1. Differences between the ultra-high-risk (UHR) and control (HC) groups. The images show the medial orbital region, where the total UHR sample showed
reduced gray matter volume relative to HCs (P! .05 after familywise error correction).






Voxels z Score P Valuex y z
Medial orbital gyrus Right 7 40.5 −16.5 130 5.44 .001
Cingulate gyrus Right 12 58.5 9 50 5.35 .001
Medial orbital gyrus Left −18 52.5 −16.5 30 4.94 .005
Gyrus rectus Right 3 25.5 −25.5 73 4.94 .01
Gyrus rectus Left −4 25.5 −22.5 4.80 .02
Abbreviations: MNI, Montreal Neurological Institute; UHR, ultra-high risk.
aP ! .05 after familywise error correction.
bNo clusters were detected for the UHR"control contrast.
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control groups (eTable 10). A series of cross-validation
analyses also revealed that GMV in this region allowed
discrimination betweenUHR-T andUHR-NTwith an ac-
curacy of up to 67%. In contrast to some previous single-
center studies,16,36 we did not find statistically signifi-
cant differences in the inferior frontal and superior
temporal gyri.
Reductions in parahippocampal volume have been re-
ported in high-risk individuals relative to controls,36 as
have alterations in parahippocampal function.38Over time,
reductions in parahippocampal volume have been de-
scribed in high-risk individuals with transient or iso-
lated psychotic symptoms,16 and longitudinal reduc-
tions have been described in high-risk individuals who
developed psychosis.15 Moreover, cross-sectional com-
parisons indicate that patients with first-episode psycho-
sis have smaller parahippocampal volumes than do con-
trols and UHR individuals.26 Meta-analyses suggest that
the parahippocampal region is one of themost robust sites
of volume reduction in chronic schizophrenia.37,39-41 Con-
temporary animal models of psychosis propose that al-
tered parahippocampal activity drives subcortical dopa-
minedysfunction.42 These observations are consistentwith
the notion that the parahippocampal cortex is critically
implicated in psychotic disorders.
At the time of scanning, the UHR-T and UHR-NT
groups were clinically indistinguishable; the volumetric
differences observed between them could be inter-
preted as neurobiological markers of an especially in-
creased vulnerability to psychosis or as early manifesta-
tions of a neuropathologic process underlying the
transition to psychosis. Because the data in the present
studywere collected at a single cross-sectional time point,
we cannot determine at what stage these differences first
emerged. This issue could be addressed by longitudinal
neuroimaging studies of individuals at different time
points in the prodromal phase of psychosis.
A limitation of this study is that the data were col-
lected using different scanners and different acquisition
sequences.22,43,44 Nevertheless, we are confident that the
results do not represent an artifact due to the use of dif-
ferent scanners for several reasons. First, we sought to
control for these effects by using only MRI data col-
lectedwith T1-weighted sequences and bymodeling scan-
ner site as an independent factor in the statistical analy-
sis. Second, a comparable proportion of controls,
nonconverters, and converters was scanned at each site,
except for 1 of the London data sets, which was, there-
fore, excluded from the UHR-T vs UHR-NT compari-
son. Third, plotting of gray matter values suggested that
the differences between the UHR-T and UHR-NT groups
were evident not only across different centers but also
within each site and, therefore, cannot be explained by
interscanner differences (Figure 2). Fourth, whenwe ex-
amined the impact of scanner site, we found no evi-
dence of either scanner effects or scanner ! group in-
teractions in regions that differed between groups, even
when lowering the statistical threshold to P" .05 (un-
corrected). Fifth, this approach to the integration ofmul-
tiscanner data in the same statistical model has been used
successfully in previous studies22,43-45 that also com-
bined different scanners and acquisition sequences; these
studies typically found that scanner differences were sub-
stantially less than group differences. Consistentwith this,












1 2 3 4
Figure 2. Differences between ultra-high-risk (UHR) individuals who did (UHR-T) and did not (UHR-NT) develop psychosis. The UHR-T individuals had less gray
matter volume than did the UHR-NT individuals in the left parahippocampal gyrus, bordering the uncus (MNI [Montreal Neurological Institute] coordinates x, y,
and z: −21, 6, and −27, respectively). For visualization purposes, effects are displayed at P" .05 uncorrected. The plot shows mean gray matter volumes for the 2
UHR subgroups at each site (x-axis:1 indicates London, United Kingdom; 2, Basel, Switzerland; 3, Munich, Germany; and 4, Melbourne, Australia); values on the
y-axis refer to cubic millimeters per voxel. Error bars represent SD.
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we found that scanner-related variance (11%) was less
than group-related variance (14%) in the left parahip-
pocampal region, which differed between theUHR-T and
UHR-NT groups. The impact of the use of different scan-
ners and acquisition sequences could be further con-
trolled for by scanning the same individuals at each site,
but this was not feasible in the present investigation.
Data from the present study suggest that in the fu-
ture it may be possible to use MRI to facilitate the pre-
diction of psychosis in those at high risk.46 This would
be particularly useful in the clinical management of in-
dividuals at UHR because it is difficult to predict which
individuals will go on to develop psychosis on the basis
of their clinical features.4 As a result, it is not possible to
focus the provision of clinical resources, such as puta-
tively preventive treatments,47 to the subgroup of UHR
individuals whowill later become psychotic. Clinical ap-
plicationof neuroimaging in this context requires the iden-
tification of predictive markers at an individual level,
whereas the present data represent group differences. Im-
age analysis methods that classify individuals according
to patterns of data associated with diagnostic categories
may provide a means of addressing this issue.48
In conclusion, UHR is associated with alterations in
regional GMV, and in this population, reductions in the
parahippocampal regionmay be specifically linked to the
later onset of psychosis. These findings suggest that neu-
roimaging data may facilitate the prediction of illness in
individuals at high risk for psychosis andmay inform the
development of new interventions designed to delay or
prevent its onset.
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Reduced parahippocampal cortical thickness in
subjects at ultra-high risk for psychosis
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Background. Grey matter volume and cortical thickness represent two complementary aspects of brain structure.
Several studies have described reductions in grey matter volume in people at ultra-high risk (UHR) of psychosis;
however, little is known about cortical thickness in this group. The aim of the present study was to investigate cortical
thickness alterations in UHR subjects and compare individuals who subsequently did and did not develop psychosis.
Method. We examined magnetic resonance imaging data collected at four different scanning sites. The UHR subjects
were followed up for at least 2 years. Subsequent to scanning, 50 UHR subjects developed psychosis and 117 did not.
Cortical thickness was examined in regions previously identiﬁed as sites of neuroanatomical alterations in UHR subjects,
using voxel-based cortical thickness.
Results. At baseline UHR subjects, compared with controls, showed reduced cortical thickness in the right parahippo-
campal gyrus (p<0.05, familywise error corrected). There were no signiﬁcant differences in cortical thickness between the
UHR subjects who later developed psychosis and those who did not.
Conclusions. These data suggest that UHR symptomatology is characterized by alterations in the thickness of
the medial temporal cortex. We did not ﬁnd evidence that the later progression to psychosis was linked to additional
alterations in cortical thickness, although we cannot exclude the possibility that the study lacked sufﬁcient power to
detect such differences.
Received 13 September 2012; Revised 6 April 2013; Accepted 11 April 2013; First published online 10 May 2013
Key words: Cerebral cortex, magnetic resonance imaging, parahippocampal gyrus, prodromal period, schizophrenic
psychoses, voxel-based cortical thickness.
Introduction
The ﬁrst episode of a psychotic disorder is usually
preceded by a prodromal period characterized by a
progressive decline in functioning and the emergence
of attenuated psychotic symptoms. Individuals with
these clinical features are said to be at ‘ultra-high
risk’ (UHR) for psychosis because 18–36% of them
will develop a psychotic disorder within 3 years
(Fusar-Poli et al. 2012). Early clinical intervention in
the UHR population may reduce the risk of later
transition to psychosis and improve long-term clinical
and functional outcome (McGorry et al. 2009); how-
ever, at present it is difﬁcult to predict based on ﬁrst
clinical presentation which UHR individual who
will and will not go on to develop psychosis. Recent
work has sought to examine if neuroimaging can be
used to identify individuals at UHR and predict who
will subsequently make transition to psychosis within
this population (Koutsouleris et al. 2009).
Studies using voxel-based morphometry (VBM)
have examined whether UHR subjects are affected by
neuroanatomical abnormalities. Cross-sectional studies
indicate that, relative to healthy controls, UHR subjects
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have reduced grey matter (GM) volume in frontal
(Meisenzahl et al. 2008; Mechelli et al. 2011), lateral
and medial temporal regions (Meisenzahl et al. 2008).
Studies that used a region of interest (ROI) approach
reported GM volume increases (Buehlmann et al.
2010) but also reductions (Phillips et al. 2002) in the
hippocampus, reductions in the planum polare/
temporale, insula and superior temporal gyrus
(Takahashi et al. 2009, 2010), increases in the pituitary
volume (Büschlen et al. 2011), and reductions in the
anterior cingulate cortex (ACC) (Röthlisberger et al.
2012) in the UHR group compared with healthy
controls.
In VBM studies, relative to UHR subjects who
did not develop psychosis (UHR-NT), those who
later became psychotic (UHR-T) had reduced volumes
in the inferior frontal cortex, medial and lateral
temporal cortex, ACC (Pantelis et al. 2003), insular,
inferior and superior frontal cortex (Borgwardt et al.
2008). ROI studies suggest that later transition to psy-
chosis is associated with reduced volume in the left
parahippocampal gyrus (Mechelli et al. 2011), the
insula bilaterally (Takahashi et al. 2009), the left ACC
(Röthlisberger et al. 2012), and with increased pituitary
(Büschlen et al. 2011) and hippocampus (Buehlmann
et al. 2010) volumes.
Some ROI studies did not ﬁnd any signiﬁcant
differences between UHR subjects and healthy controls
(Wood et al. 2005; Velakoulis et al. 2006) or between
UHR-T and UHR-NT individuals (Yucel et al. 2003;
Velakoulis et al. 2006). Nevertheless, evidence that
there may be volumetric differences between the latter
subgroups raises the possibility that neuroimaging
measures might be able to facilitate the prediction of
clinical outcome in UHR subjects.
The vast majority of structural neuroimaging studies
in UHR individuals have focused on GM volume.
However, neuroanatomical alterations in psychosis
may be expressed not only in terms of GM volume
but also as subtle changes in cortical thickness. While
the analysis of GM volume returns a mixed measure
that depends on local cortical thickness as well as cor-
tical folding and gyriﬁcation (i.e. cortical surface area),
the analysis of cortical thickness is considered to
speciﬁcally target the presence of cortical atrophy
(Hutton et al. 2009). Therefore the two approaches
provide complementary information and one can be
more sensitive than the other depending on the pro-
cess underlying neuroanatomical changes. Cortical
thickness in the human brain can be examined using
the automated data analysis of T1-weighted images
(Hutton et al. 2008). Application of this approach in
patients with ﬁrst-episode and established schizo-
phrenia suggests that there is a cortical thinning in
the anterior cingulate (Narr et al. 2005a; Fornito et al.
2008a; Schultz et al. 2010b), prefrontal (Narr et al.
2005a; Venkatasubramanian et al. 2008; Schultz et al.
2010b), temporal (Narr et al. 2005a; Fornito et al.
2008a) and occipital (Narr et al. 2005b) cortices. In
UHR subjects, reduced cortical thickness has been
reported in the prefrontal, ACC, inferior parietal,
superior temporal and parahippocampal cortices com-
pared with healthy controls (Jung et al. 2011). One
study has reported that in UHR individuals who
subsequently developed psychosis the ACC was thin-
ner than in UHR-NT (Fornito et al. 2008b) and one
has reported a progressive thinning in the anterior
cingulate, precuneus and temporo-parietal-occipital
cortex compared with UHR-NT and healthy controls
(Ziermans et al. 2012). Another study did not ﬁnd
differences in cortical thickness between individuals
at UHR, patients with a ﬁrst psychotic episode and
healthy controls, but the groups differed in cortical
thickness asymmetry (Haller et al. 2009).
The ﬁndings from studies of cortical thickness in
UHR subjects have thus been inconclusive, which
may reﬂect the relatively small sample sizes examined
to date. UHR subjects are difﬁcult to recruit and it is
therefore a signiﬁcant challenge for any single centre
to scan a large sample. Multi-centre studies provide
a means of addressing this issue with the pooling of
data from different sites to produce relatively large
samples.
We adopted this approach in the present study. Our
aim was to combine magnetic resonance imaging
(MRI) data from multiple centres and measure cortical
thickness in large samples of UHR subjects and
healthy controls. We also sought to compare cortical
thickness in UHR subjects who subsequently did or
did not developed psychosis. Whole-brain MRIs were
acquired from individuals at UHR for psychosis and
healthy controls at four psychiatric research centres
in London, Basel, Munich and Melbourne. At each
site, subjects were scanned at ﬁrst clinical presentation,
and followed up clinically or in the context of research
projects for at least 2 years, so that they could be
subcategorized according to psychosis outcome. The
MRI data from each site were combined to form a
large UHR sample, which was subdivided into sub-
jects who later had developed psychosis and subjects
who had not. The thickness of the cerebral cortex
was assessed using a voxel-based cortical thickness
(VBCT) approach that generates maps from MRI data
in which each voxel in the GM is assigned a thickness
value and regionally speciﬁc differences are compared
on a voxel-by-voxel basis (Hutton et al. 2008, 2009).
This method differs from others reported in the litera-
ture, as it does not require the construction of a three-
dimensional model for extracting cortical thickness
values. For instance, surface-based techniques involve
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the generation of surface models that are driven by
image information and surface geometry to ﬁt the
GM and white matter (WM) surfaces of the image
(Fischl & Dale, 2000; Hutton et al. 2008). Cortical thick-
ness is subsequently deﬁned at surface points and is
computed based on the measure of the distance
between them. Another approach involves extracting
only the surface between the GM and the WM and
then mapping towards the surface the thickness values
that are derived by calculating the distance between
voxels in the cortex and the surface (Lerch & Evans,
2005; Hutton et al. 2008). In contrast, using the VBCT
technique, GM and WM boundaries are deﬁned on
the basis of whole voxel information (Jones et al.
2000; Hutton et al. 2008) and cortical thickness is calcu-
lated at every volumetric point within the cortex and
based on the length of the trajectory from one bound-
ary to another (Hutton et al. 2008).
Our ﬁrst prediction, based on data from previous
studies (Narr et al. 2005a; Fornito et al. 2008a,b;
Schultz et al. 2010b; Jung et al. 2011; Ziermans et al.
2012), was that the UHR group as a whole would
show differences in cortical thickness relative to con-
trols in areas that have previously been identiﬁed in
studies of cortical thickness in UHR subjects and
patients with ﬁrst-episode psychosis: the frontal,
anterior cingulate, parahippocampal, temporal, pari-
etal cortices and the precuneus. Our ﬁnal prediction
was that within the UHR sample, subjects who devel-
oped psychosis subsequent to scanning would show
more pronounced cortical thickness abnormalities in
these regions (Narr et al. 2005a; Fornito et al. 2008a,b;
Schultz et al. 2010b; Jung et al. 2011; Ziermans et al.
2012) than those who did not.
Method
Sample
All the UHR subjects were recruited from specialized
clinical services for this group in London [Outreach
and Support in South London (OASIS)], Basel
[Clinic for Early Detection of Psychosis (FEPSY) at
the Psychiatric Outpatient Department, University
Hospital], Melbourne [Personal Assessment and
Crisis Evaluation (PACE) Clinic] and Munich [Early
Detection and Intervention Centre for Mental Crisis
(FETZ), Department of Psychiatry and Psychotherapy,
Ludwig-Maximilians-University]. Criteria used to
identify participants at UHR for psychosis were com-
parable across the different sites as reported in Sup-
plementary Table S2. Speciﬁcally, the London and
Melbourne sites used as a screening instrument the
Comprehensive Assessment for at Risk Mental State
(Yung et al. 2005); the Basel site used as a screening
assessment the Basel Screening Instrument for Psy-
chosis (Riecher-Rössler et al. 2008); and the Munich
site used the Bonn Scale for the Assessment of Basic
Symptoms (Gross et al. 1987). In addition they also
assessed attenuated psychotic symptoms and brief
limited intermittent psychotic symptoms as deﬁned
by the PACE criteria (Yung et al. 2005). Data were com-
bined from these four sites. This sample overlaps with
a multi-centre sample that was previously used to
investigate GM volume in UHR subjects (Mechelli
et al. 2011), and includes subjects that participated in
previous single-centre studies of GM volume in this
population. In total there were MRI data from 167
UHR subjects. MRI data acquired from healthy volun-
teers from the same geographical area as the UHR sub-
jects at each site were combined to form a control
dataset. Healthy controls were excluded if there was
a past or present personal or familiar history of neuro-
logical and/or psychiatric conditions. The total control
sample comprised 150 subjects, and was comparable
with the total UHR sample with respect to gender,
age and ethnicity (Table 1).
Subsequent to MRI scanning, the UHR subjects
were followed up and assessed regularly for at least
2 years at all four sites. UHR subjects who developed
a ﬁrst episode of psychosis during this period were
identiﬁed using standardized transition criteria
(McGorry et al. 2003; Yung et al. 2004). Each site used
this information to subdivide their UHR sample into
a group that had made a transition to psychosis
(UHR-T), and a group that had not (UHR-NT). In the
following 30.6 (S.D.=10.4) months, 50 (30%) of the
UHR individuals developed psychosis (UHR-T) and
117 did not (UHR-NT). Transition to psychosis
during the follow-up period was established according
to Diagnostic and Statistical Manual of Mental Dis-
orders, fourth edition (DSM-IV) criteria based on clini-
cal consensus between at least two experienced
psychiatrists. Most of the UHR group (147/167, 84%)
had never taken antipsychotics at time of scanning;
20 (12%) had been exposed to antipsychotics; the
mean antipsychotic medication exposure time was 7.5
(S.D. =11.1) weeks. UHR participants that were receiv-
ing medication were scanned at the London or Basel
sites. Inclusion and exclusion criteria for the two exper-
imental groups, clinical characteristics and socio-
demographic of the UHR subjects are reported in the
Supplementary material (Supplementary Tables S1–3,
S5–8).
Image acquisition
At all four sites, volumetric MR images were
acquired using scanner ﬁeld strengths of 1.5 T and a
T1-weighted protocol. Two sites used General Electric
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scanners (i.e. London and Melbourne) and two used
Siemens scanners (i.e. Basel and Munich). The details




Sociodemographic differences between groups were
examined using one-way analysis of variance for para-
metric data, and by χ2 test for non-parametric data, as
implemented in SPSS 19.0 for Windows (IBM, USA)
(Table 1, Supplementary Tables S5–8).
Pre-processing
Pre-processing for the analysis of cortical thickness was
carried out using the procedure described by Hutton
et al. (2008, 2009). In brief, all the images were visually
checked and re-sampled to a voxel size of 1mm3 using
trilinear interpolation. Using the uniﬁed segmentation
procedure implemented in SPM8 (http://www.ﬁl.ion.
ucl.ac.uk/spm), the images were segmented into GM,
WM and cerebrospinal ﬂuid (CSF) (Ashburner, 2007).
For each subject, this resulted in a set of three images
in the same space as the original T1-weighted
image, in which each voxel was assigned a probability
of being GM, WM and CSF, respectively. A VBCT
map was created for each subject using the GM, WM
and CSF segments created in the previous step
(Hutton et al. 2008). This method is implemented as a
toolbox for SPM (Hutton et al. 2008, 2009). In brief, it
uses the input tissue probability maps and a trans-
formed labelled brain atlas (http://www.ﬁl.ion.ucl.ac.
uk/spm/ext/#IBASPM). Starting from the initial esti-
mate of the GM/WM boundary, layers of one voxel
in thickness are successively added to surround the
WM allowing voxels to be identiﬁed where the GM
from different sides of a sulcus was in contact. Once
all GM voxels have been processed in this way,
Laplace’s equation is solved for all voxels between
the ﬁnal GM/WM and GM/CSF boundaries resulting
in a scalar ﬁeld that makes a smooth transition from
one boundary to the other. The gradient of this ﬁeld
at each point forms a unique trajectory connecting
the two boundaries, and the thickness at each point
is calculated by integrating along these trajectories.
The resulting VBCT maps are created in the space of
the original input images which contain cortical thick-
ness values within voxels identiﬁed as cortical GM and
zeros outside the cortex. DARTEL (Ashburner, 2007), an
algorithm for diffeomorphic image registration which
is implemented as a toolbox for SPM8, was used to
warp the VBCT maps into a new group-speciﬁc refer-
ence space representing an average of all the subjects.
This procedure uses the GM and WM segments
estimated from the original T1-weighted images to cal-
culate a group-speciﬁc template and the deformation
ﬁelds required to warp data from each subject to the
new template. Each VBCT map was warped to the
new template using the corresponding subject-speciﬁc
deformation ﬁeld and was re-sampled to an isotropic
voxel size of 1.5 mm3 using trilinear interpolation.
The warped VBCT maps were scaled by the Jacobian








Mean age, years (S.D.) 23.4 (4.3) 23.3 (5.3) 22.9 (4.6) F2,314=0.388, df=2, p=0.6979
Gender, n χ2=4.188, df=2, p=0.123
Female 51 49 13
Male 99 68 37
Ethnicity, n
Caucasian 128 96 43 χ2=8.320, df=6, p=0.216
Black 7 5 1
Asian 9 5 0
Mixed 6 11 6
Handedness, n
Right 132 111 45 χ2=4.164, df=4, p=0.384
Left 12 4 4
Ambidextrous 6 2 1
Medication, n N/A 21 5 χ2=1.684, df=1, p=0.194
UHR-NT, Ultra-high risk without disease transition; UHR-T, UHR with disease transition; S.D., standard deviation;
df, degrees of freedom; N/A, not applicable.
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determinant of the deformations to account for stretch-
ing and compression and subsequently smoothed with
a 6mm Gaussian kernel then divided by a binary mask
of each original VBCT map which had been identically
warped, scaled and smoothed (see Supplementary
Fig. S1). A Gaussian kernel of 6 mm was chosen
because, when investigating cortical thickness, it is
important to keep smoothing to a minimum so that
any abrupt changes in thickness that may occur at
the boundaries between cortical areas are not obscured
(Hutton et al. 2008). This procedure results in smoothed
warped VBCT maps for which the Gaussian smooth-
ing kernel applied in the warped space has been pro-
jected into the native space of the subject, and the
cortical thickness values are preserved over a region
the size of the smoothing kernel.
Statistical analysis
Statistical analysis was performed using SPM8 soft-
ware (Wellcome Trust Centre for Neuroimaging, UK)
on the smoothed warped VBCT maps. An analysis
of variance was used to compare cortical thickness
in UHR-T, UHR-NT and healthy control subjects.
Scanner site was modelled as an additional factor,
resulting in a total of 12 experimental groups.
Including scanner site as a factor in the statistical
analysis allowed us to model scanner-related variance
in the data, which had the effect of reducing error var-
iance and increasing statistical sensitivity. We also
modelled age, gender, ethnicity and handedness as
covariates of no interest to minimize any confounding
effect of these variables on the ﬁndings. An ROI ap-
proach was used to examine between-group differ-
ences in areas where abnormalities in cortical thickness
have been identiﬁed in MRI studies of individuals at
UHR or with a ﬁrst episode of psychosis, excluding
studies that included data from subjects who partici-
pated in the present investigation. These comprised
the parahippocampal gyrus, inferior frontal gyrus,
anterior cingulate, superior temporal gyrus, inferior
parietal gyrus and the precuneus (Narr et al. 2005a;
Schultz et al. 2010b; Jung et al. 2011; Ziermans et al.
2012). Using WFU PickAtlas (http://www.nitrc.org/
projects/wfu_pickatlas/) we created a mask that in-
cluded the six chosen ROIs and comprised a total of
11700 voxels. Within this mask, statistical inferences
were made using a statistical threshold of p<0.05
after familywise error (FWE) correction for multiple
comparisons as calculated in SPM8. Trends that
did not survive correction for multiple comparisons
(p<0.001 uncorrected) are reported but not discussed.
For completeness we also performed a whole-brain
analysis using a statistical threshold of p<0.05 after
FWE correction for multiple comparisons.
Results
Sociodemographics
No statistically signiﬁcant differences were noted
among the UHR-T, UHR-NT and control groups in
age, gender, ethnicity and handedness (Table 1).
Differences in cortical thickness between UHR
subjects and healthy controls
Within the ROIs, the cortex was thinner in the UHR
group than in controls in the right parahippocampal
gyrus [p<0.05 FWE corrected; z score=4.06; Montreal
Neurological Institute (MNI) coordinates x=25, y=–4,
z=–13; see Fig. 1]. There was also a trend (p<0.001
uncorrected) for a thinner cortex in the UHR group
compared with controls in the inferior part of the left
parahippocampal gyrus (z score=3.42; MNI coordi-
nates x=–20, y=–7, z=–30). Plotting of the cortical
thickness values revealed that the reduction in right
parahippocampal cortical thickness was evident in
the data from each of the four sites (Fig. 1). In contrast,
there were no areas in which UHR individuals had a
thicker cortex than healthy controls. The whole-brain
analysis did not identify signiﬁcant differences in cor-
tical thickness between the UHR group and healthy
controls at p<0.05 (FWE corrected).
Differences in cortical thickness between the UHR-T
and UHR-NT groups
No differences were observed for the comparison
between the UHR-T and UHR-NT groups at p<0.05
after FWE correction. At a less conservative statistical
threshold (p<0.001 uncorrected), there was a trend
for cortical thinning in the UHR-T group in the orbital
part of the left inferior frontal gyrus (z score=3.32;
MNI coordinates x=–33, y=32, z=–15). The whole-
brain analysis revealed no signiﬁcant differences
between the UHR-T and UHR-NT groups at p<0.05
(FWE corrected).
Discussion
Previous neuroimaging studies have reported cortical
thinning in schizophrenia, as well as in ﬁrst-episode
psychosis and in subjects at UHR for psychosis
(Narr et al. 2005a; Fornito et al. 2008a,b; Schultz et al.
2010b; Jung et al. 2011; Ziermans et al. 2012). How-
ever, the results of these studies have not always
been consistent; this may reﬂect the recruitment of rela-
tively small samples, the use of different study designs,
and the investigation of samples that were hetero-
geneous with respect to age, duration of illness and
exposure to treatment. In the present study, we sought
to reduce the impact of these potential methodological
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pitfalls by assessing cortical thickness in a relatively
large sample of individuals at UHR for psychosis, all
of whom were scanned at a similar stage of illness,
when they ﬁrst presented with clinical high-risk symp-
toms. Most of the sample had not been treated before.
Our ﬁrst hypothesis was that the UHR group as a
whole would show differences in regional cortical
thickness relative to controls, and that these would
be most evident in areas that have previously been
identiﬁed as sites of cortical thickness or volume
abnormalities in studies of UHR and ﬁrst-episode sub-
jects (i.e. the temporal, frontal, parietal, anterior cingu-
late, parahippocampal cortices and the precuneus).
This hypothesis was in part conﬁrmed, in that we
found that the right parahippocampal cortex was thin-
ner in the UHR group than in controls. This ﬁnding is
consistent with those of a recent investigation which
also found reductions in thickness in other cortical
areas (Jung et al. 2011). Our result is also in line with
evidence that the density of the parahippocampal
gyrus is altered in UHR and familial high-risk
subjects (Job et al. 2003). Furthermore, in ﬁrst-episode
schizophrenia, altered right parahippocampal–lingual
cortical folding and reduced cortical thickness have
been found (Schultz et al. 2010a). Finally, this region
has also been identiﬁed as a site of functional (Allen
et al. 2011) alterations in UHR subjects and is one of
the most robust site of volume reduction (Seidman
et al. 2003) and neuropathological abnormalities (Shen-
ton et al. 2001) in schizophrenia.
In our previous volumetric study in an UHR sample
that overlapped with that in the present study, we
found differences between the UHR sample and con-
trols in the ventral prefrontal cortex and ACC, but
not in the parahippocampal cortex (Mechelli et al.
2011). However, in that study the subgroup of UHR
subjects that subsequently developed psychosis had
smaller left parahippocampal volumes than the UHR
subjects who did not make a transition to psychosis.
This volumetric ﬁnding was in a similar part of the
parahippocampal gyrus to the site of the difference
in cortical thickness between all UHR subjects and con-
trols in the present study, although in the opposite
hemisphere. Differences in the location of alterations
in cortical thickness and cortical volume may reﬂect














Fig. 1. Cortical thickness differences between the ultra-high risk (UHR) and healthy control (HC) groups: right
parahippocampal region where the total UHR sample showed cortical thinning relative to HCs (p<0.05 after familywise error
correction). For visualization purposes, effects are displayed at p<0.001 uncorrected. The plot shows cortical thickness values
for the HC group and the two UHR subgroups (UHR-T, transition to psychosis; UHR-NT, no transition to psychosis) at each
site (x axis: 1=London; 2=Basel; 3=Melbourne; 4=Munich); values on the y axis refer to millimetres. Error bars represent
standard deviations.
494 S. Tognin et al.






not necessarily manifestations of the same underlying
neuroanatomical changes. This would be consistent
with recent evidence that cortical thickness and surface
area are genetically and phenotypically independent
and that the local cortical volume is more closely
related to surface area than to cortical thickness
(Winkler et al. 2010). Therefore differences between
the results of our present study and our previous
VBM study may be partially explained by the fact
that the cortical thickness method does not take surface
information into account. The volumetric reduction of
the left parahippocampal gyrus reported in our VBM
study (Mechelli et al. 2011) may denote a marker of
progression consistent with the results of earlier inves-
tigations (Pantelis et al. 2003; Job et al. 2005), whereas
the thinning of the right parahippocampal gyrus may
represent either a vulnerability marker (evident not
only in the UHR stage but also in the earlier asympto-
matic stage) or a speciﬁc marker of the UHR stage (not
evident in the earlier asymptomatic stage). These two
alternative options could be investigated by acquiring
longitudinal neuroimaging data from individuals at
high genetic risk.
Our second hypothesis was that UHR subjects who
went on to develop psychosis would already at base-
line show more pronounced cortical thickness abnorm-
alities than UHR subjects who did not. We did not ﬁnd
any differences that survived correction for multiple
comparisons. Two previous studies have investigated
cortical thickness in UHR subjects in relation to clinical
outcome. One study, which restricted its analysis to
the ACC, reported cortical thinning in this region in
the UHR-T group compared with the UHR-NT group
(Fornito et al. 2008b). We included the ACC as one
of our ROIs but did not replicate this ﬁnding,
although this may be in part explained by methodo-
logical differences in thickness measurements and in
ROIs investigated. The second study used MRI to
scan UHR subjects at two time points and compared
longitudinal changes in cortical thickness in UHR indi-
viduals who did and did not make a transition to
psychosis. The UHR-T group showed longitudinal
reductions in several regions including anterior cingu-
late, precuneus and temporo-parietal-occipital areas
compared with controls, whereas the UHR-NT group
did not (Ziermans et al. 2012). In contrast, no differ-
ences in cortical thickness were reported between
UHR-T and UHR-NT subjects at baseline. The incon-
sistency between previous studies and our investi-
gation could be in part explained by the use of
different techniques to measure cortical thickness. In
particular, the studies by Fornito and colleagues and
Ziermans and colleagues used two different surface-
based methods (Fischl & Dale, 2000; Kim et al. 2005;
Fornito et al. 2008b; Ziermans et al. 2012) while in the
present investigation, a voxel-based method was
used to derived cortical thickness values (Hutton
et al. 2008). Another study reported no baseline differ-
ences in cortical thickness between UHR and ﬁrst-
episode psychosis and healthy controls, although the
analysis of cortical asymmetry revealed signiﬁcant
group differences (Haller et al. 2009). The lack of sig-
niﬁcant differences between UHR-T and UHR-NT sub-
jects may seem surprising, given that the present
sample was relatively large, and abnormalities in func-
tional and in other structural measures between these
subgroups have previously been identiﬁed (Pantelis
et al. 2003; Borgwardt et al. 2008, Mechelli et al. 2011;
Allen et al. 2012). One possible explanation for the
absence of signiﬁcant differences in the present study
is that there was some heterogeneity within our UHR
sample. Individuals can meet the UHR inclusion cri-
teria through different patterns of clinical and cogni-
tive symptoms, and it is unknown if these reﬂect
distinct pathophysiological processes. Unfortunately,
a stratiﬁcation of the statistical analysis by type of
UHR inclusion criteria was not possible in the present
investigation, as incorporating this additional factor
would require much larger single-centre sample
sizes. The sample may also have been clinically hetero-
geneous with respect to the co-morbid anxiety, de-
pression and substance abuse that are often present
in UHR subjects (Svirskis et al. 2005).
Another possibility is that some subjects who met
transition criteria subsequently have returned to
lower levels of psychotic symptoms and higher levels
of functioning, while some who did not meet criteria
for transition actually have deteriorated in functioning
over time. This latter group may be more likely
to develop schizophrenia than the former group
(Yung et al. 2010). Thus, the non-transitioned but low
functioning group may show brain imaging changes
consistent with the ones observed in schizophrenia,
but the high functioning transitioned cases may not.
The age range of our UHR individuals varied
considerably across the four sites (age range
15–37 years). Previous work indicates that the pattern
of neuroanatomical ﬁndings in schizophrenia with a
relatively early onset (e.g. before the age of 18 years)
differs from that in schizophrenia with onset in adult-
hood and that the longitudinal trajectory of brain
abnormalities varies with the age of onset (Gogtay
et al. 2011). Although we modelled age as a covariate
of no interest in the statistical analysis, the fact that
the UHR sample comprised individuals at different
stages of brain development might have reduced the
likelihood of detecting reliable differences.
A further potential contributory factor is that the
MRI data we studied were collected on different scan-
ners, using different acquisition sequences. However,
Cortical thickness in ultra-high risk for psychosis 495














we are conﬁdent that our results were not signiﬁ-
cantly affected by the use of different scanners for
several reasons. First, only MRI data collected with
T1-weighted sequences were used and scanner site
was modelled as an independent factor in the statisti-
cal analysis. Second, a comparable proportion of con-
trol, UHR-NT and UHR-T subjects were scanned at
each scanning site. Third, plotting of GM values
suggested that the differences between UHR and
healthy control groups were evident also within each
site and therefore cannot be explained by inter-scanner
differences (Fig. 1). Finally, the present approach
to the integration of multi-scanner data has been
employed successfully in previous studies that also
combined different scanners and acquisition sequences
(Stonnington et al. 2008; Segall et al. 2009; Suckling et al.
2010). Nevertheless, we cannot completely exclude
an effect of scanner on the ﬁndings, and ideally multi-
centre studies should employ the same acquisition
sequence, and calibrate data across scanners using
phantoms and common subjects to minimize the risk
of scanner-related effects (Jack et al. 2008).
The whole-brain analysis did not identify signiﬁcant
differences in cortical thickness between the UHR
group and healthy controls or between UHR-T and
UHR-NT subjects at p<0.05 (FWE corrected). This
could be in part explained by the heterogeneity of
the UHR sample (e.g. symptoms, level of functioning,
age), or by the use of different scanners and sequences.
Nevertheless, when restricting the analysis to ROIs,
the method employed was able to detect a thickness
reduction in the right parahippocampal gyrus in the
UHR group compared with the control group at a
statistical threshold of p<0.05 corrected (FWE). The
reduction was evident across all the different scanning
sites. Using the whole-brain approach did not enable
us to detect differences at a corrected level; this
might indicate that group differences in the UHR
population are distributed and diluted across the
brain cortex.
In conclusion, we observed right parahippocampal
thinning in subjects at UHR for psychosis, suggesting
that thickness reduction in this region is related to
the UHR symptomatology rather than the onset of psy-
chosis. This cortical alteration could represent a marker
of vulnerability to psychosis or, alternatively, a speciﬁc
and distinctive marker of the UHR stage. No reliable
differences in cortical thickness were found between
subjects who did and did not go on to develop psycho-
sis. Future multi-centre work in this area would beneﬁt
from the subcharacterization of UHR individuals with
different clinical and cognitive proﬁles, the recruitment
of participants at the same stage of neurodevelop-
ment and the use of a standardized image acquisition
sequence.
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Neuroimaging holds the promise that it may one day aid the clinical assessment of individ-
ual psychiatric patients. However, the vast majority of studies published so far have been
based on average differences between groups, which do not permit accurate inferences
at the level of the individual.We examined the potential of structural Magnetic Resonance
Imaging (MRI) data for making accurate quantitative predictions about symptom progres-
sion in individuals at ultra-high risk for developing psychosis. Forty people at ultra-high risk
for psychosis were scanned using structural MRI at first clinical presentation and assessed
over a period of 2 years using the Positive and Negative Syndrome Scale. Using a multivari-
ate machine learning method known as relevance vector regression (RVR), we examined
the relationship between brain structure at first clinical presentation, characterized in terms
of gray matter (GM) volume and cortical thickness (CT), and symptom progression at 2-year
follow-up. The application of RVR to whole-brain CT MRI data allowed quantitative predic-
tion of clinical scores with statistically significant accuracy (correlation=0.34, p=0.026;
Mean Squared-Error=249.63, p=0.024). This prediction was informed by regions tradi-
tionally associated with schizophrenia, namely the right lateral and medial temporal cortex
and the left insular cortex. In contrast, the application of RVR to GM volume did not allow
prediction of symptom progressionwith statistically significant accuracy.These results pro-
vide proof-of-concept that it could be possible to use structural MRI to inform quantitative
prediction of symptom progression in individuals at ultra-high risk of developing psychosis.
This would enable clinicians to target those individuals at greatest need of preventative
interventions thereby resulting in a more efficient use of health care resources.
Keywords: relevance vector regression, magnetic resonance imaging, cortical thickness, ultra-high risk, psychosis,
symptom progression, prediction
INTRODUCTION
The first full-blown psychotic episode is usually preceded by a
prodromal phase which is characterized by a progressive decline
in functioning and the emergence of attenuated psychotic symp-
toms. Individuals with these clinical features are said to be at
ultra-high risk (UHR) for developing psychosis. Results from a
recent meta-analysis suggest that about 18–36% of the UHR pop-
ulation will develop a psychotic disorder within 3 years from first
clinical presentation (1). Thus, the study of the UHR population
offers a window into the early stages of the illness under minimal
influence of confounding factors such as medication and chronic-
ity, and may inform the development of new early interventions
aimed at delaying or preventing the onset of the illness.
Neuroimaging offers a promising translational tool for the
characterization of brain abnormalities in individuals at UHR for
psychosis; in particular, it has been suggested that neuroanatomical
and neurofunctional measures could eventually be used to make
individualized predictions of clinical outcome in this population.
Consistent with this notion, a growing number of studies using
structural Magnetic Resonance Imaging (MRI) have identified
neuroanatomical differences between individuals at UHR who
subsequently did and did not develop psychotic symptoms. Below
we provide a brief overview of these studies, and then report
the results of a novel investigation that examined whether struc-
turalMRI allows accurate quantitative predictions about symptom
progression in individuals at UHR for psychosis.
Structural MRI has revealed a number of neuroanatomical
differences at first clinical presentation between individuals who
subsequently make transition to psychosis (UHR-T) and those
who do not (UHR-NT). In whole-brain voxel-based morphome-
try (VBM) studies, UHR-T relative to UHR-NT subjects showed
reduced gray matter (GM) volume of the inferior frontal cor-
tex, medial and lateral temporal, anterior cingulate cortex (ACC),
insular, inferior and superior frontal cortices (2), and reduced GM
density of the left temporal lobe and right cerebellum (3). In addi-
tion, VBM studies employing a region of interest (ROI) approach
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indicated that individuals who subsequently make transition to
psychosis show reduced volume in the left parahippocampal gyrus
(4), the bilateral insula (5) and the left ACC (6), and increased vol-
umeof the pituitary gland (7,8) and thehippocampus (9).A recent
VBM investigation has also shown that, in individuals at UHR for
psychosis, lower scores on a semantic fluency task are associated
with reduced GM density in a distributed network including the
right superior/middle temporal gyrus, the right insula, and the left
ACC, suggesting that the combination of these two types of data
could inform outcome prediction in this population (10).
Neuroanatomical alterations in psychosis may be expressed
not only in terms of alterations in GM volume or density but
also as changes in regional cortical thickness (CT) (11–15) and
the degree of CT asymmetry (16). Consistent with this notion,
UHR-T compared to UHR-NT have been found to show corti-
cal thinning of the ACC (17). However, a few subsequent ROI
studies did not find any significant differences in CT between
individuals who subsequently did and did not make conversion
to psychosis (9, 18–23).
While the above studies used a cross-sectional design, a number
of investigations have employed a within-subject design to exam-
ine the neuroanatomical changes that occur in individuals at UHR
around the time of illness onset. These studies have reported pro-
gressive reductions in the GM volume of the orbitofrontal and
cerebellar cortices (2, 24), fusiform and parahippocampal cor-
tices and cingulate gyrus (24); superior frontal, inferior temporal,
superior parietal cortices, and precuneus (2) in UHR-T compared
to UHR-NT. In addition, using an ROI approach, within-subject
studies have found greater progressive reductions in the GM vol-
ume of the insula (5), planum polare, planum temporale, and
caudal region (22) in UHR-T compared to UHR-NT (22). Using
cortical patternmatching techniques, Sun and colleagues (25) have
also revealed volumetric reductions in the prefrontal cortex in
UHR-T compared to UHR-NT (25). With respect to CT, the only
longitudinal study published so far has reported progressive thin-
ning of the anterior cingulate, precuneus, and temporal-parieto-
occipital cortex in UHR-T compared to UHR-NT and healthy
controls (26).
A small fraction of studies of the UHR population have inves-
tigated white matter (WM) abnormalities associated with transi-
tion to psychosis using either VBM or diffusion tensor magnetic
resonance imaging (DTI). With respect to VBM, only two stud-
ies have investigated WM abnormalities in UHR subjects as a
function of clinical outcome (26, 27). In the first study, UHR-
T subjects showed increased WM volume in the left frontal lobe
and a progressive decrease in the left fronto-occipital fasciculus
(27). In the second study, UHR-T subjects showed a decrease in
total WM volume relative to healthy controls but not relative to
UHR-NT, in addition to which the comparison between UHR-
NT and controls was also not significant (26). With respect to
DTI, a large number of studies have compared individuals at
UHR against healthy controls (28–34) but only three of them
have subdivided the UHR group according to clinical outcome
(30–32). One of these studies revealed that UHR-T had lower
fractional anisotropy (FA), an index of WM integrity, at base-
line compared to healthy controls in the medial frontal region
(30). In addition, UHR-T had lower FA in the WM lateral to
the right putamen and in the left superior temporal gyrus but
higher FA in the left posterior temporal WM, compared to UHR-
NT (30). Finally, in UHR-T, the FA in the left middle temporal
lobe was negatively associated with the severity of positive symp-
toms (30). The remaining two studies reported no cross-sectional
differences in WM integrity between UHR-T and UHR-NT (31,
32). However, Carletti and colleagues (31) reported a progressive
reduction of left frontal WM in UHR-T which was not evident in
UHR-NT (31).
Taken collectively, the above studies provide evidence for dif-
ferences in brain structure between individuals at ultra-high risk
for psychosis who subsequently do and do not develop the ill-
ness, particularly in the prefrontal and temporal cortices. These
studies, however, each reported significant effects only at a group
level, whereas clinicians treating psychosis have to make decisions
about the individual in front of them. Because effects that are
significant at a group level do not necessarily permit accurate
inferences about individuals, the translational potential of the
above findings for everyday clinical practice is unclear. In addi-
tion, these studies were conducted using a standard univariate
analytical approach in which each voxel is considered indepen-
dently. This approach is well suited to detect effects that are
robust and localized; however, it is not very sensitive to differ-
ences that are subtle and highly distributed across the brain. For
these reasons, an increasing number of recent studies of psychi-
atric disorders have adopted an alternative approach based on
multivariate machine learning methods (35, 36). A key bene-
fit of multivariate machine learning methods is that they allow
one to make predictions that are specific to a given individual,
rather than providing an average estimate for a group. This greatly
increases the likelihood that the results can be translated into a
tool that is useful in a real world clinical setting. A further ben-
efit of multivariate machine learning methods is that they take
into account the inter-relationship between different measures
(e.g., GM volume across different voxels), and therefore are bet-
ter suited for detecting subtle and spatially distributed patterns
of alteration. The vast majority of multivariate machine learn-
ing studies of psychiatric disorders published so far have been
limited to categorical decisions such as whether an individual
belongs to a patient or control group; whether an individual
will respond to treatment or not; or whether an individual will
develop a disorder or not (35). Within this context, studies of
the UHR population employing multivariate machine learning
methods have typically focused on prediction of clinical outcome
in terms of transition/non-transition to psychosis. For example,
Koutsouleris and colleagues (37) demonstrated that a distributed
network of abnormalities in GM volume allows prediction of sub-
sequent transition to psychosis with an accuracy of 82% (37).
This notable finding was replicated in an independent cohort by a
subsequent investigation (38). However, follow-up studies of indi-
viduals at UHR have shown substantial heterogeneity in symptom
progression both among those who develop psychosis and those
who do not (39, 40). For instance, a recent investigation showed
that about 75% of those individuals who do not develop psy-
chosis present with symptoms remission after 3 years while the
remaining 25% are still showing sub-threshold symptoms (40). In
addition, even those individuals at UHR who show full or partial
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remission of positive symptoms remain at a lower level of func-
tioning compared tonon-psychiatric comparison individuals (41).
Another study reported that only 30% of those individuals who
do not develop psychosis experience a full symptomatic and func-
tional recovery (42). Despite the high degree of heterogeneity in
clinical outcome beyond and above transition of psychosis, none
of the multivariate machine learning studies of the UHR popu-
lation published so far have focused on quantitative changes in
symptomatology.
Here we sought to expand the existing literature by investi-
gating the potential of structural MRI for predicting the course
of clinical symptomatology at 2-year follow-up in individuals at
ultra-high risk for psychosis using Relevance Vector Regression
(RVR) (43). The advantage of RVR relative to other multivari-
ate machine learning techniques, such as Support Vector Machine
(35), is that it allows the quantitative prediction of a variable of
interest (e.g., a patient’s score on a clinical scale) at individual
level, without the need for a discrete categorical decision (e.g.,
patients vs. controls). In recent years, RVR has been successfully
used in several neuroimaging studies of healthy people (44,45) and
patients with psychiatric (46, 47) or neurological disorders (48).
We therefore hypothesized that the application of RVR to neu-
roanatomical data, particularly GM volume and CT, would allow
quantitative prediction of symptomprogression at individual level
with statistically significant accuracy.
MATERIALS AND METHODS
SUBJECTS
The total sample consisted of 40 subjects at ultra-high risk for
psychosis (UHR), recruited at first presentation from consecutive
referrals to the Outreach and Support in South London (OASIS)
service in London, UK (49). OASIS is a clinical service located
in Lambeth, South London, that offers treatment to individuals
between 14 and 35 years of age who meet the ultra-high risk crite-
ria for psychosis. Individuals at ultra-high risk for psychosis were
identified based on the Personal Assessment and Crisis Evaluation
(PACE) criteria (50).
Subsequent to MRI scanning, the UHR subjects were mon-
itored for at least 2 years. Over the 2-year follow-up, 7 UHR
individuals developed psychosis (UHR-T) and the remaining 33
did not (UHR-NT). Transition to psychosis during the follow-up
period was established according to the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria
based on clinical consensus between at least two experienced psy-
chiatrists. Most of the UHR group (31/44; 70%) were naïve to
antipsychotics at the time of scanning; the remaining 13 (30%)
had been exposed to antipsychotics for an average of 9.7 weeks
(SD= 13.3).
SOCIO-DEMOGRAPHIC AND CLINICAL MEASURES
Socio-demographic measures included age, gender, and years of
education. Clinical symptoms were assessed in all participants at
the time of scanning and at 2-year follow-up using the Positive
and Negative Syndrome Scale (PANSS) (51). Symptoms in the
UHR participants were also assessed using the Comprehensive
Assessment of At-Risk Mental States (CAARMS) (50). Socio-
demographic and clinical variables were analyzed using Student’s
t -test for continuous data and a chi square test for ordinal data.
These statistical analyseswereperformedusing the Statistical Pack-
age for the Social Sciences 19.0 (SPSS 19.0 for Windows, Chicago,
IL, USA).
ACQUISITION OF NEUROANATOMICAL DATA
Neuroanatomical images were acquired using a 1.5-T GE NV/I
Signa LX Horizon system (General Electric,Milwaukee,WI, USA)
at the Center for Neuroimaging Sciences, King’s College Lon-
don. T1-weighted Inversion Recovery Spoiled Gradient struc-
tural images were acquired with the following acquisition para-
meters: TE= 5200ms, TR= 15900ms, flip angle= 20°, field of
view= 220mm⇥ 176mm, slice thickness= 1.5mm, number of
slices= 124, image matrix= 256⇥ 256⇥ 124.
ANALYSIS OF NEUROANATOMICAL DATA
The analysis of the MRI data comprised of three main compo-
nents. Firstly, the unified segmentation procedure (52) imple-
mented in SPM81 was used to segment all the images into GM,
WM, and cerebrospinal fluid (CSF) partitions. We then pre-
processed the imagesusing twoalternative approaches that allowed
us to extract information on GM volume and CT respectively.
Secondly, we used multivariate RVR (43) as implemented in
the Pattern Recognition for Neuroimaging Toolbox2 (PRoNTo).
Thirdly, we performed a standard univariate analysis as imple-
mented in Statistical ParametricMapping (SPM8) software. Below
we describe each component in more detail.
Creation of voxel-based gray matter volume maps
A fast diffeomorphic image registration algorithm (DARTEL) was
used to warp the GMpartitions into a new study-specific reference
space with an isotropic spatial resolution of 1.5mm3 (53–55). The
warped GM partitions were then affine transformed into the MNI
space. An additional “modulation” step (56) was used to scale the
GM probability values by the Jacobian determinants of the defor-
mations to ensure that the total amount of GM in each voxel was
conserved after the registration. As a final step the GM probability
values were smoothed using a 8-mm FWHMGaussian kernel.
Creation of voxel-based cortical thickness maps
A voxel-based Laplacian method (57, 58) was used to create a
voxel-based cortical thickness (VBCT) map for each subject using
the GM, WM, and CSF partitions created in the segmentation
step. The resulting VBCTmaps contained CT values within voxels
identified as GM and zeros outside the cortex and were saved in
the native space of the input images (0.5mm3 resolution). Each
VBCT map was warped into the new DARTEL reference space
by applying the corresponding subject-specific deformation field
and resampled to an isotropic voxel size of 1.5mm3. The warped
images were then scaled by the Jacobian determinant of the defor-
mation and smoothed with a 6-mm Gaussian kernel. The same
warps, modulation and smoothing were also applied to a binary
mask created from each original VBCT map. Subsequently the
warped, scaled, and smoothed VBCT maps were divided by the
1http://www.fil.ion.ucl.ac.uk/spm
2http://www.mlnl.cs.ucl.ac.uk/pronto/
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corresponding warped, scaled, and smoothed mask. The effect
of this procedure was to project the Gaussian smoothing kernel
applied to the warped images, into the native space of the sub-
ject while preserving the CT value over a region the size of the
smoothing kernel.
Multivariate RVR analyses
We examined the relationship between brain structure and
changes in PANSS total score from baseline to 2 years follow-up
using multivariate RVR as implemented in PRoNTo (see text foot-
note 2) running under Matlab (Mathworks, 2010 release) (59).
This method has been described elsewhere (47). In brief, RVR is
a sparse kernel learning multivariate regression method set in a
fully probabilistic Bayesian framework. Under this framework, a
zero-mean Gaussian prior is introduced over the model weights,
governed by a set of hyperparameters – one for each weight. The
most probable values for these hyperparameters are then itera-
tively estimated from the training data, with sparseness achieved
due to the posterior distributions of many of the weights peaking
sharply around zero; those training vectors associated with non-
zero weights are referred to as “relevance” vectors. The optimized
posterior distribution over the weights can then be used to predict
the target value (e.g., PANSS score) for a previously unseen input
vector (e.g., CT map) by computing the predictive distribution
[for a more in-depth and detailed description see Tipping (43)].
In the current study, the input vectors (i.e., each subjects CT
map) were mean centered using the training data, and an estimate
for the model’s generalizability obtained via leave-one-out cross
validation, indexed using the Pearson correlation coefficient and
mean square error (MSE) between actual and predicted difference
between baseline and follow-up on PANSS total scores. The sig-
nificance of both the correlation coefficient and the MSE score
was estimated using a permutation test whereby the input-target
data were randomly paired and the RVR re-run 1000 times. This
created a distribution of correlation andMSE values reflecting the
null hypothesis that the model did not exceed chance. The num-
ber of times the permuted value was greater than (or with respect
to MSE values, less than), or equal to, the true value, was then
divided by 1000 providing an estimated p-value for both the cor-
relation coefficient and observed MSE. For ease of visualization,
a table was also created using an arbitrary 70% threshold for all
successful RVR derived weight maps, showing those regions with
weight vector values in the upper, and lower, 30% of the absolute
maximum weight vector values across all regions. These values
represent the relative contribution of each voxel to the regression
function, in the context of every other voxel.
Univariate SPM analyses
We also examined the relationship between brain structure and
changes in PANSS total score from baseline to follow-up using a
standard, univariate approach. A multiple regression model was
performed in SPM8 software to identify any voxels in the GM
volume and CT maps respectively that showed a significant asso-
ciationwith PANSS total scores. Statistical inferences weremade at
p< 0.05 [corrected for multiple comparisons using Family-Wise
Error (FWE)]. For completeness, when no significant effects were
found, we also examined trends at p< 0.001 uncorrected.
RESULTS
SOCIO-DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
Socio-demographic and clinical variables are reported in Table 1
for all participants as well as for the sub-groups that did and did
not make transition to psychosis separately. It can be seen that, on
average, participants showed clinical improvement at follow-up
relative to baseline (t = 2.555; p= 0.015; df= 39). Examina-
tion of the subject-specific scores revealed that 26 individuals
improved, 3 remained stable, and 11 worsened over the 2-years
follow-up time. No significant association were found between
the change in PANSS total scores from baseline to follow-up and
antipsychotic medication (t = 0.269, df= 38, p= 0.789).
MULTIVARIATE RVR ANALYSIS
The application of RVR to whole-brain CT images allowed
quantitative prediction of symptom progression with statistically
significant accuracy (correlation= 0.34, p-value= 0.026; Mean
Squared-Error= 249.63, p-value= 0.024, see Figure 1). The use
of an arbitrary threshold corresponding to the top, or bottom,
30% of the maximum weight vector score showed that the pre-
diction appeared to be based on a distributed pattern of CT
including, in particular, the left insular cortex and lateral and
medial regions of the right temporal cortex (seeTable 2; Figure 1).
In contrast, the application of RVR to the whole-brain GM
volume images did not allow accurate prediction of symptoms
Table 1 | Demographic and clinical variables by group.
Groups Group comparison
UHR (N =40) UHR-NT (N =33) UHR-T (N =7)
Age (years) 23.90 (4.50) 24.06 (4.61) 23.14 (4.18) t =0.48, p=0.63 df=38
N male/female 25/15 20/13 5/2 $2=0.29, p=0.59
Years of education 12.82 (2.31) 12.88 (2.31) 12.50 (2.51) t =0.36, p=0.72, df=36
PANSS total baseline 53.30 (14.95) 50.27 (12.02) 67.57 (19.85) t = 3.06, p=0.004, df=38
PANSS total follow-up 46.50 (13.34) 43.61 (10.25) 60.14 (18.27) t = 3.34, p=0.002, df=38
Difference PANSS
follow-up – baseline
 6.80 (16.83); t = 2.555;
p=0.015; df=39
6.67 (15.16) 7.43 (24.78) t = 0.10, p=0.91, df=38
Data reflect mean (and standard deviation). df, Degrees of freedom; PANSS, positive and negative syndrome scale.
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FIGURE 1 | (A) Red/Blue circles show voxels with a weight score in the
top/bottom 30% of the maximum (range  0.011608 to –0.026588). Axial
Slices (MNI) Left-Right:  65,  49,  40,  23,  17, 16, 25.
(B) Scatter plot showing the predicted difference between baseline and
follow-up total PANSS score for each subject derived from their cortical
thickness data using RVR vs. the actual difference.
Table 2 | Neuroanatomical regions with a weight vector score in the top and in the bottom 30% of the maximum weight vector score across all






REGIONSWITH POSITIVE wi SCORES
Right Temporal Fusiform Cortex 27 28.5,  9,  46.5 0.0266
Right Temporal Pole 8 25.5, 6,  48 0.0213
REGIONSWITH NEGATIVE wi SCORES
Right Temporal Pole 29 58.5, 6,  22.5 0.0115
Left Insular Cortex 26  39, 6,  4.5 0.0112
20  42,  6,  1.4 0.0116
Right Parahippocampal Gyrus (anterior division) 9 10.5,  12,  21 0.00954
Right Inferior Temporal Gyrus (posterior division) 7 60,  27,  30 0.00882
MNI, Montreal Neurological Institute; RVR, relevance rector regression; PANSS, positive and negative syndrome scale;wi, weight vector score indicating the relative
contribution of each voxel to the regression function.
wi and MNI coordinates refer to the peak weight vector score in each cluster.
progression (correlation= 0.14, p-value= 0.627; Mean Sum of
Squares= 369.50, p-value= 0.621).
UNIVARIATE SPM ANALYSIS
Whole-brain analysis of theGMvolumeandCTdata didnot detect
any regions that showed a significant positive or negative associa-
tionwith the change in PANSS total scores frombaseline to follow-
up at p< 0.05 (FWE corrected). With a less conservative statisti-
cal threshold (p< 0.001 uncorrected), we detected a number of
regions showing a positive association with the change in PANSS
total scores. With respect to GM volume, the right middle frontal
gyrus (MNI coordinates: 39, 15, 37.5; p= 0.929; z-score= 3.266)
was associated with changes in PANSS scores. With respect to
CT, the right inferior parietal lobule (MNI coordinates: 61.5,
 34.5, 25.5; p= 0.802; z-score= 3.659), left cingulate gyrus (MNI
coordinates: 9, 1.5, 46.5; p= 0.986; z-score= 3.340), right mid-
dle temporal gyrus (MNI coordinates: 49.5,  63, 4.5; p= 0.992;
z-score= 3.295) and left insula (MNI coordinates:  34.5,  15,
16.5; p= 0.998; z-score= 3.197) were associated with changes in
PANSS scores.
DISCUSSION
At present it is difficult to use clinical data acquired at first clin-
ical presentation to predict subsequent progression of symptoms
in individuals at UHR for psychosis. This prevents the selective
delivery of potentially preventative interventions to those who
are most likely to develop persistent symptoms. Recent studies
have shown that the application of multivariate machine learning
methods to structural neuroimaging data allows accurate cate-
gorical prediction of which individuals at UHR will and will not
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make transition to psychosis (37). However, as discussed in the
introduction, within the UHR population there is a substantial
heterogeneity in symptom progression above and beyond tran-
sition to psychosis (40–42). We therefore examined for the first
time whether it is possible to use neuroanatomical information to
make accurate quantitative predictions of symptom progression
in individuals at UHR. Our results indicate that the application of
RVR to whole-brain CT MRI data allows quantitative prediction
of symptomprogression (i.e., both themagnitude and direction of
change for each individual) at 2-year follow-up with statistically
significant accuracy. To our knowledge, this is the first evidence
that neuroimaging techniques may inform the clinical assessment
of UHR individuals by allowing quantitative estimation of the
course of clinical psychopathology. In contrast, GM volume did
not allow accurate prediction of symptoms progression at individ-
ual level despite two previous reports that this information allows
categorical prediction of transition to psychosis (37, 38).
What is the implication of our differential finding for CT and
GM volume? GM volume is thought to depend on local CT as
well as cortical folding and gyrification (i.e., cortical surface area),
while CT does not include measures of local surface (57). A recent
investigation has also shown that CT and cortical surface area are
genetically and phenotypically independent, and that regional GM
volume is more closely related to the latter than the former (60). It
follows that the two approaches provide complementary informa-
tion, and that one can be more or less than the other depending
on the nature of the neuroanatomical changes being examined. In
the context of our investigation, the fact that symptomprogression
was predicted by CT but not GM volume indicates that changes in
symptomatology are specifically associated with differences in CT
as opposed to cortical folding and gyrification.
Examination of the regions that provided the greatest contri-
bution to prediction of symptom progression identified specific
areas amongst others traditionally associated with schizophrenia,
namely the right temporal fusiformcortex, the right temporal pole,
the right parahippocampal gyrus, the inferior temporal gyrus,
and the left insular cortex (see Table 2; Figure 1). The tempo-
ral fusiform cortex and temporal pole have been reported to show
CT differences over time between UHR-T and controls but not
betweenUHR-NT and controls (26). The temporal pole is thought
to be implicated in different cognitive functions such as emotion,
attention, behavior, and memory (61). In people with schizophre-
nia, abnormalities in this region have been associated with a range
of clinical symptoms including, amongst others, auditory hallu-
cinations and thought disorder (62, 63). The temporal fusiform
cortex plays a central role in facial configuration processing in
the healthy brain (64). Deficits in this domain have been recently
reported in the UHR population, and may be one of the fac-
tors that underlie social dysfunction in schizophrenia (65). The
parahippocampal gyrus has also been reported to show reduced
thickness both in the UHR (20, 66) and first episode psychosis
(67). Specifically, this area has been identified as a site of robust
structural and functional alteration in individuals at ultra-high
risk for psychosis (68) and those who have developed the disorder
(69, 70). The right inferior temporal gyrus volume has also been
reported as progressively reduced overtime in UHR-T compared
to UHR-NT (2). Finally the left insular cortex plays a key role in
emotional regulation, which is typically altered in psychosis, and
has been found to show reduced volume in UHR-T compared to
UHR-NT (2, 5).
While the results of our investigation provide further evidence
for the implication of the above regions in schizophrenia, it should
be noted that in multivariate methods an individual region may
display high discriminative power due to two possible reasons:
(i) a difference in volume between groups in that region; (ii) a
difference in the correlation between that region and other areas
between groups. Thus, the regions identified in our investigation
should be interpreted as parts of a spatially distributed pattern
rather than as independent areas. In addition, it should be noted
that these regions were identified using an arbitrary threshold of
30% based on previous studies (71, 72), and that prediction of
symptom progression was to some extent informed by all voxels
in the brain since no feature extraction was employed.
In contrast to the results obtained using RVR, the univariate
analysis of the structural MRI data, in which each voxel is con-
sidered as a spatially independent unit, did not detect any regions
that showed a significant association with progression of symp-
toms after correction for multiple comparisons. This supports the
idea that multivariate methods such as RVR are more sensitive
to the subtle and spatially diffuse alterations typically observed in
psychiatric disorders, and therefore may be better suited to the
possible development of clinical diagnostic tools, than standard
mass-univariate techniques (73).
The present study has fourmain limitations. Firstly, the number
of subjects included in the study was relatively small and therefore
the generalizability of the results is unclear. Multi-center stud-
ies would be needed in order to better characterize the predictive
value of structural neuroimaging for predicting symptomprogres-
sion in real-life clinical practice. Secondly, 30% of our participants
had been exposed to antipsychotic medication which might have
influenced our results for instance by resulting in changes in brain
structure while also influencing symptom progression. Neverthe-
less, as we report in the Results, we found no evidence for an
association between antipsychotic medication at first clinical pre-
sentation (i.e., yes/no) and progression of illness. Thirdly, there are
a number of potential sources of individual variability in symp-
tom progression that were not included in our statistical model;
these include, for example, socio-demographic variables such as
age, gender, and ethnicity, and treatment course variables such as
life events and psychosocial interventions during the follow-up
period. We expect that the integration of this information within
the same statistical model would improve prediction of symptom
progression. Fourthly, in the present investigation we examined
the predictive value of gray rather than WM as the former could
be estimated more accurately than the latter. However, given the
number of studies reporting an association betweenWM integrity
and clinical outcome in the UHR population (26, 27, 30–32), it
would be interesting to use DTI scans in future studies.
In conclusion, the results of the present study provide proof-of-
concept that it might be possible to use structural neuroimaging
to inform quantitative prediction of subsequent progression of
symptoms in individuals at UHR for psychosis. This would enable
clinicians to target those individuals at greatest need of preven-
tative interventions thereby resulting in a more efficient use of
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health care resources. It should be noted, however, that daily clin-
ical practice often requires clinicians to make prompt treatment
decisions, and delaying the decisional process in order to acquire
andanalyze structural neuroimagingdata couldbe impractical and
potentially harmful to a patient. A possible solution would be the
development of a practical and flexible analytical tool for clinical
use that does not require the manual implementation of a lengthy
pipeline. In addition, it is likely that the use of structural neu-
roimaging in everyday clinical practice would ultimately require a
greater accuracy of prediction than that found in the present study.
Such accuracy might be improved, for example, by combining
structural neuroimaging with other types of data, an integrative
approach which was successfully applied to an investigation of
mild cognitive impairment (74).
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Appendix	  2.	  UHR	  clinical	  scores	  per	  site	  
	  
Table	  A2.1.	  Clinical	  Measures	  London	  site	  (Institute	  of	  Psychiatry,	  Psychology	  and	  Neuroscience)	  	  
Measures	   UHR-­‐NT	  (n=19)	  Mean	  (±SD)	  
UHR-­‐T	  (n=2)	  












1.26	  ±	  1.85	   2.50	  ±	  3.53	   p	  =	  0.410	  
PANSS_Negative	   9.42	  ±	  3.43	   7	  ±	  0.60	   p	  =	  0.343	  
PANSS_Positive	   12.32	  ±	  3.30	   7.50	  ±	  0.70	   p	  	  =	  0.058	  
PANSS	  General	   22.21	  ±	  4.09	   18.50	  ±	  3.53	   p	  =	  0.234	  
HAM–D	   10.11	  ±	  9.02	   8	  ±	  8.48	   p	  =	  0.756	  
HAM-­‐A	   12.11	  ±	  11.62	   7	  ±	  9.89	   p	  =	  0.559	  
GAF	   62.89	  ±	  14.80	   74	  ±	  12.72	   p	  =	  0.322	  
Premorbid	  IQ	  
(NART)	   96	  ±	  14.04	   82	  ±	  6.36	   p	  =	  0.187	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Table	  A2.2.	  Clinical	  Measures	  London	  site	  (Maudslay	  Hospital)	  
	  
Measures	   UHR-­‐NT	  (n=44)	  Mean	  (±SD)	  
UHR-­‐T	  (n=12)	  












1.71	  ±	  1.45	   3	  ±	  1.69	   p	  =	  0.030	  
PANSS_Negative	   12	  ±	  4.46	   14.63	  ±	  5.63	   p	  =	  0.150	  
PANSS_Positive	   10.81	  ±	  3.9	   11.25	  ±	  4.26	   p	  =	  0.775	  
PANSS_General	   25.48	  ±	  8.15	   30.25	  ±	  11.67	   p	  =	  0.159	  
GAF	   58.12	  ±	  10.15	   46.50	  ±	  10.85	   p	  =	  0.005	  
IQ	  (WAIS)*	   99	  ±	  11.49	   94	  ±	  7.47	   p	  =	  0.241	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Table	  A2.3.	  Clinical	  Measures	  Basel	  site	  
Measures	   UHR-­‐NT	  (n=23)	  
Mean	  (±SD)	  
UHR-­‐T	  (n=12)	  
Mean	  (±SD)	   Significance	  
BPRS	   37.09	  ±	  6.84	   40.83	  ±	  11.45	   p	  =	  0.233	  
SANS	   7.04	  ±	  4.50	   9.75	  ±	  5.81	   p	  =	  0.137	  
IQ	  (LPS)*	   111	  ±	  16.92	   115	  ±	  11.57	   p	  =	  0.550	  
IQ	  (MWT)**	   106	  ±	  15.76	   112	  ±	  11.59	   p	  =	  0.260	  
	   	  *	  Information	  was	  available	  for	  a	  subset	  of	  the	  whole	  sample	  (i.e.	  UHR-­‐NT=19;	  UHR-­‐T=12)	  **	  Information	  was	  available	  for	  a	  subset	  of	  the	  whole	  sample	  (i.e.	  UHR-­‐NT=18;	  UHR-­‐T=12).	  	  Abbreviations:	   UHR-­‐T,	   ultra	   high	   risk	   with	   disease	   transition;	   UHR-­‐NT,	   ultra	  high	  risk	  without	  disease	  transition;	  BPRS,	  Brief	  Psychiatric	  Rating	  Scale;	  SANS,	  Scale	   for	   the	   Assessment	   of	   Negative	   Symptoms;	   LPS,	   German	   scale	   for	  assessing	  non-­‐verbal	  IQ;	  MWT,	  German	  scale	  for	  assessing	  verbal	  IQ.	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Table	  A2.3.	  Clinical	  Measures	  Melbourne	  site	  
Measures	   UHR-­‐NT	  (n=26)	  
Mean	  (±SD)	  
UHR-­‐T	  (n=10)	  
Mean	  (±SD)	   Significance	  
BPRS	   25.52	  ±	  11.86	   25.33	  ±	  10.97	   p	  =	  0.967	  
SANS	   31.93	  ±	  18.32	   32.78	  ±	  13.59	   p	  =	  0.899	  
Premorbid	  IQ	  
(NART)*	  
91	  ±	  11.17	   98	  ±	  10.32	   p	  =	  0.175	  
	  *	  Information	  was	  available	  for	  a	  subset	  of	  the	  whole	  sample	  (i.e.	  UHR-­‐NT=17;	  UHR-­‐T=6)	  Abbreviations:	   UHR-­‐T,	   ultra	   high	   risk	   with	   disease	   transition;	   UHR-­‐NT,	   ultra	  high	  risk	  without	  disease	  transition;	  BPRS,	  Brief	  Psychiatric	  Rating	  Scale;	  SANS,	  Scale	  for	  the	  Assessment	  of	  Negative	  Symptoms;	  NART,	  National	  Adult	  Reading	  Test.	  	  	  	  	  	  	  	  	   	  
	   186	  
Table	  A2.4.	  Clinical	  Measures	  Munich	  site	  
Measures	   UHR-­‐NT	  (n=24)	  
Mean	  (±SD)	  
UHR-­‐T	  (n=16)	  
Mean	  (±SD)	   Significance	  
PANSS_Negative*	   12.05	  ±	  5.15	   16.25	  ±	  8.97	   p	  =	  0.136	  
PANSS_Positive*	   9.74	  ±	  2.28	   12.88	  ±	  4.45	   p	  =	  0.022	  
PANSS_General*	   28.42	  ±	  6.34	   29.25	  ±	  11.14	   p	  =	  0.209	  
IQ	  (MWT)**	   111	  ±	  13.87	   104	  ±	  17.22	   p	  =	  0.226	  
	  *	  Information	  was	  available	  for	  a	  subset	  of	  the	  whole	  sample	  (i.e.	  UHR-­‐NT=19;	  UHR-­‐T=8)	  **	  Information	  was	  available	  for	  a	  subset	  of	  the	  whole	  sample	  (i.e.	  UHR-­‐NT=18;	  UHR-­‐T=11)	  Abbreviations:	   UHR-­‐T,	   ultra	   high	   risk	   with	   disease	   transition;	   UHR-­‐NT,	   ultra	  high	   risk	   without	   disease	   transition;	   PANSS,	   Positive	   and	   Negative	   Symptom	  Scale;	   MWT,	   German	   scale	   for	   assessing	   verbal	   IQ.
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Appendix	  3.	  Sociodemographic	  data	  of	  the	  study	  samples	  by	  site	  
	  
A3.1.	  Sociodemographic	  data	  of	  the	  study	  samples	  included	  in	  the	  study	  described	  in	  Chapter	  3	  	  







Basel	   Munich	   Melbourne	   Significance	  
UHR-­‐NT	  
Number	  (%)	   19	  (90.5%)	   42	  (84%)	   23	  (65.7%)	   24	  (60%)	   26	  (72.2%)	   χ24	  	  =	  10.831	  p	  =	  0.029	  
Age	  (mean/	  SD)	   23.47	  ±	  4.89	   23.76	  ±	  4.64	   23.26	  ±	  5.8	   26.08	  ±	  6.11	   20.04	  ±	  3.06	   F(4,129)	  =	  4.83	  p	  =	  0.01	  
Gender	  (Female/Male)	   8/11	   16/26	   10/13	   11/13	   11/15	   χ24	  	  =	  0.428	  p	  =	  0.98	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  11	  3	  1	  4	  
	  25	  4	  2	  11	  
	  23	  0	  0	  0	  
	  24	  0	  0	  0	  
	  23	  0	  3	  0	  
χ212	  	  =	  38.651	  
p	  <	  0.01	  	  
Handedness	  Right	  Left	  Ambidextrous	  
	  18	  1	  0	  
	  41	  1	  0	  
	  22	  1	  0	  
	  20	  2	  2	  
	  25	  1	  0	  
χ28	  	  =	  10.796	  
p	  =	  0.214	  	  
GMV	  (mean,	  SD)	   1.004	  ±	  0.137	   0.928	  ±	  0.08	   0.881	  ±	  0.09	   0.921	  ±	  0.07	   0.96	  ±	  0.08	   F(4,129)	  =	  5.126	  p	  =	  0.01	  
UHR-­‐T	   Number	  (%)	   2	  (9.5%)	   8	  (16%)	   12	  (34.3%)	   16	  (40%)	   10	  (27%)	   χ24	  	  =	  10.831	  p	  =	  0.029	  	  *	  χ23	  	  =	  7.003	  
p	  =	  0.072	  
	   188	  
Age	  (mean,	  SD)	   27.5	  ±	  2.5	   21.88	  ±	  2.47	   24.58	  ±	  5.26	   23.38	  ±	  4.55	   19.20	  ±	  2.61	  	   *	  F(3,42)	  =	  3.423	  	  p	  =	  0.026	  
Gender	  (Female/Male)	   2/0	   1/7	   3/9	   4/12	   4/6	   χ23	  	  =	  1.787	  p	  =	  0.618	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  1	  0	  1	  0	  
	  2	  1	  0	  5	  
	  12	  0	  0	  0	  
	  16	  0	  0	  0	  
	  10	  0	  0	  0	  
χ26	  	  =	  32.775	  
p	  <	  0.01	  
Handedness	  Right	  Left	  Ambidextrous	  
	  2	  0	  0	  
	  7	  0	  1	  
	  9	  3	  0	  
	  16	  0	  0	  
	  10	  0	  0	  
χ28	  	  =	  14.591	  
p	  =	  0.068	  	  
GMV	  (mean,	  SD)	   0.925	  ±	  0.088	   0.916	  ±	  0.113	   0.909	  ±	  0.068	   0.976	  ±	  0.073	   0.969	  ±	  0.094	   *	  F(3,42)	  =	  1.988	  p	  =	  0.13	  
Healthy	  
Controls	  	   Number	   27	   37	   22	   42	   39	   n/a	  
Age	  (mean/	  SD)	   24.93	  ±	  3.85	   25.38	  ±	  4.51	   23	  ±	  4.3	   24.48	  ±	  3.78	   20.1	  ±	  2.34	   F(4,162)	  =	  11.956	  p	  <	  0.01	  
Gender	  (Female/Male)	   14/13	   10/27	   9/13	   14/28	   14/25	   χ24	  	  =	  4.549	  p	  =	  0.337	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  12	  9	  5	  1	  
	  25	  2	  5	  5	  
	  22	  0	  0	  0	  
	  42	  0	  0	  0	  
	  39	  0	  0	  0	  
χ212	  	  =	  76.146	  
p	  <	  0.01	  	  
Handedness	  Right	  Left	  Ambidextrous	  
	  26	  1	  0	  
	  35	  0	  2	  
	  16	  5	  1	  
	  35	  5	  2	  
	  36	  2	  1	  
χ28	  	  =	  13.824	  
p	  =	  0.86	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GMV	  (mean,	  SD)	   0.972	  ±	  0.194	   0.915	  ±	  0.089	   0.902	  ±	  0.066	   0.926	  ±	  0.091	   1.009	  ±	  0.089	   F(4,162)	  =	  5.46	  p	  <	  0.01	  	  *	  Analysis	  performed	  by	  excluding	  the	  London	  (Institute	  of	  Psychiatry)	  site.	  Abbreviations:	  UHR-­‐T,	  ultra	  high	  risk	  with	  disease	  transition;	  UHR-­‐NT,	  ultra	  high	  risk	  without	  disease	  transition.	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A3.2.	  Sociodemographic	  data	  of	  the	  study	  samples	  included	  in	  the	  studies	  described	  in	  Chapter	  4	  and	  Chapter	  5	  	  




Basel	   Munich	   Melbourne	   Significance	  
UHR-­‐NT	  
Number	  (%)	   44	  (78.6%)	   23	  (65.7%)	   24	  (60%)	   26	  (72.2%)	   χ23	  	  =	  4.259	  p	  =	  0.235	  
Age	  (mean/	  SD)	   24.14	  ±	  4.9	   23.26	  ±	  5.8	   26.08	  ±	  6.11	   20.04	  ±	  3.06	   F(3,113)	  =	  6.442	  p	  <	  0.01	  
Gender	  (Female/Male)	   17/27	   10/13	   11/13	   11/15	   χ23	  	  =	  0.370	  p	  =	  0.946	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  26	  5	  2	  11	  
	  23	  0	  0	  0	  
	  24	  0	  0	  0	  
	  23	  0	  3	  0	  
χ29	  	  =	  36.575	  
p	  <	  0.01	  	  
Handedness	  Right	  Left	  Ambidextrous	  
	  43	  1	  0	  
	  22	  1	  0	  
	  20	  2	  2	  
	  25	  1	  0	  
χ28	  	  =	  11.486	  
p	  =	  0.074	  	  
GMV	  (mean,	  SD)	   0.906	  ±	  0.09	   0.881	  ±	  0.09	   0.921	  ±	  0.07	   0.96	  ±	  0.08	   F(3,113)	  =	  3.745	  p	  =	  0.013	  
UHR-­‐T	  
Number	  (%)	   12	  (21.4%)	   12	  (34.3%)	   16	  (40%)	   10	  (27%)	   χ23	  	  =	  4.259	  p	  =	  0.235	  
Age	  (mean,	  SD)	   23.25	  ±	  4.11	   24.58	  ±	  5.26	   23.38	  ±	  4.55	   19.20	  ±	  2.61	  	   F(3,46)	  =	  3.112	  	  p=	  0.035	  
Gender	  (Female/Male)	   2/10	   3/9	   4/12	   4/6	   χ23	  	  =	  1.577	  p	  =	  0.665	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Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  5	  1	  0	  6	  
	  12	  0	  0	  0	  
	  16	  0	  0	  0	  
	  10	  0	  0	  0	  
χ26	  	  =	  25.775	  
p	  <	  0.01	  
Handedness	  Right	  Left	  Ambidextrous	  
	  10	  1	  1	  
	  9	  3	  0	  
	  16	  0	  0	  
	  10	  0	  0	  
χ26	  	  =	  10.231	  
p	  =	  0.115	  	  
GMV	  (mean,	  SD)	   0.893	  ±	  0.13	   0.909	  ±	  0.068	   0.976	  ±	  0.073	   0.969	  ±	  0.094	   F(3,46)	  =	  2.556	  p	  =	  0.067	  
Healthy	  
Controls	  	   Number	  	   47	   22	   42	   39	   n/a	  
Age	  (mean/	  SD)	   25.51	  ±	  4.45	   23	  ±	  4.3	   24.48	  ±	  3.78	   20.1	  ±	  2.34	   F(3,146)	  =	  15.882	  p	  <	  0.01	  
Gender	  (Female/Male)	   14/33	   9/13	   14/28	   14/25	   χ23	  	  =0.911	  p	  =	  0.823	  
Ethnicity	  Caucasian	  Black	  Asian	  Mixed	  
	  28	  7	  6	  6	  
	  22	  0	  0	  0	  
	  42	  0	  0	  0	  
	  39	  0	  0	  0	  
χ29	  	  =41.591	  
p	  <	  0.01	  	  
Handedness	  Right	  Left	  Ambidextrous	  
	  45	  0	  2	  
	  16	  5	  1	  
	  35	  5	  2	  
	  36	  2	  1	  
χ26	  	  =	  12.303	  
p	  =	  0.056	  	  
GMV	  (mean,	  SD)	   0.874	  ±	  0.118	   0.902	  ±	  0.066	   0.926	  ±	  0.091	   1.009	  ±	  0.089	   F(3,146)	  =	  14.601	  p	  <	  0.01	  Abbreviations:	  UHR-­‐T,	  ultra	  high	  risk	  with	  disease	  transition;	  UHR-­‐NT,	  ultra	  high	  risk	  without	  disease	  transition.	  	  
